
<html lang="en"     class="pb-page"  data-request-id="79392d9d-65a7-48d7-9b4c-9b9c9d2453ae"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01173;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-21"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α" /></meta><meta name="dc.Creator" content="Paul  Brear" /></meta><meta name="dc.Creator" content="Darby  Ball" /></meta><meta name="dc.Creator" content="Katherine  Stott" /></meta><meta name="dc.Creator" content="Sheena  D’Arcy" /></meta><meta name="dc.Creator" content="Marko  Hyvönen" /></meta><meta name="dc.Description" content="CK2α is a ubiquitous, well-studied kinase that is a target for small-molecule inhibition, for treatment of cancers. While many different classes of adenosine 5′-triphosphate (ATP)-competitive inhib..." /></meta><meta name="Description" content="CK2α is a ubiquitous, well-studied kinase that is a target for small-molecule inhibition, for treatment of cancers. While many different classes of adenosine 5′-triphosphate (ATP)-competitive inhib..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 29, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01173" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01173" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01173" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01173" /></link>
        
    
    

<title>Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01173" /></meta><meta property="og:title" content="Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0008.jpeg" /></meta><meta property="og:description" content="CK2α is a ubiquitous, well-studied kinase that is a target for small-molecule inhibition, for treatment of cancers. While many different classes of adenosine 5′-triphosphate (ATP)-competitive inhibitors have been described for CK2α, they tend to suffer from significant off-target activity and new approaches are needed. A series of inhibitors of CK2α has recently been described as allosteric, acting at a previously unidentified binding site. Given the similarity of these inhibitors to known ATP-competitive inhibitors, we have investigated them further. In our thorough structural and biophysical analyses, we have found no evidence that these inhibitors bind to the proposed allosteric site. Rather, we report crystal structures, competitive isothermal titration calorimetry (ITC) and NMR, hydrogen–deuterium exchange (HDX) mass spectrometry, and chemoinformatic analyses that all point to these compounds binding in the ATP pocket. Comparisons of our results and experimental approach with the data presented in the original report suggest that the primary reason for the disparity is nonspecific inhibition by aggregation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01173"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01173">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01173&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01173&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01173&amp;href=/doi/10.1021/acs.jmedchem.0c01173" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 12786-12798</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01107" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01178" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Paul Brear</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Brear</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#18687c7a2c2f587b797536797b366d73"><span class="__cf_email__" data-cfemail="4333272177740320222e6d22206d3628">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Brear">Paul Brear</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Darby Ball</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darby Ball</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, Texas 75080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darby++Ball">Darby Ball</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katherine Stott</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katherine Stott</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katherine++Stott">Katherine Stott</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sheena D’Arcy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sheena D’Arcy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, Texas 75080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sheena++D%E2%80%99Arcy">Sheena D’Arcy</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5055-988X" title="Orcid link">http://orcid.org/0000-0001-5055-988X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Marko Hyvönen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marko Hyvönen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#74191c464142341715195a15175a011f"><span class="__cf_email__" data-cfemail="600d085255562003010d4e01034e150b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marko++Hyv%C3%B6nen">Marko Hyvönen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8683-4070" title="Orcid link">http://orcid.org/0000-0001-8683-4070</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01173&amp;href=/doi/10.1021%2Facs.jmedchem.0c01173" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 12786–12798</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 29, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 July 2020</li><li><span class="item_label"><b>Published</b> online</span>29 October 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01173</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D12786%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BBrear%252C%2BDarby%2BBall%252C%2BKatherine%2BStott%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D21%26contentID%3Dacs.jmedchem.0c01173%26title%3DProposed%2BAllosteric%2BInhibitors%2BBind%2Bto%2Bthe%2BATP%2BSite%2Bof%2BCK2%25CE%25B1%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D12798%26publicationDate%3DNovember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01173"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">764</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01173" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Brear&quot;},{&quot;first_name&quot;:&quot;Darby&quot;,&quot;last_name&quot;:&quot;Ball&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;Stott&quot;},{&quot;first_name&quot;:&quot;Sheena&quot;,&quot;last_name&quot;:&quot;D’Arcy&quot;},{&quot;first_name&quot;:&quot;Marko&quot;,&quot;last_name&quot;:&quot;Hyvönen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;12786-12798&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01173&quot;},&quot;abstract&quot;:&quot;CK2α is a ubiquitous, well-studied kinase that is a target for small-molecule inhibition, for treatment of cancers. While many different classes of adenosine 5′-triphosphate (ATP)-competitive inhibitors have been described for CK2α, they tend to suffer from significant off-target activity and new approaches are needed. A series of inhibitors of CK2α has recently been described as allosteric, acting at a previously unidentified binding site. Given the similarity of these inhibitors to known ATP-competitive inhibitors, we have investigated them further. In our thorough structural and biophysical analyses, we have found no evidence that these inhibitors bind to the proposed allosteric site. Rather, we report crystal structures, competitive isothermal titration calorimetry (ITC) and NMR, hydrogen–deuterium exchange (HDX) mass spectrometry, and chemoinformatic analyses that all point to these compounds binding in the ATP pocket. Comparisons of our results and experimental approach with the data presented in the or&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01173&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01173" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01173&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01173" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01173&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01173" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01173&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01173&amp;href=/doi/10.1021/acs.jmedchem.0c01173" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01173" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01173" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01173%26sid%3Dliteratum%253Aachs%26pmid%3D33119282%26genre%3Darticle%26aulast%3DBrear%26date%3D2020%26atitle%3DProposed%2BAllosteric%2BInhibitors%2BBind%2Bto%2Bthe%2BATP%2BSite%2Bof%2BCK2%25CE%25B1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D21%26spage%3D12786%26epage%3D12798%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292580" title="Binding modes">Binding modes</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/jmcmar.2020.63.issue-21/20201112/jmcmar.2020.63.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">CK2α is a ubiquitous, well-studied kinase that is a target for small-molecule inhibition, for treatment of cancers. While many different classes of adenosine 5′-triphosphate (ATP)-competitive inhibitors have been described for CK2α, they tend to suffer from significant off-target activity and new approaches are needed. A series of inhibitors of CK2α has recently been described as allosteric, acting at a previously unidentified binding site. Given the similarity of these inhibitors to known ATP-competitive inhibitors, we have investigated them further. In our thorough structural and biophysical analyses, we have found no evidence that these inhibitors bind to the proposed allosteric site. Rather, we report crystal structures, competitive isothermal titration calorimetry (ITC) and NMR, hydrogen–deuterium exchange (HDX) mass spectrometry, and chemoinformatic analyses that all point to these compounds binding in the ATP pocket. Comparisons of our results and experimental approach with the data presented in the original report suggest that the primary reason for the disparity is nonspecific inhibition by aggregation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Potent inhibitors of kinases have existed for some time and the majority of these bind in the active site of the kinase, competing with the co-factor adenosine 5′-triphosphate (ATP).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Because of the significant conservation of the ATP-binding site, kinase inhibitors often suffer from poor selectivity.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3−7)</a> This poor selectivity is a disadvantage for several reasons. First, promiscuous inhibitors tend to manifest off-target toxicity if used therapeutically and, to combat this, end up being used at suboptimal concentrations.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Second, they are poor chemical tools as they cannot provide unambiguous answers to target validation questions. To develop more selective inhibitors of kinases, a promising strategy is to target sites outside the highly conserved ATP pockets. This leads to increased selectivity as these sites are structurally not constrained by the shared property of binding to ATP and therefore tend to be less conserved among different kinases.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> When developing inhibitors that bind outside the primary ATP site, it is vital that the new sites are thoroughly validated biochemically, biophysically, and structurally to confirm the inhibitor binding mode unambiguously. Often inhibitors are identified as being allosteric if they are shown to be noncompetitive in biochemical assays. However, these data can be misinterpreted, as nonspecific inhibitors also often show similar noncompetitive behavior.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This problem can be further compounded by the moderate/weak affinity of the hits being investigated, as they must be used at higher concentrations, which makes secondary binding more likely. Therefore, apparent allosteric behavior must be very carefully validated to ensure that vital time and resources are not wasted on optimizing these inhibitors further.</div><div class="NLM_p">CK2α has a long history as a target for drug discovery, due to its ubiquitous role in multiple diseases such as cancer and fibrosis.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> CK2α is an unusual kinase in that it is constitutively active and does not require phosphorylation for activation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It is also a highly promiscuous kinase with hundreds of recorded cellular substrates.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Inhibition of CK2α has been achieved mostly through an ATP-competitive mechanism and a number of high-affinity inhibitors of distinctly different chemotypes are known and characterized structurally.<a onclick="showRef(event, 'ref17 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref17 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27">(17,20−27)</a> Despite significant effort, most inhibitors have poor selectivity, although claims are often made to the contrary.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32">(28−32)</a> For example, the clinical trial candidate <b>CX4945</b> inhibits at least ten other kinases with nanomolar affinity (see Table S1 in Brear et al.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>).</div><div class="NLM_p">We have recently demonstrated a new approach to CK2α inhibition. Using a cryptic so-called αD pocket just below the active site as an anchoring point, we have been able to develop highly selective inhibitors of CK2α.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The most potent of these is the most specific CK2α inhibitor reported to date, <b>CAM4066</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The fragment-based development of these inhibitors was supported by a significant amount of structural data to identify the optimal αD site anchor moiety and subsequent growth of the fragment to the ATP site.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition to active site targeting, another approach is the inhibition of CK2α binding to its scaffolding partner CK2β. This method has the potential to generate specific inhibitors that affect only a subset of CK2 substrates<a onclick="showRef(event, 'ref24 ref33'); return false;" href="javascript:void(0);" class="ref ref24 ref33">(24,33)</a> and has led to some initial encouraging success that requires further development.<a onclick="showRef(event, 'ref24 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref24 ref33 ref34">(24,33,34)</a></div><div class="NLM_p">Recently, a series of CK2α inhibitors (series A, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S1</a>), proposed to bind in a novel site (site A, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S2</a>) just outside the highly conserved ATP site, has been published.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> The authors used enzymatic assays, native mass spectrometry, and competitive ligand-based NMR studies to characterize the mode of inhibition. They interpret their data as supporting an allosteric mechanism. While their data were presented as supporting non-ATP-competitive inhibition, there were several reasons why we speculated that the mechanism of inhibition by these molecules was not necessarily allosteric. In particular, the enzyme assays showed mixed mode inhibition; ATP analogues were replaced in NMR studies; high-affinity ligands showed unexpected signal in ligand-based NMR experiments; and mutations close to the ATP site affected inhibitory potential.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Our motivation to investigate these inhibitors in more detail arose from the somewhat conflicting data presented,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> as well as the chemical properties of these new inhibitors, which are not unlike known ATP-competitive kinase inhibitors.</div><div class="NLM_p last">We have used several orthogonal biophysical and structural methods for the characterization of the binding mode of these new CK2α inhibitors and we find no evidence for interaction with the proposed allosteric site (site A). We show, using crystal structures, competitive isothermal titration calorimetry (ITC) and NMR, hydrogen–deuterium exchange (HDX) mass spectrometry, and computational analyses of the ligand structures, that these molecules are clearly binding to the ATP site of the kinase. It thus seems likely that most of the inhibitory effect, if not all, comes from traditional type I inhibition of the kinase through orthosteric competition with ATP.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemoinformatic Analysis</h3><div class="NLM_p">The structures of the compounds presented in the original papers and their comparison to other validated kinase and CK2α inhibitors raised concerns over the claim that these compounds had a novel binding mode. The conserved scaffold of the compounds shares significant similarity to many established and well-validated kinase inhibitors that bind in the ATP site (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref28 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref28 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59">(28,37−59)</a> This scaffold consists of a central thiazole ring that is connected directly to a phenyl group on one side and to a benzoic acid moiety through an amine on the other side (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). We have used two representative compounds from series A for further investigation, which we denote <b>1</b> and <b>2</b> (these were referred to as <b>6</b> and <b>27</b>, respectively, in the original papers<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a>). Compound <b>1</b> was chosen as much of the validation of series A and site A relied upon this compound.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>2</b> was chosen as it was the highest-affinity inhibitor reported in series A.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A search of the Protein Data Bank (PDB, <a href="http://www.pdb.org" class="extLink">http://www.pdb.org</a>) for ligands that bind to serine/threonine kinases (EC = 2.7.11.1) and contain a benzoic acid group, which is a critical part of the inhibitors in question (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), identified 49 molecules. Of these, 46 bind in the ATP site and the remaining three bind in interface sites that do not exist in CK2α (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S1</a>). Narrowing the search by inclusion of the amine that links the benzoic acid to the thiazole ring identified 15 ligands (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S2</a>). Of these ligands, all 15 bind in the ATP site. When a similar search was performed on CK2α, 14 ligands were identified, all of which bound in the ATP site (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S3</a>). Four representative structures of these compounds are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C. All of these inhibitors display the same binding mode where the binding to CK2α is dominated by the interaction between the carboxylic acid and the ζ-amino group of Lys68 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Further refining the search to include only compounds that also bind in the hinge region, similar in structure to the thiazole-amine group of <b>1</b>, identified eight inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S4</a>). These compounds, including <b>CX4945</b>, an extensively validated ATP-competitive CK2α inhibitor currently in clinical trials, interact with the hinge and Lys68.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Overlaying the two-dimensional (2D) structure of <b>1</b> with <b>CX4945</b> shows that <b>1</b> could replicate the binding mode of <b>CX4945</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S3</a>) and bind in the ATP site with its carboxylic acid interacting with Lys68 and amine hydrogen bonding with the hinge (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Indeed, modeling of <b>1</b> into the ATP site of CK2α replicates the crystallographic binding mode of <b>CX4945</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S3</a>). The carboxylic acid is interacting with Lys68 and an ATP site water as predicted and the hydrophobic core of the molecule is sandwiched between Met163 and Val66. The amine is not predicted to interact with the hinge. However, the phenyl group is predicted to bind in a similar position to the phenyl chloride of <b>CX4945</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conserved pharmacophore binding in the ATP site of protein kinases. (A) Structures of <b>1</b> and <b>2</b>, denoted <b>6</b> and <b>27</b>, respectively, in the original studies. (B) Summary of the analysis of the established ligands that bind to Ser/Thr protein kinases (EC number 2.7.11.1) or CK2α in the ATP site. (C) Structures of the four CK2α inhibitors and their protein-bound crystal structures, which contain a benzoic acid group that binds in the ATP site.<a onclick="showRef(event, 'ref46 ref48 ref56 ref59'); return false;" href="javascript:void(0);" class="ref ref46 ref48 ref56 ref59">(46,48,56,59)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Further evidence in support of our hypothesis that <b>1</b> and <b>2</b> may bind in the ATP site comes from the analysis of a fragment-based X-ray crystallographic screen against CK2α<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> previously performed at our lab. One purpose of fragment-based X-ray crystallographic screening is to use the fragments to probe the target protein and identify binding hotspots.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> From the screen of 354 fragments, 21 were identified as binding to CK2α. All 21 bound in the ATP site and interacted with Lys68.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A total of 19 of the CK2α-binding fragments were structurally related to <b>1</b> and contained a carboxylic acid moiety that mediated this interaction (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S4</a>). The preference of CK2α for binding ligands with a carboxylic acid in this position is further supported by the serendipitous binding of acetate. Acetate ions can be utilized as a very low-molecular-weight probe to identify binding sites for carboxylic acids.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In CK2α structures deposited to the PDB, at least nine binding sites for acetate can be identified (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S5</a>). Among these sites are the Lys68 hotspot in the ATP site, the CK2β interface, and the substrate-binding pocket. Notably, none of the nine sites overlaps with site A, the proposed binding site of <b>1</b> and <b>2</b>. When such a conserved binding mode is observed for an ATP site-binding pharmacophore, it seems unlikely that inhibitors with significant structural similarity would not also bind to the ATP site. These observations led us to initiate additional studies to investigate the binding mode of these inhibitors using two compounds (<b>1</b> and <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) from the original publications.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> X-ray Crystallographic Analysis</h3><div class="NLM_p">The original publication contained no structural data on the inhibitor binding mode. In fact, the authors state that “cocrystallization attempts aimed at elucidating the non-ATP-competitive binding mode of 2-aminothiazole derivatives with CK2α were not successful”.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> We sought to rectify this and have determined structures of both <b>1</b> and <b>2</b> in complex with CK2α (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S5</a>). These structures were obtained by soaking the compounds into CK2α crystals at 10 mM for 16 h. The crystals diffracted at less than 2 Å resolution and unambiguous positive difference electron density corresponding to both <b>1</b> and <b>2</b> can be clearly seen in the ATP site before the ligands were included (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">S6</a>). As we predicted, the carboxylic acid groups of both compounds interact directly with Lys68 like the carboxylic acid of <b>CX4945</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). The remainder of the molecules, however, each has its own binding nuances. The amine of <b>1</b> interacts very weakly with the hinge region backbone nitrogen of Val116 via a bridging water molecule, whereas the OH group of <b>2</b> interacts with His160, via a bridging water, which pulls the amine of <b>2</b> further away from the hinge region and prevents interactions with the hinge (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). The five-membered rings from <b>1</b> and <b>2</b> stack on top of Met163, which leads to the phenyl and naphthyl ring of <b>1</b> and <b>2</b> stacking on top of His160 at the entrance to the ATP site. The observed binding mode agrees well with the binding mode of established ATP site inhibitors of CK2α, such as <b>CX4945</b>. No density corresponding to either <b>1</b> or <b>2</b> was observed in the proposed allosteric binding site (site A, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S6</a>), despite the high concentration of the ligand (>1000-fold excess over <i>K</i><sub>D</sub>) used for soaking. The binding mode of <b>1</b> in the ATP site of CK2α observed in the crystal structure agrees well with that predicted by the modeling study (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S3</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of compounds <b>1</b> and <b>2</b> bound to CK2α. (A) <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> map (green, displayed at 3σ) in the ATP site and site A before the ligand has been placed. Refined structure of <b>2</b> (green) has been superimposed on the ATP site (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>) and the predicted binding mode of <b>2</b> (transparent purple) is shown on site A. (B) The <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> map (green, contoured at 3σ) for the ATP site and site A before the ligand has been placed. Refined structure of <b>1</b> (blue) has been superimposed on the ATP site (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG">6YPG</a>) and the predicted binding mode of <b>2</b> (transparent purple, from the Supporting Information of ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>) is shown on site A. (C) <b>2</b> (green) bound to CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>), with the key interacting residues and H-bonding highlighted. (D) <b>1</b> bound to CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG">6YPG</a>), with the key interacting residues and H-bonding highlighted. The structure of <b>CX4945</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PE1">3PE1</a>, yellow) has been superimposed on the structure of <b>2</b> and <b>1</b> in panels (C) and (D). Electron densities of the final, refined structures are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S7</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To reduce the impact that different crystal forms and packing may have on the accessibility of the binding sites and bias in the resulting complex structure, we have soaked the inhibitors into two different crystal forms of CK2α. One is obtained using an engineered form of CK2α (referred to as CK2α KKK/AAA) in which lysines 74–76 are mutated to alanines to facilitate crystallization. These lysines are in the vicinity of site A and could affect binding of ligands to this site. However, these lysines do not affect the ATP site and we show later that both <b>1</b> and <b>2</b> bind to CK2α KKK/AAA and to wild-type CK2α with the same affinity (see ITC measurements). The second crystal form (CK2α SF) has no mutations in the lysine-rich loop but has a substrate peptide fused to the N-terminus of the protein, aimed at facilitating crystallization. In both crystal forms, we observe electron density for <b>1</b> and <b>2</b> only in the ATP site and not in the proposed allosteric site (site A, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S6</a>).</div><div class="NLM_p">The two crystal forms of CK2α have been extensively used for the determination of CK2α:ligand complexes (66 structures currently in the PDB). More than eight different ligand binding sites can be accessed by soaking into these crystal forms (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S8</a>), including the proposed allosteric site for <b>1</b> and <b>2</b>, site A. We have observed both adenosine 5′-diphosphate (ADP) and guanosine 5′-diphosphate (GDP) bound to site A in crystal structures of wild-type CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN">6YPN</a>) and in the KKK/AAA mutant (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The adenosine and guanosine rings sit in the hydrophobic pocket identified in the previous modeling work<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the diphosphate interacts with Arg80 that has been identified as an acetate-binding hotspot (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S5</a>). This confirms that site A is accessible to ligands in these crystal forms and soaking with <b>1</b> or <b>2</b> would be expected to result in clear electron density in the site, should they bind there. Indeed, ADP can be seen simultaneously in both the ATP site and in site A (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN">6YPN</a>). The binding conformation of ADP in site A is very different to the conformation in the ATP site (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S9</a>). These observations demonstrate that binding in site A does not in itself prevent binding in the ATP site and that if <b>1</b> or <b>2</b> did bind in both sites, we would expect to see density corresponding to it. Furthermore, <b>1</b> and <b>2</b> would be expected to bind predominantly in the highest-affinity site and this site would dominate the inhibition. These crystal structures prompted us to perform further experiments to unambiguously establish the binding site in solution and verify the likely mode of inhibition for these compounds.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of ADP and GDP binding to CK2α site A. (A) GDP binding in site A. The <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> map (contoured at 3σ) centered on the proposed allosteric site. No density was observed in the ATP site for GDP, therefore the density in the ATP site was not shown for clarity. The CK2α KKK/AAA construct was used for this structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a>). (B) Structure of GDP bound to CK2α, with the extensive H-bonding network shown by the dotted lines (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a>). (C) Proposed binding mode of <b>1</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>) superimposed on the structure of GDP bound to CK2α (6PYK). (D) Structure of ADP bound simultaneously in the ATP site and in site A of WT CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN">6YPN</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Hydrogen–Deuterium Exchange Mass Spectrometry</h3><div class="NLM_p">Hydrogen–deuterium exchange (HDX) allows the localization of interaction sites and conformational changes in proteins. We have analyzed the binding of four different classes of ligands to CK2α (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figures S10 and S11</a>) using HDX. These ligands were ADP with Mg<sup>2+</sup> and adenosine 5′-(β,γ-imido)triphosphate (AMPPNP) with Mg<sup>2+</sup>, both of which bind across the entire ATP site, interacting with the hinge region and Lys68 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10C,D</a>);<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a><b>3</b>, which is a fragment that binds only on the right-hand side of the ATP site, interacting with Lys68<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10E</a>); <b>4</b> is an αD site binder (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10G</a>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and <b>6</b> links the αD site and the ATP site (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10F</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We recovered 192 shared peptides from each of these HDX experiments that redundantly span almost the entire sequence of CK2α (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S12</a>). This allows for unbiased detection of ligand interaction fingerprints across the whole of the protein. Binding can be identified by observing changes in deuterium uptake between CK2α alone and a concurrently run ligand-bound sample (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S6</a>). We show all changes greater than ±0.25 Da that have a <i>p</i>-value less than 0.01 in Welch’s <i>t</i>-test (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">S13</a>). Extended data for all peptides and timepoints are shown in the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S13</a> and a separate spreadsheet). For all of the ligands, a decrease in deuterium uptake is observed at late timepoints, particularly for peptides containing residues 54–111 (sample peptides shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S13</a>). Since this change occurs with all of the ligands, it appears to result from general stabilization of the region termed the “N-lobe,” on ligand binding, rather than an effect attributable to a specific site.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. HDX analysis of ligand binding to CK2α. The heatmaps show the change in deuterium uptake upon binding of different ligands to apo CK2α. Each panel, with the ligand listed on the top, shows the heatmaps for 10 and 100 s timepoints for peptides corresponding to the P-loop and αD-loop, in comparison to unliganded CK2α. All depicted changes are greater than ±0.25 Da and have a <i>p</i>-value less than 0.01 in Welch’s <i>t</i>-test. The exact start and end residues for each peptide are shown on the left of the panels. Next to each heatmap are two graphs showing deuterium uptake for one peptide from each P-loop (top) and αD-loop (bottom) for apo CK2α (black) and CK2α with the ligand (gray). The <i>Y</i>-axis range is 80% of max D-uptake, assuming that the N-terminal residue undergoes 100% back-exchange. Data have not been corrected for back-exchange. The error bars are ±2σ derived from three technical replicates. A structural diagram in between the uptake plots has the P-loop and αD-loop colored purple and green, respectively, and the bound ligand in the surface rendering in yellow. Full HDX data are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S13</a> and available in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_001.xlsx" class="ext-link">Supporting Spreadsheet</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Addition of ADP and AMPPNP–Mg<sup>2+</sup> causes clear changes in deuterium uptake in the ATP site (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The largest change is a decrease in deuterium uptake for peptides covering residues 39–55 and 121–131. Residues 39–55 correspond to the P-loop that interacts directly with the phosphates of ADP, while residues 121–131 are the αD-loop that does not interact directly with ADP or AMPPNP–Mg<sup>2+</sup>. Protection occurs in the latter due to the interaction of the adenosine ring with the hinge region that directly links to and stabilizes the αD-loop. These observations are similar to those previously observed when binding of ATP analogues to other kinases has been studied.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> The observed decreases in uptake are larger for AMPPNP–Mg<sup>2+</sup> than ADP–Mg<sup>2+</sup> because AMPPNP binds with a higher affinity than ADP. To further probe interactions in a more localized area of the ATP site, we used <b>3</b> that binds only at the right-hand side of the ATP site (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10E</a>), coordinated to catalytic Lys68 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CSP">5CSP</a>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). With <b>3</b>, we see a decrease in deuterium uptake in the P-loop and no change in the αD-loop. The pattern of protection within the P-loop is also distinct, indicative of different binding contacts being used by <b>3</b> compared to the ATP analogues. We can thus distinguish binding in the entire ATP site, including interaction with the hinge, from binding on just one side where Lys68 is located.</div><div class="NLM_p">To ensure we could detect different binding sites with our HDX experiments, we used another well-characterized ligand (<b>4</b>) that binds to the αD pocket only (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10G</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This compound shows a markedly different HDX fingerprint compared to the ATP analogues and <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The largest differences are seen in the αD-loop, with the binding of <b>4</b> resulting in increased uptake compared to unbound CK2α. Increased uptake in the αD-loop is opposite to the decrease seen upon ADP and AMPPNP–Mg<sup>2+</sup> binding. This indicates that the binding of <b>4</b> in the αD pocket puts the loop in a more flexible or open conformation amenable to exchange, as is seen in the crystal structure of CK2α in complex with <b>4</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ORJ">5ORJ</a>). Finally, we characterized the HDX fingerprint for <b>6</b> that occupies both the αD pocket and the ATP site. We observed a similar increase in uptake in the αD-loop as with <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compounds <b>4</b> and <b>6</b> also cause decreased uptake in the P-loop, with <b>6</b> showing more protection than <b>4</b>, similar to the protection we observed with <b>3</b>.</div><div class="NLM_p last">All of these fingerprints are consistent with the known binding modalities of these ligands to CK2α and can be used to identify the binding modes of new compounds. We performed the same experiments to characterize the binding of compound <b>1</b> to CK2α (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Addition of <b>1</b> to CK2α causes decreased uptake in the P-loop with a pattern and magnitude of change similar to the addition of AMPPNP–Mg<sup>2+</sup>. However, no changes are observed in the αD pocket, as was observed with the addition of <b>3</b>. These results are consistent with the binding mode seen in the crystal structures where <b>1</b> makes significant hydrogen bonding just to Lys68 with only weak water-mediated interaction to the hinge region. These data do not allow us to unequivocally eliminate binding at the proposed allosteric site. However, if the allosteric binding mode were correct, two clear differences would be expected. First, a change in the uptake by residues 67–88, part of site A, would be expected due to the main interaction being with the acidic group of <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S10</a>). We do not observe changes in uptake in this region despite it being redundantly covered by eight peptides (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S13</a>). Second, no change in the uptake by the P-loop would be expected since the modeling does not predict significant interactions with that part of the protein. Interactions with the P-loop, such as that seen for <b>1</b>, are one of the major features of ATP site binders, consistent with our structural characterization of <b>1</b> and <b>CAM4066</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Ligand-Observed NMR Analyses</h3><div class="NLM_p">To further explore the binding of the new compounds to CK2α, we have used various ligand-based NMR methods, similar to the experiments in the original characterization of these molecules. We were particularly concerned about the evidence for the simultaneous binding of <b>CX4945</b> and <b>1</b> due to the presence of strong signals for <b>CX4945</b> in the saturation transfer difference (STD) NMR spectra. To observe a signal in an STD spectrum, the saturation of protein resonances has to be transferred to the bound ligand, which then dissociates to join the pool of the bulk ligand in solution before it can be detected. This means that the size of the signal for a given ligand is proportional to the amount of the ligand that binds to and is released by the protein during the saturation step of the STD experiment. Therefore, ligands with relatively fast association (<i>k</i><sub>on</sub>) and dissociation (<i>k</i><sub>off</sub>) rates give the largest signal.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a></div><div class="NLM_p">We have determined the off-rate of <b>CX4945</b>, which binds to CK2α with low nanomolar to picomolar affinity,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> from CK2α to be 0.0039 s<sup>–1</sup> by SPR (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S14</a>). When ligands have <i>k</i><sub>off</sub> rates <0.1 s<sup>–1</sup>, the saturation cannot be transferred effectively to the bulk ligand in solution resulting in no observable STD effect.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The experimentally determined off-rate for <b>CX4945</b> means that less than 1% of <b>CX4945</b> would have dissociated after the 2 s saturation time used in the NMR pulse sequence. This would mean that the concentration of the saturated ligand in solution would be less than 0.1 μM. This difference would not be observable by NMR.</div><div class="NLM_p">To resolve these issues, we have repeated the STD NMR studies reported in the original publication<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and used two additional ligand-based NMR experiments, Carr–Purcell–Meiboom–Gill (CPMG) and water-ligand observed via gradient spectroscopy (Water-LOGSY),<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> for further validation. Our STD experiment shows that <b>1</b> binds to CK2α, as revealed by detectable transferred <sup>1</sup>H intensities (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A(i)). However, when the same experiment is run in the presence of <b>CX4945</b>, a significant reduction of the STD signals from <b>1</b> is observed, indicating direct competition between the two ligands (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A(ii)). In the original paper, strong <b>CX4945</b>-derived signals are also clearly visible. The signals—which are comparable in magnitude to the much weaker-binding ligand <b>1</b>—could instead arise from nonspecific binding of <b>CX4945</b> to lower-affinity sites on CK2α (as was shown by native mass spectrometry<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>), precipitation of <b>CX4945</b> leading to false positive signals in the experiment or binding of <b>CX4945</b> to soluble aggregates of <b>1</b>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ligand-based NMR experiments to detect binding of <b>1</b> to CK2α and competition by CX4945. All panels are overlays of the spectra recorded in the presence (black) and absence (green) of CK2α. (A) Saturation transfer difference (STD) <sup>1</sup>H spectra of <b>1</b> (i) in the absence of <b>CX4945</b> and (ii) in the presence of 50 μM <b>CX4945</b>. (B) Water-LOGSY spectra of <b>1</b> (i) in the absence of <b>CX4945</b> and (ii) in the presence of 50 μM <b>CX4945</b> (ii). (C) Relaxation-edited (CPMG) <sup>1</sup>H spectra of <b>1</b> (i) in the absence of <b>CX4945</b> and (ii) in the presence of 50 μM <b>CX4945</b> (ii). (NB: the signals at ca. 7.7 ppm are in fact two overlapping doublets and therefore small changes to either chemical shift result in an apparent change to the multiplet structure.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the disparity in the STD NMR experiments between our results and those in the original report, we have also used CPMG and Water-LOGSY experiments. These exploit different NMR phenomena (relaxation rates, transfer of saturation) to observe the binding of the ligand to the protein.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Using three different methods to observe the binding of the ligand reduces the chance of experimental anomalies interfering with the outcome of the experiment. The Water-LOGSY experiment shows a clear binding of <b>1</b> to CK2α and complete inhibition of binding in the presence of <b>CX4945</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Similarly, in the CPMG experiment, an increase in the signal from the aromatic protons of <b>1</b> was observed in the presence of <b>CX4945</b>, indicating a reduction in the binding of <b>1</b> to CK2α (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). In conclusion, all three ligand-observe NMR experiments show binding of <b>1</b> to CK2α and in all three experiments binding is abolished by <b>CX4945</b>, suggesting a direct competition between these two ligands as they bind to the same site.</div><div class="NLM_p last">To further confirm the validity of our results, we repeated the CPMG NMR study using the lower-affinity ligands <b>3</b>, <b>5</b>, and <b>CAM4066</b> as competitors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S15</a>). <b>3</b> is a small, low-affinity ligand in the ATP site and as such it is less likely to have an allosteric effect that might prevent binding at the adjacent site A—an argument that could explain inhibition of the binding to <b>1</b> in the presence of <b>CX4945</b>. Therefore, the reduction in the binding of <b>1</b> in the presence of <b>3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S14B</a>) is a more convincing proof that <b>1</b> is binding in the ATP site. <b>CAM4066</b> links the ATP site and the αD site and, as predicted, reduces the binding of <b>1</b> to CK2α (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S15C</a>). To rule out binding of <b>1</b> to the αD site, we have also used <b>5</b>, an optimized fragment with high affinity for the αD site. This should not prevent binding in the ATP site. Indeed, ligands similar to <b>5</b> have been shown to bind simultaneously with the ATP site fragments by X-ray crystallography (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EHK">6EHK</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> As predicted, and unlike with <b>CX4945</b>, <b>3</b>, and <b>CAM4066</b>, the αD site ligand <b>5</b> has no effect on the binding of <b>1</b> to CK2α (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S15D</a>). Similar CPMG and STD NMR experiments were performed with the CK2α KKK/AAA mutant with the same outcomes (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figures S16 and S17</a>). These results further demonstrate that <b>1</b> binds in the ATP site.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Isothermal Titration Calorimetry</h3><div class="NLM_p">As a final confirmation, we have used isothermal titration calorimetry to determine affinities of <b>1</b> and <b>2</b> to CK2α and to evaluate the effect of competing ligands and CK2α mutations. This process has been successfully used to verify the binding site of novel CK2 inhibitors that bind in the αD site.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The affinities of compounds <b>1</b> and <b>2</b> for CK2α were determined to be 22 and 2.2 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,C). When the same experiments were performed in the presence of saturating concentrations of <b>CX4945</b>, no binding of either compound to CK2α was observed (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,D). This observation is in line with all our previous data and suggests that compounds <b>1</b> and <b>2</b> bind in the same site as <b>CX4945</b>. We also performed the experiment with <b>2</b> in the presence of <b>CAM4066</b>, which competes with ATP, but uses only a small benzoic acid moiety to interact with the ATP site, deriving most of its binding energy from the αD pocket. <b>CAM4066</b> abolished the binding of <b>2</b> to CK2α (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S18</a>). In the modeling of the binding of <b>1</b> and <b>2</b> reported previously,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Lys74 was proposed to form a vital part of the binding site and to interact with the carboxylic acid of <b>1</b> and <b>2</b>. Therefore, mutations to this residue should reduce the affinity of <b>1</b> and <b>2</b> for CK2α. To test this, we repeated the ITC experiments using the construct CK2α KKK/AAA, in which three adjacent lysine residues (Lys74–76) have been mutated to alanine. These mutations had a negligible effect on the affinity of <b>1</b> or <b>2</b> for CK2α as we determined near-identical affinities of 27 and 3.3 μM, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S18</a>). The binding of <b>1</b> and <b>2</b> to CK2α KKK/AAA was also fully inhibited by the presence of <b>CX4945</b> and <b>CAM4066</b>, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S18</a>). These results are further evidence that the ATP site, not the proposed allosteric site, is the primary binding site for <b>1</b> and <b>2</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. ITC measurement of binding of <b>1</b> and <b>2</b> to CK2α. (A) Titration of <b>1</b> into 10 μM CK2α. Titration of <b>2</b> into 10 μM CK2α. (B) Titration of <b>1</b> into 10 μM CK2α. Titration of <b>2</b> into 10 μM CK2α in the presence of <b>CX4945</b>. (C) Titration of <b>2</b> into 20 μM CK2α. (D) Titration of <b>2</b> into 20 μM CK2α in the presence of 100 μM <b>CX4945</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We present compelling and consistent evidence that <b>1</b> and <b>2</b> bind in the ATP site of CK2α, not in site A, as was previously proposed.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> We see no evidence for binding in site A. This is as expected, based on our analysis of the structural data of similar kinase inhibitors. In the original study of series A,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> five main pieces of evidence were used to verify a novel binding mode. This evidence included: competitive native mass spectroscopy studies, ligand-based NMR, thermal shift analysis, and biochemical assays. While we were preparing this manuscript for publication, the Niefind group published their analysis of the same series of compounds, which also showed binding to the ATP site by X-ray crystallography.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> While they have not done other biophysical analyses on the binding, they do show by the enzymatic assay that these inhibitors are ATP competitive, consistent with our data.</div><div class="NLM_p">One of the cornerstones of the theory of allosteric inhibition was the observation that <b>CX4945</b> binds CK2α simultaneously with <b>1</b>, and that <b>1</b> competes with inositol hexaphosphate (IP<sub>6</sub>, phytic acid), shown by mass spectrometry. The data presented indicate that at least three molecules of <b>1</b> bind to CK2α. In the presence of <b>CX4945</b>, this is reduced to two binding sites, but no data were presented to confirm the identity of these sites in which <b>1</b> was binding when it bound simultaneously with <b>CX4945</b> (for example, mutational studies combined with native mass spectrometry). Some of these sites are expected to be nonspecific, low-affinity sites, and the mass spectrometric data does not confirm which is the primary binding site of <b>1</b>. The first evidence presented for the location of the binding site of these compounds is the observation that in the presence of <b>1</b> the complex between IP<sub>6</sub> and CK2α is not observed in the native mass spectra. This led to the theory that <b>1</b> binds in the proposed site as a crystal structure was published by Lee et al. (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3W8L">3W8L</a>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> of IP<sub>6</sub> apparently binding to CK2α in this site. However, the binding site of IP<sub>6</sub> presented in that crystal structure is more controversial than is discussed in the publication.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In this structure, IP<sub>6</sub> is found at a crystal contact where half of the site is composed of residues from a symmetry-related CK2α molecule in the crystal lattice (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S19</a>). Therefore, IP<sub>6</sub> could in theory bind to both these sites. From this crystal structure, the binding site could be located around Lys74 or His276. However, as the site is only fully formed in a crystal lattice (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S19</a>), IP<sub>6</sub> may not in actual fact bind to CK2α at either of these sites in solution. IP<sub>6</sub> is also seen to bind weakly at a site centered on His236 in several other crystal structures (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQU">5OQU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ORJ">5ORJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MPJ">5MPJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CVH">5CVH</a>).<a onclick="showRef(event, 'ref26 ref27 ref56'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref56">(26,27,56)</a> The native mass spectrometric competition studies with <b>CX4945</b> or IP<sub>6</sub> do not therefore unambiguously confirm the binding mode of <b>1</b>.</div><div class="NLM_p">Another cornerstone of the allosteric site binding theory was the observation of simultaneous binding of <b>1</b> and <b>CX4945</b> by ligand-based NMR, interpreted as lack of competition. As discussed before, a high-affinity ligand like <b>CX4945</b>, with a slow dissociation rate, should not yield detectable signal in these experiments. The binding of <b>CX4945</b> observed in those STD experiments is however more likely to be due to an artifact in the experimental setup. This could be through a number of mechanisms including aggregation of the ligand or binding to nonspecific lower-affinity binding sites outside the ATP site.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> These lower-affinity sites would have higher on/off rates than the ATP site and therefore show a larger signal in the STD spectrum. Nonspecific and low-affinity sites can have a confusing influence on competition studies. This is a particular problem with the NMR studies as ligand-observed NMR is optimized for studying low-affinity sites and requires ligands with rapid on/off rates in order for the signal (and therefore binding) to be observed. Therefore, blocking the primary (high affinity) site may not remove the binding signal arising from other sites. The competition studies in the original papers were done at 500 μM ligand concentration, well beyond the observed affinities or <i>K</i><sub>i</sub>s of <b>1</b> and <b>2</b> and in a range where nonspecific binding would be more likely to occur.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> The binding signals observed for <b>CX4945</b> in the STD spectra cast some doubt on the conclusions drawn about the simultaneous binding of <b>1</b> and <b>CX4945</b>. This is because the signals observed for <b>CX4945</b> cannot be due to binding in the ATP site as the dissociation rate for this site is too slow. The major difference between our experimental system and the system reported in the literature is the dimethyl sulfoxide (DMSO) content. In brief, in the procedure reported here stocks of <b>1</b> and <b>2</b> were made in DMSO-<i>d</i><sub>6</sub> and diluted 20-fold in the buffer. This was done to ensure that the ligands were fully soluble in the experiment and led to a final DMSO-<i>d</i><sub>6</sub> content of 5% (which was also used to provide the field-frequency lock signal). When we first attempted to run the experiment without DMSO, we observed precipitation of the ligands. As aggregation can lead to false positives in STD experiments, it was decided to use DMSO in all of our experiments.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> However, in the original experiment D<sub>2</sub>O was used for the lock and no DMSO was used to solubilize the ligand. The difference in the solvent conditions may mean that <b>1</b> and <b>2</b> were closer to the limits of their solubility in the original experiments and thus more likely to form aggregates. Aggregates are common causes of false positives in biochemical assays and are often missed as they may not be easily visible to the naked eye. These aggregates may lead to the signals observed in the STD for <b>CX4945</b> and <b>1</b>.</div><div class="NLM_p">The biochemical assays performed previously showed that the compounds exhibited mixed mode noncompetitive behavior and led to the understandable conclusion that they do not bind in the ATP site. However, this is contradictory to the binding mode we see in the crystal structures. A proposed explanation for the noncompetitive inhibition observed in the assay comes from the thermal stability data also presented in the original paper.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The data show that the thermal stability of the proteins decreases in the presence of <b>1</b> and <b>2</b>. This thermal destabilization could be due to a number of different mechanisms caused by specific and nonspecific effects. These mechanisms include breaking up of protein complexes by specific binding to the protein; binding to the unfolded or partially unfolded protein; the formation of aggregates that bind the protein and unfold it; and specific binding that traps the protein in a less stable conformation.<a onclick="showRef(event, 'ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref69 ref70">(67−70)</a></div><div class="NLM_p">It is impossible that the first mechanism is operating in this example as CK2α is present as a monomer. The other mechanisms however may explain the conflicting results presented. All proteins exist in an equilibrium between the native and unfolded form of the protein.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> For the majority of ligands, the ligand binds to the native form of the protein, which stabilizes the folded form leading to a positive thermal shift. If the ligand binds to the unfolded or partially unfolded form of the protein and stabilizes the unfolded form, this could lead to a destabilization of the protein. This would in turn lead to a decrease in the <i>T</i><sub>m</sub>. Binding to the unfolded protein can occur by two mechanisms, the first mechanism is by the formation of colloidal aggregates of the small molecules, onto which the protein would then be sequestered.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The aggregates are hydrophobic and preferentially bind the unfolded or partially unfolded form of the protein where the hydrophobic core is exposed. Therefore, a negative shift in the <i>T</i><sub>m</sub> is observed. This is one of the most common forms of nonspecific inhibition that plague biochemical assays and would be seen in assays as noncompetitive inhibition. The second mechanism occurs when the ligand monomers bind to a partially unfolded or fully unfolded form of the protein stabilizing that form. It may be possible for the binding to the partially unfolded form to be a specific form of inhibition.</div><div class="NLM_p last">Modeling experiments proposed site A as the binding site for <b>1</b> and <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S1</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> We have accumulated extensive evidence that these compounds bind in the ATP site. However, site A as a general ligand binding site has been verified by our structures of ADP and GDP bound in this location. This suggests that site A could be utilized for the development of novel inhibitors of CK2α and it also demonstrates that this site is accessible for ligand binding in our crystal forms. If this site were to be successfully targeted by inhibitors, it would require extensive structural and biochemical validation to confirm that compounds are really binding in the new site and not in one of the several known small-molecule binding sites in CK2α.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We believe that the data we have presented here lead to the conclusion that the compounds represented by <b>1</b> and <b>2</b> bind to the ATP site and will inhibit CK2α via an orthosteric, ATP-competitive mechanism. This diverse set of data pointing to <b>1</b> and <b>2</b> binding at the ATP site includes multiple crystal structures, competitive ITC studies, competitive NMR studies, HDX mass spectrometry, and computational analyses of the ligand structures. We also believe that the evidence presented previously in support of an allosteric mode of inhibition for these compounds may have been distorted by nonspecific binding of the compounds to CK2α, which in turn affected the interpretation of competition data with <b>CX4945</b>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Modeling</h3><div class="NLM_p last">The modeling of binding of <b>1</b> and <b>2</b> to CK2α was done using the GOLD software package (CCDC) using the structure from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PE1">3PE1</a> as the target. The site of interest was defined as a 20 Å sphere around the ligand <b>CX4945</b>, which includes both the ATP site and the proposed allosteric site. Ligand files were generated with grade (Global Phasing). The conserved water interacting with Lys68 was included but no other waters. The ChemPLP scoring system (CCDC) was used to rank the results. Coordinates of the modeling results are included as the supplementary files.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Expression and Purification</h3><div class="NLM_p">Expression and purification of CK2α (wild-type, KKK/AAA and SF) was done as described before.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> For the surface plasmon resonance experiments, a new construct carrying two His-tags, one at the N-terminus and one at the C-terminus, was created. CK2α was amplified by PCR using primers “AGCTAGAATTCGGAGAAGGCGAGGGTAGTGAAGGCCCCGTGCCAAGCAGGGCCAGAGT” and “ATACTCAAGCTTAATGGTGATGGTGATGGTGGGAACCCTGGAAGTACAGGTTTTCCTTCACAACAGTGTAGAAATAGGGGTG”. The resulting fragment was digested with <i>Eco</i>RI and <i>Hin</i>dIII restriction enzymes and ligated into a pHAT4 vector digested with the same enzymes. The sequence of the protein for which the resulting construct (pHAT4_CK2-TEV-L-His) encodes is shown below with His-tags (bold) and two TEV cleavage sites (underlined).</div><div class="NLM_p">MNTI<b>HHHHHH</b>NTSGSGGGGGRLVPRGSMS<u class="uu">ENLYFQ</u>GSMDIEFGEGEGSEGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK<u class="uu">ENLYFQ</u>GSSGSGSGSS<b>HHHHHH</b>*</div><div class="NLM_p last">Expression of this protein was done as with other CK2α constructs, using the BL21(DE3) strain of <i>Escherichia coli</i>. Single colonies of the cells were grown in 6 L 2xTY with 100 μg/mL ampicillin at 37 °C until OD<sub>600</sub> of 0.6 after which 0.4 mM isopropyl β- <span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (IPTG) was used to induce expression. After 16 h of culturing at 20 °C, the cells were harvested by centrifugation at 4000<i>g</i> for 20 min. The cells were resuspended in 20 mM Tris pH 8.0, 500 mM NaCl and lysed using an Emulsiflex C5 homogenizer. DNaseI was added to aid with digestion of <i>E. coli</i> genomic DNA and protease inhibitor tablets were added to minimize proteolytic degradation. Following centrifugation for 30 min at 15 000<i>g</i>, the clarified supernatant was loaded onto 4 mL Ni<sup>2+</sup>-NTA agarose column and washed with the lysis buffer, followed by 20 mM Tris pH 8.0, 500 mM NaCl, and 20 mM imidazole and the protein eluted with 20 mM Tris pH 8.0, 500 mM NaCl, and 300 mM imidazole. Peak fractions, as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), were pooled together and dialyzed overnight against 4 L of 20 mM Tris pH 8.0, 500 mM NaCl at +4 °C. The dialyzed sample was diluted to ∼65 mM salt concentration in two batches and immediately loaded onto a HiTrapQ HP column to minimize aggregation in low ionic strength. CK2α was eluted using a linear salt gradient. Peak fractions of each of the two chromatographic steps were pooled, concentrated to ca. 5 mL in volume, and purified with size-exclusion chromatography on a Superdex 75 16/60 HiLoad column using 20 mM Tris pH 8.0, 500 mM NaCl buffer. The peak fractions were pooled, concentrated to ca. 10 mg/mL using Vivaspin 20 5000 molecular weight cut-off (MWCO) centrifugal concentrators, and flash-frozen in small aliquots.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Source of Compounds</h3><div class="NLM_p last">The synthesis of compound <b>1</b> and compound <b>2</b> was described previously by Bestgen et al.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Purity was determined as >95% by liquid chromatography (LC)–UV. Compound <b>1</b> was also purchased from enamine (ID: Z2239047232, no longer available). Purity was determined as >95% by liquid chromatography/mass spectrometry (LC/MS). <b>CX4945</b> was purchased from Cambridge bioscience (HY-50855B-5mg). The purity was determined as >99% by high-performance liquid chromatography (HPLC). ATP was purchased from Sigma-Aldrich (Cat: A7699). The purity was determined as >99% by HPLC. GDP was purchased from Sigma-Aldrich (G7127). The purity was determined as >96% by HPLC.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> X-ray Crystallography</h3><div class="NLM_p last">Crystallization, soaking of ligands, and structure determination were done as described before.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> X-ray diffraction data were collected at the Diamond Light Source and data from automated data processing with autoProc were used for the structure determination. <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> electron density maps for all of the ligands, calculated prior to ligand placement in the model, are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S5,</a> and the final densities, as calculated by PDB AutoDep software, are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S6</a>. All coordinates have been deposited to the Protein Data Bank under accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG">6YPG</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPH">6YPH</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN">6YPN</a>. We will release the atomic coordinates and experimental data upon article publication. Data collection and refinement statistics are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S5</a>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Hydrogen–Deuterium Exchange Mass Spectrometry</h3><div class="NLM_p last">The stocks of 25 μM CK2α with and without the ligand were prepared in 20 mM Tris–HCl, 500 mM NaCl, pH 8.0 at 25 °C. In some experiments, a small percentage of organic solvent was added to increase solubility. Variations and ligand concentrations are noted in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S6</a>. The stocks were equilibrated at 4 °C for 10 min and then diluted 1:24 with the same buffer containing H<sub>2</sub>O for controls (pH<sub>read</sub> = 8.0 at 25 °C) or D<sub>2</sub>O (final D<sub>2</sub>O of 96% (v/v) with pH<sub>read</sub> = 7.6 at 25 °C). After 10, 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup>, and 10<sup>5</sup> s, the samples were mixed 1:1 with 0.8% formic acid, 1.6 M guanidinium chloride, pH 2.3 to give a final pH of 2.6 at 0 °C and flash-frozen in liquid nitrogen for storage at −80 °C. The samples were thawed and LC–MS was performed using a Waters HDX manager and SYNAPT G2-Si Q-Tof. Three technical replicates of each sample were analyzed in a random order. The samples were digested online by <i>Sus scrofa</i> Pepsin A (Waters Enzymate BEH) at 15 °C and the peptides were trapped on a C18 pre-column (ACQUITY UPLC peptide BEH C18 VanGuard pre-column) for 3 min at 100 μL/min and 1 °C. The LC buffer was 0.1% formic acid. The peptides were separated over a C<sub>18</sub> column (Waters ACQUITY UPLC BEH) and eluted with a linear 3–40% (v/v) acetonitrile gradient for 7 min at 40 μL/min and 1 °C. Raw data of the control samples were processed by PLGS (Waters Protein Lynx Global Server 3.0.2) using a database containing <i>Sus scrofa</i> Pepsin A and<i>Homo sapiens</i> CK2α. In PLGS, the minimum fragment ion matches per peptide was 3, and methionine oxidation was allowed. The low- and elevated-energy thresholds were 250 and 50 counts, respectively, and the overall intensity threshold was 750 counts. The labeled data were analyzed in DynamX 3.0 with peptide filters of 0.3 products per amino acid and one consecutive product. All mass spectrometry data were acquired using positive ion mode in either HDMS or HDMSE modes. HDMSE mode was used to collect both low- (6 V) and high- (ramping 22–44 V) energy data-independent peptide fragmentation data for peptide identification. HDMS mode was used to collect low-energy ion data for all deuterated samples. All samples were acquired in resolution mode. The capillary voltage was set to 2.8 kV for the sample sprayer. Desolvation gas was set to 650 L/h at 175 °C. The source temperature was set to 80 °C. Cone and nebulizer gas was flowed at 90 L/h and 6.5 bar, respectively. The sampling cone and source offset were both set to 30 V. Data were acquired at a scan time of 0.4 s with a range of 100–2000 <i>m</i>/<i>z</i>. The mass correction was done using [Glu1]-fibrinopeptide B as a reference mass. To allow access to the HDX data of this study, the HDX data summary table (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Table S6</a>) and the HDX data table are available online per consensus guidelines.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ligand-Observe NMR Experiments</h3><div class="NLM_p">In the control experiment, a stock solution of 2.5% DMSO-<i>d</i><sub>6</sub>, 7 μM CK2α WT in 0.5 mM Tris, 200 mM NaCl, pH 8.0 was prepared. This was split into two samples. The ligand in DMSO-<i>d</i><sub>6</sub> or DMSO-<i>d</i><sub>6</sub> alone was added to each such that one sample contained 5% DMSO-<i>d</i><sub>6</sub> with a total volume of 180 μL, and the second sample contained 5% DMSO-<i>d</i><sub>6</sub> and 500 μM <b>1</b>. In a typical competition experiment, a stock solution of 50–500 μM competing ligand, 2.5% DMSO-<i>d</i><sub>6</sub>, 7 μM CK2α WT in 0.2 mM Tris, 100 mM NaCl, pH 8.0 was prepared. This was again split into two samples. One sample contained 5% DMSO-<i>d</i><sub>6</sub> and 50–500 μM competing ligand with a total volume of 180 μL. The second sample contained 5% DMSO-<i>d</i><sub>6</sub>, 500 μM <b>1</b> and 50–500 μM competing ligand.</div><div class="NLM_p last">NMR data were recorded at 300 K with a Bruker AVANCE spectrometer operating at 500 MHz and equipped with a room-temperature probe. CPMG-filtered one-dimensional (1D) <sup>1</sup>H experiments<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> were run with 600 loops of length 1 ms. Water suppression was achieved with low-power presaturation and DPFGSE WATERGATE W5.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> Saturation transfer difference (STD) experiments<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> were acquired with 2 s of alternating on- and off-resonance saturation (20 ms Gaussian pulse, +0.8 and −5 ppm), a <i>T</i><sub>1ρ</sub> filter to suppress protein signals, and DPFGSE WATERGATE W5. Water-LOGSY experiments<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> were recorded using a 20 ms Gaussian to invert the water resonance, a mixing time of 1.2 s, a <i>T</i><sub>2</sub> filter to suppress protein signals, and DPFGSE WATERGATE W5.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Isothermal Calorimetry</h3><div class="NLM_p last">All ITC experiments were performed at 25 °C using a MicroCal iTC200 instrument (GE Healthcare). CK2αWT (20 mg/mL, 20 mM Tris pH 8.0, 500 mM NaCl) was diluted in Tris buffer (200 mM Tris, 300 mM NaCl, 10% DMSO) and concentrated to 20–50 μM. The compounds in 100× stock solutions were diluted into the buffer, ensuring that the DMSO concentrations were carefully matched. In a typical experiment, CK2αWT (10 μM) was loaded into the sample cell and 0.4–2.0 mM of the ligand was titrated in eighteen 2 μL injections of 2 s duration at 150 s intervals, stirring at 750 rpm. Heats of dilution were determined in identical experiments, but without protein in the cell. The data fitting was performed with a single-site binding model using the Origin software package.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Surface Plasmon Resonance</h3><div class="NLM_p last">An Ni-NTA sensor chip (GE Healthcare) was activated with 0.5 mM NiCl<sub>2</sub>, 0.2 μM CK2α with both N- and C-terminal His-tags was immobilized onto the activated Ni-NTA sensor chip in 20 mM Tris pH 8.0, 500 mM NaCl. Binding of <b>CX4945</b> was determined in 0.01 M <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES), pH 7.4, 0.15 M NaCl, 0.05% v/v Tween 20, 0.5% DMSO at five different concentrations (15, 10, 5, 1, and 0 nM). The chip surface was regenerated with an initial wash of 500 mM ethylenediaminetetraacetic acid (EDTA) followed by 4 M guanidinium chloride, 250 mM EDTA, 50 mM NaOH. The reference channel was activated with 0.5 mM NiCl<sub>2</sub>. All data were processed using the manufacturer′s BIAevaluation software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01173" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01173?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01173</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HDX data tables (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_001.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">PDB file of compound <b>1</b> modeling (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">PDB file of <b>CX4945</b> modeling (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_004.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Series of proposed allosteric inhibitors of CK2α; position of the proposed allosteric site; comparison of <b>1</b> and <b>CX4945</b> by overlay and modeling; ligand structures and SMILES strings from PDB search; structures of 20 fragments; various binding sites for acetate identified in CK2α from PDB entries; X-ray crystallographic data collection; electron densities for <b>1</b> and <b>2</b> before modeling; ligand electron densities from the PDB validation reports; binding sites on CK2α; binding conformation of ADP; overlay of the compounds; six compounds used as probes in HDX and NMR competition studies; coverage map of overlapping peptides recovered in all HDX experiments; summary of HDX experimental conditions; heatmaps showing changes in deuterium uptake; kinetics of CX4945 binding to CK2α; relaxation-edited (CPMG) <sup>1</sup>H NMR analysis; ITC traces for <b>1</b> and <b>2</b> binding to KKK/AAA; binding site of IP6 for CK2α; HPLC trace and mass spectrometry data (Figures S1–S20) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_001.xlsx">jm0c01173_si_001.xlsx (1.17 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_002.pdb">jm0c01173_si_002.pdb (3.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_003.pdb">jm0c01173_si_003.pdb (4.26 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_004.csv">jm0c01173_si_004.csv (0.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf">jm0c01173_si_005.pdf (2.86 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01173" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73681" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73681" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Brear</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c2b2a6a0f6f582a1a3afeca3a1ecb7a9"><span class="__cf_email__" data-cfemail="83f3e7e1b7b4c3e0e2eeade2e0adf6e8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marko Hyvönen</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8683-4070" title="Orcid link">http://orcid.org/0000-0001-8683-4070</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#224f4a1017146241434f0c43410c5749"><span class="__cf_email__" data-cfemail="0964613b3c3f496a686427686a277c62">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darby Ball</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Texas at Dallas, Richardson, Texas 75080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine Stott</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheena D’Arcy</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, The University
of Texas at Dallas, Richardson, Texas 75080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5055-988X" title="Orcid link">http://orcid.org/0000-0001-5055-988X</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">Structural coordinates in Protein Data Bank: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG">6YPG</a> (CK2α in complex with <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPH">6YPH</a> (CK2α in complex with <b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a> (CK2α in complex with <b>1</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a> CK2α in complex with GDP), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN">6YPN</a> (CK2α in complex with ATP).</p></div></li></ul></div><div class="ack" id="ACK-d7e2123-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank Dr. Glyn Williams and Teodors Pantelejevs for their critical comments on the manuscript. We are grateful for Diamond Light Source for access to beamlines i04, i04-1, and i24 (proposals: mx9537, mx14043, and mx18548). We thank the X-ray Crystallographic and Biophysics Facilities for the access to instrumentation. We thank Apollo Therapeutics that funds our CK2α inhibitor development project for allowing the use of the data on <b>CX4945</b> binding kinetics for this publication. The work in the S.D. group was funded by the NIH National Institute of General Medical Sciences (GM133751) and start-up funds to S.D.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AMPPNP</td><td class="NLM_def"><p class="first last">adenosine 5′-(β,γ-imido)triphosphate</p></td></tr><tr><td class="NLM_term">CPMG</td><td class="NLM_def"><p class="first last">Carr–Purcell–Meiboom–Gill</p></td></tr><tr><td class="NLM_term">HDX</td><td class="NLM_def"><p class="first last">hydrogen–deuterium exchange</p></td></tr><tr><td class="NLM_term">IP<sub>6</sub></td><td class="NLM_def"><p class="first last">inositol hexaphosphate</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">STD</td><td class="NLM_def"><p class="first last">saturation transfer difference</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 77 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.</span></span> <span> </span><span class="NLM_article-title">Properties of FDA-Approved Small Molecule Protein Kinase Inhibitors</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.phrs.2019.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=30877063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=19-50&author=R.+Roskoski&title=Properties+of+FDA-Approved+Small+Molecule+Protein+Kinase+Inhibitors&doi=10.1016%2Fj.phrs.2019.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of FDA-approved small molecule protein kinase inhibitors</span></div><div class="casAuthors">Roskoski, Robert Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-50</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Because mutations, overexpression, and dysregulation of protein kinases play essential roles in the pathogenesis of many illnesses, this enzyme family has become one of the most important drug targets in the past 20 years.  The US FDA has approved 48 small mol. protein kinase inhibitors, nearly all of which are orally effective with the exceptions of netarsudil (which is given as an eye drop) and temsirolimus (which is given i.v.).  Of the 48 approved drugs, the majority (25) target receptor protein-tyrosine kinases, ten target non-receptor protein-tyrosine kinases, and 13 target protein-serine/threonine protein kinases.  The data indicate that 43 of these drugs are used in the treatment of malignancies (36 against solid tumors including lymphomas and seven against non-solid tumors, e.g., leukemias).  Seven drugs are used in the treatment of non-malignancies: baricitinib, rheumatoid arthritis; fostamatinib, chronic immune thrombocytopenia; ruxolitinib, myelofibrosis and polycythemia vera; nintedanib, idiopathic pulmonary fibrosis; sirolimus, renal graft vs. host disease; netarsudil, glaucoma; tofacitinib, rheumatoid arthritis, Crohn disease, and ulcerative colitis.  Moreover, ibrutinib and sirolimus are used for the treatment of both malignant and non-malignant diseases.  The most common drug targets include ALK, B-Raf, BCR-Abl, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor (VEGFR).  Most of the small mol. inhibitors (45) interact directly with the protein kinase domain.  In contrast, sirolimus, temsirolimus, and everolimus are larger mols. (MW ≈ 1000) that bind to FKBP-12 to generate a complex that inhibits mTOR (mammalian target of rapamycin).  This review presents the available drug-enzyme X-ray crystal structures for 27 of the approved drugs as well as the chem. structures and physicochem. properties of all of the FDA-approved small mol. protein kinase antagonists.  Six of the drugs bind covalently and irreversibly to their target.  Twenty of the 48 drugs have mol. wts. greater than 500, exceeding a Lipinski rule of five criterion.  Excluding the macrolides (everolimus, sirolimus, temsirolimus), the av. mol. wt. of drugs is 480 with a range of 306 (ruxolitinib) to 615 (trametinib).  Nearly half of the antagonists (23) have a lipophilic efficiency with values of less than five while the recommended optima range from 5-10.  One of the vexing problems is the near universal development of resistance that is assocd. with the use of small mol. protein kinase inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLum_hDK00hbVg90H21EOLACvtfcHk0lh3ehTE4VDejQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D&md5=a24dee87603bc4ea12bd34616e46f53d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DProperties%2520of%2520FDA-Approved%2520Small%2520Molecule%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50%26doi%3D10.1016%2Fj.phrs.2019.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">FDA-Approved Small-Molecule Kinase Inhibitors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.tips.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=25975227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=422-439&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=FDA-Approved+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.tips.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">FDA-approved small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">422-439</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have emerged as one of the most intensively pursued targets in current pharmacol. research, esp. for cancer, due to their crit. roles in cellular signaling.  To date, the US FDA has approved 28 small-mol. kinase inhibitors, half of which were approved in the past 3 years.  While the clin. data of these approved mols. are widely presented and structure-activity relationship (SAR) has been reported for individual mols., an updated review that analyzes all approved mols. and summarizes current achievements and trends in the field has yet to be found.  Here we present all approved small-mol. kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrudyvM3eO09bVg90H21EOLACvtfcHk0lh3ehTE4VDejQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D&md5=a6aa3dbb11e6fe3001fa5fa03a4c950a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DFDA-Approved%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D422%26epage%3D439%26doi%3D10.1016%2Fj.tips.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Measuring and Interpreting the Selectivity of Protein Kinase Inhibitors</span>. <i>J. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1007/s12154-009-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs12154-009-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=19568781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=131-151&author=L.+A.+Smythauthor=I.+Collins&title=Measuring+and+Interpreting+the+Selectivity+of+Protein+Kinase+Inhibitors&doi=10.1007%2Fs12154-009-0023-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring and interpreting the selectivity of protein kinase inhibitors</span></div><div class="casAuthors">Smyth Lynette A; Collins Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-51</span>
        ISSN:<span class="NLM_cas:issn">1864-6158</span>.
    </div><div class="casAbstract">Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer.  Achieving inhibitor selectivity for particular protein kinases often remains a significant challenge in the development of new small molecules as drugs or as tools for chemical biology research.  This review summarises the methodologies available for measuring kinase inhibitor selectivity, both in vitro and in cells.  The interpretation of kinase inhibitor selectivity data is discussed, particularly with reference to the structural biology of the protein targets.  Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU9rA5WZcz9FxYDaSSP8XfW6udTcc2eYRInBAcmHeZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D&md5=f78ff1202a949a71ffd65e804298c37f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs12154-009-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12154-009-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DL.%2BA.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMeasuring%2520and%2520Interpreting%2520the%2520Selectivity%2520of%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D2%26spage%3D131%26epage%3D151%26doi%3D10.1007%2Fs12154-009-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Analysis of Kinase Inhibitor Selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+Analysis+of+Kinase+Inhibitor+Selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0ljUyY3tGGXqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Emerging Principles in Protease-Based Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1038/nrd3053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnrd3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=20811381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=690-701&author=M.+Dragauthor=G.+S.+Salvesen&title=Emerging+Principles+in+Protease-Based+Drug+Discovery&doi=10.1038%2Fnrd3053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging principles in protease-based drug discovery</span></div><div class="casAuthors">Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">690-701</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Proteases have an important role in many signalling pathways, and represent potential drug targets for diseases ranging from cardiovascular disorders to cancer, as well as for combating many parasites and viruses.  Although inhibitors of well-established protease targets such as angiotensin-converting enzyme and HIV protease have shown substantial therapeutic success, developing drugs for new protease targets has proved challenging in recent years.  This in part could be due to issues such as the difficulty of achieving selectivity when targeting protease active sites.  This Perspective discusses the general principles in protease-based drug discovery, highlighting the lessons learned and the emerging strategies, such as targeting allosteric sites, which could help harness the therapeutic potential of new protease targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz3PQDA1pnT7Vg90H21EOLACvtfcHk0ljUyY3tGGXqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP&md5=28a9571473c3f753027665b77d3257d0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3053%26sid%3Dliteratum%253Aachs%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DEmerging%2520Principles%2520in%2520Protease-Based%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D690%26epage%3D701%26doi%3D10.1038%2Fnrd3053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The Selectivity of Protein Kinase Inhibitors: A Further Update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+Selectivity+of+Protein+Kinase+Inhibitors%3A+A+Further+Update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0ljUyY3tGGXqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520Selectivity%2520of%2520Protein%2520Kinase%2520Inhibitors%253A%2520A%2520Further%2520Update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The Specificities of Protein Kinase Inhibitors: An Update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+Specificities+of+Protein+Kinase+Inhibitors%3A+An+Update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lg2MpnVcw5fHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520Specificities%2520of%2520Protein%2520Kinase%2520Inhibitors%253A%2520An%2520Update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserú, G. M.</span></span> <span> </span><span class="NLM_article-title">Contributions of Molecular Properties to Drug Promiscuity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1795</span>, <span class="refDoi"> DOI: 10.1021/jm301514n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301514n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1789-1795&author=%C3%81.+Tarcsayauthor=G.+M.+Keser%C3%BA&title=Contributions+of+Molecular+Properties+to+Drug+Promiscuity&doi=10.1021%2Fjm301514n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of Molecular Properties to Drug Promiscuity</span></div><div class="casAuthors">Tarcsay, Akos; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In contrast to designed polypharmacol. that can result in efficient drugs for complex disorders, unintended drug promiscuity has detrimental contribution to side effects and toxicol.  Characterization of promiscuous compds. enhances the understanding of complex interaction patterns and aids the design of compds. with broader selectivity against off-targets that has a major impact on medicinal chem. outcome.  In this Miniperspective we provide insights to the effect of physicochem. parameters on promiscuity.  Information collected from recent, large-scale in vitro studies enabled us to discuss the relationships between physicochem. properties and promiscuity in detail.  In light of these data, lipophilicity and basic character have the highest influence.  On the basis of the accumulated knowledge, we propose the extensive use of pre- and postsynthesis metrics, as well as strict control of physicochem. properties during medicinal chem. optimizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1J_jqkK3DrVg90H21EOLACvtfcHk0lg2MpnVcw5fHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D&md5=c5763ee1aed897ff19e5a2344b95b9c1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm301514n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301514n%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3D%25C3%2581.%26aulast%3DKeser%25C3%25BA%26aufirst%3DG.%2BM.%26atitle%3DContributions%2520of%2520Molecular%2520Properties%2520to%2520Drug%2520Promiscuity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1789%26epage%3D1795%26doi%3D10.1021%2Fjm301514n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarolimek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitebread, S.</span></span> <span> </span><span class="NLM_article-title">Reducing Safety-Related Drug Attrition: The Use of in Vitro Pharmacological Profiling</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1038/nrd3845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnrd3845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=23197038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-922&author=J.+Bowesauthor=A.+J.+Brownauthor=J.+Hamonauthor=W.+Jarolimekauthor=A.+Sridharauthor=G.+Waldronauthor=S.+Whitebread&title=Reducing+Safety-Related+Drug+Attrition%3A+The+Use+of+in+Vitro+Pharmacological+Profiling&doi=10.1038%2Fnrd3845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span></div><div class="casAuthors">Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques; Jarolimek, Wolfgang; Sridhar, Arun; Waldron, Gareth; Whitebread, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In vitro pharmacol. profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved.  Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacol. profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process.  We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVp3wnTONWrVg90H21EOLACvtfcHk0lhpzLY65lu5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ&md5=7559001563ef3febd610535b8f096a45</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3845%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DWaldron%26aufirst%3DG.%26aulast%3DWhitebread%26aufirst%3DS.%26atitle%3DReducing%2520Safety-Related%2520Drug%2520Attrition%253A%2520The%2520Use%2520of%2520in%2520Vitro%2520Pharmacological%2520Profiling%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D922%26doi%3D10.1038%2Fnrd3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smaill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">New Promise and Opportunities for Allosteric Kinase Inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">13764</span>– <span class="NLM_lpage">13776</span>, <span class="refDoi"> DOI: 10.1002/anie.201914525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1002%2Fanie.201914525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Giurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=13764-13776&author=X.+Luauthor=J.+B.+Smaillauthor=K.+Ding&title=New+Promise+and+Opportunities+for+Allosteric+Kinase+Inhibitors&doi=10.1002%2Fanie.201914525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">New Promise and Opportunities for Allosteric Kinase Inhibitors</span></div><div class="casAuthors">Lu, Xiaoyun; Smaill, Jeff B.; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13764-13776</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Drugs that function through allosteric inhibition of kinase signaling represent a promising approach for the targeted discovery of therapeutics.  The majority of developed allosteric kinase inhibitors are characterized as type III and IV inhibitors that show good kinome selectivity but generally lack the subtype selectivity of same kinase family.  Recently allosteric inhibitors have been developed that bind outside the catalytic kinase domain with high selectivity for specific kinase subtypes.  Allosteric inhibitors that bind to the pseudokinase domain of pseudokinase or the extracellular domain of receptor tyrosine kinases are reviewed.  We also review recent developments in the field of allosteric kinase inhibitors including examples of proteolysis targeting chimeras, and highlight the unique binding modes for each type of inhibitors and address future opportunities in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIeFGyjfBKrLVg90H21EOLACvtfcHk0lhpzLY65lu5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Giurw%253D&md5=27959fdb1a96202db7ca65b2a8e19bc7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.201914525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201914525%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DNew%2520Promise%2520and%2520Opportunities%2520for%2520Allosteric%2520Kinase%2520Inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26spage%3D13764%26epage%3D13776%26doi%3D10.1002%2Fanie.201914525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebakken, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichling, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellefson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, S. M.</span></span> <span> </span><span class="NLM_article-title">Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1177/1087057112439889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1177%2F1087057112439889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=22453235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCju7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=813-821&author=C.+S.+Lebakkenauthor=L.+J.+Reichlingauthor=J.+M.+Ellefsonauthor=S.+M.+Riddle&title=Detection+of+Allosteric+Kinase+Inhibitors+by+Displacement+of+Active+Site+Probes&doi=10.1177%2F1087057112439889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of allosteric kinase inhibitors by displacement of active site probes</span></div><div class="casAuthors">Lebakken, Connie S.; Reichling, Laurie J.; Ellefson, Jason M.; Riddle, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">813-821</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Non-ATP (ATP) competitive, allosteric inhibitors provide a promising avenue to develop highly selective small-mol. kinase inhibitors.  Although this class of compds. is growing, detection of such inhibitors can be challenging as std. kinase activity assays preferentially detect compds. that bind to active kinases in an ATP competitive manner.  We have previously described a time-resolved fluorescence resonance energy transfer (TR-FRET)-based kinase binding assay using the competitive displacement of ATP competitive active site fluorescent probes ("tracers").  Although this format has gained acceptance, published data with this and related formats are almost entirely without examples of non-ATP competitive compds.  Thus, this study addresses whether this format is useful for non-ATP competitive inhibitors.  To this end, 15 com. available non-ATP competitive inhibitors were tested for their ability to displace ATP competitive probes.  Despite the diversity of both compd. structures and their resp. targets, 14 of the 15 compds. displaced the tracers with IC50 values comparable to literature values.  We conclude that such binding assays are well suited for the study of non-ATP competitive inhibitors.  In addn., we demonstrate that allosteric inhibitors of BCR-Abl and MEK bind preferentially to the nonphosphorylated (i.e., inactive) form of the kinase, indicating that binding assays may be a preferred format in some cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBTuxOBOOc5LVg90H21EOLACvtfcHk0lhpzLY65lu5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCju7rN&md5=e84b76003c5b56953e548410d25a8e08</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1087057112439889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112439889%26sid%3Dliteratum%253Aachs%26aulast%3DLebakken%26aufirst%3DC.%2BS.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DEllefson%26aufirst%3DJ.%2BM.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26atitle%3DDetection%2520of%2520Allosteric%2520Kinase%2520Inhibitors%2520by%2520Displacement%2520of%2520Active%2520Site%2520Probes%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D813%26epage%3D821%26doi%3D10.1177%2F1087057112439889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fasano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Corte, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Califano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troiani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgillo, F.</span></span> <span> </span><span class="NLM_article-title">Type III or Allosteric Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1517/13543784.2014.902934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1517%2F13543784.2014.902934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24673358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2hu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=809-821&author=M.+Fasanoauthor=C.+M.+Della+Corteauthor=R.+Califanoauthor=A.+Capuanoauthor=T.+Troianiauthor=E.+Martinelliauthor=F.+Ciardielloauthor=F.+Morgillo&title=Type+III+or+Allosteric+Kinase+Inhibitors+for+the+Treatment+of+Non-Small+Cell+Lung+Cancer&doi=10.1517%2F13543784.2014.902934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Fasano, Morena; Della Corte, Carminia Maria; Califano, Raffaele; Capuano, Annalisa; Troiani, Teresa; Martinelli, Erika; Ciardiello, Fortunato; Morgillo, Floriana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">809-821</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: In recent times, there has been much interest in the development of pharmacol. kinase inhibitors that treat NSCLC.  Furthermore, treatment options have been guided by the development of a wide panel of synthetic small mol. kinase inhibitors.  Most of the mols. developed belong to the type I class of inhibitors that target the ATP-binding site in its active conformation.  The high sequence similarity in the ATP-binding site among members of the kinase families often results in low selectivity and addnl. toxicities.  Also, second mutations in the ATP-binding site, such as threonine to methionine at position 790, have been described as a mechanism of resistance to ATP-competitive kinase inhibitors.  For these reasons, alternative drug development approaches targeting sites other than the ATP cleft are being pursued.  The class III or allosteric inhibitors, which bind outside the ATP-binding site, have been shown to neg. modulate kinase activity.  Areas covered: In this review, the authors discuss the most well-characterized allosteric inhibitors that have reached clin. development in NSCLC.  Expert opinion: Great progress has made in developing inhibitors with entirely new modes of action.  That being said, it is important to highlight that despite their apparent simplicity, biochem. assays will remain at the core of drug discovery activities to better explore these new opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ywM7JJJnbbVg90H21EOLACvtfcHk0lhpzLY65lu5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2hu74%253D&md5=0d6ed04787c0b83c81801c03b9163f0c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.902934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.902934%26sid%3Dliteratum%253Aachs%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DCalifano%26aufirst%3DR.%26aulast%3DCapuano%26aufirst%3DA.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DType%2520III%2520or%2520Allosteric%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D809%26epage%3D821%26doi%3D10.1517%2F13543784.2014.902934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span> <span> </span><span class="NLM_article-title">Allosteric Small-Molecule Kinase Inhibitors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.pharmthera.2015.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=26478442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs12qsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=59-68&author=P.+Wuauthor=M.+H.+Clausenauthor=T.+E.+Nielsen&title=Allosteric+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.pharmthera.2015.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Clausen, Mads H.; Nielsen, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors are invaluable targeted therapeutics for the treatment of various human diseases, esp. cancers.  While the majority of approved and developed preclin. small-mol. inhibitors are characterized as type I or type II inhibitors that target the ATP-binding pocket of kinases, the remarkable sequential and structural similarity among ATP pockets renders the selective inhibition of kinases a daunting challenge.  Therefore, targeting allosteric pockets of kinases outside the highly conversed ATP pocket has been proposed as a promising alternative to overcome current barriers of kinase inhibitors, including poor selectivity and emergence of drug resistance.  In spite of the small no. of identified allosteric inhibitors in comparison with that of inhibitors targeting the ATP pocket, encouraging results, such as the FDA-approval of the first small-mol. allosteric inhibitor trametinib in 2013, the progress of more than 10 other allosteric inhibitors in clin. trials, and the emergence of a pipeline of highly selective and potent preclin. mols., have been reported in the past decade.  In this article, we present the current knowledge on allosteric inhibition in terms of conception, classification, potential advantages, and summarized debatable topics in the field.  Recent progress and allosteric inhibitors that were identified in the past three years are highlighted in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK12iPyaK2ObVg90H21EOLACvtfcHk0lifhXA-1o89eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs12qsb3N&md5=26e4658d325b8f016be29df27bf69ec2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26atitle%3DAllosteric%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D156%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.pharmthera.2015.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Kinase Inhibitors: Not Just for Kinases Anymore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1021/jm020427b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020427b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1478-1483&author=S.+L.+McGovernauthor=B.+K.+Shoichet&title=Kinase+Inhibitors%3A+Not+Just+for+Kinases+Anymore&doi=10.1021%2Fjm020427b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors: Not Just for Kinases Anymore</span></div><div class="casAuthors">McGovern, Susan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1478-1483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibitors are widely employed as biol. reagents and as leads for drug design.  Their use is often complicated by their lack of specificity.  Although binding conserved ATP sites accounts for some of their nonspecificity, some compds. inhibit proteins not known to bind ATP.  It has been found that promiscuous hits from high-throughput screening may act as aggregates.  To explore whether this mechanism might explain the action of widely used nonspecific kinase inhibitors, 15 such compds. were studied.  Eight of these, rottlerin, quercetin, K-252c, bisindolylmaleimide I, bisindolylmaleimide IX, U0126, indirubin, and indigo, inhibited three diverse non-kinase enzymes.  Inhibition was time-dependent and sensitive to enzyme concn.; by light scattering, the compds. formed particles of 100-1000 nm diam.  These observations suggest that these eight kinase inhibitors, at least at micromolar concns., are promiscuous and act as aggregates.  Results obtained from the use of these compds. at micromolar or higher concns. against individual enzymes should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-JSJ7FPf7e7Vg90H21EOLACvtfcHk0lifhXA-1o89eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D&md5=1d7e4e99a27be5ab279744aff92de26d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm020427b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020427b%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DKinase%2520Inhibitors%253A%2520Not%2520Just%2520for%2520Kinases%2520Anymore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1478%26epage%3D1483%26doi%3D10.1021%2Fjm020427b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span></span> <span> </span><span class="NLM_article-title">Targeting CK2 for Cancer Therapy</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1037</span>– <span class="NLM_lpage">1043</span>, <span class="refDoi"> DOI: 10.1097/00001813-200511000-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1097%2F00001813-200511000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16222144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2ktrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1037-1043&author=K.+A.+Ahmadauthor=G.+Wangauthor=J.+Slatonauthor=G.+Ungerauthor=K.+Ahmed&title=Targeting+CK2+for+Cancer+Therapy&doi=10.1097%2F00001813-200511000-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CK2 for cancer therapy</span></div><div class="casAuthors">Ahmad, Kashif A.; Wang, Guixia; Slaton, Joel; Unger, Gretchen; Ahmed, Khalil</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1037-1043</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is a highly ubiquitous and conserved protein serine/threonine kinase that has been found to be involved not only in cell growth and proliferation, but also in suppression of apoptosis.  CK2 is capable of dynamic intracellular shuttling in response to a variety of signals.  It is localized in both the nucleus and cytoplasm in normal cells, but is particularly predominant in the nuclear compartment in cancer cells.  CK2 has been found to be uniformly dysregulated in all the cancers that have been examd.  Downregulation of CK2 by chem. or mol. methods promotes apoptosis in cells.  We have shown that antisense CK2α is particularly potent in inducing apoptosis in cancer cells in culture as well as in xenograft models of cancer such as prostate cancer and squamous cell carcinoma of head and neck.  The antisense CK2α oligodeoxynucleotide (ODN) mediates tumor cell death in a dose- and time-dependent manner such that at an appropriate concn. of the antisense, a complete resoln. of the xenograft tumor is obsd.  Interestingly, normal and benign cells (in culture as well as in vivo) demonstrate a relative resistance to the antisense CK2α ODN treatment, which raises the possibility of a significant therapeutic window for this therapy.  Further, novel approaches such as the delivery of antisense CK2α ODN encapsulated in sub-50-nm tenascin nanocapsules have become available for its targeting specifically in cancer cells.  Our studies minimize generally held concerns regarding suitability of CK2 as a target for cancer therapy and provide the first encouraging results for potential future application of this approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXGqtHo4E_tLVg90H21EOLACvtfcHk0lifhXA-1o89eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2ktrnI&md5=0929c0522e65bcabb6962f1e1d5f31db</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1097%2F00001813-200511000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200511000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DTargeting%2520CK2%2520for%2520Cancer%2520Therapy%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2005%26volume%3D16%26spage%3D1037%26epage%3D1043%26doi%3D10.1097%2F00001813-200511000-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Addiction to Protein Kinase CK2: A Common Denominator of Diverse Cancer Cells?</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbapap.2009.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=19665589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=499-504&author=M.+Ruzzeneauthor=L.+A.+Pinna&title=Addiction+to+Protein+Kinase+CK2%3A+A+Common+Denominator+of+Diverse+Cancer+Cells%3F&doi=10.1016%2Fj.bbapap.2009.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Addiction to protein kinase CK2: A common denominator of diverse cancer cells?</span></div><div class="casAuthors">Ruzzene, Maria; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">499-504</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  At variance with most oncogenic protein kinases whose malignancy is generally due to genetic alterations conferring constitutive activity, CK2 is a highly pleiotropic Ser/Thr protein kinase naturally endowed with constitutive activity and lacking gain-of-function mutants.  Nonetheless CK2 is abnormally elevated in a wide variety of tumors and there is strong evidence that it operates as a cancer driver by creating a cellular environment favorable to neoplasia: notably, CK2 plays a global role as an anti-apoptotic and pro-survival agent, it enhances the multi-drug resistance (MDR) phenotype, it assists the chaperone machinery which protects the "onco-kinome" and it promotes neo-angiogenesis.  Based on this scenario we propose that the implication of CK2 in neoplasia is an example of "non oncogene addiction", i.e. over reliance of the perturbed cellular signaling network on high CK2 level for its own maintenance.  Consistent with this, an ample spectrum of diverse types of cancer cells have been already shown to rely on high CK2 level for their survival, as judged from their response to specific CK2 inhibitors and silencing of endogenous CK2 catalytic subunits.  Remarkably, among these are cells whose cancer phenotype arises from the genetic alteration of onco-kinases (e.g. Abl and Alk) different from CK2 and insensitive to the CK2 inhibitors used in those expts.  Based on these premises, CK2 could represent a "multi-purpose" target for the treatment of different kinds of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryaRBb7mWsWrVg90H21EOLACvtfcHk0limm807MOZBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D&md5=a8088e387d13469774ce9aef315d0ae5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DAddiction%2520to%2520Protein%2520Kinase%2520CK2%253A%2520A%2520Common%2520Denominator%2520of%2520Diverse%2520Cancer%2520Cells%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D499%26epage%3D504%26doi%3D10.1016%2Fj.bbapap.2009.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panicker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span> <span> </span><span class="NLM_article-title">Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1163</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1007/978-981-13-8719-7_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2F978-981-13-8719-7_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31707707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BB3cXosFeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1163&publication_year=2019&pages=253-278&author=R.+C.+Panickerauthor=S.+Chattopadhayaauthor=A.+G.+Coyneauthor=R.+Srinivasan&title=Allosteric+Small-Molecule+Serine%2FThreonine+Kinase+Inhibitors&doi=10.1007%2F978-981-13-8719-7_11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors</span></div><div class="casAuthors">Panicker, Resmi C.; Chattopadhaya, Souvik; Coyne, Anthony G.; Srinivasan, Rajavel</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1163</span>
        (<span class="NLM_cas:issue">Protein Allostery in Drug Discovery</span>),
    <span class="NLM_cas:pages">253-278</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Deregulation of protein kinase activity has been linked to many diseases ranging from cancer to AIDS and neurodegenerative diseases.  Not surprisingly, drugging the human kinome - the complete set of kinases encoded by the human genome - has been one of the major drug discovery pipelines.  Majority of the approved clin. kinase inhibitors target the ATP binding site of kinases.  However, the remarkable sequence and structural similarity of ATP binding pockets of kinases make selective inhibition of kinases a daunting task.  To circumvent these issues, allosteric inhibitors that target sites other than the orthosteric ATP binding pocket have been developed.  The structural diversity of the allosteric sites allows these inhibitors to have higher selectivity, lower toxicity and improved physiochem. properties and overcome drug resistance assocd. with the use of conventional kinase inhibitors.  In this chapter, we will focus on the allosteric inhibitors of selected serine/threonine kinases, outline the benefits of using these inhibitors and discuss the challenges and future opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZh1hNRTh7T7Vg90H21EOLACvtfcHk0limm807MOZBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXosFeht7Y%253D&md5=aff162e9dee91f765c95fadb2ed7c487</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2F978-981-13-8719-7_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-981-13-8719-7_11%26sid%3Dliteratum%253Aachs%26aulast%3DPanicker%26aufirst%3DR.%2BC.%26aulast%3DChattopadhaya%26aufirst%3DS.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DSrinivasan%26aufirst%3DR.%26atitle%3DAllosteric%2520Small-Molecule%2520Serine%252FThreonine%2520Kinase%2520Inhibitors%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2019%26volume%3D1163%26spage%3D253%26epage%3D278%26doi%3D10.1007%2F978-981-13-8719-7_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Protein Kinase CK2: A Challenge to Canons</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3873</span>– <span class="NLM_lpage">3878</span>, <span class="refDoi"> DOI: 10.1242/jcs.00074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1242%2Fjcs.00074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=12244125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos12ktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2002&pages=3873-3878&author=L.+A.+Pinna&title=Protein+Kinase+CK2%3A+A+Challenge+to+Canons&doi=10.1242%2Fjcs.00074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: a challenge to canons</span></div><div class="casAuthors">Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3873-3878</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Casein kinase 2 (protein kinase CK2)(I) is an extremely conserved pleiotropic protein kinase with a growing list of >300 substrates, the majority of which are proteins implicated in signal transduction, gene expression, and other nuclear functions.  The I phosphoacceptor sites are specified by multiple acidic residues, with the one at position +3 relative to the target residue being of crucial relevance.  The I holoenzyme is composed of 2 catalytic subunits (αα, α'α', or αα'), which are essential for cell viability, and a dimer of 2 non-catalytic β subunits, whose precise function is still poorly understood.  Although the β subunits deeply affect many properties of I, both the isolated catalytic subunits and the holoenzyme are constitutively active, which is probably responsible for the oncogenic potential of I.  Given the structure of the holoenzyme, the β subunits could undergo reversible dissocn. under physiol. conditions and play a role as anchoring elements and/or as a docking platform for protein substrates and effectors.  These unusual features are likely to be instrumental in the involvement of I in a no. of key biol. functions, notably RNA synthesis, Wnt signaling, ubiquitination, and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfV4dtx0wAbVg90H21EOLACvtfcHk0limm807MOZBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos12ktL0%253D&md5=8800a9192d61949e5f3588c2b00c228e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00074%26sid%3Dliteratum%253Aachs%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520Kinase%2520CK2%253A%2520A%2520Challenge%2520to%2520Canons%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2002%26volume%3D115%26spage%3D3873%26epage%3D3878%26doi%3D10.1242%2Fjcs.00074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">One-Thousand-and-One Substrates of Protein Kinase CK2?</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1096/fj.02-0473rev</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1096%2Ffj.02-0473rev" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=12631575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=349-368&author=F.+Meggioauthor=L.+A.+Pinna&title=One-Thousand-and-One+Substrates+of+Protein+Kinase+CK2%3F&doi=10.1096%2Ffj.02-0473rev"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">One-thousand-and-one substrates of protein kinase CK2?</span></div><div class="casAuthors">Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-368</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review.  CK2 (formerly termed "casein kinase 2") is a ubiquitous, highly pleiotropic and constitutively active Ser/Thr protein kinase whose implication in neoplasia, cell survival, and virus infection is supported by an increasing no. of arguments.  Here an updated inventory of 307 CK2 protein substrates is presented.  More than one-third of these are implicated in gene expression and protein synthesis as being either transcriptional factors (60) or effectors of DNA/RNA structure (50) or translational elements.  Also numerous are signaling proteins and proteins of viral origin or essential to virus life cycle.  In comparison, only a minority of CK2 targets (a dozen or so) are classical metabolic enzymes.  An anal. of 308 sites phosphorylated by CK2 highlights the paramount relevance of neg. charged side chains that are (by far) predominant over any other residues at positions n+3 (the most crucial one), n+1, and n+2.  Based on this signature, it is predictable that proteins phosphorylated by CK2 are much more numerous than those identified to date, and it is possible that CK2 alone contributes to the generation of the eukaryotic phosphoproteome more so than any other individual protein kinase.  The possibility that CK2 phosphosites play some global role, e.g., by destabilizing α helices, counteracting caspase cleavage, and generating adhesive motifs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6sfPYsWeCNrVg90H21EOLACvtfcHk0limm807MOZBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D&md5=0b11315ac9652e8866a1ed99a7010b68</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1096%2Ffj.02-0473rev&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.02-0473rev%26sid%3Dliteratum%253Aachs%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOne-Thousand-and-One%2520Substrates%2520of%2520Protein%2520Kinase%2520CK2%253F%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D349%26epage%3D368%26doi%3D10.1096%2Ffj.02-0473rev" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span> <span> </span><span class="NLM_article-title">Protein Kinase CK2 Inhibitors: A Patent Review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.717615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1517%2F13543776.2012.717615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=22908959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1alt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1081-1097&author=G.+Cozzaauthor=L.+A.+Pinnaauthor=S.+Moro&title=Protein+Kinase+CK2+Inhibitors%3A+A+Patent+Review&doi=10.1517%2F13543776.2012.717615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 inhibitors: a patent review</span></div><div class="casAuthors">Cozza, Giorgio; Pinna, Lorenzo A.; Moro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1081-1097</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: CK2 is a pleiotropic, ubiquitous and constitutively active protein kinase, localized in both cytosolic and nuclear compartments, where it catalyzes the phosphorylation of hundreds of proteins.  CK2 is generally described as a tetramer composed of two catalytic (α and/or α') and two regulatory subunits (β), however, the free α/α' subunits are catalytically active by themselves.  CK2 plays a key role in several physiol. and pathol. processes and has been connected to many neoplastic, inflammatory, autoimmune and infectious disorders.  In the last 20 years, several inhibitors of CK2 have been discovered though only one of these, CX-4945, has recently entered into Phase II clin. trials as potential anticancer drug.Areas covered: The main objective of the present review is to describe the development of CK2 activity modulators over the years according to the timeline of their patent registration.Expert opinion: CK2 was discovered in 1954, but the first patent on CK2 modulators was deposited only 50 years later, in 2004.  However, in the last 5 years an increasing no. of patents on CK2 inhibitors have been registered, reflecting an increased interest in this kind of drug candidates and their possible therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_s3DgzEl87Vg90H21EOLACvtfcHk0lg8qkYpc4KflA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1alt7%252FJ&md5=4496a3ca178a15c9911e34b480a18ac3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.717615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.717615%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DProtein%2520Kinase%2520CK2%2520Inhibitors%253A%2520A%2520Patent%2520Review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D1081%26epage%3D1097%26doi%3D10.1517%2F13543776.2012.717615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quotti
Tubi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancalion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Kinase CK2 with the Clinical-Grade Small ATP-Competitive Compound CX-4945 or by RNA Interference Unveils Its Role in Acute Myeloid Leukemia Cell Survival, P53-Dependent Apoptosis and Daunorubicin-Induced Cytotoxicity</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">78</span> <span class="refDoi"> DOI: 10.1186/1756-8722-6-78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1186%2F1756-8722-6-78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24283803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVGntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&author=L.+Quotti%0ATubiauthor=C.+Gurrieriauthor=A.+Brancalionauthor=L.+Bonaldiauthor=R.+Bertorelleauthor=S.+Manniauthor=L.+Pavanauthor=F.+Lessiauthor=R.+Zambelloauthor=L.+Trentinauthor=F.+Adamiauthor=M.+Ruzzeneauthor=L.+A.+Pinnaauthor=G.+Semenzatoauthor=F.+Piazza&title=Inhibition+of+Protein+Kinase+CK2+with+the+Clinical-Grade+Small+ATP-Competitive+Compound+CX-4945+or+by+RNA+Interference+Unveils+Its+Role+in+Acute+Myeloid+Leukemia+Cell+Survival%2C+P53-Dependent+Apoptosis+and+Daunorubicin-Induced+Cytotoxicity&doi=10.1186%2F1756-8722-6-78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity</span></div><div class="casAuthors">Quotti Tubi, Laura; Gurrieri, Carmela; Brancalion, Alessandra; Bonaldi, Laura; Bertorelle, Roberta; Manni, Sabrina; Pavan, Laura; Lessi, Federica; Zambello, Renato; Trentin, Livio; Adami, Fausto; Ruzzene, Maria; Pinna, Lorenzo A.; Semenzato, Gianpietro; Piazza, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">78/1-78/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The involvement of protein kinase CK2 in sustaining cancer cell survival could have implications also in the resistance to conventional and unconventional therapies.  Moreover, CK2 role in blood tumors is rapidly emerging and this kinase has been recognized as a potential therapeutic target.  Phase I clin. trials with the oral small ATP-competitive CK2 inhibitor CX-4945 are currently ongoing in solid tumors and multiple myeloma.  Methods: We have analyzed the expression of CK2 in acute myeloid leukemia and its function in cell growth and in the response to the chemotherapeutic agent daunorubicin.  We employed acute myeloid leukemia cell lines and primary blasts from patients grouped according to the European LeukemiaNet risk classification.  Cell survival, apoptosis and sensitivity to daunorubicin were assessed by different means. p53-dependent CK2-inhibition-induced apoptosis was investigated in p53 wild-type and mutant cells.  Results: CK2α was found highly expressed in the majority of samples across the different acute myeloid leukemia prognostic subgroups as compared to normal CD34+ hematopoietic and bone marrow cells.  Inhibition of CK2 with CX-4945, K27 or siRNAs caused a p53-dependent acute myeloid leukemia cell apoptosis.  CK2 inhibition was assocd. with a synergistic increase of the cytotoxic effects of daunorubicin.  Baseline and daunorubicin-induced STAT3 activation was hampered upon CK2 blockade.  Conclusions: These results suggest that CK2 is over expressed across the different acute myeloid leukemia subsets and acts as an important regulator of acute myeloid leukemia cell survival.  CK2 neg. regulation of the protein levels of tumor suppressor p53 and activation of the STAT3 anti-apoptotic pathway might antagonize apoptosis and could be involved in acute myeloid leukemia cell resistance to daunorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBsAzrkC8CW7Vg90H21EOLACvtfcHk0lg8qkYpc4KflA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVGntrg%253D&md5=870776daed0fbf21f8f3f3080a5a5633</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-78%26sid%3Dliteratum%253Aachs%26aulast%3DQuotti%2BTubi%26aufirst%3DL.%26aulast%3DGurrieri%26aufirst%3DC.%26aulast%3DBrancalion%26aufirst%3DA.%26aulast%3DBonaldi%26aufirst%3DL.%26aulast%3DBertorelle%26aufirst%3DR.%26aulast%3DManni%26aufirst%3DS.%26aulast%3DPavan%26aufirst%3DL.%26aulast%3DLessi%26aufirst%3DF.%26aulast%3DZambello%26aufirst%3DR.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DAdami%26aufirst%3DF.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DSemenzato%26aufirst%3DG.%26aulast%3DPiazza%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520Protein%2520Kinase%2520CK2%2520with%2520the%2520Clinical-Grade%2520Small%2520ATP-Competitive%2520Compound%2520CX-4945%2520or%2520by%2520RNA%2520Interference%2520Unveils%2520Its%2520Role%2520in%2520Acute%2520Myeloid%2520Leukemia%2520Cell%2520Survival%252C%2520P53-Dependent%2520Apoptosis%2520and%2520Daunorubicin-Induced%2520Cytotoxicity%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26doi%3D10.1186%2F1756-8722-6-78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Features and Potentials of ATP-Site Directed CK2 Inhibitors</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1754</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2005.07.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbapap.2005.07.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16198160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=263-270&author=S.+Sarnoauthor=M.+Salviauthor=R.+Battistuttaauthor=G.+Zanottiauthor=L.+A.+Pinna&title=Features+and+Potentials+of+ATP-Site+Directed+CK2+Inhibitors&doi=10.1016%2Fj.bbapap.2005.07.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Features and potentials of ATP-site directed CK2 inhibitors</span></div><div class="casAuthors">Sarno, Stefania; Salvi, Mauro; Battistutta, Roberto; Zanotti, Giuseppe; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A panel of quite specific, fairly potent and cell-permeable inhibitors of protein kinase CK2 belonging to the classes of condensed polyphenolic compds., tetrabromobenzimidazole/triazole derivs. and indoloquinazolines have been developed, with K i values in the submicromolar range.  Nine structures have been solved to date of complexes between the catalytic α subunit of CK2 and a no. of these compds., many of which display a remarkable specificity toward CK2 as compared to a panel of >30 kinases tested.  The structural basis for such selectivity appears to reside in the shape and size of a hydrophobic pocket adjacent to the ATP binding site where these ATP competitive ligands are entrapped mainly by van der Waals interactions and by an energy contribution derived from the hydrophobic effect.  In CK2, this cavity is smaller than in the majority of other protein kinases due to a no. of unique bulky apolar residues.  Consequently, the replacement of two of these residues (V66 and I174) in human CK2 alpha with alanines gives rise to mutants, which are markedly less susceptible than wild type to these classes of inhibitors.  Cell-permeable CK2 inhibitors have been successfully employed, either alone or in combination with CK2 mutants refractory to inhibition, to dissect signaling pathways affected by CK2 and/or to validate the identification of in vivo targets of this pleiotropic kinase.  Moreover, the remarkable pro-apoptotic efficacy of these compds. toward cell lines derived from a wide spectrum of tumors, disclose the possibility that in perspective CK2 inhibitors might become leads for the development of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxJB8VB2RxX7Vg90H21EOLACvtfcHk0lg8qkYpc4KflA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7bF&md5=7d1140e015d6fc269a1a2700d0a107c9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.07.043%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DFeatures%2520and%2520Potentials%2520of%2520ATP-Site%2520Directed%2520CK2%2520Inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D263%26epage%3D270%26doi%3D10.1016%2Fj.bbapap.2005.07.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">A Structural Insight into CK2 Inhibition</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1007/s11010-008-9822-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs11010-008-9822-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=18626746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVansrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2008&pages=57-62&author=M.+Mazzoranaauthor=L.+A.+Pinnaauthor=R.+Battistutta&title=A+Structural+Insight+into+CK2+Inhibition&doi=10.1007%2Fs11010-008-9822-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A structural insight into CK2 inhibition</span></div><div class="casAuthors">Mazzorana, Marco; Pinna, Lorenzo A.; Battistutta, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">57-62</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The acidophilic Ser/Thr protein kinase CK2 displays some unique properties such as high pleiotropicity and constitutive activity.  CK2 is involved in many fundamental aspects of the normal cell life, for instance it promotes cell survival and enhances the tumor phenotype under special circumstances.  This makes CK2 an appealing target for the development of inhibitors with pharmacol. potential.  Here we present an overview of our recent studies on inhibitors directed to the CK2 ATP-binding site whose distinctive features are highlighted by the ability to use both ATP and GTP as co-substrates and by its low susceptibility to staurosporine inhibition.  We discuss the effects of the binding of different chem. families of fairly selective inhibitors with potency in the nanomolar or low micromolar range.  An important common energetic contribution to the binding is due to the hydrophobic interaction with the apolar surface region of the CK2 binding cleft.  The anal. of the known CK2 crystal structures reveals the presence of some highly conserved water mols. in this region.  These waters reside near Lys-68, in an area with a pos. electrostatic potential that is able to attract and orient neg. charged ligands.  The presence of this pos. region and of two unique bulky residues, Ile-66 and Ile-174, responsible for the reduced dimension of the CK2 active site, play a crit. role in detg. ligand orientation and binding selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSMNNdsb_oCLVg90H21EOLACvtfcHk0li6RnBF55XzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVansrnN&md5=5b6293bacf028688ab805312443aed90</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11010-008-9822-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-008-9822-5%26sid%3Dliteratum%253Aachs%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DA%2520Structural%2520Insight%2520into%2520CK2%2520Inhibition%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D316%26spage%3D57%26epage%3D62%26doi%3D10.1007%2Fs11010-008-9822-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moucadel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettaoussi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of Holoenzyme-Disrupting Chemicals as Substrate-Selective CK2 Inhibitors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">15893</span> <span class="refDoi"> DOI: 10.1038/s41598-019-52141-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fs41598-019-52141-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31685885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A280%3ADC%252BB3MjltVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&author=I.+Kufarevaauthor=B.+Bestgenauthor=P.+Brearauthor=R.+Prudentauthor=B.+Laudetauthor=V.+Moucadelauthor=M.+Ettaoussiauthor=C.+F.+Sautelauthor=I.+Krimmauthor=M.+Engelauthor=O.+Filholauthor=M.+Le+Borgneauthor=T.+Lombergetauthor=C.+Cochetauthor=R.+Abagyan&title=Discovery+of+Holoenzyme-Disrupting+Chemicals+as+Substrate-Selective+CK2+Inhibitors&doi=10.1038%2Fs41598-019-52141-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors</span></div><div class="casAuthors">Kufareva Irina; Abagyan Ruben; Bestgen Benoit; Ettaoussi Mohamed; Borgne Marc Le; Lomberget Thierry; Bestgen Benoit; Engel Matthias; Bestgen Benoit; Prudent Renaud; Laudet Beatrice; Moucadel Virginie; Sautel Celine F; Filhol Odile; Cochet Claude; Bestgen Benoit; Brear Paul; Prudent Renaud; Laudet Beatrice; Moucadel Virginie; Sautel Celine F; Krimm Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15893</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CK2 is a constitutively active protein kinase overexpressed in numerous malignancies.  Interaction between CK2α and CK2β subunits is essential for substrate selectivity.  The CK2α/CK2β interface has been previously targeted by peptides to achieve functional effects; however, no small molecules modulators were identified due to pocket flexibility and open shape.  Here we generated numerous plausible conformations of the interface using the fumigation modeling protocol, and virtually screened a compound library to discover compound 1 that suppressed CK2α/CK2β interaction in vitro and inhibited CK2 in a substrate-selective manner.  Orthogonal SPR, crystallography, and NMR experiments demonstrated that 4 and 6, improved analogs of 1, bind to CK2α as predicted.  Both inhibitors alter CK2 activity in cells through inhibition of CK2 holoenzyme formation.  Treatment with 6 suppressed MDA-MB231 triple negative breast cancer cell growth and induced apoptosis.  Altogether, our findings exemplify an innovative computational-experimental approach and identify novel non-peptidic inhibitors of CK2 subunit interface disclosing substrate-selective functional effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmE_81mdt7jNenUz0lpNqnfW6udTcc2eb5dF5KbXCW5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjltVOnuw%253D%253D&md5=9cbb832ee1fc84a087151c72111f6808</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-52141-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-52141-5%26sid%3Dliteratum%253Aachs%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DLaudet%26aufirst%3DB.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DEttaoussi%26aufirst%3DM.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DLomberget%26aufirst%3DT.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520Holoenzyme-Disrupting%2520Chemicals%2520as%2520Substrate-Selective%2520CK2%2520Inhibitors%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26doi%3D10.1038%2Fs41598-019-52141-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Newton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span> <span> </span><span class="NLM_article-title">Specific Inhibition of CK2α from an Anchor Outside the Active Site</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6845</span>, <span class="refDoi"> DOI: 10.1039/C6SC02335E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC6SC02335E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28451126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=6839-6845&author=P.+Brearauthor=C.+De+Fuscoauthor=K.+Hadje+Georgiouauthor=N.+J.+Francis-Newtonauthor=C.+J.+Stubbsauthor=H.+F.+Soreauthor=A.+R.+Venkitaramanauthor=C.+Abellauthor=D.+R.+Springauthor=M.+Hyv%C3%B6nen&title=Specific+Inhibition+of+CK2%CE%B1+from+an+Anchor+Outside+the+Active+Site&doi=10.1039%2FC6SC02335E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of CK2α from an anchor outside the active site</span></div><div class="casAuthors">Brear, Paul; De Fusco, Claudia; Hadje Georgiou, Kathy; Francis-Newton, Nicola J.; Stubbs, Christopher J.; Sore, Hannah F.; Venkitaraman, Ashok R.; Abell, Chris; Spring, David R.; Hyvonen, Marko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6839-6845</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site.  Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site.  We have identified a new binding site for small mols. on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket.  An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors.  CAM4066 shows target engagement in several cell lines and similar potency to clin. trial candidate CX4945.  Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α via a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FqxiBkU9frVg90H21EOLACvtfcHk0li6RnBF55XzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP&md5=c4652010f4da70a128fb1dab64f811d0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC6SC02335E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02335E%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DFrancis-Newton%26aufirst%3DN.%2BJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibition%2520of%2520CK2%25CE%25B1%2520from%2520an%2520Anchor%2520Outside%2520the%2520Active%2520Site%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D6839%26epage%3D6845%26doi%3D10.1039%2FC6SC02335E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Second-Generation CK2α Inhibitors Targeting the αD Pocket</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3041</span>– <span class="NLM_lpage">3049</span>, <span class="refDoi"> DOI: 10.1039/C7SC05122K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC7SC05122K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29732088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3041-3049&author=J.+Iegreauthor=P.+Brearauthor=C.+De+Fuscoauthor=M.+Yoshidaauthor=S.+L.+Mitchellauthor=M.+Rossmannauthor=L.+Carroauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Second-Generation+CK2%CE%B1+Inhibitors+Targeting+the+%CE%B1D+Pocket&doi=10.1039%2FC7SC05122K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation CK2α inhibitors targeting the αD pocket</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3041-3049</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CK2 is a crit. cell cycle regulator that also promotes various anti-apoptotic mechanisms.  Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases.  We have previously utilized a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066.  While CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site.  This second generation αD-site binding inhibitor, compd. CAM4712 (IC50 = 7μM, GI50 = 10.0 ± 3.6μM), has numerous advantages over the previously reported CAM4066, including a redn. in the no. of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability.  Unlike with CAM4066, there was no need to facilitate cellular uptake by making a prodrug.  Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50) and the ability to inhibit cell proliferation (GI50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPLu-nG6dLLVg90H21EOLACvtfcHk0liujZ9McrTMBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D&md5=4d57e89546e1c7bcac4868e3a02ba2f8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC05122K%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRossmann%26aufirst%3DM.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSecond-Generation%2520CK2%25CE%25B1%2520Inhibitors%2520Targeting%2520the%2520%25CE%25B1D%2520Pocket%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D3041%26epage%3D3049%26doi%3D10.1039%2FC7SC05122K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A Fragment-Based Approach Leading to the Discovery of a Novel Binding Site and the Selective CK2 Inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=A+Fragment-Based+Approach+Leading+to+the+Discovery+of+a+Novel+Binding+Site+and+the+Selective+CK2+Inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0liujZ9McrTMBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520Fragment-Based%2520Approach%2520Leading%2520to%2520the%2520Discovery%2520of%2520a%2520Novel%2520Binding%2520Site%2520and%2520the%2520Selective%2520CK2%2520Inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochscherf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O.-G.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Potent, Selective and Cell Permeable Inhibitor of Protein Kinase CK2 from the NIH/NCI Diversity Set Library</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1007/s11010-015-2433-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs11010-015-2433-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=25963666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2015&pages=151-161&author=B.+Guerraauthor=J.+Hochscherfauthor=N.+B.+Jensenauthor=O.-G.+Issinger&title=Identification+of+a+Novel+Potent%2C+Selective+and+Cell+Permeable+Inhibitor+of+Protein+Kinase+CK2+from+the+NIH%2FNCI+Diversity+Set+Library&doi=10.1007%2Fs11010-015-2433-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library</span></div><div class="casAuthors">Guerra, Barbara; Hochscherf, Jennifer; Jensen, Nina Bjelkerup; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">151-161</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The anti-apoptotic protein kinase CK2 increasingly becomes an attractive target in cancer research with great therapeutic potential.  Here, we have performed an in vitro screening of the Diversity Set III of the DTP program from the NCI/NIH, comprising 1600 compds.  We have identified 1,3-Dichloro-6-[(E)-((4-methoxyphenyl)imino)methyl] dibenzo(b,d) furan-2,7-diol (referred to as D11) to be a potent and selective inhibitor of protein kinase CK2.  The D11 compd. was tested against 354 eukaryotic protein kinases.  By setting the threshold for inhibition to <2 % remaining kinase activity, only DYRK1B, IRAK1 and PIM3 were inhibited to an extent as the tetrameric CK2 holoenzyme and its catalytic subunits α and α'.  The IC50 values for the CK2α and CK2α' were on av. 1-2 nM in comparison to the DYRK1B, IRAK1 and PIM3 kinases, which ranged from 18 to 49 nM.  Cell permeability and efficacy of D11 were tested with cells in culture.  In MIA PaCa-2 cells (human pancreatic carcinoma cell line), the phosphorylation of the CK2 biomarker CDC37 at S13 was almost completely inhibited in the presence of D11.  This was obsd. both under normoxia and hypoxia.  In the case of the human non-small cell lung carcinoma cell line, H1299, increasing amts. of D11 led to an inhibition of S380/T382/383 phosphorylation in PTEN, another biomarker for CK2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF_SAUAmFD3rVg90H21EOLACvtfcHk0liujZ9McrTMBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFKju74%253D&md5=152fb98f0414cd69be647a83dd88debb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs11010-015-2433-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-015-2433-z%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DHochscherf%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DN.%2BB.%26aulast%3DIssinger%26aufirst%3DO.-G.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Potent%252C%2520Selective%2520and%2520Cell%2520Permeable%2520Inhibitor%2520of%2520Protein%2520Kinase%2520CK2%2520from%2520the%2520NIH%252FNCI%2520Diversity%2520Set%2520Library%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2015%26volume%3D406%26spage%3D151%26epage%3D161%26doi%3D10.1007%2Fs11010-015-2433-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prins, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurgeon, S. E.</span></span> <span> </span><span class="NLM_article-title">CX-4945, a Selective Inhibitor of Casein Kinase-2 (CK2), Exhibits Anti-Tumor Activity in Hematologic Malignancies Including Enhanced Activity in Chronic Lymphocytic Leukemia When Combined with Fludarabine and Inhibitors of the B-Cell Receptor Pathway</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2094</span>– <span class="NLM_lpage">2096</span>, <span class="refDoi"> DOI: 10.1038/leu.2013.228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fleu.2013.228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=23900138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2094-2096&author=R.+C.+Prinsauthor=R.+T.+Burkeauthor=J.+W.+Tynerauthor=B.+J.+Drukerauthor=M.+M.+Loriauxauthor=S.+E.+Spurgeon&title=CX-4945%2C+a+Selective+Inhibitor+of+Casein+Kinase-2+%28CK2%29%2C+Exhibits+Anti-Tumor+Activity+in+Hematologic+Malignancies+Including+Enhanced+Activity+in+Chronic+Lymphocytic+Leukemia+When+Combined+with+Fludarabine+and+Inhibitors+of+the+B-Cell+Receptor+Pathway&doi=10.1038%2Fleu.2013.228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway</span></div><div class="casAuthors">Prins, R. C.; Burke, R. T.; Tyner, J. W.; Druker, B. J.; Loriaux, M. M.; Spurgeon, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2094-2096</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Relapsed and refractory lymphoid and myeloid malignancies are often characterized by progressive resistance to std. chemotherapy as well as poor long-term outcomes.  Addnl., many of the conventional treatment regimens may be accompanied by significant toxicity in this heavily pretreated population.  Consequently, there is a need for novel therapies in these patients.  Specific inhibition of essential signaling pathways offers potential for the design of rational therapeutic alternatives to cytotoxic chemotherapy.  Among potential promising targets is casein kinase-2 (CK2), a highly conserved serine-threonine protein kinase comprised of two catalytic (α and α') and two regulatory (β) subunits.  CK2 regulates a large no. of crit. signaling networks and downstream prosurvival and antiapoptotic substrates known to be essential to hematopoietic cell function.1, 2 CK2 has been found to be overexpressed in many cancers, including hematol. malignancies such as chronic lymphocytic leukemia (CLL),3 acute myeloid leukemia (AML),4 T-cell acute lymphocytic leukemia (T-ALL)5 and multiple myeloma.6 Malignant cells are more dependent than normal tissues on upregulated levels of CK2 to sustain their growth and viability,7 and elevated levels of CK2 have been found to correlate with inferior prognosis.2 Consequently, despite its crit. role in a diverse array of cellular processes, malignant cells are significantly more sensitive to CK2 downregulation;2, 3, 4, 5, 6, 7, 8, 9 potentially increasing its appeal as a therapeutic target.  CX-4945 is a selective, potent and orally bioavailable inhibitor of both isoforms of the CK2 catalytic subunits, and is the first small-mol. inhibitor of CK2 to progress to human clin. trials.9 Anti-tumor activity of CX-4945 has been validated in cancer cell lines and murine xenograft models, and biol. activity has been obsd. in early phase clin. trials treating solid tumors.9, 10, 11 However, little is known about its activity in leukemias and lymphomas.  Therefore, using primary patient samples, we explored the therapeutic potential of CX-4945 across a wide spectrum of hematol. malignancies.  After informed consent, in accordance with the Declaration of Helsinki and approved by the institutional review board, Ficoll-purified leukemia cells from 224 patients were cultured in the presence or absence of four serial dilns. of CX-4945 (Cylene Pharmaceuticals Inc., San Diego, CA, USA) ranging from 10 n to 10 μ.  Overall, 74 CLL, 60 AML, 58 B-cell acute lymphocytic leukemia, 13 chronic monomyelocytic leukemia (CMML), 4 T-ALL, 11 lymphoma and 4 chronic myeloid leukemia (CML) patients were included in the anal.  Purified leukemia cells were then cultured in RPMI+20̂ fetal bovine serum+β-mercaptoethanol.  A tetrazolium-based assay (MTS) was used to measure cell viability, which was then used to calc. IC50 values.  Of the seven types of hematol. malignancies evaluated, all except CMML and CML demonstrated a subset of patients with significantly decreased viability (IC50<1 μ) in response to CX-4945 (Table 1 and Figure 1a).  Median IC50 of all samples tested was 6.7 μ.  CX-4945 appeared to be the most active in lymphoid malignancies, as this group contained the highest subset of sensitive patients (Table 1).  Of note, among the 16 sensitive CLL samples tested, 6 samples had an IC50<100 nm suggesting that there is a subset of samples that are highly sensitive to CK2 inhibition.  Significant decreases in CLL cell viability in response to treatment with CX-4945 were obsd. in samples harboring a variety of high-risk features such as advanced Rai stage, CD38 and/or Zap 70 expression, unmutated variable region of the Ig heavy chain (IgVH), chromosome 11q or17p deletion.  No specific biol. factors, including IgVH mutational status, were found to correlate with sensitivity.  Notably, three of nine (33.3̂) samples with known 17p deletion exhibited sensitivity (IC50<1 μ) to CX-4945 with a median IC50 of 409.2 n.  Given that CX-4945 appeared to be most active in lymphoid malignancies, specifically CLL, we subsequently focused on this population.  The prosurvival and chemoprotective roles of the bone marrow and lymph node microenvironment have been well described in CLL.12 Therefore, we cultured purified CLL cells obtained from six CLL patients in HS-5 stromal cell-conditioned media (RPMI+10̂ fetal bovine serum plated over HS-5 cells for 3 h) to mimic the in-vivo CLL microenvironment, and found that CX-4945 decreased cell viability (Figure 1b).  This finding suggests that CX-4945 may be effective at reducing CLL cell viability not only in the peripheral blood, but also in protective compartments such as the bone marrow and lymph nodes.  B-cell receptor (BCR) activation leads to survival and proliferation of B-lymphocytes through signaling of survival kinases such as PI3K and AKT.  Drugs that inhibit the transmission of signals through the BCR have been shown to disrupt the microenvironment and promote apoptosis.13 Located downstream of the BCR, CK2 has an important role in the regulation of oncogenic pathways shared with the BCR, including PI3K and AKT,1, 3, 7, 8 and also functions in the DNA repair response.6, 10 CK2 inhibition downregulates AKT activity and enhances the cytotoxic effect of chemotherapy.3, 5, 6, 8, 9, 10 Specifically, early work using a CLL mouse model demonstrated that CX-4945 plus the purine nucleoside analog fludarabine was more effective than fludarabine alone.14 Furthermore, given that cell survival relies on the convergence of many regulatory inputs including those transmitted via the BCR, we hypothesized that inhibiting the growth and survival pathway at more than one site would lead to enhanced activity.  We therefore investigated the efficacy of CX-4945 in combination with fludarabine, which continues to form the backbone of cytotoxic CLL therapy, and with inhibitors of kinases known to be essential to the BCR pathway.  For synergy expts., purified leukemia cells were re-suspended in HS-5-conditioned media and added to wells contg. serial dilns. of CX-4945 alone and in combination with serial dilns. of agents known to disrupt BCR-mediated signaling pathways, including the PI3K-delta isoform-specific inhibitor GS-1101 (Selleck Chems., Houston, TX, USA), the inhibitor of Bruton's tyrosine kinase ibrutinib (Selleck Chems., Houston, TX, USA) and fludarabine.  Dilns. of all drugs ranged from 41.1 n to 10 μ.  Cells were cultured for 72 h and MTS was used to measure cell viability.  Synergy anal. was performed using the Chou-Talalay method.15 We obsd. synergy (defined as median combination index (CI) <1) between CX-4945 and GS-1101 in six of eight samples tested (Figure 1c).  The median CI for all samples was 0.46.  Synergy was demonstrated in 8 of 10 samples treated with CX-4945 and ibrutinib (Figure 1d), with a median CI for all samples of 0.56.  Finally, 10 of 13 CLL samples treated with a combination of CX-4945 and fludarabine showed synergy, with a median CI of 0.30 for all samples (Figure 1e).  Representative drug curves are shown in Figures 1f-h.  In conclusion, these results demonstrate that the CK2-inhibitor CX-4945 has preclin. activity across a broad range of hematol. malignancies, most significantly in lymphoid malignancies.  Addnl., CX-4945 appears to enhance the efficacy of inhibitors of the BCR pathway as well as fludarabine in primary CLL cells.  Given the complexity of the intracellular signaling networks in hematol. malignancies, rational drug combinations that target multiple sites in the prosurvival pathway represent a promising strategy for the treatment of this population.  As such, CX-4945 warrants further investigation in combination with chemotherapy and BCR pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8WhHDw3hthbVg90H21EOLACvtfcHk0liNuxrxvXAigw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7%252FO&md5=a3510c891c7b5cf20c89058efccf5837</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.228%26sid%3Dliteratum%253Aachs%26aulast%3DPrins%26aufirst%3DR.%2BC.%26aulast%3DBurke%26aufirst%3DR.%2BT.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DSpurgeon%26aufirst%3DS.%2BE.%26atitle%3DCX-4945%252C%2520a%2520Selective%2520Inhibitor%2520of%2520Casein%2520Kinase-2%2520%2528CK2%2529%252C%2520Exhibits%2520Anti-Tumor%2520Activity%2520in%2520Hematologic%2520Malignancies%2520Including%2520Enhanced%2520Activity%2520in%2520Chronic%2520Lymphocytic%2520Leukemia%2520When%2520Combined%2520with%2520Fludarabine%2520and%2520Inhibitors%2520of%2520the%2520B-Cell%2520Receptor%2520Pathway%26jtitle%3DLeukemia%26date%3D2013%26volume%3D27%26spage%3D2094%26epage%3D2096%26doi%3D10.1038%2Fleu.2013.228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alimzhanov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=300-305&author=J.+E.+Dowlingauthor=M.+Alimzhanovauthor=L.+Baoauthor=C.+Chuaquiauthor=C.+R.+Denzauthor=E.+Jenkinsauthor=N.+A.+Larsenauthor=P.+D.+Lyneauthor=T.+Pontzauthor=Q.+Yeauthor=G.+A.+Holdgateauthor=L.+Snowauthor=N.+O%E2%80%99Connellauthor=A.+D.+Ferguson&title=Potent+and+Selective+CK2+Kinase+Inhibitors+with+Effects+on+Wnt+Pathway+Signaling+in+Vivo&doi=10.1021%2Facsmedchemlett.5b00452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo</span></div><div class="casAuthors">Dowling, James E.; Alimzhanov, Marat; Bao, Larry; Chuaqui, Claudio; Denz, Christopher R.; Jenkins, Emma; Larsen, Nicholas A.; Lyne, Paul D.; Pontz, Timothy; Ye, Qing; Holdgate, Geoff A.; Snow, Lindsay; O'Connell, Nichole; Ferguson, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-305</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt pathway is an evolutionarily conserved and tightly regulated signaling network with important roles in embryonic development and adult tissue regeneration.  Impaired Wnt pathway regulation, arising from mutations in Wnt signaling components, such as Axin, APC, and β-catenin, results in uncontrolled cell growth and triggers oncogenesis.  To explore the reported link between CK2 kinase activity and Wnt pathway signaling, the authors sought to identify a potent, selective inhibitor of CK2 suitable for proof of concept studies in vivo.  Starting from a pyrazolo[1,5-a]pyrimidine lead, the authors identified N-(2-((2-aminoethyl)(methyl)amino)-5-(3-cyano-7-(cyclopropylamino) pyrazolo[1,5-a]pyrimidin-5-ylamino)phenyl)acetamide (compd. 7h), a potent CK2 inhibitor with picomolar affinity that is highly selectivity against other kinase family enzymes and inhibits Wnt pathway signaling (IC50 = 50 nM) in DLD-1 cells.  In addn., (compd. 7h) has physicochem. properties that are suitable for formulation as an i.v. soln., has demonstrated good pharmacokinetics in preclin. species, and exhibits a high level of activity as a monotherapy in HCT-116 and SW-620 xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9Sjmp1vsrLVg90H21EOLACvtfcHk0liNuxrxvXAigw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D&md5=515b631b98c356f27733856cfdca78b7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00452%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DDenz%26aufirst%3DC.%2BR.%26aulast%3DJenkins%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DSnow%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26atitle%3DPotent%2520and%2520Selective%2520CK2%2520Kinase%2520Inhibitors%2520with%2520Effects%2520on%2520Wnt%2520Pathway%2520Signaling%2520in%2520Vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D300%26epage%3D305%26doi%3D10.1021%2Facsmedchemlett.5b00452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Götz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucklaender, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jose, J.</span></span> <span> </span><span class="NLM_article-title">TF-A Novel Cell-Permeable and Selective Inhibitor of Human Protein Kinase CK2 Induces Apoptosis in the Prostate Cancer Cell Line LNCaP</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1820</i></span>,  <span class="NLM_fpage">970</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbagen.2012.02.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1820&publication_year=2012&pages=970-977&author=C.+G%C3%B6tzauthor=A.+Gratzauthor=U.+Kucklaenderauthor=J.+Jose&title=TF-A+Novel+Cell-Permeable+and+Selective+Inhibitor+of+Human+Protein+Kinase+CK2+Induces+Apoptosis+in+the+Prostate+Cancer+Cell+Line+LNCaP&doi=10.1016%2Fj.bbagen.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6tz%26aufirst%3DC.%26aulast%3DGratz%26aufirst%3DA.%26aulast%3DKucklaender%26aufirst%3DU.%26aulast%3DJose%26aufirst%3DJ.%26atitle%3DTF-A%2520Novel%2520Cell-Permeable%2520and%2520Selective%2520Inhibitor%2520of%2520Human%2520Protein%2520Kinase%2520CK2%2520Induces%2520Apoptosis%2520in%2520the%2520Prostate%2520Cancer%2520Cell%2520Line%2520LNCaP%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2012%26volume%3D1820%26spage%3D970%26epage%3D977%26doi%3D10.1016%2Fj.bbagen.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vialettes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darjania, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stansfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span> <span> </span><span class="NLM_article-title">Pre-Clinical Characterization of CX-4945, a Potent and Selective Small Molecule Inhibitor of CK2 for the Treatment of Cancer</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1007/s11010-011-0956-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs11010-011-0956-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21755459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleqsrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2011&pages=37-43&author=F.+Pierreauthor=P.+C.+Chuaauthor=S.+E.+O%E2%80%99Brienauthor=A.+Siddiqui-Jainauthor=P.+Bourbonauthor=M.+Haddachauthor=J.+Michauxauthor=J.+Nagasawaauthor=M.+K.+Schwaebeauthor=E.+Stefanauthor=A.+Vialettesauthor=J.+P.+Whittenauthor=T.+K.+Chenauthor=L.+Darjaniaauthor=R.+Stansfieldauthor=J.+Bliesathauthor=D.+Dryginauthor=C.+Hoauthor=M.+Omoriauthor=C.+Proffittauthor=N.+Streinerauthor=W.+G.+Riceauthor=D.+M.+Ryckmanauthor=K.+Anderes&title=Pre-Clinical+Characterization+of+CX-4945%2C+a+Potent+and+Selective+Small+Molecule+Inhibitor+of+CK2+for+the+Treatment+of+Cancer&doi=10.1007%2Fs11010-011-0956-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer</span></div><div class="casAuthors">Pierre, Fabrice; Chua, Peter C.; O'Brien, Sean E.; Siddiqui-Jain, Adam; Bourbon, Pauline; Haddach, Mustapha; Michaux, Jerome; Nagasawa, Johnny; Schwaebe, Michael K.; Stefan, Eric; Vialettes, Anne; Whitten, Jeffrey P.; Chen, Ta Kung; Darjania, Levan; Stansfield, Ryan; Bliesath, Joshua; Drygin, Denis; Ho, Caroline; Omori, May; Proffitt, Chris; Streiner, Nicole; Rice, William G.; Ryckman, David M.; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">37-43</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this article we describe the preclin. characterization of 5-(3-chlorophenylamino) benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first orally available small mol. inhibitor of protein CK2 in clin. trials for cancer.  CX-4945 was optimized as an ATP-competitive inhibitor of the CK2 holoenzyme (Ki = 0.38 nM).  Iterative synthesis and screening of analogs, guided by mol. modeling, led to the discovery of orally available CX-4945.  CK2 promotes signaling in the Akt pathway and CX-4945 suppresses the phosphorylation of Akt as well as other key downstream mediators of the pathway such as p21.  CX-4945 induced apoptosis and caused cell cycle arrest in cancer cells in vitro.  CX-4945 exhibited a dose-dependent antitumor activity in a xenograft model of PC3 prostate cancer model and was well tolerated.  In vivo time-dependent redn. in the phosphorylation of the biomarker p21 at T145 was obsd. by immunohistochem.  Inhibition of the newly validated CK2 target by CX-4945 represents a fresh therapeutic strategy for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH9CxZ62fC-rVg90H21EOLACvtfcHk0lj-obljmHQ5JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleqsrjO&md5=4c35a8e6f161485dffd10be9de0b2ef1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11010-011-0956-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-011-0956-5%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DChua%26aufirst%3DP.%2BC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DBourbon%26aufirst%3DP.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DNagasawa%26aufirst%3DJ.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DStefan%26aufirst%3DE.%26aulast%3DVialettes%26aufirst%3DA.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DT.%2BK.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DStansfield%26aufirst%3DR.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DPre-Clinical%2520Characterization%2520of%2520CX-4945%252C%2520a%2520Potent%2520and%2520Selective%2520Small%2520Molecule%2520Inhibitor%2520of%2520CK2%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D356%26spage%3D37%26epage%3D43%26doi%3D10.1007%2Fs11010-011-0956-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Efficient Development of Stable and Highly Functionalised Peptides Targeting the CK2α/CK2β Protein-Protein Interaction</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5056</span>– <span class="NLM_lpage">5063</span>, <span class="refDoi"> DOI: 10.1039/C9SC00798A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC9SC00798A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31183056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsFSisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=5056-5063&author=J.+Iegreauthor=P.+Brearauthor=D.+J.+Bakerauthor=Y.+S.+Tanauthor=E.+L.+Atkinsonauthor=H.+F.+Soreauthor=D.+H.+O%E2%80%99Donovanauthor=C.+S.+Vermaauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Efficient+Development+of+Stable+and+Highly+Functionalised+Peptides+Targeting+the+CK2%CE%B1%2FCK2%CE%B2+Protein-Protein+Interaction&doi=10.1039%2FC9SC00798A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein-protein interaction</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; Baker, David J.; Tan, Yaw Sing; Atkinson, Eleanor L.; Sore, Hannah F.; O' Donovan, Daniel H.; Verma, Chandra S.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5056-5063</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The discovery of new Protein-Protein Interaction (PPI) modulators is currently limited by the difficulties assocd. with the design and synthesis of selective small mol. inhibitors.  Peptides are a potential soln. for disrupting PPIs; however, they typically suffer from poor stability in vivo and limited tissue penetration hampering their wide spread use as new chem. biol. tools and potential therapeutics.  In this work, a combination of CuAAC chem., mol. modeling, X-ray crystallog., and biol. validation allowed us to develop highly functionalised peptide PPI inhibitors of the protein CK2.  The lead peptide, CAM7117, prevents the formation of the holoenzyme assembly in vitro, slows down proliferation, induces apoptosis in cancer cells and is stable in human serum.  CAM7117 could aid the development of novel CK2 inhibitors acting at the interface and help to fully understand the intracellular pathways involving CK2.  Importantly, the approach adopted herein could be applied to many PPI targets and has the potential to ease the study of PPIs by efficiently providing access to functionalised peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYHV8LQ_rU-rVg90H21EOLACvtfcHk0lj-obljmHQ5JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsFSisb4%253D&md5=f87360d6d772c26396751ec8f0e5d33c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2FC9SC00798A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC00798A%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DBaker%26aufirst%3DD.%2BJ.%26aulast%3DTan%26aufirst%3DY.%2BS.%26aulast%3DAtkinson%26aufirst%3DE.%2BL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DD.%2BH.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DEfficient%2520Development%2520of%2520Stable%2520and%2520Highly%2520Functionalised%2520Peptides%2520Targeting%2520the%2520CK2%25CE%25B1%252FCK2%25CE%25B2%2520Protein-Protein%2520Interaction%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26spage%3D5056%26epage%3D5063%26doi%3D10.1039%2FC9SC00798A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">North, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Novel Non-ATP Competitive Small Molecules Targeting the CK2 α/β Interface</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3016</span>– <span class="NLM_lpage">3020</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2018.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29759799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptl2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3016-3020&author=P.+Brearauthor=A.+Northauthor=J.+Iegreauthor=K.+Hadje+Georgiouauthor=A.+Lubinauthor=L.+Carroauthor=W.+Greenauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Novel+Non-ATP+Competitive+Small+Molecules+Targeting+the+CK2+%CE%B1%2F%CE%B2+Interface&doi=10.1016%2Fj.bmc.2018.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel non-ATP competitive small molecules targeting the CK2 α/β interface</span></div><div class="casAuthors">Brear, Paul; North, Andrew; Iegre, Jessica; Hadje Georgiou, Kathy; Lubin, Alexandra; Carro, Laura; Green, William; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3016-3020</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Increased CK2 levels are prevalent in many cancers.  Combined with the crit. role CK2 plays in many cell-signaling pathways, this makes it a prime target for down regulation to fight tumor growth.  Herein, we report a fragment-based approach to inhibiting the interaction between CK2α and CK2β at the α-β interface of the holoenzyme.  A fragment, CAM187, with an IC50 of 44μM and a mol. wt. of only 257gmol-1 has been identified as the most promising compd.  Importantly, the lead fragment only bound at the interface and was not obsd. in the ATP binding site of the protein when co-crystd. with CK2α.  The fragment-like mols. discovered in this study represent unique scaffolds to CK2 inhibition and leave room for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6go0iwXoayLVg90H21EOLACvtfcHk0lgI63vf7ZfQFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptl2ks74%253D&md5=c2ed9aad2cb3e1a33f30f0d5cb1beb00</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DNorth%26aufirst%3DA.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DLubin%26aufirst%3DA.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DGreen%26aufirst%3DW.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DNovel%2520Non-ATP%2520Competitive%2520Small%2520Molecules%2520Targeting%2520the%2520CK2%2520%25CE%25B1%252F%25CE%25B2%2520Interface%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3016%26epage%3D3020%26doi%3D10.1016%2Fj.bmc.2018.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetoh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1836</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01765</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01765" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1817-1836&author=B.+Bestgenauthor=I.+Kufarevaauthor=W.+Seetohauthor=C.+Abellauthor=R.+W.+Hartmannauthor=R.+Abagyanauthor=M.+Le+Borgneauthor=O.+Filholauthor=C.+Cochetauthor=T.+Lombergetauthor=M.+Engel&title=2-Aminothiazole+Derivatives+as+Selective+Allosteric+Modulators+of+the+Protein+Kinase+CK2.+2.+Structure-Based+Optimization+and+Investigation+of+Effects+Specific+to+the+Allosteric+Mode+of+Action&doi=10.1021%2Facs.jmedchem.8b01765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action</span></div><div class="casAuthors">Bestgen, Benoit; Kufareva, Irina; Seetoh, Weiguang; Abell, Chris; Hartmann, Rolf W.; Abagyan, Ruben; Le Borgne, Marc; Filhol, Odile; Cochet, Claude; Lomberget, Thierry; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1817-1836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein CK2 has gained much interest as an anticancer drug target in the past decade.  We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small mol. ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold.  In the present work, structure optimizations guided by a binding model led to the identification of the lead compd. 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (27), showing a submicromolar potency against purified CK2α (IC50 = 0.6 μM).  Furthermore, 27 induced apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 μM) and inhibited STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945 (EC50 of 1.6 μM vs 5.3 μM).  Notably, the potencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate.  Altogether, the novel allosteric pocket was proved a druggable site, offering an excellent perspective to develop efficient and selective allosteric CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExtWddxHflbVg90H21EOLACvtfcHk0lgI63vf7ZfQFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKjt74%253D&md5=f0f9c87e819f89b94842b8ddea81ebed</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01765%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DSeetoh%26aufirst%3DW.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DLomberget%26aufirst%3DT.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3D2-Aminothiazole%2520Derivatives%2520as%2520Selective%2520Allosteric%2520Modulators%2520of%2520the%2520Protein%2520Kinase%2520CK2.%25202.%2520Structure-Based%2520Optimization%2520and%2520Investigation%2520of%2520Effects%2520Specific%2520to%2520the%2520Allosteric%2520Mode%2520of%2520Action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1817%26epage%3D1836%26doi%3D10.1021%2Facs.jmedchem.8b01765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetoh, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span> <span> </span><span class="NLM_article-title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01766</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01766" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFKjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1803-1816&author=B.+Bestgenauthor=I.+Krimmauthor=I.+Kufarevaauthor=A.+A.+M.+Kamalauthor=W.+G.+Seetohauthor=C.+Abellauthor=R.+W.+Hartmannauthor=R.+Abagyanauthor=C.+Cochetauthor=M.+Le+Borgneauthor=M.+Engelauthor=T.+Lomberget&title=2-Aminothiazole+Derivatives+as+Selective+Allosteric+Modulators+of+the+Protein+Kinase+CK2.+1.+Identification+of+an+Allosteric+Binding+Site&doi=10.1021%2Facs.jmedchem.8b01766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site</span></div><div class="casAuthors">Bestgen, Benoit; Krimm, Isabelle; Kufareva, Irina; Kamal, Ahmed Ashraf Moustafa; Seetoh, Wei-Guang; Abell, Chris; Hartmann, Rolf W.; Abagyan, Ruben; Cochet, Claude; Le Borgne, Marc; Engel, Matthias; Lomberget, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1803-1816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a ubiquitous Ser/Thr protein kinase involved in the control of various signaling pathways and is known to be constitutively active.  In the present study, we identified aryl 2-aminothiazoles as a novel class of CK2 inhibitors, which displayed a non-ATP-competitive mode of action and stabilized an inactive conformation of CK2 in soln.  Enzyme kinetics studies, STD NMR, CD spectroscopy, and native mass spectrometry expts. demonstrated that the compds. bind in an allosteric pocket outside the ATP-binding site.  Our data, combined with mol. docking studies, strongly suggested that this new binding site was located at the interface between the αC helix and the flexible glycine-rich loop.  A first hit optimization led to compd. 7, exhibiting an IC50 of 3.4 μM against purified CK2α in combination with a favorable selectivity profile.  Thus, we identified a novel class of CK2 inhibitors targeting an allosteric pocket, offering great potential for further optimization into anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrchN5EYaEF3LVg90H21EOLACvtfcHk0lgI63vf7ZfQFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKjs74%253D&md5=11cf634261058cdaa7ffa69e4c6b5457</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01766%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DKamal%26aufirst%3DA.%2BA.%2BM.%26aulast%3DSeetoh%26aufirst%3DW.%2BG.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DLomberget%26aufirst%3DT.%26atitle%3D2-Aminothiazole%2520Derivatives%2520as%2520Selective%2520Allosteric%2520Modulators%2520of%2520the%2520Protein%2520Kinase%2520CK2.%25201.%2520Identification%2520of%2520an%2520Allosteric%2520Binding%2520Site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1803%26epage%3D1816%26doi%3D10.1021%2Facs.jmedchem.8b01766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. H.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Insights into the Regulation Mechanism of CK2 by IP<sub>6</sub> and the Intrinsically Disordered Protein Nopp140</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">19360</span>– <span class="NLM_lpage">19365</span>, <span class="refDoi"> DOI: 10.1073/pnas.1304670110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1073%2Fpnas.1304670110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24218616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19360-19365&author=W.-K.+Leeauthor=S.+H.+Sonauthor=B.-S.+Jinauthor=J.-H.+Naauthor=S.-Y.+Kimauthor=K.+H.+Kimauthor=E.+E.+Kimauthor=Y.+G.+Yuauthor=H.+H.+Lee&title=Structural+and+Functional+Insights+into+the+Regulation+Mechanism+of+CK2+by+IP6+and+the+Intrinsically+Disordered+Protein+Nopp140&doi=10.1073%2Fpnas.1304670110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140</span></div><div class="casAuthors">Lee, Won-Kyu; Son, Sang Hyeon; Jin, Bong-Suk; Na, Jung-Hyun; Kim, Soo-Youl; Kim, Kook-Han; Kim, Eunice Eun Kyeong; Yu, Yeon Gyu; Lee, Hyung Ho</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19360-19365,S19360/1-S19360/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein kinase CK2 is a ubiquitous kinase that can phosphorylate hundreds of cellular proteins and plays important roles in cell growth and development.  Deregulation of CK2 is related to a variety of human cancers, and CK2 is regarded as a suppressor of apoptosis; therefore, it is a target of anticancer therapy.  Nucleolar phosphoprotein 140 (Nopp140), which is an intrinsically disordered protein, interacts with CK2 and inhibits the latter's catalytic activity in vitro.  Interestingly, the catalytic activity of CK2 is recovered in the presence of D-myo-inositol 1,2,3,4,5,6-hexakisphosphate (IP6).  IP6 is widely distributed in animal cells, but the mol. mechanisms that govern its cellular functions in animal cells have not been completely elucidated.  Here, the crystal structure of CK2 in complex with IP6 showed that the Lys-rich cluster of CK2 plays an important role in binding to IP6.  The biochem. expts. revealed that a Nopp140 fragment (residues 568-596) and IP6 competitively bound to the catalytic subunit of CK2 (CK2α), and phospho-Ser-574 of Nopp140 significantly enhanced its interaction with CK2α.  Substitutions of K74E, K76E, and K77E in CK2α significantly reduced the interactions of CK2α with both IP6 and the Nopp140-derived peptide.  Thus, this study provided an insight into the regulation of CK2.  In particular, this work suggests that CK2 activity is inhibited by Nopp140 and reactivated by IP6 by competitive binding at the substrate recognition site of CK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwaXQRyV6TjLVg90H21EOLACvtfcHk0ljmYPUcV9qnZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemtbfF&md5=12830fc6129e71cdcdb7c2baf4a89bd6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1304670110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1304670110%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DW.-K.%26aulast%3DSon%26aufirst%3DS.%2BH.%26aulast%3DJin%26aufirst%3DB.-S.%26aulast%3DNa%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DS.-Y.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DE.%2BE.%26aulast%3DYu%26aufirst%3DY.%2BG.%26aulast%3DLee%26aufirst%3DH.%2BH.%26atitle%3DStructural%2520and%2520Functional%2520Insights%2520into%2520the%2520Regulation%2520Mechanism%2520of%2520CK2%2520by%2520IP6%2520and%2520the%2520Intrinsically%2520Disordered%2520Protein%2520Nopp140%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D19360%26epage%3D19365%26doi%3D10.1073%2Fpnas.1304670110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A Fragment-Based Approach Leading to the Discovery of a Novel Binding Site and the Selective CK2 Inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyvonenauthor=D.+R.+Spring&title=A+Fragment-Based+Approach+Leading+to+the+Discovery+of+a+Novel+Binding+Site+and+the+Selective+CK2+Inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0ljmYPUcV9qnZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyvonen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520Fragment-Based%2520Approach%2520Leading%2520to%2520the%2520Discovery%2520of%2520a%2520Novel%2520Binding%2520Site%2520and%2520the%2520Selective%2520CK2%2520Inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngoei, K. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langendorf, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, N. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camerino, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozikis, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dite, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smiles, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rider, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foitzik, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakhill, J. S.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK Alpha 2 Beta 2 Gamma 1 by the Glucose Importagog SC4</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.chembiol.2018.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29657085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFCksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=728-737&author=K.+R.+W.+Ngoeiauthor=C.+G.+Langendorfauthor=N.+X.+Y.+Lingauthor=A.+Hoqueauthor=S.+Vargheseauthor=M.+A.+Camerinoauthor=S.+R.+Walkerauthor=Y.+E.+Bozikisauthor=T.+A.+Diteauthor=A.+J.+Ovensauthor=W.+J.+Smilesauthor=R.+Jacobsauthor=H.+Huangauthor=M.+W.+Parkerauthor=J.+W.+Scottauthor=M.+H.+Riderauthor=R.+C.+Foitzikauthor=B.+E.+Kempauthor=J.+B.+Baellauthor=J.+S.+Oakhill&title=Structural+Determinants+for+Small-Molecule+Activation+of+Skeletal+Muscle+AMPK+Alpha+2+Beta+2+Gamma+1+by+the+Glucose+Importagog+SC4&doi=10.1016%2Fj.chembiol.2018.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK α2β2γ1 by the Glucose Importagog SC4</span></div><div class="casAuthors">Ngoei, Kevin R. W.; Langendorf, Christopher G.; Ling, Naomi X. Y.; Hoque, Ashfaqul; Johnson, Swapna; Camerino, Michelle C.; Walker, Scott R.; Bozikis, Ylva E.; Dite, Toby A.; Ovens, Ashley J.; Smiles, William J.; Jacobs, Roxane; Huang, He; Parker, Michael W.; Scott, John W.; Rider, Mark H.; Foitzik, Richard C.; Kemp, Bruce E.; Baell, Jonathan B.; Oakhill, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">728-737.e9</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The AMP-activated protein kinase (AMPK) αβγ heterotrimer regulates cellular energy homeostasis with tissue-specific isoform distribution.  Small-mol. activation of skeletal muscle α2β2 AMPK complexes may prove a valuable treatment strategy for type 2 diabetes and insulin resistance.  Herein, we report the small-mol. SC4 is a potent, direct AMPK activator that preferentially activates α2 complexes and stimulates skeletal muscle glucose uptake.  In parallel with the term secretagog, we propose "importagog" to define a substance that induces or augments cellular uptake of another substance.  Three-dimensional structures of the glucose importagog SC4 bound to activated α2β2γ1 and α2β1γ1 complexes reveal binding determinants, in particular a key interaction between the SC4 imidazopyridine 4'-nitrogen and β2-Asp111, which provide a design paradigm for β2-AMPK therapeutics.  The α2β2γ1/SC4 structure reveals an interaction between a β2 N-terminal α helix and the α2 autoinhibitory domain.  Our results provide a structure-function guide to accelerate development of potent, but importantly tissue-specific, β2-AMPK therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_umJeuj3fV7Vg90H21EOLACvtfcHk0ljmYPUcV9qnZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFCksLg%253D&md5=f2c3fdb43956995ea6171bac215793cb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DNgoei%26aufirst%3DK.%2BR.%2BW.%26aulast%3DLangendorf%26aufirst%3DC.%2BG.%26aulast%3DLing%26aufirst%3DN.%2BX.%2BY.%26aulast%3DHoque%26aufirst%3DA.%26aulast%3DVarghese%26aufirst%3DS.%26aulast%3DCamerino%26aufirst%3DM.%2BA.%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DBozikis%26aufirst%3DY.%2BE.%26aulast%3DDite%26aufirst%3DT.%2BA.%26aulast%3DOvens%26aufirst%3DA.%2BJ.%26aulast%3DSmiles%26aufirst%3DW.%2BJ.%26aulast%3DJacobs%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BW.%26aulast%3DRider%26aufirst%3DM.%2BH.%26aulast%3DFoitzik%26aufirst%3DR.%2BC.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DOakhill%26aufirst%3DJ.%2BS.%26atitle%3DStructural%2520Determinants%2520for%2520Small-Molecule%2520Activation%2520of%2520Skeletal%2520Muscle%2520AMPK%2520Alpha%25202%2520Beta%25202%2520Gamma%25201%2520by%2520the%2520Glucose%2520Importagog%2520SC4%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D728%26epage%3D737%26doi%3D10.1016%2Fj.chembiol.2018.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gazzard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodacre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 1,7-Diazacarbazole Class of Inhibitors of Checkpoint Kinase 1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5704</span>– <span class="NLM_lpage">5709</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmcl.2014.10.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=25453805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVemsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5704-5709&author=L.+Gazzardauthor=B.+Appletonauthor=K.+Chapmanauthor=H.+Chenauthor=K.+Clarkauthor=J.+Drobnickauthor=S.+Goodacreauthor=J.+Halladayauthor=J.+Lyssikatosauthor=S.+Schmidtauthor=S.+Siderisauthor=C.+Wiesmannauthor=K.+Williamsauthor=P.+Wuauthor=I.+Yenauthor=S.+Malek&title=Discovery+of+the+1%2C7-Diazacarbazole+Class+of+Inhibitors+of+Checkpoint+Kinase+1&doi=10.1016%2Fj.bmcl.2014.10.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1</span></div><div class="casAuthors">Gazzard, Lewis; Appleton, Brent; Chapman, Kerry; Chen, Huifen; Clark, Kevin; Drobnick, Joy; Goodacre, Simon; Halladay, Jason; Lyssikatos, Joseph; Schmidt, Stephen; Sideris, Steve; Wiesmann, Christian; Williams, Karen; Wu, Ping; Yen, Ivana; Malek, Shiva</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5704-5709</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Checkpoint kinase 1 (ChK1) is activated in response to DNA damage, acting to temporarily block cell cycle progression and allow for DNA repair.  It is envisaged that inhibition of ChK1 will sensitize tumor cells to treatment with DNA-damaging therapies, and may enhance the therapeutic window.  High throughput screening identified carboxylate-contg. diarylpyrazines as a prominent hit series, but with limited biochem. potency and no cellular activity.  Through a series of SAR investigations and x-ray crystallog. anal. the crit. role of polar contacts with conserved waters in the kinase back pocket was established.  Structure-based design, guided by in silico modeling, transformed the series to better satisfy these contacts and the novel 1,7-diazacarbazole class of inhibitors was discovered.  Here the authors present the genesis of this novel series and the identification of GNE-783 I, a potent, selective and orally bioavailable inhibitor of ChK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfVjbVYw27rVg90H21EOLACvtfcHk0ljYLzsKBBlsNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVemsLrL&md5=6a99d23ce3ebe446b57d5fe76816824b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.063%26sid%3Dliteratum%253Aachs%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DK.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DGoodacre%26aufirst%3DS.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DYen%26aufirst%3DI.%26aulast%3DMalek%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%25201%252C7-Diazacarbazole%2520Class%2520of%2520Inhibitors%2520of%2520Checkpoint%2520Kinase%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5704%26epage%3D5709%26doi%3D10.1016%2Fj.bmcl.2014.10.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Function of CX-4945 as a Splicing Regulator</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e94978</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0094978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1371%2Fjournal.pone.0094978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24743259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Kimauthor=K.+Choiauthor=H.+Kangauthor=S.-Y.+Leeauthor=S.-W.+Chiauthor=M.-S.+Leeauthor=J.+Songauthor=D.+Imauthor=Y.+Choiauthor=S.+Cho&title=Identification+of+a+Novel+Function+of+CX-4945+as+a+Splicing+Regulator&doi=10.1371%2Fjournal.pone.0094978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel function of CX-4945 as a splicing regulator</span></div><div class="casAuthors">Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-wook; Lee, Min-sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94978/1-e94978/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene.  The significance of alternative splicing has been confirmed by the increasing no. of human diseases that are caused by misregulation of splicing events.  Very few compds., however, have been reported to act as inhibitors of alternative splicing, and their potential clin. use needs to be evaluated.  Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a mol. currently in clin. trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner.  Transcriptome-wide anal. using exon array also showed a widespread alteration in alternative splicing of numerous genes.  We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells.  Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date.  Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner.  Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmZdGtUZUe7Vg90H21EOLACvtfcHk0ljYLzsKBBlsNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL&md5=5edb2338401d950cddbcba7d35e57c04</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094978%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DChi%26aufirst%3DS.-W.%26aulast%3DLee%26aufirst%3DM.-S.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Function%2520of%2520CX-4945%2520as%2520a%2520Splicing%2520Regulator%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0094978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pireddu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevariya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozcan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schonbrunn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span> <span> </span><span class="NLM_article-title">Development of O-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7392</span>– <span class="NLM_lpage">7416</span>, <span class="refDoi"> DOI: 10.1021/jm300334d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300334d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7392-7416&author=H.+R.+Lawrenceauthor=M.+P.+Martinauthor=Y.+Luoauthor=R.+Piredduauthor=H.+Yangauthor=H.+Gevariyaauthor=S.+Ozcanauthor=J.+Y.+Zhuauthor=R.+Kendigauthor=M.+Rodriguezauthor=R.+Eliasauthor=J.+Q.+Chengauthor=S.+M.+Sebtiauthor=E.+Schonbrunnauthor=N.+J.+Lawrence&title=Development+of+O-Chlorophenyl+Substituted+Pyrimidines+as+Exceptionally+Potent+Aurora+Kinase+Inhibitors&doi=10.1021%2Fjm300334d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors</span></div><div class="casAuthors">Lawrence, Harshani R.; Martin, Mathew P.; Luo, Yunting; Pireddu, Roberta; Yang, Hua; Gevariya, Harsukh; Ozcan, Sevil; Zhu, Jin-Yi; Kendig, Robert; Rodriguez, Mercedes; Elias, Roy; Cheng, Jin Q.; Sebti, Said M.; Schonbrunn, Ernst; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7392-7416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The o-carboxylic acid substituted bisanilinopyrimidine I was identified as a potent hit (Aurora A IC50 = 6.1 ± 1.0 nM) from inhouse screening.  Detailed structure-activity relationship (SAR) studies indicated that polar substituents at the para position of the B-ring are crit. for potent activity.  X-ray crystallog. studies revealed that compd. I is a type I inhibitor that binds the Aurora kinase active site in a DFG-in conformation.  Structure-activity guided replacement of the A-ring carboxylic acid with halogens and incorporation of fluorine at the pyrimidine 5-position led to highly potent inhibitors of Aurora A that bind in a DFG-out conformation.  B-Ring modifications were undertaken to improve the soly. and cell permeability.  Compds. such as II with water-solubilizing moieties at the para position of the B-ring inhibited the autophosphorylation of Aurora A in MDA-MB-468 breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeJbI5uTT-4bVg90H21EOLACvtfcHk0ljYLzsKBBlsNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN&md5=8158e18d9d2a26dfce7a831a353f333c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm300334d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300334d%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DOzcan%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DElias%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520O-Chlorophenyl%2520Substituted%2520Pyrimidines%2520as%2520Exceptionally%2520Potent%2520Aurora%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7392%26epage%3D7416%26doi%3D10.1021%2Fjm300334d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Ampk Regulation by Small Molecule Activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">3017</span> <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+Basis+of+Ampk+Regulation+by+Small+Molecule+Activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2eYWy4LLp9cr2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520Basis%2520of%2520Ampk%2520Regulation%2520by%2520Small%2520Molecule%2520Activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillertz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweikart, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span> <span> </span><span class="NLM_article-title">X-Ray Structural Analysis of Tau-Tubulin Kinase 1 and Its Interactions with Small Molecular Inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1846</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1002%2Fcmdc.201300274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24039150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1846&author=Y.+Xueauthor=P.+T.+Wanauthor=P.+Hillertzauthor=F.+Schweikartauthor=Y.+Zhaoauthor=L.+Wisslerauthor=N.+Dekker&title=X-Ray+Structural+Analysis+of+Tau-Tubulin+Kinase+1+and+Its+Interactions+with+Small+Molecular+Inhibitors&doi=10.1002%2Fcmdc.201300274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structural analysis of tau-tubulin kinase 1 and its interactions with small molecular inhibitors</span></div><div class="casAuthors">Xue, Yafeng; Wan, Paul T.; Hillertz, Per; Schweikart, Fritz; Zhao, Yanlong; Wissler, Lisa; Dekker, Niek</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1846-1854</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Tau-tubulin kinase 1 (I) is a serine/threonine/tyrosine kinase that putatively phosphorylates residues including Ser-422 in tau protein.  Hyperphosphorylation of tau protein is the primary cause of tau pathol. and neuronal death assocd. with Alzheimer's disease.  Here, a library of 12 truncation variants comprising the I kinase domain was screened for expression in Escherichia coli and insect cells.  One variant (residues 14-313) could be purified, but mass spectrometric anal. revealed extensive phosphorylation of the protein.  Co-expression with phage λ phosphatase in Escherichia coli resulted in the prodn. of homogeneous, nonphosphorylated I.  The binding of ATP and several compds. to I was characterized by surface plasmon resonance.  Crystal structures of I in the unliganded form and in complex with ATP, and 2 high-affinity ATP-competitive inhibitors, 3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol and Me 2-bromo-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)benzoate (II), were elucidated.  The structure revealed 2 clear basic patches near the ATP pocket providing an explanation of I for phosphorylation-primed substrates.  Interestingly, II displayed slow binding kinetics with I and the structure of I in complex with this compd. revealed a reorganization of the Lue-199-Asp-200 peptide backbone conformation together with altered H-bonding with II.  These conformational changes necessary for the binding of II are likely the basis of the slow kinetics.  This 1st I structure can assist the discovery of novel inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Z_a4ZEZKz7Vg90H21EOLACvtfcHk0ljbO2rroHyPyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsL%252FE&md5=467e2009dc3d5b8a5bf662048d5c6d8e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300274%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DP.%2BT.%26aulast%3DHillertz%26aufirst%3DP.%26aulast%3DSchweikart%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DDekker%26aufirst%3DN.%26atitle%3DX-Ray%2520Structural%2520Analysis%2520of%2520Tau-Tubulin%2520Kinase%25201%2520and%2520Its%2520Interactions%2520with%2520Small%2520Molecular%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1846%26doi%3D10.1002%2Fcmdc.201300274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">8478</span>– <span class="NLM_lpage">8488</span>, <span class="refDoi"> DOI: 10.1021/bi2008382</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2008382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=8478-8488&author=R.+Battistuttaauthor=G.+Cozzaauthor=F.+Pierreauthor=E.+Papinuttoauthor=G.+Lolliauthor=S.+Sarnoauthor=S.+E.+O%E2%80%99Brienauthor=A.+Siddiqui-Jainauthor=M.+Haddachauthor=K.+Anderesauthor=D.+M.+Ryckmanauthor=F.+Meggioauthor=L.+A.+Pinna&title=Unprecedented+Selectivity+and+Structural+Determinants+of+a+New+Class+of+Protein+Kinase+CK2+Inhibitors+in+Clinical+Trials+for+the+Treatment+of+Cancer&doi=10.1021%2Fbi2008382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer</span></div><div class="casAuthors">Battistutta, Roberto; Cozza, Giorgio; Pierre, Fabrice; Papinutto, Elena; Lolli, Graziano; Sarno, Stefania; O'Brien, Sean E.; Siddiqui-Jain, Adam; Haddach, Mustapha; Anderes, Kenna; Ryckman, David M.; Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">8478-8488</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clin. stage inhibitor of protein kinase CK2 for the treatment of cancer, is representative of a new class of CK2 inhibitors with Ki values in the low nanomolar range and unprecedented selectivity vs. other kinases.  Here we present the crystal structure of the complexes of CX-4945 and two analogs (CX-5011 and CX-5279) with the catalytic subunit of human CK2.  Consistent with their ATP-competitive mode of inhibition, all three compds. bind in the active site of CK2 (type I inhibitors).  The tricyclic scaffold of the inhibitors superposes on the adenine of ATP, establishing multiple hydrophobic interactions with the binding cavity.  The more extended scaffold, as compared to that of ATP, allows the carboxylic function, shared by all three ligands, to penetrate into the deepest part of the active site where it makes interactions with conserved water W1 and Lys-68, thus accounting for the crucial role of this neg. charged group in conferring high potency to this class of inhibitors.  The presence of a pyrimidine in CX-5011 and in CX-5279 instead of a pyridine (as in CX-4945) ring is likely to account for the higher specificity of these compds. whose Gini coeffs., calcd. by profiling them against panels of 102 and/or 235 kinases, are significantly higher than that of CX-4945 (0.735 and 0.755, resp., vs 0.615), marking the highest selectivity ever reported for CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjndr5Zz11z7Vg90H21EOLACvtfcHk0ljbO2rroHyPyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK&md5=4f399675d86d48b88cbfefa6b8c13edb</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbi2008382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2008382%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DUnprecedented%2520Selectivity%2520and%2520Structural%2520Determinants%2520of%2520a%2520New%2520Class%2520of%2520Protein%2520Kinase%2520CK2%2520Inhibitors%2520in%2520Clinical%2520Trials%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D8478%26epage%3D8488%26doi%3D10.1021%2Fbi2008382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmann, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of CX-4945 Binding to Human Protein Kinase CK2</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2010.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.febslet.2010.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21093442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=104-110&author=A.+D.+Fergusonauthor=P.+R.+Shethauthor=A.+D.+Bassoauthor=S.+Paliwalauthor=K.+Grayauthor=T.+O.+Fischmannauthor=H.+V.+Le&title=Structural+Basis+of+CX-4945+Binding+to+Human+Protein+Kinase+CK2&doi=10.1016%2Fj.febslet.2010.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of CX-4945 binding to human protein kinase CK2</span></div><div class="casAuthors">Ferguson, Andrew D.; Sheth, Payal R.; Basso, Andrea D.; Paliwal, Sunil; Gray, Kimberly; Fischmann, Thierry O.; Le, Hung V.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-110</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein kinase CK2 (CK2), a constitutively active serine/threonine kinase, is involved in a variety of roles essential to the maintenance of cellular homeostasis.  Elevated levels of CK2 expression results in the dysregulation of key signaling pathways that regulate transcription, and has been implicated in cancer.  The adenosine-5'-triphosphate-competitive inhibitor CX-4945 (I) has been reported to show broad spectrum anti-proliferative activity in multiple cancer cell lines.  Although the enzymic IC50 of CX-4945 has been reported, the thermodn. and structural basis of binding to CK2α remained elusive.  Presented here are the crystal structures of human CK2α in complex with CX-4945 and adenylyl phosphoramidate at 2.7 and 1.3 Å, resp.  Biophys. anal. of CX-4945 binding is also described.  This data provides the structural rationale for the design of more potent inhibitors against this emerging cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ79g72x8-abVg90H21EOLACvtfcHk0ljiCDX4QL555Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D&md5=b2fab5a9e6d75362c339ddbfa1035315</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2010.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2010.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DSheth%26aufirst%3DP.%2BR.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DLe%26aufirst%3DH.%2BV.%26atitle%3DStructural%2520Basis%2520of%2520CX-4945%2520Binding%2520to%2520Human%2520Protein%2520Kinase%2520CK2%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D104%26epage%3D110%26doi%3D10.1016%2Fj.febslet.2010.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuver-Moody, C.</span></span> <span> </span><span class="NLM_article-title">Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1975</span>, <span class="refDoi"> DOI: 10.1021/jm701248t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701248t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlOmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1972-1975&author=A.+C.+Pierceauthor=M.+Jacobsauthor=C.+Stuver-Moody&title=Docking+Study+Yields+Four+Novel+Inhibitors+of+the+Protooncogene+Pim-1+Kinase&doi=10.1021%2Fjm701248t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase</span></div><div class="casAuthors">Pierce, Albert C.; Jacobs, Marc; Stuver-Moody, Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1972-1975</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To supplement the hits from a high throughput screen, docking was performed against Pim-1 kinase.  Glide docking was augmented with a filter to require traditional or arom. CH··O hydrogen bonds to the kinase hinge.  Four diverse actives, of 96 mols. assayed, had Ki values between 0.091 and 4.5 μM.  This gives a 14-fold enrichment over the earlier HTS run, and the two crystal structures solved confirmed the binding modes predicted by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH6GwwgMwC27Vg90H21EOLACvtfcHk0ljiCDX4QL555Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlOmtLY%253D&md5=fafba52528730d4e250d489ad24a6cd8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm701248t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701248t%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DStuver-Moody%26aufirst%3DC.%26atitle%3DDocking%2520Study%2520Yields%2520Four%2520Novel%2520Inhibitors%2520of%2520the%2520Protooncogene%2520Pim-1%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1972%26epage%3D1975%26doi%3D10.1021%2Fjm701248t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kure, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Novel Potent Protein Kinase CK2 (CK2) Inhibitors with Phenyl-Azole Scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2899</span>– <span class="NLM_lpage">2903</span>, <span class="refDoi"> DOI: 10.1021/jm2015167</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2015167" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFSiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2899-2903&author=Z.+Houauthor=I.+Nakanishiauthor=T.+Kinoshitaauthor=Y.+Takeiauthor=M.+Yasueauthor=R.+Misuauthor=Y.+Suzukiauthor=S.+Nakamuraauthor=T.+Kureauthor=H.+Ohnoauthor=K.+Murataauthor=K.+Kitauraauthor=A.+Hirasawaauthor=G.+Tsujimotoauthor=S.+Oishiauthor=N.+Fujii&title=Structure-Based+Design+of+Novel+Potent+Protein+Kinase+CK2+%28CK2%29+Inhibitors+with+Phenyl-Azole+Scaffolds&doi=10.1021%2Fjm2015167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Potent Protein Kinase CK2 (CK2) Inhibitors with Phenyl-azole Scaffolds</span></div><div class="casAuthors">Hou, Zengye; Nakanishi, Isao; Kinoshita, Takayoshi; Takei, Yoshinori; Yasue, Misato; Misu, Ryosuke; Suzuki, Yamato; Nakamura, Shinya; Kure, Tatsuhide; Ohno, Hiroaki; Murata, Katsumi; Kitaura, Kazuo; Hirasawa, Akira; Tsujimoto, Gozoh; Oishi, Shinya; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2899-2903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinase CK2 (CK2) is a ubiquitous serine/threonine protein kinase for hundreds of endogenous substrates.  CK2 has been considered to be involved in many diseases, including cancers.  Herein we report the discovery of a novel ATP-competitive CK2 inhibitor.  Virtual screening of a compd. library led to the identification of a hit 2-phenyl-1,3,4-thiadiazole compd.  Subsequent structural optimization resulted in the identification of the promising 4-(thiazol-5-yl)benzoic acid deriv. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJqKTawljL8rVg90H21EOLACvtfcHk0ljiCDX4QL555Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFSiuro%253D&md5=81a61dbd32b6470909c89f4924d26b7d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm2015167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2015167%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DTakei%26aufirst%3DY.%26aulast%3DYasue%26aufirst%3DM.%26aulast%3DMisu%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DKure%26aufirst%3DT.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DKitaura%26aufirst%3DK.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Potent%2520Protein%2520Kinase%2520CK2%2520%2528CK2%2529%2520Inhibitors%2520with%2520Phenyl-Azole%2520Scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2899%26epage%3D2903%26doi%3D10.1021%2Fjm2015167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whelligan, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas-Droux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barillari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grummitt, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Montfort, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7682</span>– <span class="NLM_lpage">7698</span>, <span class="refDoi"> DOI: 10.1021/jm1008727</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1008727" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7682-7698&author=D.+K.+Whelliganauthor=S.+Solankiauthor=D.+Taylorauthor=D.+W.+Thomsonauthor=K.+M.+Cheungauthor=K.+Boxallauthor=C.+Mas-Drouxauthor=C.+Barillariauthor=S.+Burnsauthor=C.+G.+Grummittauthor=I.+Collinsauthor=R.+L.+Van+Montfortauthor=G.+W.+Aherneauthor=R.+Baylissauthor=S.+Hoelder&title=Aminopyrazine+Inhibitors+Binding+to+an+Unusual+Inactive+Conformation+of+the+Mitotic+Kinase+Nek2%3A+SAR+and+Structural+Characterization&doi=10.1021%2Fjm1008727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span></div><div class="casAuthors">Whelligan, Daniel K.; Solanki, Savade; Taylor, Dawn; Thomson, Douglas W.; Cheung, Kwai-Ming J.; Boxall, Kathy; Mas-Droux, Corine; Barillari, Caterina; Burns, Samantha; Grummitt, Charles G.; Collins, Ian; van Montfort, Rob L. M.; Aherne, G. Wynne; Bayliss, Richard; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7682-7698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the first systematic exploration of inhibitors of the mitotic kinase Nek2.  Starting from HTS hit aminopyrazine I, compds. with improved activity were identified using structure-based design.  Our structural biol. investigations reveal two notable observations.  First, I and related compds. bind to an unusual, inactive conformation of the kinase which to the best of our knowledge has not been reported for other types of kinase inhibitors.  Second, a phenylalanine residue at the center of the ATP pocket strongly affects the ability of the inhibitor to bind to the protein.  The implications of these observations are discussed, and the work described here defines key features for potent and selective Nek2 inhibition, which will aid the identification of more advanced inhibitors of Nek2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzgVaRXbQkrVg90H21EOLACvtfcHk0ljB4cWOe4IgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI&md5=d1a4af6869319bed0a340e8ff7db4397</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008727%26sid%3Dliteratum%253Aachs%26aulast%3DWhelligan%26aufirst%3DD.%2BK.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarillari%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DGrummitt%26aufirst%3DC.%2BG.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DVan%2BMontfort%26aufirst%3DR.%2BL.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DAminopyrazine%2520Inhibitors%2520Binding%2520to%2520an%2520Unusual%2520Inactive%2520Conformation%2520of%2520the%2520Mitotic%2520Kinase%2520Nek2%253A%2520SAR%2520and%2520Structural%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7682%26epage%3D7698%26doi%3D10.1021%2Fjm1008727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of an Aurora-A Mutant That Mimics Aurora-B Bound to Mln8054: Insights Into Selectivity and Drug Design</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1042/BJ20091530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1042%2FBJ20091530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=20067443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFyntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2010&pages=19-28&author=C.+A.+Dodsonauthor=M.+Kosmopoulouauthor=M.+W.+Richardsauthor=B.+Atrashauthor=V.+Bavetsiasauthor=J.+Blaggauthor=R.+Bayliss&title=Crystal+Structure+of+an+Aurora-A+Mutant+That+Mimics+Aurora-B+Bound+to+Mln8054%3A+Insights+Into+Selectivity+and+Drug+Design&doi=10.1042%2FBJ20091530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design</span></div><div class="casAuthors">Dodson, Charlotte A.; Kosmopoulou, Magda; Richards, Mark W.; Atrash, Butrus; Bavetsias, Vassilios; Blagg, Julian; Bayliss, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-28</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The prodn. of selective protein kinase inhibitors is often frustrated by the similarity of the enzyme active sites.  For this reason, it is challenging to design inhibitors that discriminate between the three Aurora kinases, which are important targets in cancer drug discovery.  We have used a triple-point mutant of Aurora-A (AurAx3) which mimics the active site of Aurora-B to investigate the structural basis of MLN8054 selectivity.  The bias toward Aurora-A inhibition by MLN8054 is fully recapitulated by AurAx3 in vitro.  X-ray crystal structures of the complex suggest that the basis for the discrimination is electrostatic repulsion due to the T217E substitution, which we have confirmed using a single-point mutant.  The activation loop of Aurora-A in the AurAx3-MLN8054 complex exhibits an unusual conformation in which Asp274 and Phe275 side chains point into the interior of the protein.  There is to our knowledge no documented precedent for this conformation, which we have termed DFG-up.  The sequence requirements of the DFG-up conformation suggest that it might be accessible to only a fraction of kinases.  MLN8054 thus circumvents the problem of highly homologous active sites.  Binding of MLN8054 to Aurora-A switches the character of a pocket within the active site from polar to a hydrophobic pocket, similar to what is obsd. in the structure of Aurora-A bound to a compd. that induces DFG-out.  We propose that targeting this pocket may be a productive route in the design of selective kinase inhibitors and describe the structural basis for the rational design of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdJs5KY2VkabVg90H21EOLACvtfcHk0ljB4cWOe4IgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFyntr8%253D&md5=fdf1a176a5fdf5fcd71fd57c3ef92817</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1042%2FBJ20091530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091530%26sid%3Dliteratum%253Aachs%26aulast%3DDodson%26aufirst%3DC.%2BA.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DRichards%26aufirst%3DM.%2BW.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBayliss%26aufirst%3DR.%26atitle%3DCrystal%2520Structure%2520of%2520an%2520Aurora-A%2520Mutant%2520That%2520Mimics%2520Aurora-B%2520Bound%2520to%2520Mln8054%253A%2520Insights%2520Into%2520Selectivity%2520and%2520Drug%2520Design%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D427%26spage%3D19%26epage%3D28%26doi%3D10.1042%2FBJ20091530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claiborne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Credo, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sowin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1,4-Dihydroindeno[1,2-c]Pyrazoles as a Novel Class of Potent and Selective Checkpoint Kinase 1 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2759</span>– <span class="NLM_lpage">2767</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2007.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=17287122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2759-2767&author=Y.+Tongauthor=A.+Claiborneauthor=K.+D.+Stewartauthor=C.+Parkauthor=P.+Kovarauthor=Z.+Chenauthor=R.+B.+Credoauthor=W.+Z.+Guauthor=S.+L.+Gwaltneyauthor=R.+A.+Judgeauthor=H.+Zhangauthor=S.+H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.+H.+Lin&title=Discovery+of+1%2C4-Dihydroindeno%5B1%2C2-c%5DPyrazoles+as+a+Novel+Class+of+Potent+and+Selective+Checkpoint+Kinase+1+Inhibitors&doi=10.1016%2Fj.bmc.2007.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span></div><div class="casAuthors">Tong, Yunsong; Claiborne, Akiyo; Stewart, Kent D.; Park, Chang; Kovar, Peter; Chen, Zehan; Credo, Robert B.; Gu, Wen-Zhen; Gwaltney, Stephen L.; Judge, Russell A.; Zhang, Haiying; Rosenberg, Saul H.; Sham, Hing L.; Sowin, Thomas J.; Lin, Nan-horng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2759-2767</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening.  The efficient hit-to-lead process was facilitated by X-ray crystallog. and led to potent inhibitors (<10 nM) against CHK-1.  X-ray co-crystal structures of bound inhibitors demonstrated that two sub-series of this class of compds., exemplified by 21 and 41, exhibit distinctive hydrogen bonding patterns in the specificity pocket of the active site.  Two compds., 41 and 43, were capable of potentiating doxorubicin and camptothecin, both DNA-damaging agents, in cell proliferation assays (MTS and soft agar assays) and abrogating G2/M checkpoint in a mechanism-based FACS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVp7DNSZaexbVg90H21EOLACvtfcHk0ljB4cWOe4IgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D&md5=0966753ebf59128001db7601ca7d8cee</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DGu%26aufirst%3DW.%2BZ.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%2BH.%26atitle%3DDiscovery%2520of%25201%252C4-Dihydroindeno%255B1%252C2-c%255DPyrazoles%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520Checkpoint%2520Kinase%25201%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2759%26epage%3D2767%26doi%3D10.1016%2Fj.bmc.2007.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nédellec, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevrel, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macalino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span> <span> </span><span class="NLM_article-title">7-(4H-1,2,4-Triazol-3-Yl)Benzo[c][2,6]Naphthyridines: A Novel Class of Pim Kinase Inhibitors with Potent Cell Antiproliferative Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6687</span>– <span class="NLM_lpage">6692</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmcl.2011.09.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21982499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6687-6692&author=F.+Pierreauthor=E.+Stefanauthor=A.-S.+N%C3%A9dellecauthor=M.-C.+Chevrelauthor=C.+F.+Reganauthor=A.+Siddiqui-Jainauthor=D.+Macalinoauthor=N.+Streinerauthor=D.+Dryginauthor=M.+Haddachauthor=S.+E.+O%E2%80%99Brienauthor=K.+Anderesauthor=D.+M.+Ryckman&title=7-%284H-1%2C2%2C4-Triazol-3-Yl%29Benzo%5Bc%5D%5B2%2C6%5DNaphthyridines%3A+A+Novel+Class+of+Pim+Kinase+Inhibitors+with+Potent+Cell+Antiproliferative+Activity&doi=10.1016%2Fj.bmcl.2011.09.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity</span></div><div class="casAuthors">Pierre, Fabrice; Stefan, Eric; Nedellec, Anne-Sophie; Chevrel, Marie-Claire; Regan, Collin F.; Siddiqui-Jain, Adam; Macalino, Diwata; Streiner, Nicole; Drygin, Denis; Haddach, Mustapha; O'Brien, Sean E.; Anderes, Kenna; Ryckman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6687-6692</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of pan-Pim kinase inhibitors was designed by modifying the CK2 inhibitor CX-4945.  Introduction of a triazole or secondary amide functionality on the C-7 position and 2'-halogenoanilines on C-5 resulted in potent inhibitors of the Pim-1 and Pim-2 isoforms, with many analogs active at single digit nanomolar concns.  The mols. inhibited the phosphorylation at Serine 112 of the apoptosis effector BAD, and had potent antiproliferative effects on the AML cell line MV-4-11 (IC50 <30 nM).  This work delivers an excellent lead-optimization platform for Pim targeting anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ofDFEMV1erVg90H21EOLACvtfcHk0lgezKWki6LQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr%252FO&md5=00f6b75384ba3f3975c845ba7ff97ed1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.059%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DStefan%26aufirst%3DE.%26aulast%3DN%25C3%25A9dellec%26aufirst%3DA.-S.%26aulast%3DChevrel%26aufirst%3DM.-C.%26aulast%3DRegan%26aufirst%3DC.%2BF.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3D7-%25284H-1%252C2%252C4-Triazol-3-Yl%2529Benzo%255Bc%255D%255B2%252C6%255DNaphthyridines%253A%2520A%2520Novel%2520Class%2520of%2520Pim%2520Kinase%2520Inhibitors%2520with%2520Potent%2520Cell%2520Antiproliferative%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6687%26epage%3D6692%26doi%3D10.1016%2Fj.bmcl.2011.09.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pattanayek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, M.</span></span> <span> </span><span class="NLM_article-title">Protein-Protein Interactions in the Cyanobacterial Circadian Clock: Structure of KaiA Dimer in Complex with C-Terminal KaiC Peptides at 2.8 Angstrom Resolution</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4575</span>– <span class="NLM_lpage">4578</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b00694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b00694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=4575-4578&author=R.+Pattanayekauthor=M.+Egli&title=Protein-Protein+Interactions+in+the+Cyanobacterial+Circadian+Clock%3A+Structure+of+KaiA+Dimer+in+Complex+with+C-Terminal+KaiC+Peptides+at+2.8+Angstrom+Resolution&doi=10.1021%2Facs.biochem.5b00694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-Protein Interactions in the Cyanobacterial Circadian Clock: Structure of KaiA Dimer in Complex with C-Terminal KaiC Peptides at 2.8 Å Resolution</span></div><div class="casAuthors">Pattanayek, Rekha; Egli, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4575-4578</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the cyanobacterial circadian clock, the KaiA, -B, and -C proteins with ATP constitute a post-translational oscillator.  KaiA stimulates the KaiC autokinase, and KaiB antagonizes KaiA action.  KaiA contacts the intrinsically disordered C-terminal regions of KaiC hexamer to promote phosphorylation across subunit interfaces.  The crystal structure of KaiA dimer from Synechococcus elongatus with two KaiC C-terminal 20mer peptides bound reveals that the latter adopt an α-helical conformation and contact KaiA α-helical bundles via mostly hydrophobic interactions.  This complex and the crystal structure of KaiC hexamer with truncated C-terminal tails can be fit into the electron microscopy (EM) d. of the KaiA:KaiC complex.  The hybrid model helps rationalize clock phenotypes of KaiA and KaiC mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeObdAF6I1brVg90H21EOLACvtfcHk0lgezKWki6LQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgsL%252FM&md5=34a0ea3f485baa17b25de93debaabe6c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b00694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b00694%26sid%3Dliteratum%253Aachs%26aulast%3DPattanayek%26aufirst%3DR.%26aulast%3DEgli%26aufirst%3DM.%26atitle%3DProtein-Protein%2520Interactions%2520in%2520the%2520Cyanobacterial%2520Circadian%2520Clock%253A%2520Structure%2520of%2520KaiA%2520Dimer%2520in%2520Complex%2520with%2520C-Terminal%2520KaiC%2520Peptides%2520at%25202.8%2520Angstrom%2520Resolution%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D4575%26epage%3D4578%26doi%3D10.1021%2Facs.biochem.5b00694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaeger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzlmeir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polzer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruprecht, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzoldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huenges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garz, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolg, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vooder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiche, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greif, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiekermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span> <span> </span><span class="NLM_article-title">The Target Landscape of Clinical Kinase Drugs</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>, <span class="NLM_elocation-id">eaan4368</span> <span class="refDoi"> DOI: 10.1126/science.aan4368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1126%2Fscience.aan4368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29191878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&author=S.+Klaegerauthor=S.+Heinzlmeirauthor=M.+Wilhelmauthor=H.+Polzerauthor=B.+Vickauthor=P.+A.+Koenigauthor=M.+Reineckeauthor=B.+Ruprechtauthor=S.+Petzoldtauthor=C.+Mengauthor=J.+Zechaauthor=K.+Reiterauthor=H.+Qiaoauthor=D.+Helmauthor=H.+Kochauthor=M.+Schoofauthor=G.+Canevariauthor=E.+Casaleauthor=S.+R.+Depaoliniauthor=A.+Feuchtingerauthor=Z.+Wuauthor=T.+Schmidtauthor=L.+Rueckertauthor=W.+Beckerauthor=J.+Huengesauthor=A.+K.+Garzauthor=B.+O.+Gohlkeauthor=D.+P.+Zolgauthor=G.+Kayserauthor=T.+Vooderauthor=R.+Preissnerauthor=H.+Hahneauthor=N.+Tonissonauthor=K.+Kramerauthor=K.+Gotzeauthor=F.+Bassermannauthor=J.+Schleglauthor=H.+C.+Ehrlichauthor=S.+Aicheauthor=A.+Walchauthor=P.+A.+Greifauthor=S.+Schneiderauthor=E.+R.+Felderauthor=J.+Rulandauthor=G.+Medardauthor=I.+Jeremiasauthor=K.+Spiekermannauthor=B.+Kuster&title=The+Target+Landscape+of+Clinical+Kinase+Drugs&doi=10.1126%2Fscience.aan4368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan4368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan4368%26sid%3Dliteratum%253Aachs%26aulast%3DKlaeger%26aufirst%3DS.%26aulast%3DHeinzlmeir%26aufirst%3DS.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DH.%26aulast%3DVick%26aufirst%3DB.%26aulast%3DKoenig%26aufirst%3DP.%2BA.%26aulast%3DReinecke%26aufirst%3DM.%26aulast%3DRuprecht%26aufirst%3DB.%26aulast%3DPetzoldt%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DC.%26aulast%3DZecha%26aufirst%3DJ.%26aulast%3DReiter%26aufirst%3DK.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DHelm%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DH.%26aulast%3DSchoof%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DRueckert%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHuenges%26aufirst%3DJ.%26aulast%3DGarz%26aufirst%3DA.%2BK.%26aulast%3DGohlke%26aufirst%3DB.%2BO.%26aulast%3DZolg%26aufirst%3DD.%2BP.%26aulast%3DKayser%26aufirst%3DG.%26aulast%3DVooder%26aufirst%3DT.%26aulast%3DPreissner%26aufirst%3DR.%26aulast%3DHahne%26aufirst%3DH.%26aulast%3DTonisson%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DGotze%26aufirst%3DK.%26aulast%3DBassermann%26aufirst%3DF.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DH.%2BC.%26aulast%3DAiche%26aufirst%3DS.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DGreif%26aufirst%3DP.%2BA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DMedard%26aufirst%3DG.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DSpiekermann%26aufirst%3DK.%26aulast%3DKuster%26aufirst%3DB.%26atitle%3DThe%2520Target%2520Landscape%2520of%2520Clinical%2520Kinase%2520Drugs%26jtitle%3DScience%26date%3D2017%26volume%3D358%26doi%3D10.1126%2Fscience.aan4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bdzhola, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balanda, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prykhod’ko, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmoluk, S. M.</span></span> <span> </span><span class="NLM_article-title">Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]Pyrimidine-Based Inhibitor</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">9</span> <span class="refDoi"> DOI: 10.3390/ph10010009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.3390%2Fph10010009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1ems7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=K.+Niefindauthor=N.+Bischoffauthor=A.+G.+Golubauthor=V.+G.+Bdzholaauthor=A.+O.+Balandaauthor=A.+O.+Prykhod%E2%80%99koauthor=S.+M.+Yarmoluk&title=Structural+Hypervariability+of+the+Two+Human+Protein+Kinase+CK2+Catalytic+Subunit+Paralogs+Revealed+by+Complex+Structures+with+a+Flavonol-+and+a+Thieno%5B2%2C3-d%5DPyrimidine-Based+Inhibitor&doi=10.3390%2Fph10010009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structural hypervariability of the two human protein kinase CK2 catalytic subunit paralogs revealed by complex structures with a flavonol- and a thieno[2,3-d]pyrimidine-based inhibitor</span></div><div class="casAuthors">Niefind, Karsten; Bischoff, Nils; Golub, Andriy G.; Bdzhola, Volodymyr G.; Balanda, Anatoliy O.; Prykhod'ko, Andriy O.; Yarmoluk, Sergiy M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9/1-9/16</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Protein kinase CK2 is assocd. with a no. of human diseases, among them cancer, and is therefore a target for inhibitor development in industry and academia.  Six crystal structures of either CK2α, the catalytic subunit of human protein kinase CK2, or its paralog CK2α' in complex with two ATP-competitive inhibitors-based on either a flavonol or a thieno[2,3-d]pyrimidine framework-are presented.  The structures show examples for extreme structural deformations of the ATP-binding loop and its neighborhood and of the hinge/helix αD region, i.e., of two zones of the broader ATP site environment.  Thus, they supplement our picture of the conformational space available for CK2α and CK2α'.  Further, they document the potential of synthetic ligands to trap unusual conformations of the enzymes and allow to envision a new generation of inhibitors that stabilize such conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwVeYAGf2ikLVg90H21EOLACvtfcHk0lhQeMx3fSbypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1ems7s%253D&md5=e4dd3999e41ec49425347304b496db42</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3390%2Fph10010009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10010009%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DGolub%26aufirst%3DA.%2BG.%26aulast%3DBdzhola%26aufirst%3DV.%2BG.%26aulast%3DBalanda%26aufirst%3DA.%2BO.%26aulast%3DPrykhod%25E2%2580%2599ko%26aufirst%3DA.%2BO.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26atitle%3DStructural%2520Hypervariability%2520of%2520the%2520Two%2520Human%2520Protein%2520Kinase%2520CK2%2520Catalytic%2520Subunit%2520Paralogs%2520Revealed%2520by%2520Complex%2520Structures%2520with%2520a%2520Flavonol-%2520and%2520a%2520Thieno%255B2%252C3-d%255DPyrimidine-Based%2520Inhibitor%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26doi%3D10.3390%2Fph10010009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Newton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvonen, M.</span></span> <span> </span><span class="NLM_article-title">Specific Inhibition of CK2 Alpha from an Anchor Outside the Active Site</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6845</span>, <span class="refDoi"> DOI: 10.1039/C6SC02335E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC6SC02335E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28451126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=6839-6845&author=P.+Brearauthor=C.+De+Fuscoauthor=K.+Hadje+Georgiouauthor=N.+J.+Francis-Newtonauthor=C.+J.+Stubbsauthor=H.+F.+Soreauthor=A.+R.+Venkitaramanauthor=C.+Abellauthor=D.+R.+Springauthor=M.+Hyvonen&title=Specific+Inhibition+of+CK2+Alpha+from+an+Anchor+Outside+the+Active+Site&doi=10.1039%2FC6SC02335E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of CK2α from an anchor outside the active site</span></div><div class="casAuthors">Brear, Paul; De Fusco, Claudia; Hadje Georgiou, Kathy; Francis-Newton, Nicola J.; Stubbs, Christopher J.; Sore, Hannah F.; Venkitaraman, Ashok R.; Abell, Chris; Spring, David R.; Hyvonen, Marko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6839-6845</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site.  Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site.  We have identified a new binding site for small mols. on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket.  An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors.  CAM4066 shows target engagement in several cell lines and similar potency to clin. trial candidate CX4945.  Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α via a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FqxiBkU9frVg90H21EOLACvtfcHk0lhQeMx3fSbypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP&md5=c4652010f4da70a128fb1dab64f811d0</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC6SC02335E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02335E%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DFrancis-Newton%26aufirst%3DN.%2BJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DHyvonen%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibition%2520of%2520CK2%2520Alpha%2520from%2520an%2520Anchor%2520Outside%2520the%2520Active%2520Site%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D6839%26epage%3D6845%26doi%3D10.1039%2FC6SC02335E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamiguchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship Study of 4-(Thiazol-5-Yl)Benzoic Acid Derivatives as Potent Protein Kinase CK2 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1136</span>– <span class="NLM_lpage">1141</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2016.01.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=26850376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1136-1141&author=H.+Ohnoauthor=D.+Minamiguchiauthor=S.+Nakamuraauthor=K.+Shuauthor=S.+Okazakiauthor=M.+Hondaauthor=R.+Misuauthor=H.+Moriwakiauthor=S.+Nakanishiauthor=S.+Oishiauthor=T.+Kinoshitaauthor=I.+Nakanishiauthor=N.+Fujii&title=Structure-Activity+Relationship+Study+of+4-%28Thiazol-5-Yl%29Benzoic+Acid+Derivatives+as+Potent+Protein+Kinase+CK2+Inhibitors&doi=10.1016%2Fj.bmc.2016.01.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of 4-(thiazol-5-yl)benzoic acid derivatives as potent protein kinase CK2 inhibitors</span></div><div class="casAuthors">Ohno, Hiroaki; Minamiguchi, Daiki; Nakamura, Shinya; Shu, Keito; Okazaki, Shiho; Honda, Maho; Misu, Ryosuke; Moriwaki, Hirotomo; Nakanishi, Shinsuke; Oishi, Shinya; Kinoshita, Takayoshi; Nakanishi, Isao; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1136-1141</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two classes of modified analogs of 4-(thiazol-5-yl)benzoic acid-type CK2 inhibitors were designed.  The azabenzene analogs, pyridine- and pyridazine-carboxylic acid derivs., showed potent protein kinase CK2 inhibitory activities [IC50 (CK2α) = 0.014-0.017 μM; IC50 (CK2α') = 0.0046-0.010 μM].  Introduction of a 2-halo- or 2-methoxy-benzyloxy group at the 3-position of the benzoic acid moiety maintained the potent CK2 inhibitory activities [IC50 (CK2α) = 0.014-0.016 μM; IC50 (CK2α') = 0.0088-0.014 μM] and led to antiproliferative activities [CC50 (A549) = 1.5-3.3 μM] three to six times higher than those of the parent compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPsh5G-h_c7Vg90H21EOLACvtfcHk0ljodQUc4dVUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWjsLk%253D&md5=7380c8d630ea0695a85d9e9922fde1b2</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DMinamiguchi%26aufirst%3DD.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DK.%26aulast%3DOkazaki%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DM.%26aulast%3DMisu%26aufirst%3DR.%26aulast%3DMoriwaki%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520of%25204-%2528Thiazol-5-Yl%2529Benzoic%2520Acid%2520Derivatives%2520as%2520Potent%2520Protein%2520Kinase%2520CK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1136%26epage%3D1141%26doi%3D10.1016%2Fj.bmc.2016.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraets, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeders, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castermans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panitti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanormelingen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Defert, O.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4309</span>– <span class="NLM_lpage">4324</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00308</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00308" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4309-4324&author=S.+Bolandauthor=A.+Bourinauthor=J.+Alenauthor=J.+Geraetsauthor=P.+Schroedersauthor=K.+Castermansauthor=N.+Kindtauthor=N.+Boumansauthor=L.+Panittiauthor=S.+Fransenauthor=J.+Vanormelingenauthor=J.+M.+Stassenauthor=D.+Leysenauthor=O.+Defert&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel%2C+Highly+Active+Soft+ROCK+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors</span></div><div class="casAuthors">Boland, Sandro; Bourin, Arnaud; Alen, Jo; Geraets, Jacques; Schroeders, Pieter; Castermans, Karolien; Kindt, Nele; Boumans, Nicki; Panitti, Laura; Fransen, Silke; Vanormelingen, Jessica; Stassen, Jean Marie; Leysen, Dirk; Defert, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4309-4324</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ROCK1 and ROCK2 play important roles in numerous cellular functions, including smooth muscle cell contraction, cell proliferation, adhesion, and migration.  Consequently, ROCK inhibitors are of interest for treating multiple indications including cardiovascular diseases, inflammatory and autoimmune diseases, lung diseases, and eye diseases.  However, systemic inhibition of ROCK is expected to result in significant side effects.  Strategies allowing reduced systemic exposure are therefore of interest.  In a continuing effort toward identification of ROCK inhibitors, we here report the design, synthesis, and evaluation of novel soft ROCK inhibitors displaying an ester function allowing their rapid inactivation in the systemic circulation.  Those compds., e.g. I, display subnanomolar activity against ROCK and strong differences of functional activity between parent compds. and expected metabolites.  The binding mode of a representative compd. was detd. exptl. in a single-crystal X-ray diffraction study.  Enzymes responsible for inactivation of these compds. once they enter systemic circulation are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWI5LwOkT64rVg90H21EOLACvtfcHk0ljodQUc4dVUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D&md5=320e6fbb1cf87ba8c03fc17795f6802f</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00308%26sid%3Dliteratum%253Aachs%26aulast%3DBoland%26aufirst%3DS.%26aulast%3DBourin%26aufirst%3DA.%26aulast%3DAlen%26aufirst%3DJ.%26aulast%3DGeraets%26aufirst%3DJ.%26aulast%3DSchroeders%26aufirst%3DP.%26aulast%3DCastermans%26aufirst%3DK.%26aulast%3DKindt%26aufirst%3DN.%26aulast%3DBoumans%26aufirst%3DN.%26aulast%3DPanitti%26aufirst%3DL.%26aulast%3DFransen%26aufirst%3DS.%26aulast%3DVanormelingen%26aufirst%3DJ.%26aulast%3DStassen%26aufirst%3DJ.%2BM.%26aulast%3DLeysen%26aufirst%3DD.%26aulast%3DDefert%26aufirst%3DO.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%252C%2520Highly%2520Active%2520Soft%2520ROCK%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4309%26epage%3D4324%26doi%3D10.1021%2Facs.jmedchem.5b00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bdzhola, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmoluk, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1654</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00235</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00235" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1654-1660&author=B.+Guerraauthor=N.+Bischoffauthor=V.+G.+Bdzholaauthor=S.+M.+Yarmolukauthor=O.-G.+Issingerauthor=A.+G.+Golubauthor=K.+Niefind&title=A+Note+of+Caution+on+the+Role+of+Halogen+Bonds+for+Protein+Kinase%2FInhibitor+Recognition+Suggested+by+High-+And+Low-Salt+CK2%CE%B1+Complex+Structures&doi=10.1021%2Facschembio.5b00235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures</span></div><div class="casAuthors">Guerra, Barbara; Bischoff, Nils; Bdzhola, Volodymyr G.; Yarmoluk, Sergiy M.; Issinger, Olaf-Georg; Golub, Andriy G.; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1654-1660</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a Ser/Thr kinase recruited by tumor cells to avoid cell death.  4'-Carboxy-6,8-dibromo-flavonol (FLC26) is a nanomolar CK2 inhibitor reducing the physiol. phosphorylation of CK2 biomarkers and inducing cell death.  Its binding mode to the ATP site was predicted to depend primarily on noncovalent interactions not comprising halogen bonds.  We confirm this by two independent cocrystal structures which addnl. show that FLC26 is selective for an open, protein kinase-untypical conformation of the hinge/helix αD region.  The structures suggest how the bromo substituents, found previously in lead optimization studies, contribute to the inhibitory efficacy.  In this context, one of the complex structures, obtained by crystn. with the kosmotropic salt NaCl, revealed an unconventional π-halogen bond between the 8-bromo substituent of FLC26 and an arom. side chain which is absent under low-salt conditions.  The kosmotropic salt sensitivity of π-halogen bonds is a novel feature which requires attention in structural comparisons and halogen-bond-based explanations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolnSDoVENUrbVg90H21EOLACvtfcHk0ljodQUc4dVUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D&md5=88774b705a45a2fe08917c44545fcd04</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00235%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DBdzhola%26aufirst%3DV.%2BG.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26aulast%3DIssinger%26aufirst%3DO.-G.%26aulast%3DGolub%26aufirst%3DA.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DA%2520Note%2520of%2520Caution%2520on%2520the%2520Role%2520of%2520Halogen%2520Bonds%2520for%2520Protein%2520Kinase%252FInhibitor%2520Recognition%2520Suggested%2520by%2520High-%2520And%2520Low-Salt%2520CK2%25CE%25B1%2520Complex%2520Structures%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1654%26epage%3D1660%26doi%3D10.1021%2Facschembio.5b00235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlow, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Crystallographic Screening Using Ultra-Low-Molecular-Weight Ligands to Guide Drug Design</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2019.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.drudis.2019.03.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1081-1086&author=M.+O%E2%80%99Reillyauthor=A.+Cleasbyauthor=T.+G.+Daviesauthor=R.+J.+Hallauthor=R.+F.+Ludlowauthor=C.+W.+Murrayauthor=D.+Tisiauthor=H.+Jhoti&title=Crystallographic+Screening+Using+Ultra-Low-Molecular-Weight+Ligands+to+Guide+Drug+Design&doi=10.1016%2Fj.drudis.2019.03.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DHall%26aufirst%3DR.%2BJ.%26aulast%3DLudlow%26aufirst%3DR.%2BF.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystallographic%2520Screening%2520Using%2520Ultra-Low-Molecular-Weight%2520Ligands%2520to%2520Guide%2520Drug%2520Design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2019%26volume%3D5%26spage%3D1081%26epage%3D1086%26doi%3D10.1016%2Fj.drudis.2019.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoofnagle, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resing, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, N. G.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Exchange Solvent Protection by an ATP Analogue Reveals Conformational Changes in ERK2 upon Activation</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.jmb.2005.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16185715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOktrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=600-612&author=T.+Leeauthor=A.+N.+Hoofnagleauthor=K.+A.+Resingauthor=N.+G.+Ahn&title=Hydrogen+Exchange+Solvent+Protection+by+an+ATP+Analogue+Reveals+Conformational+Changes+in+ERK2+upon+Activation&doi=10.1016%2Fj.jmb.2005.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Exchange Solvent Protection by an ATP Analogue Reveals Conformational Changes in ERK2 upon Activation</span></div><div class="casAuthors">Lee, Thomas; Hoofnagle, Andrew N.; Resing, Katheryn A.; Ahn, Natalie G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">600-612</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structural and kinetic studies have provided extensive information about the mol. mechanisms of kinase activation by phosphorylation.  However, it is still unclear how changes in protein dynamics and flexibility contribute to catalytic function.  Mass spectrometry was used to probe changes in hydrogen/deuterium exchange in the MAP kinase, ERK2, in the presence and absence of the ATP analog, AMP-PNP.  In both active and inactive forms of ERK2, protection from hydrogen exchange by AMP-PNP binding was obsd. within conserved ATP binding motifs in the N-terminal lobe, which are known to directly interact with nucleotide in various protein kinases.  In contrast, higher protection from exchange by AMP-PNP was obsd. in active ERK2 compared to inactive ERK2, in a region corresponding to the conserved DFG motif, which is located in the C-terminal lobe and coordinates Mg2+ at the catalytic site.  Thus, AMP-PNP binding simultaneously protects residues within the N and C terminus in the active form of ERK2, but not the inactive form.  This demonstrates that ERK2 binds nucleotide in two modes, in which active ERK2 adopts a closed conformation following nucleotide binding in soln., while inactive ERK2 adopts an open conformation.  The finding provides novel evidence that phosphorylation of ERK2 facilitates interdomain closure, allowing proper orientation between ATP and substrate to facilitate phosphoryl transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3O6fC5n7OErVg90H21EOLACvtfcHk0lhAlSCwudCvCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOktrvO&md5=8fd0f441c479632d44d4bdfa89dcf143</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DHoofnagle%26aufirst%3DA.%2BN.%26aulast%3DResing%26aufirst%3DK.%2BA.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26atitle%3DHydrogen%2520Exchange%2520Solvent%2520Protection%2520by%2520an%2520ATP%2520Analogue%2520Reveals%2520Conformational%2520Changes%2520in%2520ERK2%2520upon%2520Activation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D600%26epage%3D612%26doi%3D10.1016%2Fj.jmb.2005.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. A.</span></span> <span> </span><span class="NLM_article-title">Structural Characterization of Protein Kinase A as a Function of Nucleotide Binding. Hydrogen-Deuterium Exchange Studies Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Detection</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">14204</span>– <span class="NLM_lpage">14211</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011543200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1074%2Fjbc.M011543200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=11278927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt12rsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14204-14211&author=M.+D.+Andersenauthor=J.+Shafferauthor=P.+A.+Jenningsauthor=J.+A.+Adams&title=Structural+Characterization+of+Protein+Kinase+A+as+a+Function+of+Nucleotide+Binding.+Hydrogen-Deuterium+Exchange+Studies+Using+Matrix-Assisted+Laser+Desorption+Ionization-Time+of+Flight+Mass+Spectrometry+Detection&doi=10.1074%2Fjbc.M011543200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of protein kinase A as a function of nucleotide binding. Hydrogen-deuterium exchange studies using matrix-assisted laser desorption ionization-time of flight mass spectrometry detection</span></div><div class="casAuthors">Andersen, Mette D.; Shaffer, Jennifer; Jennings, Patricia A.; Adams, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">14204-14211</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Transient state kinetic studies indicate that substrate phosphorylation in protein kinase A is partially rate-limited by conformational changes, some of which may be assocd. with nucleotide binding.  To assess whether specific structural changes are assocd. with the binding of nucleotides, hydrogen-deuterium exchange expts. were performed on the enzyme in the absence and presence of ADP.  Four regions of the protein are protected from exchange in the presence of ADP.  Two regions encompass the catalytic and glycine-rich loops and are integral parts of the active site.  Conversely, protection of probes in the C terminus is consistent with nucleotide-induced domain closure.  One protected probe encompasses a portion of helix C, a secondary structural element that does not make any direct contacts with the nucleotide but has been reported to undergo segmental motion upon the activation of some protein kinases.  The combined data suggest that binding of the nucleotide has distal structural effects that may include stabilizing the closed state of the enzyme and altering the position of a crit. helix outside the active site.  The latter represents the first evidence that the nucleotide alone can induce changes in helix C in soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojALNL-43U-rVg90H21EOLACvtfcHk0lhAlSCwudCvCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt12rsbg%253D&md5=29c442440a6a64d94cf1676baa421ef2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011543200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011543200%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DM.%2BD.%26aulast%3DShaffer%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DP.%2BA.%26aulast%3DAdams%26aufirst%3DJ.%2BA.%26atitle%3DStructural%2520Characterization%2520of%2520Protein%2520Kinase%2520A%2520as%2520a%2520Function%2520of%2520Nucleotide%2520Binding.%2520Hydrogen-Deuterium%2520Exchange%2520Studies%2520Using%2520Matrix-Assisted%2520Laser%2520Desorption%2520Ionization-Time%2520of%2520Flight%2520Mass%2520Spectrometry%2520Detection%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14204%26epage%3D14211%26doi%3D10.1074%2Fjbc.M011543200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleckner, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, M. P.</span></span> <span> </span><span class="NLM_article-title">An Introduction to NMR-Based Approaches for Measuring Protein Dynamics</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1814</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2010.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbapap.2010.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21059410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1814&publication_year=2011&pages=942-968&author=I.+R.+Klecknerauthor=M.+P.+Foster&title=An+Introduction+to+NMR-Based+Approaches+for+Measuring+Protein+Dynamics&doi=10.1016%2Fj.bbapap.2010.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">An introduction to NMR-based approaches for measuring protein dynamics</span></div><div class="casAuthors">Kleckner, Ian R.; Foster, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1814</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">942-968</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Proteins are inherently flexible at ambient temp.  At equil., they are characterized by a set of conformations that undergo continuous exchange within a hierarchy of spatial and temporal scales ranging from nanometers to micrometers and femtoseconds to hours.  Dynamic properties of proteins are essential for describing the structural bases of their biol. functions including catalysis, binding, regulation and cellular structure.  NMR spectroscopy represents a powerful technique for measuring these essential features of proteins.  Here the authors provide an introduction to NMR-based approaches for studying protein dynamics, highlighting eight distinct methods with recent examples, contextualized within a common exptl. and anal. framework.  The selected methods are (1) Real-time NMR, (2) Exchange spectroscopy, (3) Lineshape anal., (4) CPMG relaxation dispersion, (5) Rotating frame relaxation dispersion, (6) Nuclear spin relaxation, (7) Residual dipolar coupling, (8) Paramagnetic relaxation enhancement.  This article is part of a Special Issue entitled: Protein Dynamics: Exptl. and Computational Approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlAS8_XeKx77Vg90H21EOLACvtfcHk0lhAlSCwudCvCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCnsbo%253D&md5=2c047b195fd796a815e800bd162a49de</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2010.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2010.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DKleckner%26aufirst%3DI.%2BR.%26aulast%3DFoster%26aufirst%3DM.%2BP.%26atitle%3DAn%2520Introduction%2520to%2520NMR-Based%2520Approaches%2520for%2520Measuring%2520Protein%2520Dynamics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2011%26volume%3D1814%26spage%3D942%26epage%3D968%26doi%3D10.1016%2Fj.bbapap.2010.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobrega, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrita, E. J.</span></span> <span> </span><span class="NLM_article-title">Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding</span>. <i>J. Chem. Educ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1021/ed101169t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ed101169t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVant7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2011&pages=990-994&author=A.+Viegasauthor=J.+Mansoauthor=F.+L.+Nobregaauthor=E.+J.+Cabrita&title=Saturation-Transfer+Difference+%28STD%29+NMR%3A+A+Simple+and+Fast+Method+for+Ligand+Screening+and+Characterization+of+Protein+Binding&doi=10.1021%2Fed101169t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding</span></div><div class="casAuthors">Viegas, Aldino; Manso, Joao; Nobrega, Franklin L.; Cabrita, Eurico J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Education</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">990-994</span>CODEN:
                <span class="NLM_cas:coden">JCEDA8</span>;
        ISSN:<span class="NLM_cas:issn">0021-9584</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society and Division of Chemical Education, Inc.</span>)
        </div><div class="casAbstract">Satn. transfer difference (STD) NMR has emerged as one of the most popular ligand-based NMR techniques for the study of protein-ligand interactions.  The success of this technique is a consequence of its robustness and the fact that it is focused on the signals of the ligand, without any need of processing NMR information about the receptor and only using small quantities of nonlabeled macromol.  Moreover, the attractiveness of this expt. is also extendable to the classroom.  In the context of a practical NMR class, this expt. is ideal to illustrate some fundamental NMR concepts, such as the nuclear Overhauser effect and relaxation in a multidisciplinary context, bridging chem. and biochem. with a taste of medicinal chem.  We use the readily available human serum albumin (HSA), 6-D,L-methyl-tryptophan (6-CH3-Trp), and 7- D,L-methyl-tryptophan (7-CH3-Trp) to introduce the STD-NMR expt. and to illustrate its applicability for ligand screening, mapping of binding moieties, and detn. of the dissocn. const., in a context that can be explored or adapted to the student's course level and topic (chem. or biochem.).  We also cover the most important theor. aspects of the STD expt., calling attention to some of its limitations and drawbacks without a complex theor. approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo29sluoDoJ87Vg90H21EOLACvtfcHk0lh5NIUDnMsJXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVant7c%253D&md5=807194fdb33d075121408463767cbf74</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fed101169t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fed101169t%26sid%3Dliteratum%253Aachs%26aulast%3DViegas%26aufirst%3DA.%26aulast%3DManso%26aufirst%3DJ.%26aulast%3DNobrega%26aufirst%3DF.%2BL.%26aulast%3DCabrita%26aufirst%3DE.%2BJ.%26atitle%3DSaturation-Transfer%2520Difference%2520%2528STD%2529%2520NMR%253A%2520A%2520Simple%2520and%2520Fast%2520Method%2520for%2520Ligand%2520Screening%2520and%2520Characterization%2520of%2520Protein%2520Binding%26jtitle%3DJ.%2520Chem.%2520Educ.%26date%3D2011%26volume%3D88%26spage%3D990%26epage%3D994%26doi%3D10.1021%2Fed101169t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindenblatt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickelsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applegate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">7766</span>– <span class="NLM_lpage">7772</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00587</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00587" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Ohur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=7766-7772&author=D.+Lindenblattauthor=A.+Nickelsenauthor=V.+Applegateauthor=J.+Joseauthor=K.+Niefind&title=Structural+and+Mechanistic+Basis+of+the+Inhibitory+Potency+of+Selected+2-Aminothiazole+Compounds+on+Protein+Kinase+CK2&doi=10.1021%2Facs.jmedchem.0c00587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2</span></div><div class="casAuthors">Lindenblatt, Dirk; Nickelsen, Anna; Applegate, Violetta M.; Jose, Joachim; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7766-7772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors of protein kinase CK2 with significant cytotoxicity on tumor cells based on a 2-aminothiazole scaffold were described recently.  Here, these studies are supplemented with representative CK2α/CK2α' complex structures.  They reveal that the 2-aminothiazole-based inhibitors occupy the ATP cavity, whereas preliminary data had indicated an allosteric binding site.  The crystal structure findings are corroborated by subsequent enzyme kinetic studies; their at.-resoln. quality provides the basis for future optimization of these promising CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoY8TYAgUidLVg90H21EOLACvtfcHk0lh5NIUDnMsJXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Ohur7P&md5=7e130a22bf2bc72a207b79c3e55a6892</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00587%26sid%3Dliteratum%253Aachs%26aulast%3DLindenblatt%26aufirst%3DD.%26aulast%3DNickelsen%26aufirst%3DA.%26aulast%3DApplegate%26aufirst%3DV.%26aulast%3DJose%26aufirst%3DJ.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DStructural%2520and%2520Mechanistic%2520Basis%2520of%2520the%2520Inhibitory%2520Potency%2520of%2520Selected%25202-Aminothiazole%2520Compounds%2520on%2520Protein%2520Kinase%2520CK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D7766%26epage%3D7772%26doi%3D10.1021%2Facs.jmedchem.0c00587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuriev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanlon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, J. S.</span></span> <span> </span><span class="NLM_article-title">Detection and Prevention of Aggregation-Based False Positives in STD-NMR-Based Fragment Screening</span>. <i>Aust. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1518</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1071/CH13286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1071%2FCH13286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=1518-1524&author=A.+Vomauthor=S.+Headeyauthor=G.+Wangauthor=B.+Capuanoauthor=E.+Yurievauthor=M.+J.+Scanlonauthor=J.+S.+Simpson&title=Detection+and+Prevention+of+Aggregation-Based+False+Positives+in+STD-NMR-Based+Fragment+Screening&doi=10.1071%2FCH13286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and Prevention of Aggregation-based False Positives in STD-NMR-based Fragment Screening</span></div><div class="casAuthors">Vom, Amelia; Headey, Stephen; Wang, Geqing; Capuano, Ben; Yuriev, Elizabeth; Scanlon, Martin J.; Simpson, Jamie S.</div><div class="citationInfo"><span class="NLM_cas:title">Australian Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1518-1524</span>CODEN:
                <span class="NLM_cas:coden">AJCHAS</span>;
        ISSN:<span class="NLM_cas:issn">0004-9425</span>.
    
            (<span class="NLM_cas:orgname">CSIRO Publishing</span>)
        </div><div class="casAbstract">Aggregation of small org. compds. is a problem encountered in a variety of assay screening formats where it often results in detection of false positives.  A satn. transfer difference-NMR-detected screen of a com. available fragment library, followed by biochem. assay, identified several inhibitors of the enzyme ketopantoate reductase.  These inhibitors were subsequently revealed to be aggregation-based false positives.  Modification of the fragment screen by addn. of detergent in the satn. transfer difference-NMR expts. allowed an assay format to be developed that resulted in the identification of genuine hit mols. suitable for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf6Q1uHTRgUbVg90H21EOLACvtfcHk0licc3QLs1MVsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLrO&md5=2fd1e1c425eab14da1cb299e4818dc8a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1071%2FCH13286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FCH13286%26sid%3Dliteratum%253Aachs%26aulast%3DVom%26aufirst%3DA.%26aulast%3DHeadey%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DYuriev%26aufirst%3DE.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26aulast%3DSimpson%26aufirst%3DJ.%2BS.%26atitle%3DDetection%2520and%2520Prevention%2520of%2520Aggregation-Based%2520False%2520Positives%2520in%2520STD-NMR-Based%2520Fragment%2520Screening%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D1518%26epage%3D1524%26doi%3D10.1071%2FCH13286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">A Detergent-Based Assay for the Detection of Promiscuous Inhibitors</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnprot.2006.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=17191086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=550-553&author=B.+Y.+Fengauthor=B.+K.+Shoichet&title=A+Detergent-Based+Assay+for+the+Detection+of+Promiscuous+Inhibitors&doi=10.1038%2Fnprot.2006.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A detergent-based assay for the detection of promiscuous inhibitors</span></div><div class="casAuthors">Feng, Brian Y.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">550-553</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">At micromolar concns., many small mols. self-assoc. into colloidal aggregates that non-specifically inhibit enzymes and other proteins.  Here the authors describe a protocol for identifying aggregate-based inhibitors and distinguishing them from small mols. that inhibit via specific mechanisms.  As a convenient proxy for promiscuous, aggregate-based inhibition, the authors monitor inhibition of β-lactamase in the absence and presence of detergent.  Inhibition that is attenuated in the presence of detergent is characteristic of an aggregate-based mechanism.  In the 96-well-format assay described here, about 200 mols. can be tested, in duplicate, per h for detergent-dependent sensitivity.  Furthermore, the authors also describe simple expts. that can offer addnl. confirmation of aggregate-based inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGQSBvMgM-7Vg90H21EOLACvtfcHk0licc3QLs1MVsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO&md5=8aa7562b5f69c896af7e133ecc35e6de</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.77%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520Detergent-Based%2520Assay%2520for%2520the%2520Detection%2520of%2520Promiscuous%2520Inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D550%26epage%3D553%26doi%3D10.1038%2Fnprot.2006.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Screening in a Spirit Haunted World</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2006.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.drudis.2006.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16793529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=607-615&author=B.+K.+Shoichet&title=Screening+in+a+Spirit+Haunted+World&doi=10.1016%2Fj.drudis.2006.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Screening in a spirit haunted world</span></div><div class="casAuthors">Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13 & 14</span>),
    <span class="NLM_cas:pages">607-615</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) campaigns can be dominated by hits that ultimately turn out to be non-drug-like.  These 'nuisance' compds. often behave strangely, with steep dose-response curves, absence of clear structure-activity relationships, and high sensitivity to assay conditions.  Several mechanisms contribute to these artifacts, including chem. reactive mols., those that absorb light in assays and those that affect redox conditions.  One of the most common mechanisms behind artifactual inhibition is discussed in this review: at micromolar concns. org. mols. can aggregate to form particles in aq. buffers, and these aggregates can sequester and thereby inhibit protein targets.  Aggregation-based inhibition is baffling from a chem. perspective, but viewed biophys. such behavior is expected.  The range of mols. that behave this way, their rapid detection in a screening environment and their possible biol. implications will be considered here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzoEkwI2izy7Vg90H21EOLACvtfcHk0licc3QLs1MVsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqtLk%253D&md5=08d22b6b06215ac435824b7664b3674c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DScreening%2520in%2520a%2520Spirit%2520Haunted%2520World%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D607%26epage%3D615%26doi%3D10.1016%2Fj.drudis.2006.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coan, K. E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltby, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2075</span>, <span class="refDoi"> DOI: 10.1021/jm801605r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801605r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2067-2075&author=K.+E.+D.+Coanauthor=D.+A.+Maltbyauthor=A.+L.+Burlingameauthor=B.+K.+Shoichet&title=Promiscuous+Aggregate-Based+Inhibitors+Promote+Enzyme+Unfolding&doi=10.1021%2Fjm801605r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding</span></div><div class="casAuthors">Coan, Kristin E. D.; Maltby, David A.; Burlingame, Alma L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2067-2075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the leading sources of false positives in early drug discovery is the formation of org. small mol. aggregates, which inhibit enzymes nonspecifically at micromolar concns. in aq. soln.  The mol. basis for this widespread problem remains hazy.  To investigate the mechanism of inhibition at a mol. level, we detd. changes in solvent accessibility that occur when an enzyme binds to an aggregate using hydrogen-deuterium exchange mass spectrometry.  For AmpC β-lactamase, binding to aggregates of the small mol. rottlerin increased the deuterium exchange of all 10 reproducibly detectable peptides, which covered 41% of the sequence of β-lactamase.  This suggested a global increase in proton accessibility upon aggregate binding, consistent with denaturation.  We then investigated whether enzyme-aggregate complexes were more susceptible to proteolysis than uninhibited enzyme.  For five aggregators, trypsin degrdn. of β-lactamase increased substantially when β-lactamase was inhibited by aggregates, whereas uninhibited enzyme was generally stable to digestion.  Combined, these results suggest that the mechanism of action of aggregate-based inhibitors proceeds via partial protein unfolding when bound to an aggregate particle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA67zj68-C17Vg90H21EOLACvtfcHk0lhvSP_q8SFloQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFKlsL4%253D&md5=d771ee54b647cf93efe5085c7977bb42</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm801605r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801605r%26sid%3Dliteratum%253Aachs%26aulast%3DCoan%26aufirst%3DK.%2BE.%2BD.%26aulast%3DMaltby%26aufirst%3DD.%2BA.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DPromiscuous%2520Aggregate-Based%2520Inhibitors%2520Promote%2520Enzyme%2520Unfolding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2067%26epage%3D2075%26doi%3D10.1021%2Fjm801605r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helfand, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">A Specific Mechanism of Nonspecific Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4265</span>– <span class="NLM_lpage">4272</span>, <span class="refDoi"> DOI: 10.1021/jm030266r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030266r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4265-4272&author=S.+L.+McGovernauthor=B.+T.+Helfandauthor=B.+Fengauthor=B.+K.+Shoichet&title=A+Specific+Mechanism+of+Nonspecific+Inhibition&doi=10.1021%2Fjm030266r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Specific Mechanism of Nonspecific Inhibition</span></div><div class="casAuthors">McGovern, Susan L.; Helfand, Brian T.; Feng, Brian; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4265-4272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Promiscuous small mols. plague screening libraries and hit lists.  Previous work has found that several nonspecific compds. form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes.  It is not understood how aggregates inhibit their targets.  To address this question, biophys., kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins.  By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact.  This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates conc. green fluorescent protein.  β-Lactamase mutants with increased or decreased thermodn. stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compd., suggesting that denaturation by unfolding was not the primary mechanism of interaction.  Instead, visualization by electron microscopy revealed that enzyme assocs. with the surface of inhibitor aggregates.  This assocn. could be reversed or prevented by the addn. of Triton X-100.  These observations suggest that the aggregates formed by promiscuous compds. reversibly sequester enzyme, resulting in apparent inhibition.  They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppdLVG_GeLZbVg90H21EOLACvtfcHk0lhvSP_q8SFloQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D&md5=cd0fd6bf0a64ceb7d7219dae2406dd21</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm030266r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030266r%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DHelfand%26aufirst%3DB.%2BT.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520Specific%2520Mechanism%2520of%2520Nonspecific%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4265%26epage%3D4272%26doi%3D10.1021%2Fjm030266r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walters, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milam, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. C.</span></span> <span> </span><span class="NLM_article-title">Chapter 1 Practical Approaches to Protein Folding and Assembly. Spectroscopic Strategies in Thermodynamics and Kinetics</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(08)04201-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2FS0076-6879%2808%2904201-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=19289201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlynt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2009&pages=1-39&author=J.+Waltersauthor=S.+L.+Milamauthor=A.+C.+Clark&title=Chapter+1+Practical+Approaches+to+Protein+Folding+and+Assembly.+Spectroscopic+Strategies+in+Thermodynamics+and+Kinetics&doi=10.1016%2FS0076-6879%2808%2904201-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Practical approaches to protein folding and assembly: spectroscopic strategies in thermodynamics and kinetics</span></div><div class="casAuthors">Walters, Jad; Milam, Sara L.; Clark, A. Clay</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">Biothermodynamics, Part A</span>),
    <span class="NLM_cas:pages">1-39</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We describe here the use of several spectroscopies, such as fluorescence emission, CD, and differential quenching by acrylamide, in examg. the equil. and kinetic folding of proteins.  The first section regarding equil. techniques provides practical information for detg. the conformational stability of a protein.  In addn., several equil.-folding models are discussed, from two-state monomer to four-state homodimer, providing a comprehensive protocol for interpretation of folding curves.  The second section focuses on the exptl. design and interpretation of kinetic data, such as burst-phase anal. and exponential fits, used in elucidating kinetic folding pathways.  In addn., simulation programs are used routinely to support folding models generated by kinetic expts., and the fundamentals of simulations are covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaMy2S1-SAI7Vg90H21EOLACvtfcHk0liv5VLKTmZP9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlynt7k%253D&md5=58d4801b39b748744352e0385b36084a</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2808%2904201-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252808%252904201-8%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DJ.%26aulast%3DMilam%26aufirst%3DS.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DChapter%25201%2520Practical%2520Approaches%2520to%2520Protein%2520Folding%2520and%2520Assembly.%2520Spectroscopic%2520Strategies%2520in%2520Thermodynamics%2520and%2520Kinetics%26jtitle%3DMethods%2520Enzymol.%26date%3D2009%26volume%3D455%26spage%3D1%26epage%3D39%26doi%3D10.1016%2FS0076-6879%2808%2904201-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bou-Assaf, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englander, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlish, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamuro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, A. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houde, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, T. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaltashov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konermann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascal, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skehel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strutzenberg, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underbakke, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wales, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintrode, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schriemer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, K. D.</span></span> <span> </span><span class="NLM_article-title">Recommendations for Performing, Interpreting and Reporting Hydrogen Deuterium Exchange Mass Spectrometry (HDX-MS) Experiments</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1038/s41592-019-0459-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fs41592-019-0459-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31249422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1ykur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=595-602&author=G.+R.+Massonauthor=J.+E.+Burkeauthor=N.+G.+Ahnauthor=G.+S.+Anandauthor=C.+Borchersauthor=S.+Brierauthor=G.+M.+Bou-Assafauthor=J.+R.+Engenauthor=S.+W.+Englanderauthor=J.+Faberauthor=R.+Garlishauthor=P.+R.+Griffinauthor=M.+L.+Grossauthor=M.+Guttmanauthor=Y.+Hamuroauthor=A.+J.+R.+Heckauthor=D.+Houdeauthor=R.+E.+Iacobauthor=T.+J.+D.+J%C3%B8rgensenauthor=I.+A.+Kaltashovauthor=J.+P.+Klinmanauthor=L.+Konermannauthor=P.+Manauthor=L.+Mayneauthor=B.+D.+Pascalauthor=D.+Reichmannauthor=M.+Skehelauthor=J.+Snijderauthor=T.+S.+Strutzenbergauthor=E.+S.+Underbakkeauthor=C.+Wagnerauthor=T.+E.+Walesauthor=B.+T.+Waltersauthor=D.+D.+Weisauthor=D.+J.+Wilsonauthor=P.+L.+Wintrodeauthor=Z.+Zhangauthor=J.+Zhengauthor=D.+C.+Schriemerauthor=K.+D.+Rand&title=Recommendations+for+Performing%2C+Interpreting+and+Reporting+Hydrogen+Deuterium+Exchange+Mass+Spectrometry+%28HDX-MS%29+Experiments&doi=10.1038%2Fs41592-019-0459-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments</span></div><div class="casAuthors">Masson, Glenn R.; Burke, John E.; Ahn, Natalie G.; Anand, Ganesh S.; Borchers, Christoph; Brier, Sebastien; Bou-Assaf, George M.; Engen, John R.; Englander, S. Walter; Faber, Johan; Garlish, Rachel; Griffin, Patrick R.; Gross, Michael L.; Guttman, Miklos; Hamuro, Yoshitomo; Heck, Albert J. R.; Houde, Damian; Iacob, Roxana E.; Joergensen, Thomas J. D.; Kaltashov, Igor A.; Klinman, Judith P.; Konermann, Lars; Man, Petr; Mayne, Leland; Pascal, Bruce D.; Reichmann, Dana; Skehel, Mark; Snijder, Joost; Strutzenberg, Timothy S.; Underbakke, Eric S.; Wagner, Cornelia; Wales, Thomas E.; Walters, Benjamin T.; Weis, David D.; Wilson, Derek J.; Wintrode, Patrick L.; Zhang, Zhongqi; Zheng, Jie; Schriemer, David C.; Rand, Kasper D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">595-602</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Hydrogen deuterium exchange mass spectrometry (HDX-MS) is a powerful biophys. technique being increasingly applied to a wide variety of problems.  As the HDX-MS community continues to grow, adoption of best practices in data collection, anal., presentation and interpretation will greatly enhance the accessibility of this technique to nonspecialists.  Here we provide recommendations arising from community discussions emerging out of the first International Conference on Hydrogen-Exchange Mass Spectrometry (IC-HDX; 2017).  It is meant to represent both a consensus viewpoint and an opportunity to stimulate further addns. and refinements as the field advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnzhV6F6lrLVg90H21EOLACvtfcHk0liv5VLKTmZP9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1ykur7K&md5=e25a742a0405d47ec31fbc0a36743261</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fs41592-019-0459-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41592-019-0459-y%26sid%3Dliteratum%253Aachs%26aulast%3DMasson%26aufirst%3DG.%2BR.%26aulast%3DBurke%26aufirst%3DJ.%2BE.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26aulast%3DAnand%26aufirst%3DG.%2BS.%26aulast%3DBorchers%26aufirst%3DC.%26aulast%3DBrier%26aufirst%3DS.%26aulast%3DBou-Assaf%26aufirst%3DG.%2BM.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DEnglander%26aufirst%3DS.%2BW.%26aulast%3DFaber%26aufirst%3DJ.%26aulast%3DGarlish%26aufirst%3DR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DGross%26aufirst%3DM.%2BL.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DHeck%26aufirst%3DA.%2BJ.%2BR.%26aulast%3DHoude%26aufirst%3DD.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DT.%2BJ.%2BD.%26aulast%3DKaltashov%26aufirst%3DI.%2BA.%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26aulast%3DKonermann%26aufirst%3DL.%26aulast%3DMan%26aufirst%3DP.%26aulast%3DMayne%26aufirst%3DL.%26aulast%3DPascal%26aufirst%3DB.%2BD.%26aulast%3DReichmann%26aufirst%3DD.%26aulast%3DSkehel%26aufirst%3DM.%26aulast%3DSnijder%26aufirst%3DJ.%26aulast%3DStrutzenberg%26aufirst%3DT.%2BS.%26aulast%3DUnderbakke%26aufirst%3DE.%2BS.%26aulast%3DWagner%26aufirst%3DC.%26aulast%3DWales%26aufirst%3DT.%2BE.%26aulast%3DWalters%26aufirst%3DB.%2BT.%26aulast%3DWeis%26aufirst%3DD.%2BD.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DWintrode%26aufirst%3DP.%2BL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DSchriemer%26aufirst%3DD.%2BC.%26aulast%3DRand%26aufirst%3DK.%2BD.%26atitle%3DRecommendations%2520for%2520Performing%252C%2520Interpreting%2520and%2520Reporting%2520Hydrogen%2520Deuterium%2520Exchange%2520Mass%2520Spectrometry%2520%2528HDX-MS%2529%2520Experiments%26jtitle%3DNat.%2520Methods%26date%3D2019%26volume%3D16%26spage%3D595%26epage%3D602%26doi%3D10.1038%2Fs41592-019-0459-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">12257</span>– <span class="NLM_lpage">12261</span>, <span class="refDoi"> DOI: 10.1021/ja9715962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9715962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVCh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=12257-12261&author=P.+J.+Hajdukauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=One-Dimensional+Relaxation-+and+Diffusion-Edited+NMR+Methods+for+Screening+Compounds+That+Bind+to+Macromolecules&doi=10.1021%2Fja9715962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules</span></div><div class="casAuthors">Hajduk, Philip J.; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">12257-12261</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two one-dimensional 1H NMR techniques for efficiently screening libraries of compds. for binding to macromols. are described that exploit the changes in relaxation or diffusion rates of small mols. which occur upon complex formation.  The techniques are demonstrated by detecting ligands that bind to the FK506 binding protein and the catalytic domain of stromelysin in the presence of compds. that do not bind to these proteins.  These one-dimensional methods directly detect complex formation between a ligand and a macromol. and thus eliminate false positives often obsd. with other techniques.  In addn., since these methods rely on the detection of the uncomplexed compd. rather than the bound ligand or macromol., ligands for macromols. of unlimited size can be detected.  Furthermore, active compds. can be directly identified from a mixt., significantly reducing the time and material needed for screening large libraries of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot9O_RpUcMj7Vg90H21EOLACvtfcHk0lh7P--XtB6HRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVCh&md5=bcd34f47e094b408b1de34eca7b01051</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fja9715962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9715962%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DOne-Dimensional%2520Relaxation-%2520and%2520Diffusion-Edited%2520NMR%2520Methods%2520for%2520Screening%2520Compounds%2520That%2520Bind%2520to%2520Macromolecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D12257%26epage%3D12261%26doi%3D10.1021%2Fja9715962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stott, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaka, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stonehouse, J.</span></span> <span> </span><span class="NLM_article-title">Excitation Sculpting in High-Resolution Nuclear Magnetic Resonance Spectroscopy: Application to Selective NOE Experiments</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">4199</span>– <span class="NLM_lpage">4200</span>, <span class="refDoi"> DOI: 10.1021/ja00119a048</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00119a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=4199-4200&author=K.+Stottauthor=J.+Keelerauthor=T.+L.+Hwangauthor=A.+J.+Shakaauthor=J.+Stonehouse&title=Excitation+Sculpting+in+High-Resolution+Nuclear+Magnetic+Resonance+Spectroscopy%3A+Application+to+Selective+NOE+Experiments&doi=10.1021%2Fja00119a048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Excitation Sculpting in High-Resolution Nuclear Magnetic Resonance Spectroscopy: Application to Selective NOE Experiments</span></div><div class="casAuthors">Stott, Katherine; Stonehouse, Jonathan; Keeler, James; Hwang, Tsang-Lin; Shaka, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4199-200</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We propose a method, termed excitation sculpting, for selective excitation in pulsed NMR expts.  The method is applicable to a wide variety of important NMR expts. and has a no. of advantages compared to familiar pulse shaping methods, namely: (i) the phase of the signal is const. over the excitation bandwidth and this bandwidth is easily varied; (ii) there are no out-of-band excitation side lobes; (iii) different net flip angles can be achieved, with no degrdn. of the performance; (i.v.) the excitation profile is very tolerant of inhomogeneity of the radiofrequency field; (v) in the selective excitation of a scalar coupled multiplet, the evolution of the coupling is refocused; and (vi) points (i)-(v) are achieved in a single scan; no phase cycling or difference spectroscopy is needed.  We show that the method can be used to considerable advantage in a one-dimensional expt. to measure transient NOE enhancements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjJByQQsuJWLVg90H21EOLACvtfcHk0lgSTlY2Ap1GQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVaisrY%253D&md5=aa7ab1883609ebb2ef7d18c126364a30</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fja00119a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00119a048%26sid%3Dliteratum%253Aachs%26aulast%3DStott%26aufirst%3DK.%26aulast%3DKeeler%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DT.%2BL.%26aulast%3DShaka%26aufirst%3DA.%2BJ.%26aulast%3DStonehouse%26aufirst%3DJ.%26atitle%3DExcitation%2520Sculpting%2520in%2520High-Resolution%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%253A%2520Application%2520to%2520Selective%2520NOE%2520Experiments%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D4199%26epage%3D4200%26doi%3D10.1021%2Fja00119a048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindon, J. C.</span></span> <span> </span><span class="NLM_article-title">Improved Watergate Pulse Sequences for Solvent Suppression in NMR Spectroscopy</span>. <i>J. Magn. Reson.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1006/jmre.1998.1405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1006%2Fjmre.1998.1405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFSjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=1998&pages=125-129&author=M.+Liuauthor=X.+A.+Maoauthor=C.+Yeauthor=H.+Huangauthor=J.+K.+Nicholsonauthor=J.+C.+Lindon&title=Improved+Watergate+Pulse+Sequences+for+Solvent+Suppression+in+NMR+Spectroscopy&doi=10.1006%2Fjmre.1998.1405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy</span></div><div class="casAuthors">Liu, Maili; Mao, Xi-An; Ye, Chaohui; Huang, He; Nicholson, Jeremy K.; Lindon, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Magnetic Resonance</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-129</span>CODEN:
                <span class="NLM_cas:coden">JMARF3</span>;
        ISSN:<span class="NLM_cas:issn">1090-7807</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Modifications to the WATERGATE method for removing the solvent resonance from 1H NMR spectra are presented.  In the conventional WATERGATE, a pulse train with three pairs of sym. pulses in the form 3α-τ-9α-τ-19α-τ-19α-τ-9α-τ-3α (designated here W3), where 26α = 180°, was used, while the improved versions use four and five pairs of sym. pulses (designated here W4 and W5), resp.  The modified methods provide narrower noninversion regions and hence enhance the sensitivities of the peaks close to the H2O resonance.  The inversion and suppression profiles of the pulse trains W3, W4, and W5 are compared theor. and exptl. and good agreement was obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprCKgUD2LwjbVg90H21EOLACvtfcHk0lhKIq0eNGdgWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFSjsbg%253D&md5=86687bb8536ee190f075defbc4bfffcb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1006%2Fjmre.1998.1405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmre.1998.1405%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DX.%2BA.%26aulast%3DYe%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DNicholson%26aufirst%3DJ.%2BK.%26aulast%3DLindon%26aufirst%3DJ.%2BC.%26atitle%3DImproved%2520Watergate%2520Pulse%2520Sequences%2520for%2520Solvent%2520Suppression%2520in%2520NMR%2520Spectroscopy%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D1998%26volume%3D132%26spage%3D125%26epage%3D129%26doi%3D10.1006%2Fjmre.1998.1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span> <span> </span><span class="NLM_article-title">Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1784</span>– <span class="NLM_lpage">1788</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterization+of+Ligand+Binding+by+Saturation+Transfer+Difference+NMR+Spectroscopy&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1784-1788</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The difference between a satn. transfer spectrum and a normal NMR spectrum provides a new and fast method (satn. transfer difference (STD) NMR spectroscopy) to screen compd. libraries for binding activity to proteins.  STD NMR spectroscopy of mixts. of potential ligands with as little as 1 nmol of protein yields 1D and 2D NMR spectra that exclusively show signals from mols. with binding affinity.  In addn., the ligand's binding epitope is easily identified because ligand residues in direct contact to the protein show much stronger STD signals.  For example, the binding specificity of Lewisb-hexasaccharide to Aleulria aurantia agglutinin (AAA) can be mapped to the two fucosyl residues.  The efficiency of the STD NMR technique is shown by the binding of N-acetylglucosamine (GlcNAc) to wheat germ agglutinin (WGA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8j8HiAqDArVg90H21EOLACvtfcHk0lgv0UJw51cBxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D&md5=03f825af40d22911062112dc6074cf46</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1784%253A%253AAID-ANIE1784%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520Ligand%2520Binding%2520by%2520Saturation%2520Transfer%2520Difference%2520NMR%2520Spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogliatto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockman, B.</span></span> <span> </span><span class="NLM_article-title">WaterLOGSY as a Method for Primary NMR Screening: Practical Aspects and Range of Applicability</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1023/A:1013302231549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1023%2FA%3A1013302231549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=11824754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD38XptVyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=349-359&author=C.+Dalvitauthor=G.+Fogliattoauthor=a.+Stewartauthor=M.+Veronesiauthor=B.+Stockman&title=WaterLOGSY+as+a+Method+for+Primary+NMR+Screening%3A+Practical+Aspects+and+Range+of+Applicability&doi=10.1023%2FA%3A1013302231549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability</span></div><div class="casAuthors">Dalvit, Claudio; Fogliatto, GianPaolo; Stewart, Albert; Veronesi, Marina; Stockman, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">WaterLOGSY represents a powerful method for primary NMR screening in the identification of compds. interacting with macromols., including proteins and DNA or RNA fragments.  Several relay pathways are used constructively in the expt. for transferring bulk water magnetization to the ligand.  The method is particularly useful for the identification of novel scaffolds of micromolar affinity that can be then optimized using directed screening, combinatorial chem., medicinal chem. and structure-based drug design.  The practical aspects and range of applicability of the WaterLOGSY expt. are analyzed in detail here.  Competition binding and titrn. WaterLOGSY permit, after proper correction, the evaluation of the dissocn. binding const.  The high sensitivity of the technique in combination with the easy deconvolution of the mixts. for the identification of the active components, significantly reduces the amt. of material and time needed for the NMR screening process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqqsXXXVX77Vg90H21EOLACvtfcHk0lgv0UJw51cBxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptVyksw%253D%253D&md5=e7b431d72aa17c499c1e751956605dee</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1023%2FA%3A1013302231549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1013302231549%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DStewart%26aufirst%3Da.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DStockman%26aufirst%3DB.%26atitle%3DWaterLOGSY%2520as%2520a%2520Method%2520for%2520Primary%2520NMR%2520Screening%253A%2520Practical%2520Aspects%2520and%2520Range%2520of%2520Applicability%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2001%26volume%3D21%26spage%3D349%26epage%3D359%26doi%3D10.1023%2FA%3A1013302231549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Oliver Laufkötter, Huabin Hu, Filip Miljković, <span class="NLM_string-name hlFld-ContribAuthor">Jürgen Bajorath</span>. </span><span class="cited-content_cbyCitation_article-title">Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-%252Band%252BSimilarity-Based%252BSurvey%252Bof%252BAllosteric%252BKinase%252BInhibitors%25252C%252BActivators%25252C%252Band%252BClosely%252BRelated%252BCompounds%26aulast%3DLaufk%25C3%25B6tter%26aufirst%3DOliver%26date%3D2021%26date%3D2020%26date%3D30112020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Eleanor L.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Paul D.  Brear</span>, <span class="hlFld-ContribAuthor ">Bethany M.  Cooper</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical probes targeting the kinase CK2: a journey outside the catalytic box. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (20)
                                     , 4380-4396. <a href="https://doi.org/10.1039/D1OB00257K" title="DOI URL">https://doi.org/10.1039/D1OB00257K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00257K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00257K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DChemical%252Bprobes%252Btargeting%252Bthe%252Bkinase%252BCK2%25253A%252Ba%252Bjourney%252Boutside%252Bthe%252Bcatalytic%252Bbox%26aulast%3DIegre%26aufirst%3DJessica%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D20%26spage%3D4380%26epage%3D4396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleanor L.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Paul D.  Brear</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Zhabina</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1977. <a href="https://doi.org/10.3390/molecules26071977" title="DOI URL">https://doi.org/10.3390/molecules26071977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071977%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDownfalls%252Bof%252BChemical%252BProbes%252BActing%252Bat%252Bthe%252BKinase%252BATP-Site%25253A%252BCK2%252Bas%252Ba%252BCase%252BStudy%26aulast%3DAtkinson%26aufirst%3DEleanor%2BL.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Doller</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00057-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00057-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00057-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00057-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252BModulation%26aulast%3DDoller%26aufirst%3DDario%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conserved pharmacophore binding in the ATP site of protein kinases. (A) Structures of <b>1</b> and <b>2</b>, denoted <b>6</b> and <b>27</b>, respectively, in the original studies. (B) Summary of the analysis of the established ligands that bind to Ser/Thr protein kinases (EC number 2.7.11.1) or CK2α in the ATP site. (C) Structures of the four CK2α inhibitors and their protein-bound crystal structures, which contain a benzoic acid group that binds in the ATP site.<a onclick="showRef(event, 'ref46 ref48 ref56 ref59'); return false;" href="javascript:void(0);" class="ref ref46 ref48 ref56 ref59">(46,48,56,59)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of compounds <b>1</b> and <b>2</b> bound to CK2α. (A) <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> map (green, displayed at 3σ) in the ATP site and site A before the ligand has been placed. Refined structure of <b>2</b> (green) has been superimposed on the ATP site (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>) and the predicted binding mode of <b>2</b> (transparent purple) is shown on site A. (B) The <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> map (green, contoured at 3σ) for the ATP site and site A before the ligand has been placed. Refined structure of <b>1</b> (blue) has been superimposed on the ATP site (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG">6YPG</a>) and the predicted binding mode of <b>2</b> (transparent purple, from the Supporting Information of ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>) is shown on site A. (C) <b>2</b> (green) bound to CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>), with the key interacting residues and H-bonding highlighted. (D) <b>1</b> bound to CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG">6YPG</a>), with the key interacting residues and H-bonding highlighted. The structure of <b>CX4945</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PE1">3PE1</a>, yellow) has been superimposed on the structure of <b>2</b> and <b>1</b> in panels (C) and (D). Electron densities of the final, refined structures are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S7</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of ADP and GDP binding to CK2α site A. (A) GDP binding in site A. The <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> map (contoured at 3σ) centered on the proposed allosteric site. No density was observed in the ATP site for GDP, therefore the density in the ATP site was not shown for clarity. The CK2α KKK/AAA construct was used for this structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a>). (B) Structure of GDP bound to CK2α, with the extensive H-bonding network shown by the dotted lines (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK">6YPK</a>). (C) Proposed binding mode of <b>1</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ">6YPJ</a>) superimposed on the structure of GDP bound to CK2α (6PYK). (D) Structure of ADP bound simultaneously in the ATP site and in site A of WT CK2α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN">6YPN</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. HDX analysis of ligand binding to CK2α. The heatmaps show the change in deuterium uptake upon binding of different ligands to apo CK2α. Each panel, with the ligand listed on the top, shows the heatmaps for 10 and 100 s timepoints for peptides corresponding to the P-loop and αD-loop, in comparison to unliganded CK2α. All depicted changes are greater than ±0.25 Da and have a <i>p</i>-value less than 0.01 in Welch’s <i>t</i>-test. The exact start and end residues for each peptide are shown on the left of the panels. Next to each heatmap are two graphs showing deuterium uptake for one peptide from each P-loop (top) and αD-loop (bottom) for apo CK2α (black) and CK2α with the ligand (gray). The <i>Y</i>-axis range is 80% of max D-uptake, assuming that the N-terminal residue undergoes 100% back-exchange. Data have not been corrected for back-exchange. The error bars are ±2σ derived from three technical replicates. A structural diagram in between the uptake plots has the P-loop and αD-loop colored purple and green, respectively, and the bound ligand in the surface rendering in yellow. Full HDX data are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf" class="ext-link">Figure S13</a> and available in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_001.xlsx" class="ext-link">Supporting Spreadsheet</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ligand-based NMR experiments to detect binding of <b>1</b> to CK2α and competition by CX4945. All panels are overlays of the spectra recorded in the presence (black) and absence (green) of CK2α. (A) Saturation transfer difference (STD) <sup>1</sup>H spectra of <b>1</b> (i) in the absence of <b>CX4945</b> and (ii) in the presence of 50 μM <b>CX4945</b>. (B) Water-LOGSY spectra of <b>1</b> (i) in the absence of <b>CX4945</b> and (ii) in the presence of 50 μM <b>CX4945</b> (ii). (C) Relaxation-edited (CPMG) <sup>1</sup>H spectra of <b>1</b> (i) in the absence of <b>CX4945</b> and (ii) in the presence of 50 μM <b>CX4945</b> (ii). (NB: the signals at ca. 7.7 ppm are in fact two overlapping doublets and therefore small changes to either chemical shift result in an apparent change to the multiplet structure.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/medium/jm0c01173_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. ITC measurement of binding of <b>1</b> and <b>2</b> to CK2α. (A) Titration of <b>1</b> into 10 μM CK2α. Titration of <b>2</b> into 10 μM CK2α. (B) Titration of <b>1</b> into 10 μM CK2α. Titration of <b>2</b> into 10 μM CK2α in the presence of <b>CX4945</b>. (C) Titration of <b>2</b> into 20 μM CK2α. (D) Titration of <b>2</b> into 20 μM CK2α in the presence of 100 μM <b>CX4945</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c01173/20201105/images/large/jm0c01173_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01173&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 77 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.</span></span> <span> </span><span class="NLM_article-title">Properties of FDA-Approved Small Molecule Protein Kinase Inhibitors</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.phrs.2019.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=30877063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=19-50&author=R.+Roskoski&title=Properties+of+FDA-Approved+Small+Molecule+Protein+Kinase+Inhibitors&doi=10.1016%2Fj.phrs.2019.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of FDA-approved small molecule protein kinase inhibitors</span></div><div class="casAuthors">Roskoski, Robert Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-50</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Because mutations, overexpression, and dysregulation of protein kinases play essential roles in the pathogenesis of many illnesses, this enzyme family has become one of the most important drug targets in the past 20 years.  The US FDA has approved 48 small mol. protein kinase inhibitors, nearly all of which are orally effective with the exceptions of netarsudil (which is given as an eye drop) and temsirolimus (which is given i.v.).  Of the 48 approved drugs, the majority (25) target receptor protein-tyrosine kinases, ten target non-receptor protein-tyrosine kinases, and 13 target protein-serine/threonine protein kinases.  The data indicate that 43 of these drugs are used in the treatment of malignancies (36 against solid tumors including lymphomas and seven against non-solid tumors, e.g., leukemias).  Seven drugs are used in the treatment of non-malignancies: baricitinib, rheumatoid arthritis; fostamatinib, chronic immune thrombocytopenia; ruxolitinib, myelofibrosis and polycythemia vera; nintedanib, idiopathic pulmonary fibrosis; sirolimus, renal graft vs. host disease; netarsudil, glaucoma; tofacitinib, rheumatoid arthritis, Crohn disease, and ulcerative colitis.  Moreover, ibrutinib and sirolimus are used for the treatment of both malignant and non-malignant diseases.  The most common drug targets include ALK, B-Raf, BCR-Abl, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor (VEGFR).  Most of the small mol. inhibitors (45) interact directly with the protein kinase domain.  In contrast, sirolimus, temsirolimus, and everolimus are larger mols. (MW ≈ 1000) that bind to FKBP-12 to generate a complex that inhibits mTOR (mammalian target of rapamycin).  This review presents the available drug-enzyme X-ray crystal structures for 27 of the approved drugs as well as the chem. structures and physicochem. properties of all of the FDA-approved small mol. protein kinase antagonists.  Six of the drugs bind covalently and irreversibly to their target.  Twenty of the 48 drugs have mol. wts. greater than 500, exceeding a Lipinski rule of five criterion.  Excluding the macrolides (everolimus, sirolimus, temsirolimus), the av. mol. wt. of drugs is 480 with a range of 306 (ruxolitinib) to 615 (trametinib).  Nearly half of the antagonists (23) have a lipophilic efficiency with values of less than five while the recommended optima range from 5-10.  One of the vexing problems is the near universal development of resistance that is assocd. with the use of small mol. protein kinase inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLum_hDK00hbVg90H21EOLACvtfcHk0lgauNGWuXdKCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntVGnurg%253D&md5=a24dee87603bc4ea12bd34616e46f53d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DProperties%2520of%2520FDA-Approved%2520Small%2520Molecule%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50%26doi%3D10.1016%2Fj.phrs.2019.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">FDA-Approved Small-Molecule Kinase Inhibitors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.tips.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=25975227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=422-439&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=FDA-Approved+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.tips.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">FDA-approved small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">422-439</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have emerged as one of the most intensively pursued targets in current pharmacol. research, esp. for cancer, due to their crit. roles in cellular signaling.  To date, the US FDA has approved 28 small-mol. kinase inhibitors, half of which were approved in the past 3 years.  While the clin. data of these approved mols. are widely presented and structure-activity relationship (SAR) has been reported for individual mols., an updated review that analyzes all approved mols. and summarizes current achievements and trends in the field has yet to be found.  Here we present all approved small-mol. kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrudyvM3eO09bVg90H21EOLACvtfcHk0linY1Dj8QZ-gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D&md5=a6aa3dbb11e6fe3001fa5fa03a4c950a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DFDA-Approved%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D422%26epage%3D439%26doi%3D10.1016%2Fj.tips.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Measuring and Interpreting the Selectivity of Protein Kinase Inhibitors</span>. <i>J. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1007/s12154-009-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs12154-009-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=19568781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=131-151&author=L.+A.+Smythauthor=I.+Collins&title=Measuring+and+Interpreting+the+Selectivity+of+Protein+Kinase+Inhibitors&doi=10.1007%2Fs12154-009-0023-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring and interpreting the selectivity of protein kinase inhibitors</span></div><div class="casAuthors">Smyth Lynette A; Collins Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-51</span>
        ISSN:<span class="NLM_cas:issn">1864-6158</span>.
    </div><div class="casAbstract">Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer.  Achieving inhibitor selectivity for particular protein kinases often remains a significant challenge in the development of new small molecules as drugs or as tools for chemical biology research.  This review summarises the methodologies available for measuring kinase inhibitor selectivity, both in vitro and in cells.  The interpretation of kinase inhibitor selectivity data is discussed, particularly with reference to the structural biology of the protein targets.  Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU9rA5WZcz9FxYDaSSP8XfW6udTcc2eYiovabqHp1MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D&md5=f78ff1202a949a71ffd65e804298c37f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs12154-009-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12154-009-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DL.%2BA.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMeasuring%2520and%2520Interpreting%2520the%2520Selectivity%2520of%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D2%26spage%3D131%26epage%3D151%26doi%3D10.1007%2Fs12154-009-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Analysis of Kinase Inhibitor Selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+Analysis+of+Kinase+Inhibitor+Selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0linY1Dj8QZ-gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">Emerging Principles in Protease-Based Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1038/nrd3053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnrd3053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=20811381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=690-701&author=M.+Dragauthor=G.+S.+Salvesen&title=Emerging+Principles+in+Protease-Based+Drug+Discovery&doi=10.1038%2Fnrd3053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging principles in protease-based drug discovery</span></div><div class="casAuthors">Drag, Marcin; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">690-701</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Proteases have an important role in many signalling pathways, and represent potential drug targets for diseases ranging from cardiovascular disorders to cancer, as well as for combating many parasites and viruses.  Although inhibitors of well-established protease targets such as angiotensin-converting enzyme and HIV protease have shown substantial therapeutic success, developing drugs for new protease targets has proved challenging in recent years.  This in part could be due to issues such as the difficulty of achieving selectivity when targeting protease active sites.  This Perspective discusses the general principles in protease-based drug discovery, highlighting the lessons learned and the emerging strategies, such as targeting allosteric sites, which could help harness the therapeutic potential of new protease targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz3PQDA1pnT7Vg90H21EOLACvtfcHk0ljiOzBnwKYSKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSisbzP&md5=28a9571473c3f753027665b77d3257d0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3053%26sid%3Dliteratum%253Aachs%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DEmerging%2520Principles%2520in%2520Protease-Based%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D690%26epage%3D701%26doi%3D10.1038%2Fnrd3053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The Selectivity of Protein Kinase Inhibitors: A Further Update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+Selectivity+of+Protein+Kinase+Inhibitors%3A+A+Further+Update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0ljiOzBnwKYSKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520Selectivity%2520of%2520Protein%2520Kinase%2520Inhibitors%253A%2520A%2520Further%2520Update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The Specificities of Protein Kinase Inhibitors: An Update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+Specificities+of+Protein+Kinase+Inhibitors%3A+An+Update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0ljiOzBnwKYSKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520Specificities%2520of%2520Protein%2520Kinase%2520Inhibitors%253A%2520An%2520Update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserú, G. M.</span></span> <span> </span><span class="NLM_article-title">Contributions of Molecular Properties to Drug Promiscuity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1795</span>, <span class="refDoi"> DOI: 10.1021/jm301514n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301514n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1789-1795&author=%C3%81.+Tarcsayauthor=G.+M.+Keser%C3%BA&title=Contributions+of+Molecular+Properties+to+Drug+Promiscuity&doi=10.1021%2Fjm301514n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of Molecular Properties to Drug Promiscuity</span></div><div class="casAuthors">Tarcsay, Akos; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In contrast to designed polypharmacol. that can result in efficient drugs for complex disorders, unintended drug promiscuity has detrimental contribution to side effects and toxicol.  Characterization of promiscuous compds. enhances the understanding of complex interaction patterns and aids the design of compds. with broader selectivity against off-targets that has a major impact on medicinal chem. outcome.  In this Miniperspective we provide insights to the effect of physicochem. parameters on promiscuity.  Information collected from recent, large-scale in vitro studies enabled us to discuss the relationships between physicochem. properties and promiscuity in detail.  In light of these data, lipophilicity and basic character have the highest influence.  On the basis of the accumulated knowledge, we propose the extensive use of pre- and postsynthesis metrics, as well as strict control of physicochem. properties during medicinal chem. optimizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1J_jqkK3DrVg90H21EOLACvtfcHk0lj6uiTv3UcrIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D&md5=c5763ee1aed897ff19e5a2344b95b9c1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm301514n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301514n%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3D%25C3%2581.%26aulast%3DKeser%25C3%25BA%26aufirst%3DG.%2BM.%26atitle%3DContributions%2520of%2520Molecular%2520Properties%2520to%2520Drug%2520Promiscuity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1789%26epage%3D1795%26doi%3D10.1021%2Fjm301514n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarolimek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitebread, S.</span></span> <span> </span><span class="NLM_article-title">Reducing Safety-Related Drug Attrition: The Use of in Vitro Pharmacological Profiling</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1038/nrd3845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnrd3845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=23197038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-922&author=J.+Bowesauthor=A.+J.+Brownauthor=J.+Hamonauthor=W.+Jarolimekauthor=A.+Sridharauthor=G.+Waldronauthor=S.+Whitebread&title=Reducing+Safety-Related+Drug+Attrition%3A+The+Use+of+in+Vitro+Pharmacological+Profiling&doi=10.1038%2Fnrd3845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span></div><div class="casAuthors">Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques; Jarolimek, Wolfgang; Sridhar, Arun; Waldron, Gareth; Whitebread, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In vitro pharmacol. profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved.  Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacol. profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process.  We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVp3wnTONWrVg90H21EOLACvtfcHk0lj6uiTv3UcrIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ&md5=7559001563ef3febd610535b8f096a45</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3845%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DWaldron%26aufirst%3DG.%26aulast%3DWhitebread%26aufirst%3DS.%26atitle%3DReducing%2520Safety-Related%2520Drug%2520Attrition%253A%2520The%2520Use%2520of%2520in%2520Vitro%2520Pharmacological%2520Profiling%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D922%26doi%3D10.1038%2Fnrd3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smaill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">New Promise and Opportunities for Allosteric Kinase Inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">13764</span>– <span class="NLM_lpage">13776</span>, <span class="refDoi"> DOI: 10.1002/anie.201914525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1002%2Fanie.201914525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Giurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=13764-13776&author=X.+Luauthor=J.+B.+Smaillauthor=K.+Ding&title=New+Promise+and+Opportunities+for+Allosteric+Kinase+Inhibitors&doi=10.1002%2Fanie.201914525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">New Promise and Opportunities for Allosteric Kinase Inhibitors</span></div><div class="casAuthors">Lu, Xiaoyun; Smaill, Jeff B.; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13764-13776</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Drugs that function through allosteric inhibition of kinase signaling represent a promising approach for the targeted discovery of therapeutics.  The majority of developed allosteric kinase inhibitors are characterized as type III and IV inhibitors that show good kinome selectivity but generally lack the subtype selectivity of same kinase family.  Recently allosteric inhibitors have been developed that bind outside the catalytic kinase domain with high selectivity for specific kinase subtypes.  Allosteric inhibitors that bind to the pseudokinase domain of pseudokinase or the extracellular domain of receptor tyrosine kinases are reviewed.  We also review recent developments in the field of allosteric kinase inhibitors including examples of proteolysis targeting chimeras, and highlight the unique binding modes for each type of inhibitors and address future opportunities in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIeFGyjfBKrLVg90H21EOLACvtfcHk0lj6uiTv3UcrIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Giurw%253D&md5=27959fdb1a96202db7ca65b2a8e19bc7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.201914525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201914525%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DNew%2520Promise%2520and%2520Opportunities%2520for%2520Allosteric%2520Kinase%2520Inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26spage%3D13764%26epage%3D13776%26doi%3D10.1002%2Fanie.201914525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebakken, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichling, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellefson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddle, S. M.</span></span> <span> </span><span class="NLM_article-title">Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1177/1087057112439889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1177%2F1087057112439889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=22453235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCju7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=813-821&author=C.+S.+Lebakkenauthor=L.+J.+Reichlingauthor=J.+M.+Ellefsonauthor=S.+M.+Riddle&title=Detection+of+Allosteric+Kinase+Inhibitors+by+Displacement+of+Active+Site+Probes&doi=10.1177%2F1087057112439889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of allosteric kinase inhibitors by displacement of active site probes</span></div><div class="casAuthors">Lebakken, Connie S.; Reichling, Laurie J.; Ellefson, Jason M.; Riddle, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">813-821</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Non-ATP (ATP) competitive, allosteric inhibitors provide a promising avenue to develop highly selective small-mol. kinase inhibitors.  Although this class of compds. is growing, detection of such inhibitors can be challenging as std. kinase activity assays preferentially detect compds. that bind to active kinases in an ATP competitive manner.  We have previously described a time-resolved fluorescence resonance energy transfer (TR-FRET)-based kinase binding assay using the competitive displacement of ATP competitive active site fluorescent probes ("tracers").  Although this format has gained acceptance, published data with this and related formats are almost entirely without examples of non-ATP competitive compds.  Thus, this study addresses whether this format is useful for non-ATP competitive inhibitors.  To this end, 15 com. available non-ATP competitive inhibitors were tested for their ability to displace ATP competitive probes.  Despite the diversity of both compd. structures and their resp. targets, 14 of the 15 compds. displaced the tracers with IC50 values comparable to literature values.  We conclude that such binding assays are well suited for the study of non-ATP competitive inhibitors.  In addn., we demonstrate that allosteric inhibitors of BCR-Abl and MEK bind preferentially to the nonphosphorylated (i.e., inactive) form of the kinase, indicating that binding assays may be a preferred format in some cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBTuxOBOOc5LVg90H21EOLACvtfcHk0lj6uiTv3UcrIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCju7rN&md5=e84b76003c5b56953e548410d25a8e08</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1087057112439889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112439889%26sid%3Dliteratum%253Aachs%26aulast%3DLebakken%26aufirst%3DC.%2BS.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DEllefson%26aufirst%3DJ.%2BM.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26atitle%3DDetection%2520of%2520Allosteric%2520Kinase%2520Inhibitors%2520by%2520Displacement%2520of%2520Active%2520Site%2520Probes%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D813%26epage%3D821%26doi%3D10.1177%2F1087057112439889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fasano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Corte, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Califano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troiani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgillo, F.</span></span> <span> </span><span class="NLM_article-title">Type III or Allosteric Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1517/13543784.2014.902934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1517%2F13543784.2014.902934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24673358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2hu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=809-821&author=M.+Fasanoauthor=C.+M.+Della+Corteauthor=R.+Califanoauthor=A.+Capuanoauthor=T.+Troianiauthor=E.+Martinelliauthor=F.+Ciardielloauthor=F.+Morgillo&title=Type+III+or+Allosteric+Kinase+Inhibitors+for+the+Treatment+of+Non-Small+Cell+Lung+Cancer&doi=10.1517%2F13543784.2014.902934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Fasano, Morena; Della Corte, Carminia Maria; Califano, Raffaele; Capuano, Annalisa; Troiani, Teresa; Martinelli, Erika; Ciardiello, Fortunato; Morgillo, Floriana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">809-821</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: In recent times, there has been much interest in the development of pharmacol. kinase inhibitors that treat NSCLC.  Furthermore, treatment options have been guided by the development of a wide panel of synthetic small mol. kinase inhibitors.  Most of the mols. developed belong to the type I class of inhibitors that target the ATP-binding site in its active conformation.  The high sequence similarity in the ATP-binding site among members of the kinase families often results in low selectivity and addnl. toxicities.  Also, second mutations in the ATP-binding site, such as threonine to methionine at position 790, have been described as a mechanism of resistance to ATP-competitive kinase inhibitors.  For these reasons, alternative drug development approaches targeting sites other than the ATP cleft are being pursued.  The class III or allosteric inhibitors, which bind outside the ATP-binding site, have been shown to neg. modulate kinase activity.  Areas covered: In this review, the authors discuss the most well-characterized allosteric inhibitors that have reached clin. development in NSCLC.  Expert opinion: Great progress has made in developing inhibitors with entirely new modes of action.  That being said, it is important to highlight that despite their apparent simplicity, biochem. assays will remain at the core of drug discovery activities to better explore these new opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ywM7JJJnbbVg90H21EOLACvtfcHk0lh_jXPi86AOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2hu74%253D&md5=0d6ed04787c0b83c81801c03b9163f0c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.902934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.902934%26sid%3Dliteratum%253Aachs%26aulast%3DFasano%26aufirst%3DM.%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DCalifano%26aufirst%3DR.%26aulast%3DCapuano%26aufirst%3DA.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMorgillo%26aufirst%3DF.%26atitle%3DType%2520III%2520or%2520Allosteric%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D809%26epage%3D821%26doi%3D10.1517%2F13543784.2014.902934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span> <span> </span><span class="NLM_article-title">Allosteric Small-Molecule Kinase Inhibitors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.pharmthera.2015.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=26478442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs12qsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=59-68&author=P.+Wuauthor=M.+H.+Clausenauthor=T.+E.+Nielsen&title=Allosteric+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.pharmthera.2015.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Clausen, Mads H.; Nielsen, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors are invaluable targeted therapeutics for the treatment of various human diseases, esp. cancers.  While the majority of approved and developed preclin. small-mol. inhibitors are characterized as type I or type II inhibitors that target the ATP-binding pocket of kinases, the remarkable sequential and structural similarity among ATP pockets renders the selective inhibition of kinases a daunting challenge.  Therefore, targeting allosteric pockets of kinases outside the highly conversed ATP pocket has been proposed as a promising alternative to overcome current barriers of kinase inhibitors, including poor selectivity and emergence of drug resistance.  In spite of the small no. of identified allosteric inhibitors in comparison with that of inhibitors targeting the ATP pocket, encouraging results, such as the FDA-approval of the first small-mol. allosteric inhibitor trametinib in 2013, the progress of more than 10 other allosteric inhibitors in clin. trials, and the emergence of a pipeline of highly selective and potent preclin. mols., have been reported in the past decade.  In this article, we present the current knowledge on allosteric inhibition in terms of conception, classification, potential advantages, and summarized debatable topics in the field.  Recent progress and allosteric inhibitors that were identified in the past three years are highlighted in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK12iPyaK2ObVg90H21EOLACvtfcHk0lh_jXPi86AOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs12qsb3N&md5=26e4658d325b8f016be29df27bf69ec2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26atitle%3DAllosteric%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D156%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.pharmthera.2015.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Kinase Inhibitors: Not Just for Kinases Anymore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1021/jm020427b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020427b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1478-1483&author=S.+L.+McGovernauthor=B.+K.+Shoichet&title=Kinase+Inhibitors%3A+Not+Just+for+Kinases+Anymore&doi=10.1021%2Fjm020427b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors: Not Just for Kinases Anymore</span></div><div class="casAuthors">McGovern, Susan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1478-1483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibitors are widely employed as biol. reagents and as leads for drug design.  Their use is often complicated by their lack of specificity.  Although binding conserved ATP sites accounts for some of their nonspecificity, some compds. inhibit proteins not known to bind ATP.  It has been found that promiscuous hits from high-throughput screening may act as aggregates.  To explore whether this mechanism might explain the action of widely used nonspecific kinase inhibitors, 15 such compds. were studied.  Eight of these, rottlerin, quercetin, K-252c, bisindolylmaleimide I, bisindolylmaleimide IX, U0126, indirubin, and indigo, inhibited three diverse non-kinase enzymes.  Inhibition was time-dependent and sensitive to enzyme concn.; by light scattering, the compds. formed particles of 100-1000 nm diam.  These observations suggest that these eight kinase inhibitors, at least at micromolar concns., are promiscuous and act as aggregates.  Results obtained from the use of these compds. at micromolar or higher concns. against individual enzymes should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-JSJ7FPf7e7Vg90H21EOLACvtfcHk0lh_jXPi86AOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D&md5=1d7e4e99a27be5ab279744aff92de26d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm020427b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020427b%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DKinase%2520Inhibitors%253A%2520Not%2520Just%2520for%2520Kinases%2520Anymore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1478%26epage%3D1483%26doi%3D10.1021%2Fjm020427b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span></span> <span> </span><span class="NLM_article-title">Targeting CK2 for Cancer Therapy</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1037</span>– <span class="NLM_lpage">1043</span>, <span class="refDoi"> DOI: 10.1097/00001813-200511000-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1097%2F00001813-200511000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16222144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2ktrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1037-1043&author=K.+A.+Ahmadauthor=G.+Wangauthor=J.+Slatonauthor=G.+Ungerauthor=K.+Ahmed&title=Targeting+CK2+for+Cancer+Therapy&doi=10.1097%2F00001813-200511000-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CK2 for cancer therapy</span></div><div class="casAuthors">Ahmad, Kashif A.; Wang, Guixia; Slaton, Joel; Unger, Gretchen; Ahmed, Khalil</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1037-1043</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is a highly ubiquitous and conserved protein serine/threonine kinase that has been found to be involved not only in cell growth and proliferation, but also in suppression of apoptosis.  CK2 is capable of dynamic intracellular shuttling in response to a variety of signals.  It is localized in both the nucleus and cytoplasm in normal cells, but is particularly predominant in the nuclear compartment in cancer cells.  CK2 has been found to be uniformly dysregulated in all the cancers that have been examd.  Downregulation of CK2 by chem. or mol. methods promotes apoptosis in cells.  We have shown that antisense CK2α is particularly potent in inducing apoptosis in cancer cells in culture as well as in xenograft models of cancer such as prostate cancer and squamous cell carcinoma of head and neck.  The antisense CK2α oligodeoxynucleotide (ODN) mediates tumor cell death in a dose- and time-dependent manner such that at an appropriate concn. of the antisense, a complete resoln. of the xenograft tumor is obsd.  Interestingly, normal and benign cells (in culture as well as in vivo) demonstrate a relative resistance to the antisense CK2α ODN treatment, which raises the possibility of a significant therapeutic window for this therapy.  Further, novel approaches such as the delivery of antisense CK2α ODN encapsulated in sub-50-nm tenascin nanocapsules have become available for its targeting specifically in cancer cells.  Our studies minimize generally held concerns regarding suitability of CK2 as a target for cancer therapy and provide the first encouraging results for potential future application of this approach for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXGqtHo4E_tLVg90H21EOLACvtfcHk0lgzgc2I-lSryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2ktrnI&md5=0929c0522e65bcabb6962f1e1d5f31db</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1097%2F00001813-200511000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200511000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DTargeting%2520CK2%2520for%2520Cancer%2520Therapy%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2005%26volume%3D16%26spage%3D1037%26epage%3D1043%26doi%3D10.1097%2F00001813-200511000-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Addiction to Protein Kinase CK2: A Common Denominator of Diverse Cancer Cells?</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbapap.2009.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=19665589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=499-504&author=M.+Ruzzeneauthor=L.+A.+Pinna&title=Addiction+to+Protein+Kinase+CK2%3A+A+Common+Denominator+of+Diverse+Cancer+Cells%3F&doi=10.1016%2Fj.bbapap.2009.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Addiction to protein kinase CK2: A common denominator of diverse cancer cells?</span></div><div class="casAuthors">Ruzzene, Maria; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">499-504</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  At variance with most oncogenic protein kinases whose malignancy is generally due to genetic alterations conferring constitutive activity, CK2 is a highly pleiotropic Ser/Thr protein kinase naturally endowed with constitutive activity and lacking gain-of-function mutants.  Nonetheless CK2 is abnormally elevated in a wide variety of tumors and there is strong evidence that it operates as a cancer driver by creating a cellular environment favorable to neoplasia: notably, CK2 plays a global role as an anti-apoptotic and pro-survival agent, it enhances the multi-drug resistance (MDR) phenotype, it assists the chaperone machinery which protects the "onco-kinome" and it promotes neo-angiogenesis.  Based on this scenario we propose that the implication of CK2 in neoplasia is an example of "non oncogene addiction", i.e. over reliance of the perturbed cellular signaling network on high CK2 level for its own maintenance.  Consistent with this, an ample spectrum of diverse types of cancer cells have been already shown to rely on high CK2 level for their survival, as judged from their response to specific CK2 inhibitors and silencing of endogenous CK2 catalytic subunits.  Remarkably, among these are cells whose cancer phenotype arises from the genetic alteration of onco-kinases (e.g. Abl and Alk) different from CK2 and insensitive to the CK2 inhibitors used in those expts.  Based on these premises, CK2 could represent a "multi-purpose" target for the treatment of different kinds of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryaRBb7mWsWrVg90H21EOLACvtfcHk0lgzgc2I-lSryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D&md5=a8088e387d13469774ce9aef315d0ae5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DAddiction%2520to%2520Protein%2520Kinase%2520CK2%253A%2520A%2520Common%2520Denominator%2520of%2520Diverse%2520Cancer%2520Cells%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D499%26epage%3D504%26doi%3D10.1016%2Fj.bbapap.2009.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panicker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyne, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span> <span> </span><span class="NLM_article-title">Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1163</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1007/978-981-13-8719-7_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2F978-981-13-8719-7_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31707707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BB3cXosFeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1163&publication_year=2019&pages=253-278&author=R.+C.+Panickerauthor=S.+Chattopadhayaauthor=A.+G.+Coyneauthor=R.+Srinivasan&title=Allosteric+Small-Molecule+Serine%2FThreonine+Kinase+Inhibitors&doi=10.1007%2F978-981-13-8719-7_11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors</span></div><div class="casAuthors">Panicker, Resmi C.; Chattopadhaya, Souvik; Coyne, Anthony G.; Srinivasan, Rajavel</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1163</span>
        (<span class="NLM_cas:issue">Protein Allostery in Drug Discovery</span>),
    <span class="NLM_cas:pages">253-278</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Deregulation of protein kinase activity has been linked to many diseases ranging from cancer to AIDS and neurodegenerative diseases.  Not surprisingly, drugging the human kinome - the complete set of kinases encoded by the human genome - has been one of the major drug discovery pipelines.  Majority of the approved clin. kinase inhibitors target the ATP binding site of kinases.  However, the remarkable sequence and structural similarity of ATP binding pockets of kinases make selective inhibition of kinases a daunting task.  To circumvent these issues, allosteric inhibitors that target sites other than the orthosteric ATP binding pocket have been developed.  The structural diversity of the allosteric sites allows these inhibitors to have higher selectivity, lower toxicity and improved physiochem. properties and overcome drug resistance assocd. with the use of conventional kinase inhibitors.  In this chapter, we will focus on the allosteric inhibitors of selected serine/threonine kinases, outline the benefits of using these inhibitors and discuss the challenges and future opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZh1hNRTh7T7Vg90H21EOLACvtfcHk0lgzgc2I-lSryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXosFeht7Y%253D&md5=aff162e9dee91f765c95fadb2ed7c487</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2F978-981-13-8719-7_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-981-13-8719-7_11%26sid%3Dliteratum%253Aachs%26aulast%3DPanicker%26aufirst%3DR.%2BC.%26aulast%3DChattopadhaya%26aufirst%3DS.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DSrinivasan%26aufirst%3DR.%26atitle%3DAllosteric%2520Small-Molecule%2520Serine%252FThreonine%2520Kinase%2520Inhibitors%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2019%26volume%3D1163%26spage%3D253%26epage%3D278%26doi%3D10.1007%2F978-981-13-8719-7_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Protein Kinase CK2: A Challenge to Canons</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3873</span>– <span class="NLM_lpage">3878</span>, <span class="refDoi"> DOI: 10.1242/jcs.00074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1242%2Fjcs.00074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=12244125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos12ktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2002&pages=3873-3878&author=L.+A.+Pinna&title=Protein+Kinase+CK2%3A+A+Challenge+to+Canons&doi=10.1242%2Fjcs.00074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: a challenge to canons</span></div><div class="casAuthors">Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3873-3878</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Casein kinase 2 (protein kinase CK2)(I) is an extremely conserved pleiotropic protein kinase with a growing list of >300 substrates, the majority of which are proteins implicated in signal transduction, gene expression, and other nuclear functions.  The I phosphoacceptor sites are specified by multiple acidic residues, with the one at position +3 relative to the target residue being of crucial relevance.  The I holoenzyme is composed of 2 catalytic subunits (αα, α'α', or αα'), which are essential for cell viability, and a dimer of 2 non-catalytic β subunits, whose precise function is still poorly understood.  Although the β subunits deeply affect many properties of I, both the isolated catalytic subunits and the holoenzyme are constitutively active, which is probably responsible for the oncogenic potential of I.  Given the structure of the holoenzyme, the β subunits could undergo reversible dissocn. under physiol. conditions and play a role as anchoring elements and/or as a docking platform for protein substrates and effectors.  These unusual features are likely to be instrumental in the involvement of I in a no. of key biol. functions, notably RNA synthesis, Wnt signaling, ubiquitination, and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfV4dtx0wAbVg90H21EOLACvtfcHk0liYxrPyEc4XXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos12ktL0%253D&md5=8800a9192d61949e5f3588c2b00c228e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00074%26sid%3Dliteratum%253Aachs%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520Kinase%2520CK2%253A%2520A%2520Challenge%2520to%2520Canons%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2002%26volume%3D115%26spage%3D3873%26epage%3D3878%26doi%3D10.1242%2Fjcs.00074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">One-Thousand-and-One Substrates of Protein Kinase CK2?</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1096/fj.02-0473rev</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1096%2Ffj.02-0473rev" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=12631575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=349-368&author=F.+Meggioauthor=L.+A.+Pinna&title=One-Thousand-and-One+Substrates+of+Protein+Kinase+CK2%3F&doi=10.1096%2Ffj.02-0473rev"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">One-thousand-and-one substrates of protein kinase CK2?</span></div><div class="casAuthors">Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-368</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review.  CK2 (formerly termed "casein kinase 2") is a ubiquitous, highly pleiotropic and constitutively active Ser/Thr protein kinase whose implication in neoplasia, cell survival, and virus infection is supported by an increasing no. of arguments.  Here an updated inventory of 307 CK2 protein substrates is presented.  More than one-third of these are implicated in gene expression and protein synthesis as being either transcriptional factors (60) or effectors of DNA/RNA structure (50) or translational elements.  Also numerous are signaling proteins and proteins of viral origin or essential to virus life cycle.  In comparison, only a minority of CK2 targets (a dozen or so) are classical metabolic enzymes.  An anal. of 308 sites phosphorylated by CK2 highlights the paramount relevance of neg. charged side chains that are (by far) predominant over any other residues at positions n+3 (the most crucial one), n+1, and n+2.  Based on this signature, it is predictable that proteins phosphorylated by CK2 are much more numerous than those identified to date, and it is possible that CK2 alone contributes to the generation of the eukaryotic phosphoproteome more so than any other individual protein kinase.  The possibility that CK2 phosphosites play some global role, e.g., by destabilizing α helices, counteracting caspase cleavage, and generating adhesive motifs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6sfPYsWeCNrVg90H21EOLACvtfcHk0liYxrPyEc4XXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D&md5=0b11315ac9652e8866a1ed99a7010b68</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1096%2Ffj.02-0473rev&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.02-0473rev%26sid%3Dliteratum%253Aachs%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOne-Thousand-and-One%2520Substrates%2520of%2520Protein%2520Kinase%2520CK2%253F%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D349%26epage%3D368%26doi%3D10.1096%2Ffj.02-0473rev" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span> <span> </span><span class="NLM_article-title">Protein Kinase CK2 Inhibitors: A Patent Review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1097</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.717615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1517%2F13543776.2012.717615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=22908959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1alt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1081-1097&author=G.+Cozzaauthor=L.+A.+Pinnaauthor=S.+Moro&title=Protein+Kinase+CK2+Inhibitors%3A+A+Patent+Review&doi=10.1517%2F13543776.2012.717615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 inhibitors: a patent review</span></div><div class="casAuthors">Cozza, Giorgio; Pinna, Lorenzo A.; Moro, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1081-1097</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: CK2 is a pleiotropic, ubiquitous and constitutively active protein kinase, localized in both cytosolic and nuclear compartments, where it catalyzes the phosphorylation of hundreds of proteins.  CK2 is generally described as a tetramer composed of two catalytic (α and/or α') and two regulatory subunits (β), however, the free α/α' subunits are catalytically active by themselves.  CK2 plays a key role in several physiol. and pathol. processes and has been connected to many neoplastic, inflammatory, autoimmune and infectious disorders.  In the last 20 years, several inhibitors of CK2 have been discovered though only one of these, CX-4945, has recently entered into Phase II clin. trials as potential anticancer drug.Areas covered: The main objective of the present review is to describe the development of CK2 activity modulators over the years according to the timeline of their patent registration.Expert opinion: CK2 was discovered in 1954, but the first patent on CK2 modulators was deposited only 50 years later, in 2004.  However, in the last 5 years an increasing no. of patents on CK2 inhibitors have been registered, reflecting an increased interest in this kind of drug candidates and their possible therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_s3DgzEl87Vg90H21EOLACvtfcHk0liYxrPyEc4XXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1alt7%252FJ&md5=4496a3ca178a15c9911e34b480a18ac3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.717615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.717615%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DProtein%2520Kinase%2520CK2%2520Inhibitors%253A%2520A%2520Patent%2520Review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D1081%26epage%3D1097%26doi%3D10.1517%2F13543776.2012.717615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quotti
Tubi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancalion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein Kinase CK2 with the Clinical-Grade Small ATP-Competitive Compound CX-4945 or by RNA Interference Unveils Its Role in Acute Myeloid Leukemia Cell Survival, P53-Dependent Apoptosis and Daunorubicin-Induced Cytotoxicity</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">78</span> <span class="refDoi"> DOI: 10.1186/1756-8722-6-78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1186%2F1756-8722-6-78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24283803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVGntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&author=L.+Quotti%0ATubiauthor=C.+Gurrieriauthor=A.+Brancalionauthor=L.+Bonaldiauthor=R.+Bertorelleauthor=S.+Manniauthor=L.+Pavanauthor=F.+Lessiauthor=R.+Zambelloauthor=L.+Trentinauthor=F.+Adamiauthor=M.+Ruzzeneauthor=L.+A.+Pinnaauthor=G.+Semenzatoauthor=F.+Piazza&title=Inhibition+of+Protein+Kinase+CK2+with+the+Clinical-Grade+Small+ATP-Competitive+Compound+CX-4945+or+by+RNA+Interference+Unveils+Its+Role+in+Acute+Myeloid+Leukemia+Cell+Survival%2C+P53-Dependent+Apoptosis+and+Daunorubicin-Induced+Cytotoxicity&doi=10.1186%2F1756-8722-6-78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity</span></div><div class="casAuthors">Quotti Tubi, Laura; Gurrieri, Carmela; Brancalion, Alessandra; Bonaldi, Laura; Bertorelle, Roberta; Manni, Sabrina; Pavan, Laura; Lessi, Federica; Zambello, Renato; Trentin, Livio; Adami, Fausto; Ruzzene, Maria; Pinna, Lorenzo A.; Semenzato, Gianpietro; Piazza, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">78/1-78/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The involvement of protein kinase CK2 in sustaining cancer cell survival could have implications also in the resistance to conventional and unconventional therapies.  Moreover, CK2 role in blood tumors is rapidly emerging and this kinase has been recognized as a potential therapeutic target.  Phase I clin. trials with the oral small ATP-competitive CK2 inhibitor CX-4945 are currently ongoing in solid tumors and multiple myeloma.  Methods: We have analyzed the expression of CK2 in acute myeloid leukemia and its function in cell growth and in the response to the chemotherapeutic agent daunorubicin.  We employed acute myeloid leukemia cell lines and primary blasts from patients grouped according to the European LeukemiaNet risk classification.  Cell survival, apoptosis and sensitivity to daunorubicin were assessed by different means. p53-dependent CK2-inhibition-induced apoptosis was investigated in p53 wild-type and mutant cells.  Results: CK2α was found highly expressed in the majority of samples across the different acute myeloid leukemia prognostic subgroups as compared to normal CD34+ hematopoietic and bone marrow cells.  Inhibition of CK2 with CX-4945, K27 or siRNAs caused a p53-dependent acute myeloid leukemia cell apoptosis.  CK2 inhibition was assocd. with a synergistic increase of the cytotoxic effects of daunorubicin.  Baseline and daunorubicin-induced STAT3 activation was hampered upon CK2 blockade.  Conclusions: These results suggest that CK2 is over expressed across the different acute myeloid leukemia subsets and acts as an important regulator of acute myeloid leukemia cell survival.  CK2 neg. regulation of the protein levels of tumor suppressor p53 and activation of the STAT3 anti-apoptotic pathway might antagonize apoptosis and could be involved in acute myeloid leukemia cell resistance to daunorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBsAzrkC8CW7Vg90H21EOLACvtfcHk0liYxrPyEc4XXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVGntrg%253D&md5=870776daed0fbf21f8f3f3080a5a5633</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-78%26sid%3Dliteratum%253Aachs%26aulast%3DQuotti%2BTubi%26aufirst%3DL.%26aulast%3DGurrieri%26aufirst%3DC.%26aulast%3DBrancalion%26aufirst%3DA.%26aulast%3DBonaldi%26aufirst%3DL.%26aulast%3DBertorelle%26aufirst%3DR.%26aulast%3DManni%26aufirst%3DS.%26aulast%3DPavan%26aufirst%3DL.%26aulast%3DLessi%26aufirst%3DF.%26aulast%3DZambello%26aufirst%3DR.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DAdami%26aufirst%3DF.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DSemenzato%26aufirst%3DG.%26aulast%3DPiazza%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520Protein%2520Kinase%2520CK2%2520with%2520the%2520Clinical-Grade%2520Small%2520ATP-Competitive%2520Compound%2520CX-4945%2520or%2520by%2520RNA%2520Interference%2520Unveils%2520Its%2520Role%2520in%2520Acute%2520Myeloid%2520Leukemia%2520Cell%2520Survival%252C%2520P53-Dependent%2520Apoptosis%2520and%2520Daunorubicin-Induced%2520Cytotoxicity%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26doi%3D10.1186%2F1756-8722-6-78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Features and Potentials of ATP-Site Directed CK2 Inhibitors</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1754</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2005.07.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbapap.2005.07.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16198160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=263-270&author=S.+Sarnoauthor=M.+Salviauthor=R.+Battistuttaauthor=G.+Zanottiauthor=L.+A.+Pinna&title=Features+and+Potentials+of+ATP-Site+Directed+CK2+Inhibitors&doi=10.1016%2Fj.bbapap.2005.07.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Features and potentials of ATP-site directed CK2 inhibitors</span></div><div class="casAuthors">Sarno, Stefania; Salvi, Mauro; Battistutta, Roberto; Zanotti, Giuseppe; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A panel of quite specific, fairly potent and cell-permeable inhibitors of protein kinase CK2 belonging to the classes of condensed polyphenolic compds., tetrabromobenzimidazole/triazole derivs. and indoloquinazolines have been developed, with K i values in the submicromolar range.  Nine structures have been solved to date of complexes between the catalytic α subunit of CK2 and a no. of these compds., many of which display a remarkable specificity toward CK2 as compared to a panel of >30 kinases tested.  The structural basis for such selectivity appears to reside in the shape and size of a hydrophobic pocket adjacent to the ATP binding site where these ATP competitive ligands are entrapped mainly by van der Waals interactions and by an energy contribution derived from the hydrophobic effect.  In CK2, this cavity is smaller than in the majority of other protein kinases due to a no. of unique bulky apolar residues.  Consequently, the replacement of two of these residues (V66 and I174) in human CK2 alpha with alanines gives rise to mutants, which are markedly less susceptible than wild type to these classes of inhibitors.  Cell-permeable CK2 inhibitors have been successfully employed, either alone or in combination with CK2 mutants refractory to inhibition, to dissect signaling pathways affected by CK2 and/or to validate the identification of in vivo targets of this pleiotropic kinase.  Moreover, the remarkable pro-apoptotic efficacy of these compds. toward cell lines derived from a wide spectrum of tumors, disclose the possibility that in perspective CK2 inhibitors might become leads for the development of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxJB8VB2RxX7Vg90H21EOLACvtfcHk0lghtkKS0juqTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7bF&md5=7d1140e015d6fc269a1a2700d0a107c9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.07.043%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DFeatures%2520and%2520Potentials%2520of%2520ATP-Site%2520Directed%2520CK2%2520Inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D263%26epage%3D270%26doi%3D10.1016%2Fj.bbapap.2005.07.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">A Structural Insight into CK2 Inhibition</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1007/s11010-008-9822-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs11010-008-9822-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=18626746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVansrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2008&pages=57-62&author=M.+Mazzoranaauthor=L.+A.+Pinnaauthor=R.+Battistutta&title=A+Structural+Insight+into+CK2+Inhibition&doi=10.1007%2Fs11010-008-9822-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A structural insight into CK2 inhibition</span></div><div class="casAuthors">Mazzorana, Marco; Pinna, Lorenzo A.; Battistutta, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">57-62</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The acidophilic Ser/Thr protein kinase CK2 displays some unique properties such as high pleiotropicity and constitutive activity.  CK2 is involved in many fundamental aspects of the normal cell life, for instance it promotes cell survival and enhances the tumor phenotype under special circumstances.  This makes CK2 an appealing target for the development of inhibitors with pharmacol. potential.  Here we present an overview of our recent studies on inhibitors directed to the CK2 ATP-binding site whose distinctive features are highlighted by the ability to use both ATP and GTP as co-substrates and by its low susceptibility to staurosporine inhibition.  We discuss the effects of the binding of different chem. families of fairly selective inhibitors with potency in the nanomolar or low micromolar range.  An important common energetic contribution to the binding is due to the hydrophobic interaction with the apolar surface region of the CK2 binding cleft.  The anal. of the known CK2 crystal structures reveals the presence of some highly conserved water mols. in this region.  These waters reside near Lys-68, in an area with a pos. electrostatic potential that is able to attract and orient neg. charged ligands.  The presence of this pos. region and of two unique bulky residues, Ile-66 and Ile-174, responsible for the reduced dimension of the CK2 active site, play a crit. role in detg. ligand orientation and binding selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSMNNdsb_oCLVg90H21EOLACvtfcHk0lghtkKS0juqTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVansrnN&md5=5b6293bacf028688ab805312443aed90</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11010-008-9822-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-008-9822-5%26sid%3Dliteratum%253Aachs%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DA%2520Structural%2520Insight%2520into%2520CK2%2520Inhibition%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D316%26spage%3D57%26epage%3D62%26doi%3D10.1007%2Fs11010-008-9822-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moucadel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettaoussi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of Holoenzyme-Disrupting Chemicals as Substrate-Selective CK2 Inhibitors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">15893</span> <span class="refDoi"> DOI: 10.1038/s41598-019-52141-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fs41598-019-52141-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31685885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A280%3ADC%252BB3MjltVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&author=I.+Kufarevaauthor=B.+Bestgenauthor=P.+Brearauthor=R.+Prudentauthor=B.+Laudetauthor=V.+Moucadelauthor=M.+Ettaoussiauthor=C.+F.+Sautelauthor=I.+Krimmauthor=M.+Engelauthor=O.+Filholauthor=M.+Le+Borgneauthor=T.+Lombergetauthor=C.+Cochetauthor=R.+Abagyan&title=Discovery+of+Holoenzyme-Disrupting+Chemicals+as+Substrate-Selective+CK2+Inhibitors&doi=10.1038%2Fs41598-019-52141-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors</span></div><div class="casAuthors">Kufareva Irina; Abagyan Ruben; Bestgen Benoit; Ettaoussi Mohamed; Borgne Marc Le; Lomberget Thierry; Bestgen Benoit; Engel Matthias; Bestgen Benoit; Prudent Renaud; Laudet Beatrice; Moucadel Virginie; Sautel Celine F; Filhol Odile; Cochet Claude; Bestgen Benoit; Brear Paul; Prudent Renaud; Laudet Beatrice; Moucadel Virginie; Sautel Celine F; Krimm Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15893</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CK2 is a constitutively active protein kinase overexpressed in numerous malignancies.  Interaction between CK2α and CK2β subunits is essential for substrate selectivity.  The CK2α/CK2β interface has been previously targeted by peptides to achieve functional effects; however, no small molecules modulators were identified due to pocket flexibility and open shape.  Here we generated numerous plausible conformations of the interface using the fumigation modeling protocol, and virtually screened a compound library to discover compound 1 that suppressed CK2α/CK2β interaction in vitro and inhibited CK2 in a substrate-selective manner.  Orthogonal SPR, crystallography, and NMR experiments demonstrated that 4 and 6, improved analogs of 1, bind to CK2α as predicted.  Both inhibitors alter CK2 activity in cells through inhibition of CK2 holoenzyme formation.  Treatment with 6 suppressed MDA-MB231 triple negative breast cancer cell growth and induced apoptosis.  Altogether, our findings exemplify an innovative computational-experimental approach and identify novel non-peptidic inhibitors of CK2 subunit interface disclosing substrate-selective functional effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmE_81mdt7jNenUz0lpNqnfW6udTcc2eYs7mwg9y2_Lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjltVOnuw%253D%253D&md5=9cbb832ee1fc84a087151c72111f6808</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-52141-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-52141-5%26sid%3Dliteratum%253Aachs%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DLaudet%26aufirst%3DB.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DEttaoussi%26aufirst%3DM.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DLomberget%26aufirst%3DT.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520Holoenzyme-Disrupting%2520Chemicals%2520as%2520Substrate-Selective%2520CK2%2520Inhibitors%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26doi%3D10.1038%2Fs41598-019-52141-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Newton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span> <span> </span><span class="NLM_article-title">Specific Inhibition of CK2α from an Anchor Outside the Active Site</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6845</span>, <span class="refDoi"> DOI: 10.1039/C6SC02335E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC6SC02335E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28451126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=6839-6845&author=P.+Brearauthor=C.+De+Fuscoauthor=K.+Hadje+Georgiouauthor=N.+J.+Francis-Newtonauthor=C.+J.+Stubbsauthor=H.+F.+Soreauthor=A.+R.+Venkitaramanauthor=C.+Abellauthor=D.+R.+Springauthor=M.+Hyv%C3%B6nen&title=Specific+Inhibition+of+CK2%CE%B1+from+an+Anchor+Outside+the+Active+Site&doi=10.1039%2FC6SC02335E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of CK2α from an anchor outside the active site</span></div><div class="casAuthors">Brear, Paul; De Fusco, Claudia; Hadje Georgiou, Kathy; Francis-Newton, Nicola J.; Stubbs, Christopher J.; Sore, Hannah F.; Venkitaraman, Ashok R.; Abell, Chris; Spring, David R.; Hyvonen, Marko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6839-6845</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site.  Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site.  We have identified a new binding site for small mols. on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket.  An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors.  CAM4066 shows target engagement in several cell lines and similar potency to clin. trial candidate CX4945.  Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α via a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FqxiBkU9frVg90H21EOLACvtfcHk0ljQegHzkZW28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP&md5=c4652010f4da70a128fb1dab64f811d0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC6SC02335E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02335E%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DFrancis-Newton%26aufirst%3DN.%2BJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibition%2520of%2520CK2%25CE%25B1%2520from%2520an%2520Anchor%2520Outside%2520the%2520Active%2520Site%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D6839%26epage%3D6845%26doi%3D10.1039%2FC6SC02335E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Second-Generation CK2α Inhibitors Targeting the αD Pocket</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3041</span>– <span class="NLM_lpage">3049</span>, <span class="refDoi"> DOI: 10.1039/C7SC05122K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC7SC05122K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29732088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3041-3049&author=J.+Iegreauthor=P.+Brearauthor=C.+De+Fuscoauthor=M.+Yoshidaauthor=S.+L.+Mitchellauthor=M.+Rossmannauthor=L.+Carroauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Second-Generation+CK2%CE%B1+Inhibitors+Targeting+the+%CE%B1D+Pocket&doi=10.1039%2FC7SC05122K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation CK2α inhibitors targeting the αD pocket</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3041-3049</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CK2 is a crit. cell cycle regulator that also promotes various anti-apoptotic mechanisms.  Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases.  We have previously utilized a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066.  While CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site.  This second generation αD-site binding inhibitor, compd. CAM4712 (IC50 = 7μM, GI50 = 10.0 ± 3.6μM), has numerous advantages over the previously reported CAM4066, including a redn. in the no. of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability.  Unlike with CAM4066, there was no need to facilitate cellular uptake by making a prodrug.  Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50) and the ability to inhibit cell proliferation (GI50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPLu-nG6dLLVg90H21EOLACvtfcHk0ljQegHzkZW28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D&md5=4d57e89546e1c7bcac4868e3a02ba2f8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC05122K%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRossmann%26aufirst%3DM.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSecond-Generation%2520CK2%25CE%25B1%2520Inhibitors%2520Targeting%2520the%2520%25CE%25B1D%2520Pocket%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D3041%26epage%3D3049%26doi%3D10.1039%2FC7SC05122K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A Fragment-Based Approach Leading to the Discovery of a Novel Binding Site and the Selective CK2 Inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=A+Fragment-Based+Approach+Leading+to+the+Discovery+of+a+Novel+Binding+Site+and+the+Selective+CK2+Inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0ljQegHzkZW28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520Fragment-Based%2520Approach%2520Leading%2520to%2520the%2520Discovery%2520of%2520a%2520Novel%2520Binding%2520Site%2520and%2520the%2520Selective%2520CK2%2520Inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochscherf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O.-G.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Potent, Selective and Cell Permeable Inhibitor of Protein Kinase CK2 from the NIH/NCI Diversity Set Library</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1007/s11010-015-2433-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs11010-015-2433-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=25963666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2015&pages=151-161&author=B.+Guerraauthor=J.+Hochscherfauthor=N.+B.+Jensenauthor=O.-G.+Issinger&title=Identification+of+a+Novel+Potent%2C+Selective+and+Cell+Permeable+Inhibitor+of+Protein+Kinase+CK2+from+the+NIH%2FNCI+Diversity+Set+Library&doi=10.1007%2Fs11010-015-2433-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library</span></div><div class="casAuthors">Guerra, Barbara; Hochscherf, Jennifer; Jensen, Nina Bjelkerup; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">151-161</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The anti-apoptotic protein kinase CK2 increasingly becomes an attractive target in cancer research with great therapeutic potential.  Here, we have performed an in vitro screening of the Diversity Set III of the DTP program from the NCI/NIH, comprising 1600 compds.  We have identified 1,3-Dichloro-6-[(E)-((4-methoxyphenyl)imino)methyl] dibenzo(b,d) furan-2,7-diol (referred to as D11) to be a potent and selective inhibitor of protein kinase CK2.  The D11 compd. was tested against 354 eukaryotic protein kinases.  By setting the threshold for inhibition to <2 % remaining kinase activity, only DYRK1B, IRAK1 and PIM3 were inhibited to an extent as the tetrameric CK2 holoenzyme and its catalytic subunits α and α'.  The IC50 values for the CK2α and CK2α' were on av. 1-2 nM in comparison to the DYRK1B, IRAK1 and PIM3 kinases, which ranged from 18 to 49 nM.  Cell permeability and efficacy of D11 were tested with cells in culture.  In MIA PaCa-2 cells (human pancreatic carcinoma cell line), the phosphorylation of the CK2 biomarker CDC37 at S13 was almost completely inhibited in the presence of D11.  This was obsd. both under normoxia and hypoxia.  In the case of the human non-small cell lung carcinoma cell line, H1299, increasing amts. of D11 led to an inhibition of S380/T382/383 phosphorylation in PTEN, another biomarker for CK2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF_SAUAmFD3rVg90H21EOLACvtfcHk0lhshyv9Tc1EFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFKju74%253D&md5=152fb98f0414cd69be647a83dd88debb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs11010-015-2433-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-015-2433-z%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DHochscherf%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DN.%2BB.%26aulast%3DIssinger%26aufirst%3DO.-G.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Potent%252C%2520Selective%2520and%2520Cell%2520Permeable%2520Inhibitor%2520of%2520Protein%2520Kinase%2520CK2%2520from%2520the%2520NIH%252FNCI%2520Diversity%2520Set%2520Library%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2015%26volume%3D406%26spage%3D151%26epage%3D161%26doi%3D10.1007%2Fs11010-015-2433-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prins, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurgeon, S. E.</span></span> <span> </span><span class="NLM_article-title">CX-4945, a Selective Inhibitor of Casein Kinase-2 (CK2), Exhibits Anti-Tumor Activity in Hematologic Malignancies Including Enhanced Activity in Chronic Lymphocytic Leukemia When Combined with Fludarabine and Inhibitors of the B-Cell Receptor Pathway</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2094</span>– <span class="NLM_lpage">2096</span>, <span class="refDoi"> DOI: 10.1038/leu.2013.228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fleu.2013.228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=23900138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2094-2096&author=R.+C.+Prinsauthor=R.+T.+Burkeauthor=J.+W.+Tynerauthor=B.+J.+Drukerauthor=M.+M.+Loriauxauthor=S.+E.+Spurgeon&title=CX-4945%2C+a+Selective+Inhibitor+of+Casein+Kinase-2+%28CK2%29%2C+Exhibits+Anti-Tumor+Activity+in+Hematologic+Malignancies+Including+Enhanced+Activity+in+Chronic+Lymphocytic+Leukemia+When+Combined+with+Fludarabine+and+Inhibitors+of+the+B-Cell+Receptor+Pathway&doi=10.1038%2Fleu.2013.228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway</span></div><div class="casAuthors">Prins, R. C.; Burke, R. T.; Tyner, J. W.; Druker, B. J.; Loriaux, M. M.; Spurgeon, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2094-2096</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Relapsed and refractory lymphoid and myeloid malignancies are often characterized by progressive resistance to std. chemotherapy as well as poor long-term outcomes.  Addnl., many of the conventional treatment regimens may be accompanied by significant toxicity in this heavily pretreated population.  Consequently, there is a need for novel therapies in these patients.  Specific inhibition of essential signaling pathways offers potential for the design of rational therapeutic alternatives to cytotoxic chemotherapy.  Among potential promising targets is casein kinase-2 (CK2), a highly conserved serine-threonine protein kinase comprised of two catalytic (α and α') and two regulatory (β) subunits.  CK2 regulates a large no. of crit. signaling networks and downstream prosurvival and antiapoptotic substrates known to be essential to hematopoietic cell function.1, 2 CK2 has been found to be overexpressed in many cancers, including hematol. malignancies such as chronic lymphocytic leukemia (CLL),3 acute myeloid leukemia (AML),4 T-cell acute lymphocytic leukemia (T-ALL)5 and multiple myeloma.6 Malignant cells are more dependent than normal tissues on upregulated levels of CK2 to sustain their growth and viability,7 and elevated levels of CK2 have been found to correlate with inferior prognosis.2 Consequently, despite its crit. role in a diverse array of cellular processes, malignant cells are significantly more sensitive to CK2 downregulation;2, 3, 4, 5, 6, 7, 8, 9 potentially increasing its appeal as a therapeutic target.  CX-4945 is a selective, potent and orally bioavailable inhibitor of both isoforms of the CK2 catalytic subunits, and is the first small-mol. inhibitor of CK2 to progress to human clin. trials.9 Anti-tumor activity of CX-4945 has been validated in cancer cell lines and murine xenograft models, and biol. activity has been obsd. in early phase clin. trials treating solid tumors.9, 10, 11 However, little is known about its activity in leukemias and lymphomas.  Therefore, using primary patient samples, we explored the therapeutic potential of CX-4945 across a wide spectrum of hematol. malignancies.  After informed consent, in accordance with the Declaration of Helsinki and approved by the institutional review board, Ficoll-purified leukemia cells from 224 patients were cultured in the presence or absence of four serial dilns. of CX-4945 (Cylene Pharmaceuticals Inc., San Diego, CA, USA) ranging from 10 n to 10 μ.  Overall, 74 CLL, 60 AML, 58 B-cell acute lymphocytic leukemia, 13 chronic monomyelocytic leukemia (CMML), 4 T-ALL, 11 lymphoma and 4 chronic myeloid leukemia (CML) patients were included in the anal.  Purified leukemia cells were then cultured in RPMI+20̂ fetal bovine serum+β-mercaptoethanol.  A tetrazolium-based assay (MTS) was used to measure cell viability, which was then used to calc. IC50 values.  Of the seven types of hematol. malignancies evaluated, all except CMML and CML demonstrated a subset of patients with significantly decreased viability (IC50<1 μ) in response to CX-4945 (Table 1 and Figure 1a).  Median IC50 of all samples tested was 6.7 μ.  CX-4945 appeared to be the most active in lymphoid malignancies, as this group contained the highest subset of sensitive patients (Table 1).  Of note, among the 16 sensitive CLL samples tested, 6 samples had an IC50<100 nm suggesting that there is a subset of samples that are highly sensitive to CK2 inhibition.  Significant decreases in CLL cell viability in response to treatment with CX-4945 were obsd. in samples harboring a variety of high-risk features such as advanced Rai stage, CD38 and/or Zap 70 expression, unmutated variable region of the Ig heavy chain (IgVH), chromosome 11q or17p deletion.  No specific biol. factors, including IgVH mutational status, were found to correlate with sensitivity.  Notably, three of nine (33.3̂) samples with known 17p deletion exhibited sensitivity (IC50<1 μ) to CX-4945 with a median IC50 of 409.2 n.  Given that CX-4945 appeared to be most active in lymphoid malignancies, specifically CLL, we subsequently focused on this population.  The prosurvival and chemoprotective roles of the bone marrow and lymph node microenvironment have been well described in CLL.12 Therefore, we cultured purified CLL cells obtained from six CLL patients in HS-5 stromal cell-conditioned media (RPMI+10̂ fetal bovine serum plated over HS-5 cells for 3 h) to mimic the in-vivo CLL microenvironment, and found that CX-4945 decreased cell viability (Figure 1b).  This finding suggests that CX-4945 may be effective at reducing CLL cell viability not only in the peripheral blood, but also in protective compartments such as the bone marrow and lymph nodes.  B-cell receptor (BCR) activation leads to survival and proliferation of B-lymphocytes through signaling of survival kinases such as PI3K and AKT.  Drugs that inhibit the transmission of signals through the BCR have been shown to disrupt the microenvironment and promote apoptosis.13 Located downstream of the BCR, CK2 has an important role in the regulation of oncogenic pathways shared with the BCR, including PI3K and AKT,1, 3, 7, 8 and also functions in the DNA repair response.6, 10 CK2 inhibition downregulates AKT activity and enhances the cytotoxic effect of chemotherapy.3, 5, 6, 8, 9, 10 Specifically, early work using a CLL mouse model demonstrated that CX-4945 plus the purine nucleoside analog fludarabine was more effective than fludarabine alone.14 Furthermore, given that cell survival relies on the convergence of many regulatory inputs including those transmitted via the BCR, we hypothesized that inhibiting the growth and survival pathway at more than one site would lead to enhanced activity.  We therefore investigated the efficacy of CX-4945 in combination with fludarabine, which continues to form the backbone of cytotoxic CLL therapy, and with inhibitors of kinases known to be essential to the BCR pathway.  For synergy expts., purified leukemia cells were re-suspended in HS-5-conditioned media and added to wells contg. serial dilns. of CX-4945 alone and in combination with serial dilns. of agents known to disrupt BCR-mediated signaling pathways, including the PI3K-delta isoform-specific inhibitor GS-1101 (Selleck Chems., Houston, TX, USA), the inhibitor of Bruton's tyrosine kinase ibrutinib (Selleck Chems., Houston, TX, USA) and fludarabine.  Dilns. of all drugs ranged from 41.1 n to 10 μ.  Cells were cultured for 72 h and MTS was used to measure cell viability.  Synergy anal. was performed using the Chou-Talalay method.15 We obsd. synergy (defined as median combination index (CI) <1) between CX-4945 and GS-1101 in six of eight samples tested (Figure 1c).  The median CI for all samples was 0.46.  Synergy was demonstrated in 8 of 10 samples treated with CX-4945 and ibrutinib (Figure 1d), with a median CI for all samples of 0.56.  Finally, 10 of 13 CLL samples treated with a combination of CX-4945 and fludarabine showed synergy, with a median CI of 0.30 for all samples (Figure 1e).  Representative drug curves are shown in Figures 1f-h.  In conclusion, these results demonstrate that the CK2-inhibitor CX-4945 has preclin. activity across a broad range of hematol. malignancies, most significantly in lymphoid malignancies.  Addnl., CX-4945 appears to enhance the efficacy of inhibitors of the BCR pathway as well as fludarabine in primary CLL cells.  Given the complexity of the intracellular signaling networks in hematol. malignancies, rational drug combinations that target multiple sites in the prosurvival pathway represent a promising strategy for the treatment of this population.  As such, CX-4945 warrants further investigation in combination with chemotherapy and BCR pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8WhHDw3hthbVg90H21EOLACvtfcHk0lhshyv9Tc1EFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2nt7%252FO&md5=a3510c891c7b5cf20c89058efccf5837</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.228%26sid%3Dliteratum%253Aachs%26aulast%3DPrins%26aufirst%3DR.%2BC.%26aulast%3DBurke%26aufirst%3DR.%2BT.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DSpurgeon%26aufirst%3DS.%2BE.%26atitle%3DCX-4945%252C%2520a%2520Selective%2520Inhibitor%2520of%2520Casein%2520Kinase-2%2520%2528CK2%2529%252C%2520Exhibits%2520Anti-Tumor%2520Activity%2520in%2520Hematologic%2520Malignancies%2520Including%2520Enhanced%2520Activity%2520in%2520Chronic%2520Lymphocytic%2520Leukemia%2520When%2520Combined%2520with%2520Fludarabine%2520and%2520Inhibitors%2520of%2520the%2520B-Cell%2520Receptor%2520Pathway%26jtitle%3DLeukemia%26date%3D2013%26volume%3D27%26spage%3D2094%26epage%3D2096%26doi%3D10.1038%2Fleu.2013.228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alimzhanov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=300-305&author=J.+E.+Dowlingauthor=M.+Alimzhanovauthor=L.+Baoauthor=C.+Chuaquiauthor=C.+R.+Denzauthor=E.+Jenkinsauthor=N.+A.+Larsenauthor=P.+D.+Lyneauthor=T.+Pontzauthor=Q.+Yeauthor=G.+A.+Holdgateauthor=L.+Snowauthor=N.+O%E2%80%99Connellauthor=A.+D.+Ferguson&title=Potent+and+Selective+CK2+Kinase+Inhibitors+with+Effects+on+Wnt+Pathway+Signaling+in+Vivo&doi=10.1021%2Facsmedchemlett.5b00452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo</span></div><div class="casAuthors">Dowling, James E.; Alimzhanov, Marat; Bao, Larry; Chuaqui, Claudio; Denz, Christopher R.; Jenkins, Emma; Larsen, Nicholas A.; Lyne, Paul D.; Pontz, Timothy; Ye, Qing; Holdgate, Geoff A.; Snow, Lindsay; O'Connell, Nichole; Ferguson, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-305</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt pathway is an evolutionarily conserved and tightly regulated signaling network with important roles in embryonic development and adult tissue regeneration.  Impaired Wnt pathway regulation, arising from mutations in Wnt signaling components, such as Axin, APC, and β-catenin, results in uncontrolled cell growth and triggers oncogenesis.  To explore the reported link between CK2 kinase activity and Wnt pathway signaling, the authors sought to identify a potent, selective inhibitor of CK2 suitable for proof of concept studies in vivo.  Starting from a pyrazolo[1,5-a]pyrimidine lead, the authors identified N-(2-((2-aminoethyl)(methyl)amino)-5-(3-cyano-7-(cyclopropylamino) pyrazolo[1,5-a]pyrimidin-5-ylamino)phenyl)acetamide (compd. 7h), a potent CK2 inhibitor with picomolar affinity that is highly selectivity against other kinase family enzymes and inhibits Wnt pathway signaling (IC50 = 50 nM) in DLD-1 cells.  In addn., (compd. 7h) has physicochem. properties that are suitable for formulation as an i.v. soln., has demonstrated good pharmacokinetics in preclin. species, and exhibits a high level of activity as a monotherapy in HCT-116 and SW-620 xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9Sjmp1vsrLVg90H21EOLACvtfcHk0lhusDmD6ghUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D&md5=515b631b98c356f27733856cfdca78b7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00452%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DDenz%26aufirst%3DC.%2BR.%26aulast%3DJenkins%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DSnow%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26atitle%3DPotent%2520and%2520Selective%2520CK2%2520Kinase%2520Inhibitors%2520with%2520Effects%2520on%2520Wnt%2520Pathway%2520Signaling%2520in%2520Vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D300%26epage%3D305%26doi%3D10.1021%2Facsmedchemlett.5b00452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Götz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucklaender, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jose, J.</span></span> <span> </span><span class="NLM_article-title">TF-A Novel Cell-Permeable and Selective Inhibitor of Human Protein Kinase CK2 Induces Apoptosis in the Prostate Cancer Cell Line LNCaP</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1820</i></span>,  <span class="NLM_fpage">970</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbagen.2012.02.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1820&publication_year=2012&pages=970-977&author=C.+G%C3%B6tzauthor=A.+Gratzauthor=U.+Kucklaenderauthor=J.+Jose&title=TF-A+Novel+Cell-Permeable+and+Selective+Inhibitor+of+Human+Protein+Kinase+CK2+Induces+Apoptosis+in+the+Prostate+Cancer+Cell+Line+LNCaP&doi=10.1016%2Fj.bbagen.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6tz%26aufirst%3DC.%26aulast%3DGratz%26aufirst%3DA.%26aulast%3DKucklaender%26aufirst%3DU.%26aulast%3DJose%26aufirst%3DJ.%26atitle%3DTF-A%2520Novel%2520Cell-Permeable%2520and%2520Selective%2520Inhibitor%2520of%2520Human%2520Protein%2520Kinase%2520CK2%2520Induces%2520Apoptosis%2520in%2520the%2520Prostate%2520Cancer%2520Cell%2520Line%2520LNCaP%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2012%26volume%3D1820%26spage%3D970%26epage%3D977%26doi%3D10.1016%2Fj.bbagen.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vialettes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darjania, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stansfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span> <span> </span><span class="NLM_article-title">Pre-Clinical Characterization of CX-4945, a Potent and Selective Small Molecule Inhibitor of CK2 for the Treatment of Cancer</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1007/s11010-011-0956-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1007%2Fs11010-011-0956-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21755459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleqsrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2011&pages=37-43&author=F.+Pierreauthor=P.+C.+Chuaauthor=S.+E.+O%E2%80%99Brienauthor=A.+Siddiqui-Jainauthor=P.+Bourbonauthor=M.+Haddachauthor=J.+Michauxauthor=J.+Nagasawaauthor=M.+K.+Schwaebeauthor=E.+Stefanauthor=A.+Vialettesauthor=J.+P.+Whittenauthor=T.+K.+Chenauthor=L.+Darjaniaauthor=R.+Stansfieldauthor=J.+Bliesathauthor=D.+Dryginauthor=C.+Hoauthor=M.+Omoriauthor=C.+Proffittauthor=N.+Streinerauthor=W.+G.+Riceauthor=D.+M.+Ryckmanauthor=K.+Anderes&title=Pre-Clinical+Characterization+of+CX-4945%2C+a+Potent+and+Selective+Small+Molecule+Inhibitor+of+CK2+for+the+Treatment+of+Cancer&doi=10.1007%2Fs11010-011-0956-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer</span></div><div class="casAuthors">Pierre, Fabrice; Chua, Peter C.; O'Brien, Sean E.; Siddiqui-Jain, Adam; Bourbon, Pauline; Haddach, Mustapha; Michaux, Jerome; Nagasawa, Johnny; Schwaebe, Michael K.; Stefan, Eric; Vialettes, Anne; Whitten, Jeffrey P.; Chen, Ta Kung; Darjania, Levan; Stansfield, Ryan; Bliesath, Joshua; Drygin, Denis; Ho, Caroline; Omori, May; Proffitt, Chris; Streiner, Nicole; Rice, William G.; Ryckman, David M.; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">37-43</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this article we describe the preclin. characterization of 5-(3-chlorophenylamino) benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first orally available small mol. inhibitor of protein CK2 in clin. trials for cancer.  CX-4945 was optimized as an ATP-competitive inhibitor of the CK2 holoenzyme (Ki = 0.38 nM).  Iterative synthesis and screening of analogs, guided by mol. modeling, led to the discovery of orally available CX-4945.  CK2 promotes signaling in the Akt pathway and CX-4945 suppresses the phosphorylation of Akt as well as other key downstream mediators of the pathway such as p21.  CX-4945 induced apoptosis and caused cell cycle arrest in cancer cells in vitro.  CX-4945 exhibited a dose-dependent antitumor activity in a xenograft model of PC3 prostate cancer model and was well tolerated.  In vivo time-dependent redn. in the phosphorylation of the biomarker p21 at T145 was obsd. by immunohistochem.  Inhibition of the newly validated CK2 target by CX-4945 represents a fresh therapeutic strategy for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH9CxZ62fC-rVg90H21EOLACvtfcHk0lhusDmD6ghUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleqsrjO&md5=4c35a8e6f161485dffd10be9de0b2ef1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11010-011-0956-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-011-0956-5%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DChua%26aufirst%3DP.%2BC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DBourbon%26aufirst%3DP.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DNagasawa%26aufirst%3DJ.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DStefan%26aufirst%3DE.%26aulast%3DVialettes%26aufirst%3DA.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DT.%2BK.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DStansfield%26aufirst%3DR.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DPre-Clinical%2520Characterization%2520of%2520CX-4945%252C%2520a%2520Potent%2520and%2520Selective%2520Small%2520Molecule%2520Inhibitor%2520of%2520CK2%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D356%26spage%3D37%26epage%3D43%26doi%3D10.1007%2Fs11010-011-0956-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Efficient Development of Stable and Highly Functionalised Peptides Targeting the CK2α/CK2β Protein-Protein Interaction</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5056</span>– <span class="NLM_lpage">5063</span>, <span class="refDoi"> DOI: 10.1039/C9SC00798A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC9SC00798A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31183056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsFSisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=5056-5063&author=J.+Iegreauthor=P.+Brearauthor=D.+J.+Bakerauthor=Y.+S.+Tanauthor=E.+L.+Atkinsonauthor=H.+F.+Soreauthor=D.+H.+O%E2%80%99Donovanauthor=C.+S.+Vermaauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Efficient+Development+of+Stable+and+Highly+Functionalised+Peptides+Targeting+the+CK2%CE%B1%2FCK2%CE%B2+Protein-Protein+Interaction&doi=10.1039%2FC9SC00798A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein-protein interaction</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; Baker, David J.; Tan, Yaw Sing; Atkinson, Eleanor L.; Sore, Hannah F.; O' Donovan, Daniel H.; Verma, Chandra S.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5056-5063</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The discovery of new Protein-Protein Interaction (PPI) modulators is currently limited by the difficulties assocd. with the design and synthesis of selective small mol. inhibitors.  Peptides are a potential soln. for disrupting PPIs; however, they typically suffer from poor stability in vivo and limited tissue penetration hampering their wide spread use as new chem. biol. tools and potential therapeutics.  In this work, a combination of CuAAC chem., mol. modeling, X-ray crystallog., and biol. validation allowed us to develop highly functionalised peptide PPI inhibitors of the protein CK2.  The lead peptide, CAM7117, prevents the formation of the holoenzyme assembly in vitro, slows down proliferation, induces apoptosis in cancer cells and is stable in human serum.  CAM7117 could aid the development of novel CK2 inhibitors acting at the interface and help to fully understand the intracellular pathways involving CK2.  Importantly, the approach adopted herein could be applied to many PPI targets and has the potential to ease the study of PPIs by efficiently providing access to functionalised peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYHV8LQ_rU-rVg90H21EOLACvtfcHk0lhusDmD6ghUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsFSisb4%253D&md5=f87360d6d772c26396751ec8f0e5d33c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2FC9SC00798A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9SC00798A%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DBaker%26aufirst%3DD.%2BJ.%26aulast%3DTan%26aufirst%3DY.%2BS.%26aulast%3DAtkinson%26aufirst%3DE.%2BL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DD.%2BH.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DEfficient%2520Development%2520of%2520Stable%2520and%2520Highly%2520Functionalised%2520Peptides%2520Targeting%2520the%2520CK2%25CE%25B1%252FCK2%25CE%25B2%2520Protein-Protein%2520Interaction%26jtitle%3DChem.%2520Sci.%26date%3D2019%26volume%3D10%26spage%3D5056%26epage%3D5063%26doi%3D10.1039%2FC9SC00798A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">North, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Novel Non-ATP Competitive Small Molecules Targeting the CK2 α/β Interface</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3016</span>– <span class="NLM_lpage">3020</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2018.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29759799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptl2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3016-3020&author=P.+Brearauthor=A.+Northauthor=J.+Iegreauthor=K.+Hadje+Georgiouauthor=A.+Lubinauthor=L.+Carroauthor=W.+Greenauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Novel+Non-ATP+Competitive+Small+Molecules+Targeting+the+CK2+%CE%B1%2F%CE%B2+Interface&doi=10.1016%2Fj.bmc.2018.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel non-ATP competitive small molecules targeting the CK2 α/β interface</span></div><div class="casAuthors">Brear, Paul; North, Andrew; Iegre, Jessica; Hadje Georgiou, Kathy; Lubin, Alexandra; Carro, Laura; Green, William; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3016-3020</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Increased CK2 levels are prevalent in many cancers.  Combined with the crit. role CK2 plays in many cell-signaling pathways, this makes it a prime target for down regulation to fight tumor growth.  Herein, we report a fragment-based approach to inhibiting the interaction between CK2α and CK2β at the α-β interface of the holoenzyme.  A fragment, CAM187, with an IC50 of 44μM and a mol. wt. of only 257gmol-1 has been identified as the most promising compd.  Importantly, the lead fragment only bound at the interface and was not obsd. in the ATP binding site of the protein when co-crystd. with CK2α.  The fragment-like mols. discovered in this study represent unique scaffolds to CK2 inhibition and leave room for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6go0iwXoayLVg90H21EOLACvtfcHk0lgqgeUDAggTDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptl2ks74%253D&md5=c2ed9aad2cb3e1a33f30f0d5cb1beb00</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DNorth%26aufirst%3DA.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DLubin%26aufirst%3DA.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DGreen%26aufirst%3DW.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DNovel%2520Non-ATP%2520Competitive%2520Small%2520Molecules%2520Targeting%2520the%2520CK2%2520%25CE%25B1%252F%25CE%25B2%2520Interface%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3016%26epage%3D3020%26doi%3D10.1016%2Fj.bmc.2018.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetoh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1836</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01765</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01765" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1817-1836&author=B.+Bestgenauthor=I.+Kufarevaauthor=W.+Seetohauthor=C.+Abellauthor=R.+W.+Hartmannauthor=R.+Abagyanauthor=M.+Le+Borgneauthor=O.+Filholauthor=C.+Cochetauthor=T.+Lombergetauthor=M.+Engel&title=2-Aminothiazole+Derivatives+as+Selective+Allosteric+Modulators+of+the+Protein+Kinase+CK2.+2.+Structure-Based+Optimization+and+Investigation+of+Effects+Specific+to+the+Allosteric+Mode+of+Action&doi=10.1021%2Facs.jmedchem.8b01765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action</span></div><div class="casAuthors">Bestgen, Benoit; Kufareva, Irina; Seetoh, Weiguang; Abell, Chris; Hartmann, Rolf W.; Abagyan, Ruben; Le Borgne, Marc; Filhol, Odile; Cochet, Claude; Lomberget, Thierry; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1817-1836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein CK2 has gained much interest as an anticancer drug target in the past decade.  We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small mol. ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold.  In the present work, structure optimizations guided by a binding model led to the identification of the lead compd. 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (27), showing a submicromolar potency against purified CK2α (IC50 = 0.6 μM).  Furthermore, 27 induced apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 μM) and inhibited STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945 (EC50 of 1.6 μM vs 5.3 μM).  Notably, the potencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate.  Altogether, the novel allosteric pocket was proved a druggable site, offering an excellent perspective to develop efficient and selective allosteric CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpExtWddxHflbVg90H21EOLACvtfcHk0lgqgeUDAggTDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKjt74%253D&md5=f0f9c87e819f89b94842b8ddea81ebed</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01765%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DSeetoh%26aufirst%3DW.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DLomberget%26aufirst%3DT.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3D2-Aminothiazole%2520Derivatives%2520as%2520Selective%2520Allosteric%2520Modulators%2520of%2520the%2520Protein%2520Kinase%2520CK2.%25202.%2520Structure-Based%2520Optimization%2520and%2520Investigation%2520of%2520Effects%2520Specific%2520to%2520the%2520Allosteric%2520Mode%2520of%2520Action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1817%26epage%3D1836%26doi%3D10.1021%2Facs.jmedchem.8b01765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetoh, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span> <span> </span><span class="NLM_article-title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1816</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01766</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01766" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFKjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1803-1816&author=B.+Bestgenauthor=I.+Krimmauthor=I.+Kufarevaauthor=A.+A.+M.+Kamalauthor=W.+G.+Seetohauthor=C.+Abellauthor=R.+W.+Hartmannauthor=R.+Abagyanauthor=C.+Cochetauthor=M.+Le+Borgneauthor=M.+Engelauthor=T.+Lomberget&title=2-Aminothiazole+Derivatives+as+Selective+Allosteric+Modulators+of+the+Protein+Kinase+CK2.+1.+Identification+of+an+Allosteric+Binding+Site&doi=10.1021%2Facs.jmedchem.8b01766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site</span></div><div class="casAuthors">Bestgen, Benoit; Krimm, Isabelle; Kufareva, Irina; Kamal, Ahmed Ashraf Moustafa; Seetoh, Wei-Guang; Abell, Chris; Hartmann, Rolf W.; Abagyan, Ruben; Cochet, Claude; Le Borgne, Marc; Engel, Matthias; Lomberget, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1803-1816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a ubiquitous Ser/Thr protein kinase involved in the control of various signaling pathways and is known to be constitutively active.  In the present study, we identified aryl 2-aminothiazoles as a novel class of CK2 inhibitors, which displayed a non-ATP-competitive mode of action and stabilized an inactive conformation of CK2 in soln.  Enzyme kinetics studies, STD NMR, CD spectroscopy, and native mass spectrometry expts. demonstrated that the compds. bind in an allosteric pocket outside the ATP-binding site.  Our data, combined with mol. docking studies, strongly suggested that this new binding site was located at the interface between the αC helix and the flexible glycine-rich loop.  A first hit optimization led to compd. 7, exhibiting an IC50 of 3.4 μM against purified CK2α in combination with a favorable selectivity profile.  Thus, we identified a novel class of CK2 inhibitors targeting an allosteric pocket, offering great potential for further optimization into anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrchN5EYaEF3LVg90H21EOLACvtfcHk0lgJaiqIHhau9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKjs74%253D&md5=11cf634261058cdaa7ffa69e4c6b5457</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01766%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DKamal%26aufirst%3DA.%2BA.%2BM.%26aulast%3DSeetoh%26aufirst%3DW.%2BG.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DLomberget%26aufirst%3DT.%26atitle%3D2-Aminothiazole%2520Derivatives%2520as%2520Selective%2520Allosteric%2520Modulators%2520of%2520the%2520Protein%2520Kinase%2520CK2.%25201.%2520Identification%2520of%2520an%2520Allosteric%2520Binding%2520Site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1803%26epage%3D1816%26doi%3D10.1021%2Facs.jmedchem.8b01766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. H.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Insights into the Regulation Mechanism of CK2 by IP<sub>6</sub> and the Intrinsically Disordered Protein Nopp140</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">19360</span>– <span class="NLM_lpage">19365</span>, <span class="refDoi"> DOI: 10.1073/pnas.1304670110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1073%2Fpnas.1304670110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24218616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19360-19365&author=W.-K.+Leeauthor=S.+H.+Sonauthor=B.-S.+Jinauthor=J.-H.+Naauthor=S.-Y.+Kimauthor=K.+H.+Kimauthor=E.+E.+Kimauthor=Y.+G.+Yuauthor=H.+H.+Lee&title=Structural+and+Functional+Insights+into+the+Regulation+Mechanism+of+CK2+by+IP6+and+the+Intrinsically+Disordered+Protein+Nopp140&doi=10.1073%2Fpnas.1304670110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140</span></div><div class="casAuthors">Lee, Won-Kyu; Son, Sang Hyeon; Jin, Bong-Suk; Na, Jung-Hyun; Kim, Soo-Youl; Kim, Kook-Han; Kim, Eunice Eun Kyeong; Yu, Yeon Gyu; Lee, Hyung Ho</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19360-19365,S19360/1-S19360/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein kinase CK2 is a ubiquitous kinase that can phosphorylate hundreds of cellular proteins and plays important roles in cell growth and development.  Deregulation of CK2 is related to a variety of human cancers, and CK2 is regarded as a suppressor of apoptosis; therefore, it is a target of anticancer therapy.  Nucleolar phosphoprotein 140 (Nopp140), which is an intrinsically disordered protein, interacts with CK2 and inhibits the latter's catalytic activity in vitro.  Interestingly, the catalytic activity of CK2 is recovered in the presence of D-myo-inositol 1,2,3,4,5,6-hexakisphosphate (IP6).  IP6 is widely distributed in animal cells, but the mol. mechanisms that govern its cellular functions in animal cells have not been completely elucidated.  Here, the crystal structure of CK2 in complex with IP6 showed that the Lys-rich cluster of CK2 plays an important role in binding to IP6.  The biochem. expts. revealed that a Nopp140 fragment (residues 568-596) and IP6 competitively bound to the catalytic subunit of CK2 (CK2α), and phospho-Ser-574 of Nopp140 significantly enhanced its interaction with CK2α.  Substitutions of K74E, K76E, and K77E in CK2α significantly reduced the interactions of CK2α with both IP6 and the Nopp140-derived peptide.  Thus, this study provided an insight into the regulation of CK2.  In particular, this work suggests that CK2 activity is inhibited by Nopp140 and reactivated by IP6 by competitive binding at the substrate recognition site of CK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwaXQRyV6TjLVg90H21EOLACvtfcHk0lgJaiqIHhau9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemtbfF&md5=12830fc6129e71cdcdb7c2baf4a89bd6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1304670110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1304670110%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DW.-K.%26aulast%3DSon%26aufirst%3DS.%2BH.%26aulast%3DJin%26aufirst%3DB.-S.%26aulast%3DNa%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DS.-Y.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DE.%2BE.%26aulast%3DYu%26aufirst%3DY.%2BG.%26aulast%3DLee%26aufirst%3DH.%2BH.%26atitle%3DStructural%2520and%2520Functional%2520Insights%2520into%2520the%2520Regulation%2520Mechanism%2520of%2520CK2%2520by%2520IP6%2520and%2520the%2520Intrinsically%2520Disordered%2520Protein%2520Nopp140%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D19360%26epage%3D19365%26doi%3D10.1073%2Fpnas.1304670110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A Fragment-Based Approach Leading to the Discovery of a Novel Binding Site and the Selective CK2 Inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyvonenauthor=D.+R.+Spring&title=A+Fragment-Based+Approach+Leading+to+the+Discovery+of+a+Novel+Binding+Site+and+the+Selective+CK2+Inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0lgMQjVQ7foBlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyvonen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520Fragment-Based%2520Approach%2520Leading%2520to%2520the%2520Discovery%2520of%2520a%2520Novel%2520Binding%2520Site%2520and%2520the%2520Selective%2520CK2%2520Inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngoei, K. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langendorf, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, N. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camerino, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozikis, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dite, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovens, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smiles, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rider, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foitzik, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakhill, J. S.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK Alpha 2 Beta 2 Gamma 1 by the Glucose Importagog SC4</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.chembiol.2018.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29657085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFCksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=728-737&author=K.+R.+W.+Ngoeiauthor=C.+G.+Langendorfauthor=N.+X.+Y.+Lingauthor=A.+Hoqueauthor=S.+Vargheseauthor=M.+A.+Camerinoauthor=S.+R.+Walkerauthor=Y.+E.+Bozikisauthor=T.+A.+Diteauthor=A.+J.+Ovensauthor=W.+J.+Smilesauthor=R.+Jacobsauthor=H.+Huangauthor=M.+W.+Parkerauthor=J.+W.+Scottauthor=M.+H.+Riderauthor=R.+C.+Foitzikauthor=B.+E.+Kempauthor=J.+B.+Baellauthor=J.+S.+Oakhill&title=Structural+Determinants+for+Small-Molecule+Activation+of+Skeletal+Muscle+AMPK+Alpha+2+Beta+2+Gamma+1+by+the+Glucose+Importagog+SC4&doi=10.1016%2Fj.chembiol.2018.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK α2β2γ1 by the Glucose Importagog SC4</span></div><div class="casAuthors">Ngoei, Kevin R. W.; Langendorf, Christopher G.; Ling, Naomi X. Y.; Hoque, Ashfaqul; Johnson, Swapna; Camerino, Michelle C.; Walker, Scott R.; Bozikis, Ylva E.; Dite, Toby A.; Ovens, Ashley J.; Smiles, William J.; Jacobs, Roxane; Huang, He; Parker, Michael W.; Scott, John W.; Rider, Mark H.; Foitzik, Richard C.; Kemp, Bruce E.; Baell, Jonathan B.; Oakhill, Jonathan S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">728-737.e9</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The AMP-activated protein kinase (AMPK) αβγ heterotrimer regulates cellular energy homeostasis with tissue-specific isoform distribution.  Small-mol. activation of skeletal muscle α2β2 AMPK complexes may prove a valuable treatment strategy for type 2 diabetes and insulin resistance.  Herein, we report the small-mol. SC4 is a potent, direct AMPK activator that preferentially activates α2 complexes and stimulates skeletal muscle glucose uptake.  In parallel with the term secretagog, we propose "importagog" to define a substance that induces or augments cellular uptake of another substance.  Three-dimensional structures of the glucose importagog SC4 bound to activated α2β2γ1 and α2β1γ1 complexes reveal binding determinants, in particular a key interaction between the SC4 imidazopyridine 4'-nitrogen and β2-Asp111, which provide a design paradigm for β2-AMPK therapeutics.  The α2β2γ1/SC4 structure reveals an interaction between a β2 N-terminal α helix and the α2 autoinhibitory domain.  Our results provide a structure-function guide to accelerate development of potent, but importantly tissue-specific, β2-AMPK therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_umJeuj3fV7Vg90H21EOLACvtfcHk0lgMQjVQ7foBlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFCksLg%253D&md5=f2c3fdb43956995ea6171bac215793cb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DNgoei%26aufirst%3DK.%2BR.%2BW.%26aulast%3DLangendorf%26aufirst%3DC.%2BG.%26aulast%3DLing%26aufirst%3DN.%2BX.%2BY.%26aulast%3DHoque%26aufirst%3DA.%26aulast%3DVarghese%26aufirst%3DS.%26aulast%3DCamerino%26aufirst%3DM.%2BA.%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DBozikis%26aufirst%3DY.%2BE.%26aulast%3DDite%26aufirst%3DT.%2BA.%26aulast%3DOvens%26aufirst%3DA.%2BJ.%26aulast%3DSmiles%26aufirst%3DW.%2BJ.%26aulast%3DJacobs%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BW.%26aulast%3DRider%26aufirst%3DM.%2BH.%26aulast%3DFoitzik%26aufirst%3DR.%2BC.%26aulast%3DKemp%26aufirst%3DB.%2BE.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DOakhill%26aufirst%3DJ.%2BS.%26atitle%3DStructural%2520Determinants%2520for%2520Small-Molecule%2520Activation%2520of%2520Skeletal%2520Muscle%2520AMPK%2520Alpha%25202%2520Beta%25202%2520Gamma%25201%2520by%2520the%2520Glucose%2520Importagog%2520SC4%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D728%26epage%3D737%26doi%3D10.1016%2Fj.chembiol.2018.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gazzard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodacre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 1,7-Diazacarbazole Class of Inhibitors of Checkpoint Kinase 1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5704</span>– <span class="NLM_lpage">5709</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmcl.2014.10.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=25453805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVemsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5704-5709&author=L.+Gazzardauthor=B.+Appletonauthor=K.+Chapmanauthor=H.+Chenauthor=K.+Clarkauthor=J.+Drobnickauthor=S.+Goodacreauthor=J.+Halladayauthor=J.+Lyssikatosauthor=S.+Schmidtauthor=S.+Siderisauthor=C.+Wiesmannauthor=K.+Williamsauthor=P.+Wuauthor=I.+Yenauthor=S.+Malek&title=Discovery+of+the+1%2C7-Diazacarbazole+Class+of+Inhibitors+of+Checkpoint+Kinase+1&doi=10.1016%2Fj.bmcl.2014.10.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1</span></div><div class="casAuthors">Gazzard, Lewis; Appleton, Brent; Chapman, Kerry; Chen, Huifen; Clark, Kevin; Drobnick, Joy; Goodacre, Simon; Halladay, Jason; Lyssikatos, Joseph; Schmidt, Stephen; Sideris, Steve; Wiesmann, Christian; Williams, Karen; Wu, Ping; Yen, Ivana; Malek, Shiva</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5704-5709</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Checkpoint kinase 1 (ChK1) is activated in response to DNA damage, acting to temporarily block cell cycle progression and allow for DNA repair.  It is envisaged that inhibition of ChK1 will sensitize tumor cells to treatment with DNA-damaging therapies, and may enhance the therapeutic window.  High throughput screening identified carboxylate-contg. diarylpyrazines as a prominent hit series, but with limited biochem. potency and no cellular activity.  Through a series of SAR investigations and x-ray crystallog. anal. the crit. role of polar contacts with conserved waters in the kinase back pocket was established.  Structure-based design, guided by in silico modeling, transformed the series to better satisfy these contacts and the novel 1,7-diazacarbazole class of inhibitors was discovered.  Here the authors present the genesis of this novel series and the identification of GNE-783 I, a potent, selective and orally bioavailable inhibitor of ChK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfVjbVYw27rVg90H21EOLACvtfcHk0lhAqPa2Oga5hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVemsLrL&md5=6a99d23ce3ebe446b57d5fe76816824b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.063%26sid%3Dliteratum%253Aachs%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DK.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DGoodacre%26aufirst%3DS.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DYen%26aufirst%3DI.%26aulast%3DMalek%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%25201%252C7-Diazacarbazole%2520Class%2520of%2520Inhibitors%2520of%2520Checkpoint%2520Kinase%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5704%26epage%3D5709%26doi%3D10.1016%2Fj.bmcl.2014.10.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Function of CX-4945 as a Splicing Regulator</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e94978</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0094978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1371%2Fjournal.pone.0094978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24743259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Kimauthor=K.+Choiauthor=H.+Kangauthor=S.-Y.+Leeauthor=S.-W.+Chiauthor=M.-S.+Leeauthor=J.+Songauthor=D.+Imauthor=Y.+Choiauthor=S.+Cho&title=Identification+of+a+Novel+Function+of+CX-4945+as+a+Splicing+Regulator&doi=10.1371%2Fjournal.pone.0094978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel function of CX-4945 as a splicing regulator</span></div><div class="casAuthors">Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-wook; Lee, Min-sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94978/1-e94978/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene.  The significance of alternative splicing has been confirmed by the increasing no. of human diseases that are caused by misregulation of splicing events.  Very few compds., however, have been reported to act as inhibitors of alternative splicing, and their potential clin. use needs to be evaluated.  Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a mol. currently in clin. trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner.  Transcriptome-wide anal. using exon array also showed a widespread alteration in alternative splicing of numerous genes.  We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells.  Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date.  Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner.  Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmZdGtUZUe7Vg90H21EOLACvtfcHk0lhAqPa2Oga5hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL&md5=5edb2338401d950cddbcba7d35e57c04</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094978%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DChi%26aufirst%3DS.-W.%26aulast%3DLee%26aufirst%3DM.-S.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Function%2520of%2520CX-4945%2520as%2520a%2520Splicing%2520Regulator%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0094978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pireddu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevariya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozcan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schonbrunn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span> <span> </span><span class="NLM_article-title">Development of O-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7392</span>– <span class="NLM_lpage">7416</span>, <span class="refDoi"> DOI: 10.1021/jm300334d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300334d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7392-7416&author=H.+R.+Lawrenceauthor=M.+P.+Martinauthor=Y.+Luoauthor=R.+Piredduauthor=H.+Yangauthor=H.+Gevariyaauthor=S.+Ozcanauthor=J.+Y.+Zhuauthor=R.+Kendigauthor=M.+Rodriguezauthor=R.+Eliasauthor=J.+Q.+Chengauthor=S.+M.+Sebtiauthor=E.+Schonbrunnauthor=N.+J.+Lawrence&title=Development+of+O-Chlorophenyl+Substituted+Pyrimidines+as+Exceptionally+Potent+Aurora+Kinase+Inhibitors&doi=10.1021%2Fjm300334d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors</span></div><div class="casAuthors">Lawrence, Harshani R.; Martin, Mathew P.; Luo, Yunting; Pireddu, Roberta; Yang, Hua; Gevariya, Harsukh; Ozcan, Sevil; Zhu, Jin-Yi; Kendig, Robert; Rodriguez, Mercedes; Elias, Roy; Cheng, Jin Q.; Sebti, Said M.; Schonbrunn, Ernst; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7392-7416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The o-carboxylic acid substituted bisanilinopyrimidine I was identified as a potent hit (Aurora A IC50 = 6.1 ± 1.0 nM) from inhouse screening.  Detailed structure-activity relationship (SAR) studies indicated that polar substituents at the para position of the B-ring are crit. for potent activity.  X-ray crystallog. studies revealed that compd. I is a type I inhibitor that binds the Aurora kinase active site in a DFG-in conformation.  Structure-activity guided replacement of the A-ring carboxylic acid with halogens and incorporation of fluorine at the pyrimidine 5-position led to highly potent inhibitors of Aurora A that bind in a DFG-out conformation.  B-Ring modifications were undertaken to improve the soly. and cell permeability.  Compds. such as II with water-solubilizing moieties at the para position of the B-ring inhibited the autophosphorylation of Aurora A in MDA-MB-468 breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeJbI5uTT-4bVg90H21EOLACvtfcHk0lhAqPa2Oga5hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN&md5=8158e18d9d2a26dfce7a831a353f333c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm300334d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300334d%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DOzcan%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DElias%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520O-Chlorophenyl%2520Substituted%2520Pyrimidines%2520as%2520Exceptionally%2520Potent%2520Aurora%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7392%26epage%3D7416%26doi%3D10.1021%2Fjm300334d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Ampk Regulation by Small Molecule Activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">3017</span> <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+Basis+of+Ampk+Regulation+by+Small+Molecule+Activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2ebEHgxwm8XlO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520Basis%2520of%2520Ampk%2520Regulation%2520by%2520Small%2520Molecule%2520Activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillertz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweikart, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span> <span> </span><span class="NLM_article-title">X-Ray Structural Analysis of Tau-Tubulin Kinase 1 and Its Interactions with Small Molecular Inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1846</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1002%2Fcmdc.201300274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=24039150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1846&author=Y.+Xueauthor=P.+T.+Wanauthor=P.+Hillertzauthor=F.+Schweikartauthor=Y.+Zhaoauthor=L.+Wisslerauthor=N.+Dekker&title=X-Ray+Structural+Analysis+of+Tau-Tubulin+Kinase+1+and+Its+Interactions+with+Small+Molecular+Inhibitors&doi=10.1002%2Fcmdc.201300274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structural analysis of tau-tubulin kinase 1 and its interactions with small molecular inhibitors</span></div><div class="casAuthors">Xue, Yafeng; Wan, Paul T.; Hillertz, Per; Schweikart, Fritz; Zhao, Yanlong; Wissler, Lisa; Dekker, Niek</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1846-1854</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Tau-tubulin kinase 1 (I) is a serine/threonine/tyrosine kinase that putatively phosphorylates residues including Ser-422 in tau protein.  Hyperphosphorylation of tau protein is the primary cause of tau pathol. and neuronal death assocd. with Alzheimer's disease.  Here, a library of 12 truncation variants comprising the I kinase domain was screened for expression in Escherichia coli and insect cells.  One variant (residues 14-313) could be purified, but mass spectrometric anal. revealed extensive phosphorylation of the protein.  Co-expression with phage λ phosphatase in Escherichia coli resulted in the prodn. of homogeneous, nonphosphorylated I.  The binding of ATP and several compds. to I was characterized by surface plasmon resonance.  Crystal structures of I in the unliganded form and in complex with ATP, and 2 high-affinity ATP-competitive inhibitors, 3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol and Me 2-bromo-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)benzoate (II), were elucidated.  The structure revealed 2 clear basic patches near the ATP pocket providing an explanation of I for phosphorylation-primed substrates.  Interestingly, II displayed slow binding kinetics with I and the structure of I in complex with this compd. revealed a reorganization of the Lue-199-Asp-200 peptide backbone conformation together with altered H-bonding with II.  These conformational changes necessary for the binding of II are likely the basis of the slow kinetics.  This 1st I structure can assist the discovery of novel inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_Z_a4ZEZKz7Vg90H21EOLACvtfcHk0lhdHepXeD-SoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeqsL%252FE&md5=467e2009dc3d5b8a5bf662048d5c6d8e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300274%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DP.%2BT.%26aulast%3DHillertz%26aufirst%3DP.%26aulast%3DSchweikart%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DDekker%26aufirst%3DN.%26atitle%3DX-Ray%2520Structural%2520Analysis%2520of%2520Tau-Tubulin%2520Kinase%25201%2520and%2520Its%2520Interactions%2520with%2520Small%2520Molecular%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1846%26doi%3D10.1002%2Fcmdc.201300274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">8478</span>– <span class="NLM_lpage">8488</span>, <span class="refDoi"> DOI: 10.1021/bi2008382</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2008382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=8478-8488&author=R.+Battistuttaauthor=G.+Cozzaauthor=F.+Pierreauthor=E.+Papinuttoauthor=G.+Lolliauthor=S.+Sarnoauthor=S.+E.+O%E2%80%99Brienauthor=A.+Siddiqui-Jainauthor=M.+Haddachauthor=K.+Anderesauthor=D.+M.+Ryckmanauthor=F.+Meggioauthor=L.+A.+Pinna&title=Unprecedented+Selectivity+and+Structural+Determinants+of+a+New+Class+of+Protein+Kinase+CK2+Inhibitors+in+Clinical+Trials+for+the+Treatment+of+Cancer&doi=10.1021%2Fbi2008382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer</span></div><div class="casAuthors">Battistutta, Roberto; Cozza, Giorgio; Pierre, Fabrice; Papinutto, Elena; Lolli, Graziano; Sarno, Stefania; O'Brien, Sean E.; Siddiqui-Jain, Adam; Haddach, Mustapha; Anderes, Kenna; Ryckman, David M.; Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">8478-8488</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clin. stage inhibitor of protein kinase CK2 for the treatment of cancer, is representative of a new class of CK2 inhibitors with Ki values in the low nanomolar range and unprecedented selectivity vs. other kinases.  Here we present the crystal structure of the complexes of CX-4945 and two analogs (CX-5011 and CX-5279) with the catalytic subunit of human CK2.  Consistent with their ATP-competitive mode of inhibition, all three compds. bind in the active site of CK2 (type I inhibitors).  The tricyclic scaffold of the inhibitors superposes on the adenine of ATP, establishing multiple hydrophobic interactions with the binding cavity.  The more extended scaffold, as compared to that of ATP, allows the carboxylic function, shared by all three ligands, to penetrate into the deepest part of the active site where it makes interactions with conserved water W1 and Lys-68, thus accounting for the crucial role of this neg. charged group in conferring high potency to this class of inhibitors.  The presence of a pyrimidine in CX-5011 and in CX-5279 instead of a pyridine (as in CX-4945) ring is likely to account for the higher specificity of these compds. whose Gini coeffs., calcd. by profiling them against panels of 102 and/or 235 kinases, are significantly higher than that of CX-4945 (0.735 and 0.755, resp., vs 0.615), marking the highest selectivity ever reported for CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjndr5Zz11z7Vg90H21EOLACvtfcHk0lhdHepXeD-SoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK&md5=4f399675d86d48b88cbfefa6b8c13edb</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbi2008382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2008382%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DUnprecedented%2520Selectivity%2520and%2520Structural%2520Determinants%2520of%2520a%2520New%2520Class%2520of%2520Protein%2520Kinase%2520CK2%2520Inhibitors%2520in%2520Clinical%2520Trials%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D8478%26epage%3D8488%26doi%3D10.1021%2Fbi2008382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmann, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of CX-4945 Binding to Human Protein Kinase CK2</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2010.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.febslet.2010.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21093442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=104-110&author=A.+D.+Fergusonauthor=P.+R.+Shethauthor=A.+D.+Bassoauthor=S.+Paliwalauthor=K.+Grayauthor=T.+O.+Fischmannauthor=H.+V.+Le&title=Structural+Basis+of+CX-4945+Binding+to+Human+Protein+Kinase+CK2&doi=10.1016%2Fj.febslet.2010.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of CX-4945 binding to human protein kinase CK2</span></div><div class="casAuthors">Ferguson, Andrew D.; Sheth, Payal R.; Basso, Andrea D.; Paliwal, Sunil; Gray, Kimberly; Fischmann, Thierry O.; Le, Hung V.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-110</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein kinase CK2 (CK2), a constitutively active serine/threonine kinase, is involved in a variety of roles essential to the maintenance of cellular homeostasis.  Elevated levels of CK2 expression results in the dysregulation of key signaling pathways that regulate transcription, and has been implicated in cancer.  The adenosine-5'-triphosphate-competitive inhibitor CX-4945 (I) has been reported to show broad spectrum anti-proliferative activity in multiple cancer cell lines.  Although the enzymic IC50 of CX-4945 has been reported, the thermodn. and structural basis of binding to CK2α remained elusive.  Presented here are the crystal structures of human CK2α in complex with CX-4945 and adenylyl phosphoramidate at 2.7 and 1.3 Å, resp.  Biophys. anal. of CX-4945 binding is also described.  This data provides the structural rationale for the design of more potent inhibitors against this emerging cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ79g72x8-abVg90H21EOLACvtfcHk0lhfI4-7wDS-Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D&md5=b2fab5a9e6d75362c339ddbfa1035315</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2010.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2010.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DSheth%26aufirst%3DP.%2BR.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DLe%26aufirst%3DH.%2BV.%26atitle%3DStructural%2520Basis%2520of%2520CX-4945%2520Binding%2520to%2520Human%2520Protein%2520Kinase%2520CK2%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D104%26epage%3D110%26doi%3D10.1016%2Fj.febslet.2010.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuver-Moody, C.</span></span> <span> </span><span class="NLM_article-title">Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1975</span>, <span class="refDoi"> DOI: 10.1021/jm701248t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701248t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlOmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1972-1975&author=A.+C.+Pierceauthor=M.+Jacobsauthor=C.+Stuver-Moody&title=Docking+Study+Yields+Four+Novel+Inhibitors+of+the+Protooncogene+Pim-1+Kinase&doi=10.1021%2Fjm701248t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase</span></div><div class="casAuthors">Pierce, Albert C.; Jacobs, Marc; Stuver-Moody, Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1972-1975</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To supplement the hits from a high throughput screen, docking was performed against Pim-1 kinase.  Glide docking was augmented with a filter to require traditional or arom. CH··O hydrogen bonds to the kinase hinge.  Four diverse actives, of 96 mols. assayed, had Ki values between 0.091 and 4.5 μM.  This gives a 14-fold enrichment over the earlier HTS run, and the two crystal structures solved confirmed the binding modes predicted by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH6GwwgMwC27Vg90H21EOLACvtfcHk0lhfI4-7wDS-Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlOmtLY%253D&md5=fafba52528730d4e250d489ad24a6cd8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm701248t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701248t%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DStuver-Moody%26aufirst%3DC.%26atitle%3DDocking%2520Study%2520Yields%2520Four%2520Novel%2520Inhibitors%2520of%2520the%2520Protooncogene%2520Pim-1%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1972%26epage%3D1975%26doi%3D10.1021%2Fjm701248t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kure, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirasawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Novel Potent Protein Kinase CK2 (CK2) Inhibitors with Phenyl-Azole Scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2899</span>– <span class="NLM_lpage">2903</span>, <span class="refDoi"> DOI: 10.1021/jm2015167</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2015167" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFSiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2899-2903&author=Z.+Houauthor=I.+Nakanishiauthor=T.+Kinoshitaauthor=Y.+Takeiauthor=M.+Yasueauthor=R.+Misuauthor=Y.+Suzukiauthor=S.+Nakamuraauthor=T.+Kureauthor=H.+Ohnoauthor=K.+Murataauthor=K.+Kitauraauthor=A.+Hirasawaauthor=G.+Tsujimotoauthor=S.+Oishiauthor=N.+Fujii&title=Structure-Based+Design+of+Novel+Potent+Protein+Kinase+CK2+%28CK2%29+Inhibitors+with+Phenyl-Azole+Scaffolds&doi=10.1021%2Fjm2015167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Potent Protein Kinase CK2 (CK2) Inhibitors with Phenyl-azole Scaffolds</span></div><div class="casAuthors">Hou, Zengye; Nakanishi, Isao; Kinoshita, Takayoshi; Takei, Yoshinori; Yasue, Misato; Misu, Ryosuke; Suzuki, Yamato; Nakamura, Shinya; Kure, Tatsuhide; Ohno, Hiroaki; Murata, Katsumi; Kitaura, Kazuo; Hirasawa, Akira; Tsujimoto, Gozoh; Oishi, Shinya; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2899-2903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein kinase CK2 (CK2) is a ubiquitous serine/threonine protein kinase for hundreds of endogenous substrates.  CK2 has been considered to be involved in many diseases, including cancers.  Herein we report the discovery of a novel ATP-competitive CK2 inhibitor.  Virtual screening of a compd. library led to the identification of a hit 2-phenyl-1,3,4-thiadiazole compd.  Subsequent structural optimization resulted in the identification of the promising 4-(thiazol-5-yl)benzoic acid deriv. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJqKTawljL8rVg90H21EOLACvtfcHk0lhfI4-7wDS-Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFSiuro%253D&md5=81a61dbd32b6470909c89f4924d26b7d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm2015167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2015167%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DTakei%26aufirst%3DY.%26aulast%3DYasue%26aufirst%3DM.%26aulast%3DMisu%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DKure%26aufirst%3DT.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DK.%26aulast%3DKitaura%26aufirst%3DK.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Potent%2520Protein%2520Kinase%2520CK2%2520%2528CK2%2529%2520Inhibitors%2520with%2520Phenyl-Azole%2520Scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2899%26epage%3D2903%26doi%3D10.1021%2Fjm2015167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whelligan, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas-Droux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barillari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grummitt, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Montfort, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7682</span>– <span class="NLM_lpage">7698</span>, <span class="refDoi"> DOI: 10.1021/jm1008727</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1008727" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7682-7698&author=D.+K.+Whelliganauthor=S.+Solankiauthor=D.+Taylorauthor=D.+W.+Thomsonauthor=K.+M.+Cheungauthor=K.+Boxallauthor=C.+Mas-Drouxauthor=C.+Barillariauthor=S.+Burnsauthor=C.+G.+Grummittauthor=I.+Collinsauthor=R.+L.+Van+Montfortauthor=G.+W.+Aherneauthor=R.+Baylissauthor=S.+Hoelder&title=Aminopyrazine+Inhibitors+Binding+to+an+Unusual+Inactive+Conformation+of+the+Mitotic+Kinase+Nek2%3A+SAR+and+Structural+Characterization&doi=10.1021%2Fjm1008727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span></div><div class="casAuthors">Whelligan, Daniel K.; Solanki, Savade; Taylor, Dawn; Thomson, Douglas W.; Cheung, Kwai-Ming J.; Boxall, Kathy; Mas-Droux, Corine; Barillari, Caterina; Burns, Samantha; Grummitt, Charles G.; Collins, Ian; van Montfort, Rob L. M.; Aherne, G. Wynne; Bayliss, Richard; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7682-7698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the first systematic exploration of inhibitors of the mitotic kinase Nek2.  Starting from HTS hit aminopyrazine I, compds. with improved activity were identified using structure-based design.  Our structural biol. investigations reveal two notable observations.  First, I and related compds. bind to an unusual, inactive conformation of the kinase which to the best of our knowledge has not been reported for other types of kinase inhibitors.  Second, a phenylalanine residue at the center of the ATP pocket strongly affects the ability of the inhibitor to bind to the protein.  The implications of these observations are discussed, and the work described here defines key features for potent and selective Nek2 inhibition, which will aid the identification of more advanced inhibitors of Nek2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzgVaRXbQkrVg90H21EOLACvtfcHk0lhN2eJEcqTpqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Krs7nI&md5=d1a4af6869319bed0a340e8ff7db4397</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008727%26sid%3Dliteratum%253Aachs%26aulast%3DWhelligan%26aufirst%3DD.%2BK.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarillari%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DGrummitt%26aufirst%3DC.%2BG.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DVan%2BMontfort%26aufirst%3DR.%2BL.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DAminopyrazine%2520Inhibitors%2520Binding%2520to%2520an%2520Unusual%2520Inactive%2520Conformation%2520of%2520the%2520Mitotic%2520Kinase%2520Nek2%253A%2520SAR%2520and%2520Structural%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7682%26epage%3D7698%26doi%3D10.1021%2Fjm1008727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of an Aurora-A Mutant That Mimics Aurora-B Bound to Mln8054: Insights Into Selectivity and Drug Design</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1042/BJ20091530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1042%2FBJ20091530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=20067443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFyntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2010&pages=19-28&author=C.+A.+Dodsonauthor=M.+Kosmopoulouauthor=M.+W.+Richardsauthor=B.+Atrashauthor=V.+Bavetsiasauthor=J.+Blaggauthor=R.+Bayliss&title=Crystal+Structure+of+an+Aurora-A+Mutant+That+Mimics+Aurora-B+Bound+to+Mln8054%3A+Insights+Into+Selectivity+and+Drug+Design&doi=10.1042%2FBJ20091530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design</span></div><div class="casAuthors">Dodson, Charlotte A.; Kosmopoulou, Magda; Richards, Mark W.; Atrash, Butrus; Bavetsias, Vassilios; Blagg, Julian; Bayliss, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-28</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The prodn. of selective protein kinase inhibitors is often frustrated by the similarity of the enzyme active sites.  For this reason, it is challenging to design inhibitors that discriminate between the three Aurora kinases, which are important targets in cancer drug discovery.  We have used a triple-point mutant of Aurora-A (AurAx3) which mimics the active site of Aurora-B to investigate the structural basis of MLN8054 selectivity.  The bias toward Aurora-A inhibition by MLN8054 is fully recapitulated by AurAx3 in vitro.  X-ray crystal structures of the complex suggest that the basis for the discrimination is electrostatic repulsion due to the T217E substitution, which we have confirmed using a single-point mutant.  The activation loop of Aurora-A in the AurAx3-MLN8054 complex exhibits an unusual conformation in which Asp274 and Phe275 side chains point into the interior of the protein.  There is to our knowledge no documented precedent for this conformation, which we have termed DFG-up.  The sequence requirements of the DFG-up conformation suggest that it might be accessible to only a fraction of kinases.  MLN8054 thus circumvents the problem of highly homologous active sites.  Binding of MLN8054 to Aurora-A switches the character of a pocket within the active site from polar to a hydrophobic pocket, similar to what is obsd. in the structure of Aurora-A bound to a compd. that induces DFG-out.  We propose that targeting this pocket may be a productive route in the design of selective kinase inhibitors and describe the structural basis for the rational design of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdJs5KY2VkabVg90H21EOLACvtfcHk0lhN2eJEcqTpqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFyntr8%253D&md5=fdf1a176a5fdf5fcd71fd57c3ef92817</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1042%2FBJ20091530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091530%26sid%3Dliteratum%253Aachs%26aulast%3DDodson%26aufirst%3DC.%2BA.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DRichards%26aufirst%3DM.%2BW.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBayliss%26aufirst%3DR.%26atitle%3DCrystal%2520Structure%2520of%2520an%2520Aurora-A%2520Mutant%2520That%2520Mimics%2520Aurora-B%2520Bound%2520to%2520Mln8054%253A%2520Insights%2520Into%2520Selectivity%2520and%2520Drug%2520Design%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D427%26spage%3D19%26epage%3D28%26doi%3D10.1042%2FBJ20091530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claiborne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Credo, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sowin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1,4-Dihydroindeno[1,2-c]Pyrazoles as a Novel Class of Potent and Selective Checkpoint Kinase 1 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2759</span>– <span class="NLM_lpage">2767</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2007.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=17287122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2759-2767&author=Y.+Tongauthor=A.+Claiborneauthor=K.+D.+Stewartauthor=C.+Parkauthor=P.+Kovarauthor=Z.+Chenauthor=R.+B.+Credoauthor=W.+Z.+Guauthor=S.+L.+Gwaltneyauthor=R.+A.+Judgeauthor=H.+Zhangauthor=S.+H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.+H.+Lin&title=Discovery+of+1%2C4-Dihydroindeno%5B1%2C2-c%5DPyrazoles+as+a+Novel+Class+of+Potent+and+Selective+Checkpoint+Kinase+1+Inhibitors&doi=10.1016%2Fj.bmc.2007.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span></div><div class="casAuthors">Tong, Yunsong; Claiborne, Akiyo; Stewart, Kent D.; Park, Chang; Kovar, Peter; Chen, Zehan; Credo, Robert B.; Gu, Wen-Zhen; Gwaltney, Stephen L.; Judge, Russell A.; Zhang, Haiying; Rosenberg, Saul H.; Sham, Hing L.; Sowin, Thomas J.; Lin, Nan-horng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2759-2767</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening.  The efficient hit-to-lead process was facilitated by X-ray crystallog. and led to potent inhibitors (<10 nM) against CHK-1.  X-ray co-crystal structures of bound inhibitors demonstrated that two sub-series of this class of compds., exemplified by 21 and 41, exhibit distinctive hydrogen bonding patterns in the specificity pocket of the active site.  Two compds., 41 and 43, were capable of potentiating doxorubicin and camptothecin, both DNA-damaging agents, in cell proliferation assays (MTS and soft agar assays) and abrogating G2/M checkpoint in a mechanism-based FACS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVp7DNSZaexbVg90H21EOLACvtfcHk0lhN2eJEcqTpqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D&md5=0966753ebf59128001db7601ca7d8cee</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DGu%26aufirst%3DW.%2BZ.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%2BH.%26atitle%3DDiscovery%2520of%25201%252C4-Dihydroindeno%255B1%252C2-c%255DPyrazoles%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520Checkpoint%2520Kinase%25201%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2759%26epage%3D2767%26doi%3D10.1016%2Fj.bmc.2007.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nédellec, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevrel, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macalino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span> <span> </span><span class="NLM_article-title">7-(4H-1,2,4-Triazol-3-Yl)Benzo[c][2,6]Naphthyridines: A Novel Class of Pim Kinase Inhibitors with Potent Cell Antiproliferative Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6687</span>– <span class="NLM_lpage">6692</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmcl.2011.09.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21982499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6687-6692&author=F.+Pierreauthor=E.+Stefanauthor=A.-S.+N%C3%A9dellecauthor=M.-C.+Chevrelauthor=C.+F.+Reganauthor=A.+Siddiqui-Jainauthor=D.+Macalinoauthor=N.+Streinerauthor=D.+Dryginauthor=M.+Haddachauthor=S.+E.+O%E2%80%99Brienauthor=K.+Anderesauthor=D.+M.+Ryckman&title=7-%284H-1%2C2%2C4-Triazol-3-Yl%29Benzo%5Bc%5D%5B2%2C6%5DNaphthyridines%3A+A+Novel+Class+of+Pim+Kinase+Inhibitors+with+Potent+Cell+Antiproliferative+Activity&doi=10.1016%2Fj.bmcl.2011.09.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity</span></div><div class="casAuthors">Pierre, Fabrice; Stefan, Eric; Nedellec, Anne-Sophie; Chevrel, Marie-Claire; Regan, Collin F.; Siddiqui-Jain, Adam; Macalino, Diwata; Streiner, Nicole; Drygin, Denis; Haddach, Mustapha; O'Brien, Sean E.; Anderes, Kenna; Ryckman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6687-6692</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of pan-Pim kinase inhibitors was designed by modifying the CK2 inhibitor CX-4945.  Introduction of a triazole or secondary amide functionality on the C-7 position and 2'-halogenoanilines on C-5 resulted in potent inhibitors of the Pim-1 and Pim-2 isoforms, with many analogs active at single digit nanomolar concns.  The mols. inhibited the phosphorylation at Serine 112 of the apoptosis effector BAD, and had potent antiproliferative effects on the AML cell line MV-4-11 (IC50 <30 nM).  This work delivers an excellent lead-optimization platform for Pim targeting anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ofDFEMV1erVg90H21EOLACvtfcHk0lhxYogg3Idz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr%252FO&md5=00f6b75384ba3f3975c845ba7ff97ed1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.059%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DStefan%26aufirst%3DE.%26aulast%3DN%25C3%25A9dellec%26aufirst%3DA.-S.%26aulast%3DChevrel%26aufirst%3DM.-C.%26aulast%3DRegan%26aufirst%3DC.%2BF.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3D7-%25284H-1%252C2%252C4-Triazol-3-Yl%2529Benzo%255Bc%255D%255B2%252C6%255DNaphthyridines%253A%2520A%2520Novel%2520Class%2520of%2520Pim%2520Kinase%2520Inhibitors%2520with%2520Potent%2520Cell%2520Antiproliferative%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6687%26epage%3D6692%26doi%3D10.1016%2Fj.bmcl.2011.09.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pattanayek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, M.</span></span> <span> </span><span class="NLM_article-title">Protein-Protein Interactions in the Cyanobacterial Circadian Clock: Structure of KaiA Dimer in Complex with C-Terminal KaiC Peptides at 2.8 Angstrom Resolution</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4575</span>– <span class="NLM_lpage">4578</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.5b00694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b00694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=4575-4578&author=R.+Pattanayekauthor=M.+Egli&title=Protein-Protein+Interactions+in+the+Cyanobacterial+Circadian+Clock%3A+Structure+of+KaiA+Dimer+in+Complex+with+C-Terminal+KaiC+Peptides+at+2.8+Angstrom+Resolution&doi=10.1021%2Facs.biochem.5b00694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-Protein Interactions in the Cyanobacterial Circadian Clock: Structure of KaiA Dimer in Complex with C-Terminal KaiC Peptides at 2.8 Å Resolution</span></div><div class="casAuthors">Pattanayek, Rekha; Egli, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4575-4578</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the cyanobacterial circadian clock, the KaiA, -B, and -C proteins with ATP constitute a post-translational oscillator.  KaiA stimulates the KaiC autokinase, and KaiB antagonizes KaiA action.  KaiA contacts the intrinsically disordered C-terminal regions of KaiC hexamer to promote phosphorylation across subunit interfaces.  The crystal structure of KaiA dimer from Synechococcus elongatus with two KaiC C-terminal 20mer peptides bound reveals that the latter adopt an α-helical conformation and contact KaiA α-helical bundles via mostly hydrophobic interactions.  This complex and the crystal structure of KaiC hexamer with truncated C-terminal tails can be fit into the electron microscopy (EM) d. of the KaiA:KaiC complex.  The hybrid model helps rationalize clock phenotypes of KaiA and KaiC mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeObdAF6I1brVg90H21EOLACvtfcHk0lhxYogg3Idz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgsL%252FM&md5=34a0ea3f485baa17b25de93debaabe6c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b00694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b00694%26sid%3Dliteratum%253Aachs%26aulast%3DPattanayek%26aufirst%3DR.%26aulast%3DEgli%26aufirst%3DM.%26atitle%3DProtein-Protein%2520Interactions%2520in%2520the%2520Cyanobacterial%2520Circadian%2520Clock%253A%2520Structure%2520of%2520KaiA%2520Dimer%2520in%2520Complex%2520with%2520C-Terminal%2520KaiC%2520Peptides%2520at%25202.8%2520Angstrom%2520Resolution%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D4575%26epage%3D4578%26doi%3D10.1021%2Facs.biochem.5b00694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaeger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzlmeir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polzer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruprecht, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzoldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huenges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garz, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolg, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vooder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiche, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greif, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiekermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span> <span> </span><span class="NLM_article-title">The Target Landscape of Clinical Kinase Drugs</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span>, <span class="NLM_elocation-id">eaan4368</span> <span class="refDoi"> DOI: 10.1126/science.aan4368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1126%2Fscience.aan4368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=29191878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&author=S.+Klaegerauthor=S.+Heinzlmeirauthor=M.+Wilhelmauthor=H.+Polzerauthor=B.+Vickauthor=P.+A.+Koenigauthor=M.+Reineckeauthor=B.+Ruprechtauthor=S.+Petzoldtauthor=C.+Mengauthor=J.+Zechaauthor=K.+Reiterauthor=H.+Qiaoauthor=D.+Helmauthor=H.+Kochauthor=M.+Schoofauthor=G.+Canevariauthor=E.+Casaleauthor=S.+R.+Depaoliniauthor=A.+Feuchtingerauthor=Z.+Wuauthor=T.+Schmidtauthor=L.+Rueckertauthor=W.+Beckerauthor=J.+Huengesauthor=A.+K.+Garzauthor=B.+O.+Gohlkeauthor=D.+P.+Zolgauthor=G.+Kayserauthor=T.+Vooderauthor=R.+Preissnerauthor=H.+Hahneauthor=N.+Tonissonauthor=K.+Kramerauthor=K.+Gotzeauthor=F.+Bassermannauthor=J.+Schleglauthor=H.+C.+Ehrlichauthor=S.+Aicheauthor=A.+Walchauthor=P.+A.+Greifauthor=S.+Schneiderauthor=E.+R.+Felderauthor=J.+Rulandauthor=G.+Medardauthor=I.+Jeremiasauthor=K.+Spiekermannauthor=B.+Kuster&title=The+Target+Landscape+of+Clinical+Kinase+Drugs&doi=10.1126%2Fscience.aan4368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan4368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan4368%26sid%3Dliteratum%253Aachs%26aulast%3DKlaeger%26aufirst%3DS.%26aulast%3DHeinzlmeir%26aufirst%3DS.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DH.%26aulast%3DVick%26aufirst%3DB.%26aulast%3DKoenig%26aufirst%3DP.%2BA.%26aulast%3DReinecke%26aufirst%3DM.%26aulast%3DRuprecht%26aufirst%3DB.%26aulast%3DPetzoldt%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DC.%26aulast%3DZecha%26aufirst%3DJ.%26aulast%3DReiter%26aufirst%3DK.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DHelm%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DH.%26aulast%3DSchoof%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DRueckert%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHuenges%26aufirst%3DJ.%26aulast%3DGarz%26aufirst%3DA.%2BK.%26aulast%3DGohlke%26aufirst%3DB.%2BO.%26aulast%3DZolg%26aufirst%3DD.%2BP.%26aulast%3DKayser%26aufirst%3DG.%26aulast%3DVooder%26aufirst%3DT.%26aulast%3DPreissner%26aufirst%3DR.%26aulast%3DHahne%26aufirst%3DH.%26aulast%3DTonisson%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DGotze%26aufirst%3DK.%26aulast%3DBassermann%26aufirst%3DF.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DH.%2BC.%26aulast%3DAiche%26aufirst%3DS.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DGreif%26aufirst%3DP.%2BA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DMedard%26aufirst%3DG.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DSpiekermann%26aufirst%3DK.%26aulast%3DKuster%26aufirst%3DB.%26atitle%3DThe%2520Target%2520Landscape%2520of%2520Clinical%2520Kinase%2520Drugs%26jtitle%3DScience%26date%3D2017%26volume%3D358%26doi%3D10.1126%2Fscience.aan4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bdzhola, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balanda, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prykhod’ko, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmoluk, S. M.</span></span> <span> </span><span class="NLM_article-title">Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]Pyrimidine-Based Inhibitor</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">9</span> <span class="refDoi"> DOI: 10.3390/ph10010009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.3390%2Fph10010009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1ems7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&author=K.+Niefindauthor=N.+Bischoffauthor=A.+G.+Golubauthor=V.+G.+Bdzholaauthor=A.+O.+Balandaauthor=A.+O.+Prykhod%E2%80%99koauthor=S.+M.+Yarmoluk&title=Structural+Hypervariability+of+the+Two+Human+Protein+Kinase+CK2+Catalytic+Subunit+Paralogs+Revealed+by+Complex+Structures+with+a+Flavonol-+and+a+Thieno%5B2%2C3-d%5DPyrimidine-Based+Inhibitor&doi=10.3390%2Fph10010009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structural hypervariability of the two human protein kinase CK2 catalytic subunit paralogs revealed by complex structures with a flavonol- and a thieno[2,3-d]pyrimidine-based inhibitor</span></div><div class="casAuthors">Niefind, Karsten; Bischoff, Nils; Golub, Andriy G.; Bdzhola, Volodymyr G.; Balanda, Anatoliy O.; Prykhod'ko, Andriy O.; Yarmoluk, Sergiy M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9/1-9/16</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Protein kinase CK2 is assocd. with a no. of human diseases, among them cancer, and is therefore a target for inhibitor development in industry and academia.  Six crystal structures of either CK2α, the catalytic subunit of human protein kinase CK2, or its paralog CK2α' in complex with two ATP-competitive inhibitors-based on either a flavonol or a thieno[2,3-d]pyrimidine framework-are presented.  The structures show examples for extreme structural deformations of the ATP-binding loop and its neighborhood and of the hinge/helix αD region, i.e., of two zones of the broader ATP site environment.  Thus, they supplement our picture of the conformational space available for CK2α and CK2α'.  Further, they document the potential of synthetic ligands to trap unusual conformations of the enzymes and allow to envision a new generation of inhibitors that stabilize such conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwVeYAGf2ikLVg90H21EOLACvtfcHk0lg4nrYH5Fb1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1ems7s%253D&md5=e4dd3999e41ec49425347304b496db42</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3390%2Fph10010009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10010009%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DGolub%26aufirst%3DA.%2BG.%26aulast%3DBdzhola%26aufirst%3DV.%2BG.%26aulast%3DBalanda%26aufirst%3DA.%2BO.%26aulast%3DPrykhod%25E2%2580%2599ko%26aufirst%3DA.%2BO.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26atitle%3DStructural%2520Hypervariability%2520of%2520the%2520Two%2520Human%2520Protein%2520Kinase%2520CK2%2520Catalytic%2520Subunit%2520Paralogs%2520Revealed%2520by%2520Complex%2520Structures%2520with%2520a%2520Flavonol-%2520and%2520a%2520Thieno%255B2%252C3-d%255DPyrimidine-Based%2520Inhibitor%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26doi%3D10.3390%2Fph10010009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadje Georgiou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis-Newton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkitaraman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvonen, M.</span></span> <span> </span><span class="NLM_article-title">Specific Inhibition of CK2 Alpha from an Anchor Outside the Active Site</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6845</span>, <span class="refDoi"> DOI: 10.1039/C6SC02335E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1039%2FC6SC02335E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=28451126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=6839-6845&author=P.+Brearauthor=C.+De+Fuscoauthor=K.+Hadje+Georgiouauthor=N.+J.+Francis-Newtonauthor=C.+J.+Stubbsauthor=H.+F.+Soreauthor=A.+R.+Venkitaramanauthor=C.+Abellauthor=D.+R.+Springauthor=M.+Hyvonen&title=Specific+Inhibition+of+CK2+Alpha+from+an+Anchor+Outside+the+Active+Site&doi=10.1039%2FC6SC02335E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of CK2α from an anchor outside the active site</span></div><div class="casAuthors">Brear, Paul; De Fusco, Claudia; Hadje Georgiou, Kathy; Francis-Newton, Nicola J.; Stubbs, Christopher J.; Sore, Hannah F.; Venkitaraman, Ashok R.; Abell, Chris; Spring, David R.; Hyvonen, Marko</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6839-6845</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site.  Here, we describe a new mechanism by which the protein kinase CK2α can be selectively inhibited using features outside the ATP site.  We have identified a new binding site for small mols. on CK2α adjacent to the ATP site and behind the αD loop, termed the αD pocket.  An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2α with a Kd of 320 nM and shows significantly improved selectivity compared to other CK2α inhibitors.  CAM4066 shows target engagement in several cell lines and similar potency to clin. trial candidate CX4945.  Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2α via a novel mechanism, enabling the development of a new generation of selective CK2α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3FqxiBkU9frVg90H21EOLACvtfcHk0lg4nrYH5Fb1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFCrtbbP&md5=c4652010f4da70a128fb1dab64f811d0</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC6SC02335E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02335E%26sid%3Dliteratum%253Aachs%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DHadje%2BGeorgiou%26aufirst%3DK.%26aulast%3DFrancis-Newton%26aufirst%3DN.%2BJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DVenkitaraman%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DHyvonen%26aufirst%3DM.%26atitle%3DSpecific%2520Inhibition%2520of%2520CK2%2520Alpha%2520from%2520an%2520Anchor%2520Outside%2520the%2520Active%2520Site%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D6839%26epage%3D6845%26doi%3D10.1039%2FC6SC02335E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamiguchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship Study of 4-(Thiazol-5-Yl)Benzoic Acid Derivatives as Potent Protein Kinase CK2 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1136</span>– <span class="NLM_lpage">1141</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bmc.2016.01.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=26850376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFWjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1136-1141&author=H.+Ohnoauthor=D.+Minamiguchiauthor=S.+Nakamuraauthor=K.+Shuauthor=S.+Okazakiauthor=M.+Hondaauthor=R.+Misuauthor=H.+Moriwakiauthor=S.+Nakanishiauthor=S.+Oishiauthor=T.+Kinoshitaauthor=I.+Nakanishiauthor=N.+Fujii&title=Structure-Activity+Relationship+Study+of+4-%28Thiazol-5-Yl%29Benzoic+Acid+Derivatives+as+Potent+Protein+Kinase+CK2+Inhibitors&doi=10.1016%2Fj.bmc.2016.01.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of 4-(thiazol-5-yl)benzoic acid derivatives as potent protein kinase CK2 inhibitors</span></div><div class="casAuthors">Ohno, Hiroaki; Minamiguchi, Daiki; Nakamura, Shinya; Shu, Keito; Okazaki, Shiho; Honda, Maho; Misu, Ryosuke; Moriwaki, Hirotomo; Nakanishi, Shinsuke; Oishi, Shinya; Kinoshita, Takayoshi; Nakanishi, Isao; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1136-1141</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two classes of modified analogs of 4-(thiazol-5-yl)benzoic acid-type CK2 inhibitors were designed.  The azabenzene analogs, pyridine- and pyridazine-carboxylic acid derivs., showed potent protein kinase CK2 inhibitory activities [IC50 (CK2α) = 0.014-0.017 μM; IC50 (CK2α') = 0.0046-0.010 μM].  Introduction of a 2-halo- or 2-methoxy-benzyloxy group at the 3-position of the benzoic acid moiety maintained the potent CK2 inhibitory activities [IC50 (CK2α) = 0.014-0.016 μM; IC50 (CK2α') = 0.0088-0.014 μM] and led to antiproliferative activities [CC50 (A549) = 1.5-3.3 μM] three to six times higher than those of the parent compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPsh5G-h_c7Vg90H21EOLACvtfcHk0lg4nrYH5Fb1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFWjsLk%253D&md5=7380c8d630ea0695a85d9e9922fde1b2</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.043%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DMinamiguchi%26aufirst%3DD.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DK.%26aulast%3DOkazaki%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DM.%26aulast%3DMisu%26aufirst%3DR.%26aulast%3DMoriwaki%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520of%25204-%2528Thiazol-5-Yl%2529Benzoic%2520Acid%2520Derivatives%2520as%2520Potent%2520Protein%2520Kinase%2520CK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1136%26epage%3D1141%26doi%3D10.1016%2Fj.bmc.2016.01.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraets, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeders, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castermans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panitti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanormelingen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Defert, O.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4309</span>– <span class="NLM_lpage">4324</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00308</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00308" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4309-4324&author=S.+Bolandauthor=A.+Bourinauthor=J.+Alenauthor=J.+Geraetsauthor=P.+Schroedersauthor=K.+Castermansauthor=N.+Kindtauthor=N.+Boumansauthor=L.+Panittiauthor=S.+Fransenauthor=J.+Vanormelingenauthor=J.+M.+Stassenauthor=D.+Leysenauthor=O.+Defert&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel%2C+Highly+Active+Soft+ROCK+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors</span></div><div class="casAuthors">Boland, Sandro; Bourin, Arnaud; Alen, Jo; Geraets, Jacques; Schroeders, Pieter; Castermans, Karolien; Kindt, Nele; Boumans, Nicki; Panitti, Laura; Fransen, Silke; Vanormelingen, Jessica; Stassen, Jean Marie; Leysen, Dirk; Defert, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4309-4324</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ROCK1 and ROCK2 play important roles in numerous cellular functions, including smooth muscle cell contraction, cell proliferation, adhesion, and migration.  Consequently, ROCK inhibitors are of interest for treating multiple indications including cardiovascular diseases, inflammatory and autoimmune diseases, lung diseases, and eye diseases.  However, systemic inhibition of ROCK is expected to result in significant side effects.  Strategies allowing reduced systemic exposure are therefore of interest.  In a continuing effort toward identification of ROCK inhibitors, we here report the design, synthesis, and evaluation of novel soft ROCK inhibitors displaying an ester function allowing their rapid inactivation in the systemic circulation.  Those compds., e.g. I, display subnanomolar activity against ROCK and strong differences of functional activity between parent compds. and expected metabolites.  The binding mode of a representative compd. was detd. exptl. in a single-crystal X-ray diffraction study.  Enzymes responsible for inactivation of these compds. once they enter systemic circulation are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWI5LwOkT64rVg90H21EOLACvtfcHk0ljNRmohLahtoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D&md5=320e6fbb1cf87ba8c03fc17795f6802f</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00308%26sid%3Dliteratum%253Aachs%26aulast%3DBoland%26aufirst%3DS.%26aulast%3DBourin%26aufirst%3DA.%26aulast%3DAlen%26aufirst%3DJ.%26aulast%3DGeraets%26aufirst%3DJ.%26aulast%3DSchroeders%26aufirst%3DP.%26aulast%3DCastermans%26aufirst%3DK.%26aulast%3DKindt%26aufirst%3DN.%26aulast%3DBoumans%26aufirst%3DN.%26aulast%3DPanitti%26aufirst%3DL.%26aulast%3DFransen%26aufirst%3DS.%26aulast%3DVanormelingen%26aufirst%3DJ.%26aulast%3DStassen%26aufirst%3DJ.%2BM.%26aulast%3DLeysen%26aufirst%3DD.%26aulast%3DDefert%26aufirst%3DO.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%252C%2520Highly%2520Active%2520Soft%2520ROCK%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4309%26epage%3D4324%26doi%3D10.1021%2Facs.jmedchem.5b00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bdzhola, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmoluk, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1654</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00235</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00235" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1654-1660&author=B.+Guerraauthor=N.+Bischoffauthor=V.+G.+Bdzholaauthor=S.+M.+Yarmolukauthor=O.-G.+Issingerauthor=A.+G.+Golubauthor=K.+Niefind&title=A+Note+of+Caution+on+the+Role+of+Halogen+Bonds+for+Protein+Kinase%2FInhibitor+Recognition+Suggested+by+High-+And+Low-Salt+CK2%CE%B1+Complex+Structures&doi=10.1021%2Facschembio.5b00235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures</span></div><div class="casAuthors">Guerra, Barbara; Bischoff, Nils; Bdzhola, Volodymyr G.; Yarmoluk, Sergiy M.; Issinger, Olaf-Georg; Golub, Andriy G.; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1654-1660</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a Ser/Thr kinase recruited by tumor cells to avoid cell death.  4'-Carboxy-6,8-dibromo-flavonol (FLC26) is a nanomolar CK2 inhibitor reducing the physiol. phosphorylation of CK2 biomarkers and inducing cell death.  Its binding mode to the ATP site was predicted to depend primarily on noncovalent interactions not comprising halogen bonds.  We confirm this by two independent cocrystal structures which addnl. show that FLC26 is selective for an open, protein kinase-untypical conformation of the hinge/helix αD region.  The structures suggest how the bromo substituents, found previously in lead optimization studies, contribute to the inhibitory efficacy.  In this context, one of the complex structures, obtained by crystn. with the kosmotropic salt NaCl, revealed an unconventional π-halogen bond between the 8-bromo substituent of FLC26 and an arom. side chain which is absent under low-salt conditions.  The kosmotropic salt sensitivity of π-halogen bonds is a novel feature which requires attention in structural comparisons and halogen-bond-based explanations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolnSDoVENUrbVg90H21EOLACvtfcHk0ljNRmohLahtoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D&md5=88774b705a45a2fe08917c44545fcd04</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00235%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DBdzhola%26aufirst%3DV.%2BG.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26aulast%3DIssinger%26aufirst%3DO.-G.%26aulast%3DGolub%26aufirst%3DA.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DA%2520Note%2520of%2520Caution%2520on%2520the%2520Role%2520of%2520Halogen%2520Bonds%2520for%2520Protein%2520Kinase%252FInhibitor%2520Recognition%2520Suggested%2520by%2520High-%2520And%2520Low-Salt%2520CK2%25CE%25B1%2520Complex%2520Structures%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1654%26epage%3D1660%26doi%3D10.1021%2Facschembio.5b00235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlow, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Crystallographic Screening Using Ultra-Low-Molecular-Weight Ligands to Guide Drug Design</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2019.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.drudis.2019.03.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1081-1086&author=M.+O%E2%80%99Reillyauthor=A.+Cleasbyauthor=T.+G.+Daviesauthor=R.+J.+Hallauthor=R.+F.+Ludlowauthor=C.+W.+Murrayauthor=D.+Tisiauthor=H.+Jhoti&title=Crystallographic+Screening+Using+Ultra-Low-Molecular-Weight+Ligands+to+Guide+Drug+Design&doi=10.1016%2Fj.drudis.2019.03.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DHall%26aufirst%3DR.%2BJ.%26aulast%3DLudlow%26aufirst%3DR.%2BF.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystallographic%2520Screening%2520Using%2520Ultra-Low-Molecular-Weight%2520Ligands%2520to%2520Guide%2520Drug%2520Design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2019%26volume%3D5%26spage%3D1081%26epage%3D1086%26doi%3D10.1016%2Fj.drudis.2019.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoofnagle, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resing, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, N. G.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Exchange Solvent Protection by an ATP Analogue Reveals Conformational Changes in ERK2 upon Activation</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.jmb.2005.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16185715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOktrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=600-612&author=T.+Leeauthor=A.+N.+Hoofnagleauthor=K.+A.+Resingauthor=N.+G.+Ahn&title=Hydrogen+Exchange+Solvent+Protection+by+an+ATP+Analogue+Reveals+Conformational+Changes+in+ERK2+upon+Activation&doi=10.1016%2Fj.jmb.2005.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Exchange Solvent Protection by an ATP Analogue Reveals Conformational Changes in ERK2 upon Activation</span></div><div class="casAuthors">Lee, Thomas; Hoofnagle, Andrew N.; Resing, Katheryn A.; Ahn, Natalie G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">600-612</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structural and kinetic studies have provided extensive information about the mol. mechanisms of kinase activation by phosphorylation.  However, it is still unclear how changes in protein dynamics and flexibility contribute to catalytic function.  Mass spectrometry was used to probe changes in hydrogen/deuterium exchange in the MAP kinase, ERK2, in the presence and absence of the ATP analog, AMP-PNP.  In both active and inactive forms of ERK2, protection from hydrogen exchange by AMP-PNP binding was obsd. within conserved ATP binding motifs in the N-terminal lobe, which are known to directly interact with nucleotide in various protein kinases.  In contrast, higher protection from exchange by AMP-PNP was obsd. in active ERK2 compared to inactive ERK2, in a region corresponding to the conserved DFG motif, which is located in the C-terminal lobe and coordinates Mg2+ at the catalytic site.  Thus, AMP-PNP binding simultaneously protects residues within the N and C terminus in the active form of ERK2, but not the inactive form.  This demonstrates that ERK2 binds nucleotide in two modes, in which active ERK2 adopts a closed conformation following nucleotide binding in soln., while inactive ERK2 adopts an open conformation.  The finding provides novel evidence that phosphorylation of ERK2 facilitates interdomain closure, allowing proper orientation between ATP and substrate to facilitate phosphoryl transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3O6fC5n7OErVg90H21EOLACvtfcHk0ljNRmohLahtoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOktrvO&md5=8fd0f441c479632d44d4bdfa89dcf143</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26aulast%3DHoofnagle%26aufirst%3DA.%2BN.%26aulast%3DResing%26aufirst%3DK.%2BA.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26atitle%3DHydrogen%2520Exchange%2520Solvent%2520Protection%2520by%2520an%2520ATP%2520Analogue%2520Reveals%2520Conformational%2520Changes%2520in%2520ERK2%2520upon%2520Activation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D600%26epage%3D612%26doi%3D10.1016%2Fj.jmb.2005.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. A.</span></span> <span> </span><span class="NLM_article-title">Structural Characterization of Protein Kinase A as a Function of Nucleotide Binding. Hydrogen-Deuterium Exchange Studies Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Detection</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">14204</span>– <span class="NLM_lpage">14211</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011543200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1074%2Fjbc.M011543200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=11278927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt12rsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14204-14211&author=M.+D.+Andersenauthor=J.+Shafferauthor=P.+A.+Jenningsauthor=J.+A.+Adams&title=Structural+Characterization+of+Protein+Kinase+A+as+a+Function+of+Nucleotide+Binding.+Hydrogen-Deuterium+Exchange+Studies+Using+Matrix-Assisted+Laser+Desorption+Ionization-Time+of+Flight+Mass+Spectrometry+Detection&doi=10.1074%2Fjbc.M011543200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of protein kinase A as a function of nucleotide binding. Hydrogen-deuterium exchange studies using matrix-assisted laser desorption ionization-time of flight mass spectrometry detection</span></div><div class="casAuthors">Andersen, Mette D.; Shaffer, Jennifer; Jennings, Patricia A.; Adams, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">14204-14211</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Transient state kinetic studies indicate that substrate phosphorylation in protein kinase A is partially rate-limited by conformational changes, some of which may be assocd. with nucleotide binding.  To assess whether specific structural changes are assocd. with the binding of nucleotides, hydrogen-deuterium exchange expts. were performed on the enzyme in the absence and presence of ADP.  Four regions of the protein are protected from exchange in the presence of ADP.  Two regions encompass the catalytic and glycine-rich loops and are integral parts of the active site.  Conversely, protection of probes in the C terminus is consistent with nucleotide-induced domain closure.  One protected probe encompasses a portion of helix C, a secondary structural element that does not make any direct contacts with the nucleotide but has been reported to undergo segmental motion upon the activation of some protein kinases.  The combined data suggest that binding of the nucleotide has distal structural effects that may include stabilizing the closed state of the enzyme and altering the position of a crit. helix outside the active site.  The latter represents the first evidence that the nucleotide alone can induce changes in helix C in soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojALNL-43U-rVg90H21EOLACvtfcHk0lhIXclBWDbjow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt12rsbg%253D&md5=29c442440a6a64d94cf1676baa421ef2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011543200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011543200%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DM.%2BD.%26aulast%3DShaffer%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DP.%2BA.%26aulast%3DAdams%26aufirst%3DJ.%2BA.%26atitle%3DStructural%2520Characterization%2520of%2520Protein%2520Kinase%2520A%2520as%2520a%2520Function%2520of%2520Nucleotide%2520Binding.%2520Hydrogen-Deuterium%2520Exchange%2520Studies%2520Using%2520Matrix-Assisted%2520Laser%2520Desorption%2520Ionization-Time%2520of%2520Flight%2520Mass%2520Spectrometry%2520Detection%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14204%26epage%3D14211%26doi%3D10.1074%2Fjbc.M011543200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleckner, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, M. P.</span></span> <span> </span><span class="NLM_article-title">An Introduction to NMR-Based Approaches for Measuring Protein Dynamics</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1814</i></span>,  <span class="NLM_fpage">942</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2010.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.bbapap.2010.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=21059410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1814&publication_year=2011&pages=942-968&author=I.+R.+Klecknerauthor=M.+P.+Foster&title=An+Introduction+to+NMR-Based+Approaches+for+Measuring+Protein+Dynamics&doi=10.1016%2Fj.bbapap.2010.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">An introduction to NMR-based approaches for measuring protein dynamics</span></div><div class="casAuthors">Kleckner, Ian R.; Foster, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1814</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">942-968</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Proteins are inherently flexible at ambient temp.  At equil., they are characterized by a set of conformations that undergo continuous exchange within a hierarchy of spatial and temporal scales ranging from nanometers to micrometers and femtoseconds to hours.  Dynamic properties of proteins are essential for describing the structural bases of their biol. functions including catalysis, binding, regulation and cellular structure.  NMR spectroscopy represents a powerful technique for measuring these essential features of proteins.  Here the authors provide an introduction to NMR-based approaches for studying protein dynamics, highlighting eight distinct methods with recent examples, contextualized within a common exptl. and anal. framework.  The selected methods are (1) Real-time NMR, (2) Exchange spectroscopy, (3) Lineshape anal., (4) CPMG relaxation dispersion, (5) Rotating frame relaxation dispersion, (6) Nuclear spin relaxation, (7) Residual dipolar coupling, (8) Paramagnetic relaxation enhancement.  This article is part of a Special Issue entitled: Protein Dynamics: Exptl. and Computational Approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlAS8_XeKx77Vg90H21EOLACvtfcHk0lhIXclBWDbjow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCnsbo%253D&md5=2c047b195fd796a815e800bd162a49de</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2010.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2010.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DKleckner%26aufirst%3DI.%2BR.%26aulast%3DFoster%26aufirst%3DM.%2BP.%26atitle%3DAn%2520Introduction%2520to%2520NMR-Based%2520Approaches%2520for%2520Measuring%2520Protein%2520Dynamics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2011%26volume%3D1814%26spage%3D942%26epage%3D968%26doi%3D10.1016%2Fj.bbapap.2010.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobrega, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrita, E. J.</span></span> <span> </span><span class="NLM_article-title">Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding</span>. <i>J. Chem. Educ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1021/ed101169t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ed101169t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVant7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2011&pages=990-994&author=A.+Viegasauthor=J.+Mansoauthor=F.+L.+Nobregaauthor=E.+J.+Cabrita&title=Saturation-Transfer+Difference+%28STD%29+NMR%3A+A+Simple+and+Fast+Method+for+Ligand+Screening+and+Characterization+of+Protein+Binding&doi=10.1021%2Fed101169t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding</span></div><div class="casAuthors">Viegas, Aldino; Manso, Joao; Nobrega, Franklin L.; Cabrita, Eurico J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Education</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">990-994</span>CODEN:
                <span class="NLM_cas:coden">JCEDA8</span>;
        ISSN:<span class="NLM_cas:issn">0021-9584</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society and Division of Chemical Education, Inc.</span>)
        </div><div class="casAbstract">Satn. transfer difference (STD) NMR has emerged as one of the most popular ligand-based NMR techniques for the study of protein-ligand interactions.  The success of this technique is a consequence of its robustness and the fact that it is focused on the signals of the ligand, without any need of processing NMR information about the receptor and only using small quantities of nonlabeled macromol.  Moreover, the attractiveness of this expt. is also extendable to the classroom.  In the context of a practical NMR class, this expt. is ideal to illustrate some fundamental NMR concepts, such as the nuclear Overhauser effect and relaxation in a multidisciplinary context, bridging chem. and biochem. with a taste of medicinal chem.  We use the readily available human serum albumin (HSA), 6-D,L-methyl-tryptophan (6-CH3-Trp), and 7- D,L-methyl-tryptophan (7-CH3-Trp) to introduce the STD-NMR expt. and to illustrate its applicability for ligand screening, mapping of binding moieties, and detn. of the dissocn. const., in a context that can be explored or adapted to the student's course level and topic (chem. or biochem.).  We also cover the most important theor. aspects of the STD expt., calling attention to some of its limitations and drawbacks without a complex theor. approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo29sluoDoJ87Vg90H21EOLACvtfcHk0lhIXclBWDbjow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVant7c%253D&md5=807194fdb33d075121408463767cbf74</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fed101169t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fed101169t%26sid%3Dliteratum%253Aachs%26aulast%3DViegas%26aufirst%3DA.%26aulast%3DManso%26aufirst%3DJ.%26aulast%3DNobrega%26aufirst%3DF.%2BL.%26aulast%3DCabrita%26aufirst%3DE.%2BJ.%26atitle%3DSaturation-Transfer%2520Difference%2520%2528STD%2529%2520NMR%253A%2520A%2520Simple%2520and%2520Fast%2520Method%2520for%2520Ligand%2520Screening%2520and%2520Characterization%2520of%2520Protein%2520Binding%26jtitle%3DJ.%2520Chem.%2520Educ.%26date%3D2011%26volume%3D88%26spage%3D990%26epage%3D994%26doi%3D10.1021%2Fed101169t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindenblatt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickelsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applegate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">7766</span>– <span class="NLM_lpage">7772</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00587</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00587" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Ohur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=7766-7772&author=D.+Lindenblattauthor=A.+Nickelsenauthor=V.+Applegateauthor=J.+Joseauthor=K.+Niefind&title=Structural+and+Mechanistic+Basis+of+the+Inhibitory+Potency+of+Selected+2-Aminothiazole+Compounds+on+Protein+Kinase+CK2&doi=10.1021%2Facs.jmedchem.0c00587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2</span></div><div class="casAuthors">Lindenblatt, Dirk; Nickelsen, Anna; Applegate, Violetta M.; Jose, Joachim; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7766-7772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors of protein kinase CK2 with significant cytotoxicity on tumor cells based on a 2-aminothiazole scaffold were described recently.  Here, these studies are supplemented with representative CK2α/CK2α' complex structures.  They reveal that the 2-aminothiazole-based inhibitors occupy the ATP cavity, whereas preliminary data had indicated an allosteric binding site.  The crystal structure findings are corroborated by subsequent enzyme kinetic studies; their at.-resoln. quality provides the basis for future optimization of these promising CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoY8TYAgUidLVg90H21EOLACvtfcHk0lh4jeDL_HvP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Ohur7P&md5=7e130a22bf2bc72a207b79c3e55a6892</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00587%26sid%3Dliteratum%253Aachs%26aulast%3DLindenblatt%26aufirst%3DD.%26aulast%3DNickelsen%26aufirst%3DA.%26aulast%3DApplegate%26aufirst%3DV.%26aulast%3DJose%26aufirst%3DJ.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DStructural%2520and%2520Mechanistic%2520Basis%2520of%2520the%2520Inhibitory%2520Potency%2520of%2520Selected%25202-Aminothiazole%2520Compounds%2520on%2520Protein%2520Kinase%2520CK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D7766%26epage%3D7772%26doi%3D10.1021%2Facs.jmedchem.0c00587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuriev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanlon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, J. S.</span></span> <span> </span><span class="NLM_article-title">Detection and Prevention of Aggregation-Based False Positives in STD-NMR-Based Fragment Screening</span>. <i>Aust. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1518</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1071/CH13286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1071%2FCH13286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=1518-1524&author=A.+Vomauthor=S.+Headeyauthor=G.+Wangauthor=B.+Capuanoauthor=E.+Yurievauthor=M.+J.+Scanlonauthor=J.+S.+Simpson&title=Detection+and+Prevention+of+Aggregation-Based+False+Positives+in+STD-NMR-Based+Fragment+Screening&doi=10.1071%2FCH13286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and Prevention of Aggregation-based False Positives in STD-NMR-based Fragment Screening</span></div><div class="casAuthors">Vom, Amelia; Headey, Stephen; Wang, Geqing; Capuano, Ben; Yuriev, Elizabeth; Scanlon, Martin J.; Simpson, Jamie S.</div><div class="citationInfo"><span class="NLM_cas:title">Australian Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1518-1524</span>CODEN:
                <span class="NLM_cas:coden">AJCHAS</span>;
        ISSN:<span class="NLM_cas:issn">0004-9425</span>.
    
            (<span class="NLM_cas:orgname">CSIRO Publishing</span>)
        </div><div class="casAbstract">Aggregation of small org. compds. is a problem encountered in a variety of assay screening formats where it often results in detection of false positives.  A satn. transfer difference-NMR-detected screen of a com. available fragment library, followed by biochem. assay, identified several inhibitors of the enzyme ketopantoate reductase.  These inhibitors were subsequently revealed to be aggregation-based false positives.  Modification of the fragment screen by addn. of detergent in the satn. transfer difference-NMR expts. allowed an assay format to be developed that resulted in the identification of genuine hit mols. suitable for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf6Q1uHTRgUbVg90H21EOLACvtfcHk0lh4jeDL_HvP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLrO&md5=2fd1e1c425eab14da1cb299e4818dc8a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1071%2FCH13286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FCH13286%26sid%3Dliteratum%253Aachs%26aulast%3DVom%26aufirst%3DA.%26aulast%3DHeadey%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DYuriev%26aufirst%3DE.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26aulast%3DSimpson%26aufirst%3DJ.%2BS.%26atitle%3DDetection%2520and%2520Prevention%2520of%2520Aggregation-Based%2520False%2520Positives%2520in%2520STD-NMR-Based%2520Fragment%2520Screening%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D1518%26epage%3D1524%26doi%3D10.1071%2FCH13286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">A Detergent-Based Assay for the Detection of Promiscuous Inhibitors</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fnprot.2006.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=17191086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=550-553&author=B.+Y.+Fengauthor=B.+K.+Shoichet&title=A+Detergent-Based+Assay+for+the+Detection+of+Promiscuous+Inhibitors&doi=10.1038%2Fnprot.2006.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A detergent-based assay for the detection of promiscuous inhibitors</span></div><div class="casAuthors">Feng, Brian Y.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">550-553</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">At micromolar concns., many small mols. self-assoc. into colloidal aggregates that non-specifically inhibit enzymes and other proteins.  Here the authors describe a protocol for identifying aggregate-based inhibitors and distinguishing them from small mols. that inhibit via specific mechanisms.  As a convenient proxy for promiscuous, aggregate-based inhibition, the authors monitor inhibition of β-lactamase in the absence and presence of detergent.  Inhibition that is attenuated in the presence of detergent is characteristic of an aggregate-based mechanism.  In the 96-well-format assay described here, about 200 mols. can be tested, in duplicate, per h for detergent-dependent sensitivity.  Furthermore, the authors also describe simple expts. that can offer addnl. confirmation of aggregate-based inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGQSBvMgM-7Vg90H21EOLACvtfcHk0ljSP4L3PrYrWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitLjO&md5=8aa7562b5f69c896af7e133ecc35e6de</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.77%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%2BY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520Detergent-Based%2520Assay%2520for%2520the%2520Detection%2520of%2520Promiscuous%2520Inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D550%26epage%3D553%26doi%3D10.1038%2Fnprot.2006.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Screening in a Spirit Haunted World</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2006.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2Fj.drudis.2006.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=16793529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=607-615&author=B.+K.+Shoichet&title=Screening+in+a+Spirit+Haunted+World&doi=10.1016%2Fj.drudis.2006.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Screening in a spirit haunted world</span></div><div class="casAuthors">Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13 & 14</span>),
    <span class="NLM_cas:pages">607-615</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) campaigns can be dominated by hits that ultimately turn out to be non-drug-like.  These 'nuisance' compds. often behave strangely, with steep dose-response curves, absence of clear structure-activity relationships, and high sensitivity to assay conditions.  Several mechanisms contribute to these artifacts, including chem. reactive mols., those that absorb light in assays and those that affect redox conditions.  One of the most common mechanisms behind artifactual inhibition is discussed in this review: at micromolar concns. org. mols. can aggregate to form particles in aq. buffers, and these aggregates can sequester and thereby inhibit protein targets.  Aggregation-based inhibition is baffling from a chem. perspective, but viewed biophys. such behavior is expected.  The range of mols. that behave this way, their rapid detection in a screening environment and their possible biol. implications will be considered here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzoEkwI2izy7Vg90H21EOLACvtfcHk0ljSP4L3PrYrWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqtLk%253D&md5=08d22b6b06215ac435824b7664b3674c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DScreening%2520in%2520a%2520Spirit%2520Haunted%2520World%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D607%26epage%3D615%26doi%3D10.1016%2Fj.drudis.2006.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coan, K. E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltby, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlingame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2067</span>– <span class="NLM_lpage">2075</span>, <span class="refDoi"> DOI: 10.1021/jm801605r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801605r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2067-2075&author=K.+E.+D.+Coanauthor=D.+A.+Maltbyauthor=A.+L.+Burlingameauthor=B.+K.+Shoichet&title=Promiscuous+Aggregate-Based+Inhibitors+Promote+Enzyme+Unfolding&doi=10.1021%2Fjm801605r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding</span></div><div class="casAuthors">Coan, Kristin E. D.; Maltby, David A.; Burlingame, Alma L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2067-2075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the leading sources of false positives in early drug discovery is the formation of org. small mol. aggregates, which inhibit enzymes nonspecifically at micromolar concns. in aq. soln.  The mol. basis for this widespread problem remains hazy.  To investigate the mechanism of inhibition at a mol. level, we detd. changes in solvent accessibility that occur when an enzyme binds to an aggregate using hydrogen-deuterium exchange mass spectrometry.  For AmpC β-lactamase, binding to aggregates of the small mol. rottlerin increased the deuterium exchange of all 10 reproducibly detectable peptides, which covered 41% of the sequence of β-lactamase.  This suggested a global increase in proton accessibility upon aggregate binding, consistent with denaturation.  We then investigated whether enzyme-aggregate complexes were more susceptible to proteolysis than uninhibited enzyme.  For five aggregators, trypsin degrdn. of β-lactamase increased substantially when β-lactamase was inhibited by aggregates, whereas uninhibited enzyme was generally stable to digestion.  Combined, these results suggest that the mechanism of action of aggregate-based inhibitors proceeds via partial protein unfolding when bound to an aggregate particle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA67zj68-C17Vg90H21EOLACvtfcHk0ljSP4L3PrYrWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFKlsL4%253D&md5=d771ee54b647cf93efe5085c7977bb42</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm801605r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801605r%26sid%3Dliteratum%253Aachs%26aulast%3DCoan%26aufirst%3DK.%2BE.%2BD.%26aulast%3DMaltby%26aufirst%3DD.%2BA.%26aulast%3DBurlingame%26aufirst%3DA.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DPromiscuous%2520Aggregate-Based%2520Inhibitors%2520Promote%2520Enzyme%2520Unfolding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2067%26epage%3D2075%26doi%3D10.1021%2Fjm801605r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helfand, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">A Specific Mechanism of Nonspecific Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4265</span>– <span class="NLM_lpage">4272</span>, <span class="refDoi"> DOI: 10.1021/jm030266r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030266r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4265-4272&author=S.+L.+McGovernauthor=B.+T.+Helfandauthor=B.+Fengauthor=B.+K.+Shoichet&title=A+Specific+Mechanism+of+Nonspecific+Inhibition&doi=10.1021%2Fjm030266r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Specific Mechanism of Nonspecific Inhibition</span></div><div class="casAuthors">McGovern, Susan L.; Helfand, Brian T.; Feng, Brian; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4265-4272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Promiscuous small mols. plague screening libraries and hit lists.  Previous work has found that several nonspecific compds. form submicrometer aggregates, and it has been suggested that this aggregate species is responsible for the inhibition of many different enzymes.  It is not understood how aggregates inhibit their targets.  To address this question, biophys., kinetic, and microscopy methods were used to study the interaction of promiscuous, aggregate-forming inhibitors with model proteins.  By use of centrifugation and gel electrophoresis, aggregates and protein were found to directly interact.  This is consistent with a subsequent observation from confocal fluorescence microscopy that aggregates conc. green fluorescent protein.  β-Lactamase mutants with increased or decreased thermodn. stability relative to wild-type enzyme were equally inhibited by an aggregate-forming compd., suggesting that denaturation by unfolding was not the primary mechanism of interaction.  Instead, visualization by electron microscopy revealed that enzyme assocs. with the surface of inhibitor aggregates.  This assocn. could be reversed or prevented by the addn. of Triton X-100.  These observations suggest that the aggregates formed by promiscuous compds. reversibly sequester enzyme, resulting in apparent inhibition.  They also suggest a simple method to identify or reverse the action of aggregate-based inhibitors, which appear to be widespread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppdLVG_GeLZbVg90H21EOLACvtfcHk0ljSP4L3PrYrWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFamsbs%253D&md5=cd0fd6bf0a64ceb7d7219dae2406dd21</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm030266r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030266r%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DHelfand%26aufirst%3DB.%2BT.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DA%2520Specific%2520Mechanism%2520of%2520Nonspecific%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4265%26epage%3D4272%26doi%3D10.1021%2Fjm030266r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walters, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milam, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. C.</span></span> <span> </span><span class="NLM_article-title">Chapter 1 Practical Approaches to Protein Folding and Assembly. Spectroscopic Strategies in Thermodynamics and Kinetics</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(08)04201-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1016%2FS0076-6879%2808%2904201-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=19289201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlynt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2009&pages=1-39&author=J.+Waltersauthor=S.+L.+Milamauthor=A.+C.+Clark&title=Chapter+1+Practical+Approaches+to+Protein+Folding+and+Assembly.+Spectroscopic+Strategies+in+Thermodynamics+and+Kinetics&doi=10.1016%2FS0076-6879%2808%2904201-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Practical approaches to protein folding and assembly: spectroscopic strategies in thermodynamics and kinetics</span></div><div class="casAuthors">Walters, Jad; Milam, Sara L.; Clark, A. Clay</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">Biothermodynamics, Part A</span>),
    <span class="NLM_cas:pages">1-39</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We describe here the use of several spectroscopies, such as fluorescence emission, CD, and differential quenching by acrylamide, in examg. the equil. and kinetic folding of proteins.  The first section regarding equil. techniques provides practical information for detg. the conformational stability of a protein.  In addn., several equil.-folding models are discussed, from two-state monomer to four-state homodimer, providing a comprehensive protocol for interpretation of folding curves.  The second section focuses on the exptl. design and interpretation of kinetic data, such as burst-phase anal. and exponential fits, used in elucidating kinetic folding pathways.  In addn., simulation programs are used routinely to support folding models generated by kinetic expts., and the fundamentals of simulations are covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaMy2S1-SAI7Vg90H21EOLACvtfcHk0lii6K71oQkO7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlynt7k%253D&md5=58d4801b39b748744352e0385b36084a</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2808%2904201-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252808%252904201-8%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DJ.%26aulast%3DMilam%26aufirst%3DS.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DChapter%25201%2520Practical%2520Approaches%2520to%2520Protein%2520Folding%2520and%2520Assembly.%2520Spectroscopic%2520Strategies%2520in%2520Thermodynamics%2520and%2520Kinetics%26jtitle%3DMethods%2520Enzymol.%26date%3D2009%26volume%3D455%26spage%3D1%26epage%3D39%26doi%3D10.1016%2FS0076-6879%2808%2904201-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bou-Assaf, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englander, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlish, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamuro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, A. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houde, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, T. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaltashov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konermann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascal, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skehel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strutzenberg, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underbakke, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wales, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintrode, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schriemer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rand, K. D.</span></span> <span> </span><span class="NLM_article-title">Recommendations for Performing, Interpreting and Reporting Hydrogen Deuterium Exchange Mass Spectrometry (HDX-MS) Experiments</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1038/s41592-019-0459-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1038%2Fs41592-019-0459-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=31249422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1ykur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=595-602&author=G.+R.+Massonauthor=J.+E.+Burkeauthor=N.+G.+Ahnauthor=G.+S.+Anandauthor=C.+Borchersauthor=S.+Brierauthor=G.+M.+Bou-Assafauthor=J.+R.+Engenauthor=S.+W.+Englanderauthor=J.+Faberauthor=R.+Garlishauthor=P.+R.+Griffinauthor=M.+L.+Grossauthor=M.+Guttmanauthor=Y.+Hamuroauthor=A.+J.+R.+Heckauthor=D.+Houdeauthor=R.+E.+Iacobauthor=T.+J.+D.+J%C3%B8rgensenauthor=I.+A.+Kaltashovauthor=J.+P.+Klinmanauthor=L.+Konermannauthor=P.+Manauthor=L.+Mayneauthor=B.+D.+Pascalauthor=D.+Reichmannauthor=M.+Skehelauthor=J.+Snijderauthor=T.+S.+Strutzenbergauthor=E.+S.+Underbakkeauthor=C.+Wagnerauthor=T.+E.+Walesauthor=B.+T.+Waltersauthor=D.+D.+Weisauthor=D.+J.+Wilsonauthor=P.+L.+Wintrodeauthor=Z.+Zhangauthor=J.+Zhengauthor=D.+C.+Schriemerauthor=K.+D.+Rand&title=Recommendations+for+Performing%2C+Interpreting+and+Reporting+Hydrogen+Deuterium+Exchange+Mass+Spectrometry+%28HDX-MS%29+Experiments&doi=10.1038%2Fs41592-019-0459-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments</span></div><div class="casAuthors">Masson, Glenn R.; Burke, John E.; Ahn, Natalie G.; Anand, Ganesh S.; Borchers, Christoph; Brier, Sebastien; Bou-Assaf, George M.; Engen, John R.; Englander, S. Walter; Faber, Johan; Garlish, Rachel; Griffin, Patrick R.; Gross, Michael L.; Guttman, Miklos; Hamuro, Yoshitomo; Heck, Albert J. R.; Houde, Damian; Iacob, Roxana E.; Joergensen, Thomas J. D.; Kaltashov, Igor A.; Klinman, Judith P.; Konermann, Lars; Man, Petr; Mayne, Leland; Pascal, Bruce D.; Reichmann, Dana; Skehel, Mark; Snijder, Joost; Strutzenberg, Timothy S.; Underbakke, Eric S.; Wagner, Cornelia; Wales, Thomas E.; Walters, Benjamin T.; Weis, David D.; Wilson, Derek J.; Wintrode, Patrick L.; Zhang, Zhongqi; Zheng, Jie; Schriemer, David C.; Rand, Kasper D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">595-602</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Hydrogen deuterium exchange mass spectrometry (HDX-MS) is a powerful biophys. technique being increasingly applied to a wide variety of problems.  As the HDX-MS community continues to grow, adoption of best practices in data collection, anal., presentation and interpretation will greatly enhance the accessibility of this technique to nonspecialists.  Here we provide recommendations arising from community discussions emerging out of the first International Conference on Hydrogen-Exchange Mass Spectrometry (IC-HDX; 2017).  It is meant to represent both a consensus viewpoint and an opportunity to stimulate further addns. and refinements as the field advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnzhV6F6lrLVg90H21EOLACvtfcHk0lii6K71oQkO7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1ykur7K&md5=e25a742a0405d47ec31fbc0a36743261</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fs41592-019-0459-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41592-019-0459-y%26sid%3Dliteratum%253Aachs%26aulast%3DMasson%26aufirst%3DG.%2BR.%26aulast%3DBurke%26aufirst%3DJ.%2BE.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26aulast%3DAnand%26aufirst%3DG.%2BS.%26aulast%3DBorchers%26aufirst%3DC.%26aulast%3DBrier%26aufirst%3DS.%26aulast%3DBou-Assaf%26aufirst%3DG.%2BM.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DEnglander%26aufirst%3DS.%2BW.%26aulast%3DFaber%26aufirst%3DJ.%26aulast%3DGarlish%26aufirst%3DR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DGross%26aufirst%3DM.%2BL.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DHeck%26aufirst%3DA.%2BJ.%2BR.%26aulast%3DHoude%26aufirst%3DD.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DT.%2BJ.%2BD.%26aulast%3DKaltashov%26aufirst%3DI.%2BA.%26aulast%3DKlinman%26aufirst%3DJ.%2BP.%26aulast%3DKonermann%26aufirst%3DL.%26aulast%3DMan%26aufirst%3DP.%26aulast%3DMayne%26aufirst%3DL.%26aulast%3DPascal%26aufirst%3DB.%2BD.%26aulast%3DReichmann%26aufirst%3DD.%26aulast%3DSkehel%26aufirst%3DM.%26aulast%3DSnijder%26aufirst%3DJ.%26aulast%3DStrutzenberg%26aufirst%3DT.%2BS.%26aulast%3DUnderbakke%26aufirst%3DE.%2BS.%26aulast%3DWagner%26aufirst%3DC.%26aulast%3DWales%26aufirst%3DT.%2BE.%26aulast%3DWalters%26aufirst%3DB.%2BT.%26aulast%3DWeis%26aufirst%3DD.%2BD.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DWintrode%26aufirst%3DP.%2BL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DSchriemer%26aufirst%3DD.%2BC.%26aulast%3DRand%26aufirst%3DK.%2BD.%26atitle%3DRecommendations%2520for%2520Performing%252C%2520Interpreting%2520and%2520Reporting%2520Hydrogen%2520Deuterium%2520Exchange%2520Mass%2520Spectrometry%2520%2528HDX-MS%2529%2520Experiments%26jtitle%3DNat.%2520Methods%26date%3D2019%26volume%3D16%26spage%3D595%26epage%3D602%26doi%3D10.1038%2Fs41592-019-0459-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">12257</span>– <span class="NLM_lpage">12261</span>, <span class="refDoi"> DOI: 10.1021/ja9715962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9715962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVCh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=12257-12261&author=P.+J.+Hajdukauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=One-Dimensional+Relaxation-+and+Diffusion-Edited+NMR+Methods+for+Screening+Compounds+That+Bind+to+Macromolecules&doi=10.1021%2Fja9715962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules</span></div><div class="casAuthors">Hajduk, Philip J.; Olejniczak, Edward T.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">12257-12261</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two one-dimensional 1H NMR techniques for efficiently screening libraries of compds. for binding to macromols. are described that exploit the changes in relaxation or diffusion rates of small mols. which occur upon complex formation.  The techniques are demonstrated by detecting ligands that bind to the FK506 binding protein and the catalytic domain of stromelysin in the presence of compds. that do not bind to these proteins.  These one-dimensional methods directly detect complex formation between a ligand and a macromol. and thus eliminate false positives often obsd. with other techniques.  In addn., since these methods rely on the detection of the uncomplexed compd. rather than the bound ligand or macromol., ligands for macromols. of unlimited size can be detected.  Furthermore, active compds. can be directly identified from a mixt., significantly reducing the time and material needed for screening large libraries of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot9O_RpUcMj7Vg90H21EOLACvtfcHk0ljOSsfn1SqMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVCh&md5=bcd34f47e094b408b1de34eca7b01051</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fja9715962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9715962%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DOne-Dimensional%2520Relaxation-%2520and%2520Diffusion-Edited%2520NMR%2520Methods%2520for%2520Screening%2520Compounds%2520That%2520Bind%2520to%2520Macromolecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D12257%26epage%3D12261%26doi%3D10.1021%2Fja9715962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stott, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaka, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stonehouse, J.</span></span> <span> </span><span class="NLM_article-title">Excitation Sculpting in High-Resolution Nuclear Magnetic Resonance Spectroscopy: Application to Selective NOE Experiments</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">4199</span>– <span class="NLM_lpage">4200</span>, <span class="refDoi"> DOI: 10.1021/ja00119a048</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00119a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=4199-4200&author=K.+Stottauthor=J.+Keelerauthor=T.+L.+Hwangauthor=A.+J.+Shakaauthor=J.+Stonehouse&title=Excitation+Sculpting+in+High-Resolution+Nuclear+Magnetic+Resonance+Spectroscopy%3A+Application+to+Selective+NOE+Experiments&doi=10.1021%2Fja00119a048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Excitation Sculpting in High-Resolution Nuclear Magnetic Resonance Spectroscopy: Application to Selective NOE Experiments</span></div><div class="casAuthors">Stott, Katherine; Stonehouse, Jonathan; Keeler, James; Hwang, Tsang-Lin; Shaka, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4199-200</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We propose a method, termed excitation sculpting, for selective excitation in pulsed NMR expts.  The method is applicable to a wide variety of important NMR expts. and has a no. of advantages compared to familiar pulse shaping methods, namely: (i) the phase of the signal is const. over the excitation bandwidth and this bandwidth is easily varied; (ii) there are no out-of-band excitation side lobes; (iii) different net flip angles can be achieved, with no degrdn. of the performance; (i.v.) the excitation profile is very tolerant of inhomogeneity of the radiofrequency field; (v) in the selective excitation of a scalar coupled multiplet, the evolution of the coupling is refocused; and (vi) points (i)-(v) are achieved in a single scan; no phase cycling or difference spectroscopy is needed.  We show that the method can be used to considerable advantage in a one-dimensional expt. to measure transient NOE enhancements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjJByQQsuJWLVg90H21EOLACvtfcHk0ljOSsfn1SqMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVaisrY%253D&md5=aa7ab1883609ebb2ef7d18c126364a30</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fja00119a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00119a048%26sid%3Dliteratum%253Aachs%26aulast%3DStott%26aufirst%3DK.%26aulast%3DKeeler%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DT.%2BL.%26aulast%3DShaka%26aufirst%3DA.%2BJ.%26aulast%3DStonehouse%26aufirst%3DJ.%26atitle%3DExcitation%2520Sculpting%2520in%2520High-Resolution%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%253A%2520Application%2520to%2520Selective%2520NOE%2520Experiments%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D4199%26epage%3D4200%26doi%3D10.1021%2Fja00119a048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindon, J. C.</span></span> <span> </span><span class="NLM_article-title">Improved Watergate Pulse Sequences for Solvent Suppression in NMR Spectroscopy</span>. <i>J. Magn. Reson.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1006/jmre.1998.1405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1006%2Fjmre.1998.1405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFSjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=1998&pages=125-129&author=M.+Liuauthor=X.+A.+Maoauthor=C.+Yeauthor=H.+Huangauthor=J.+K.+Nicholsonauthor=J.+C.+Lindon&title=Improved+Watergate+Pulse+Sequences+for+Solvent+Suppression+in+NMR+Spectroscopy&doi=10.1006%2Fjmre.1998.1405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy</span></div><div class="casAuthors">Liu, Maili; Mao, Xi-An; Ye, Chaohui; Huang, He; Nicholson, Jeremy K.; Lindon, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Magnetic Resonance</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-129</span>CODEN:
                <span class="NLM_cas:coden">JMARF3</span>;
        ISSN:<span class="NLM_cas:issn">1090-7807</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Modifications to the WATERGATE method for removing the solvent resonance from 1H NMR spectra are presented.  In the conventional WATERGATE, a pulse train with three pairs of sym. pulses in the form 3α-τ-9α-τ-19α-τ-19α-τ-9α-τ-3α (designated here W3), where 26α = 180°, was used, while the improved versions use four and five pairs of sym. pulses (designated here W4 and W5), resp.  The modified methods provide narrower noninversion regions and hence enhance the sensitivities of the peaks close to the H2O resonance.  The inversion and suppression profiles of the pulse trains W3, W4, and W5 are compared theor. and exptl. and good agreement was obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprCKgUD2LwjbVg90H21EOLACvtfcHk0ljOSsfn1SqMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFSjsbg%253D&md5=86687bb8536ee190f075defbc4bfffcb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1006%2Fjmre.1998.1405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmre.1998.1405%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DX.%2BA.%26aulast%3DYe%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DNicholson%26aufirst%3DJ.%2BK.%26aulast%3DLindon%26aufirst%3DJ.%2BC.%26atitle%3DImproved%2520Watergate%2520Pulse%2520Sequences%2520for%2520Solvent%2520Suppression%2520in%2520NMR%2520Spectroscopy%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D1998%26volume%3D132%26spage%3D125%26epage%3D129%26doi%3D10.1006%2Fjmre.1998.1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span> <span> </span><span class="NLM_article-title">Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1784</span>– <span class="NLM_lpage">1788</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterization+of+Ligand+Binding+by+Saturation+Transfer+Difference+NMR+Spectroscopy&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1784-1788</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The difference between a satn. transfer spectrum and a normal NMR spectrum provides a new and fast method (satn. transfer difference (STD) NMR spectroscopy) to screen compd. libraries for binding activity to proteins.  STD NMR spectroscopy of mixts. of potential ligands with as little as 1 nmol of protein yields 1D and 2D NMR spectra that exclusively show signals from mols. with binding affinity.  In addn., the ligand's binding epitope is easily identified because ligand residues in direct contact to the protein show much stronger STD signals.  For example, the binding specificity of Lewisb-hexasaccharide to Aleulria aurantia agglutinin (AAA) can be mapped to the two fucosyl residues.  The efficiency of the STD NMR technique is shown by the binding of N-acetylglucosamine (GlcNAc) to wheat germ agglutinin (WGA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8j8HiAqDArVg90H21EOLACvtfcHk0ljOSsfn1SqMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D&md5=03f825af40d22911062112dc6074cf46</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1784%253A%253AAID-ANIE1784%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520Ligand%2520Binding%2520by%2520Saturation%2520Transfer%2520Difference%2520NMR%2520Spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogliatto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockman, B.</span></span> <span> </span><span class="NLM_article-title">WaterLOGSY as a Method for Primary NMR Screening: Practical Aspects and Range of Applicability</span>. <i>J. Biomol. NMR</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1023/A:1013302231549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=10.1023%2FA%3A1013302231549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=11824754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;key=1%3ACAS%3A528%3ADC%252BD38XptVyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=349-359&author=C.+Dalvitauthor=G.+Fogliattoauthor=a.+Stewartauthor=M.+Veronesiauthor=B.+Stockman&title=WaterLOGSY+as+a+Method+for+Primary+NMR+Screening%3A+Practical+Aspects+and+Range+of+Applicability&doi=10.1023%2FA%3A1013302231549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability</span></div><div class="casAuthors">Dalvit, Claudio; Fogliatto, GianPaolo; Stewart, Albert; Veronesi, Marina; Stockman, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">WaterLOGSY represents a powerful method for primary NMR screening in the identification of compds. interacting with macromols., including proteins and DNA or RNA fragments.  Several relay pathways are used constructively in the expt. for transferring bulk water magnetization to the ligand.  The method is particularly useful for the identification of novel scaffolds of micromolar affinity that can be then optimized using directed screening, combinatorial chem., medicinal chem. and structure-based drug design.  The practical aspects and range of applicability of the WaterLOGSY expt. are analyzed in detail here.  Competition binding and titrn. WaterLOGSY permit, after proper correction, the evaluation of the dissocn. binding const.  The high sensitivity of the technique in combination with the easy deconvolution of the mixts. for the identification of the active components, significantly reduces the amt. of material and time needed for the NMR screening process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqqsXXXVX77Vg90H21EOLACvtfcHk0ljhnIS1kQNX6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptVyksw%253D%253D&md5=e7b431d72aa17c499c1e751956605dee</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1023%2FA%3A1013302231549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1013302231549%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DStewart%26aufirst%3Da.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DStockman%26aufirst%3DB.%26atitle%3DWaterLOGSY%2520as%2520a%2520Method%2520for%2520Primary%2520NMR%2520Screening%253A%2520Practical%2520Aspects%2520and%2520Range%2520of%2520Applicability%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2001%26volume%3D21%26spage%3D349%26epage%3D359%26doi%3D10.1023%2FA%3A1013302231549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPJ','PDB','6YPJ'); return false;">PDB: 6YPJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPG','PDB','6YPG'); return false;">PDB: 6YPG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PE1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PE1','PDB','3PE1'); return false;">PDB: 3PE1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPN','PDB','6YPN'); return false;">PDB: 6YPN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPK','PDB','6YPK'); return false;">PDB: 6YPK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CSP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CSP','PDB','5CSP'); return false;">PDB: 5CSP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ORJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ORJ','PDB','5ORJ'); return false;">PDB: 5ORJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EHK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EHK','PDB','6EHK'); return false;">PDB: 6EHK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3W8L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3W8L','PDB','3W8L'); return false;">PDB: 3W8L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQU','PDB','5OQU'); return false;">PDB: 5OQU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MPJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MPJ','PDB','5MPJ'); return false;">PDB: 5MPJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CVH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CVH','PDB','5CVH'); return false;">PDB: 5CVH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YPH','PDB','6YPH'); return false;">PDB: 6YPH</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01173">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54635"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01173?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01173</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HDX data tables (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_001.xlsx">XLSX</a>)</p></li><li><p class="inline">PDB file of compound <b>1</b> modeling (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_002.pdb">PDB</a>)</p></li><li><p class="inline">PDB file of <b>CX4945</b> modeling (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_004.csv">CSV</a>)</p></li><li><p class="inline">Series of proposed allosteric inhibitors of CK2α; position of the proposed allosteric site; comparison of <b>1</b> and <b>CX4945</b> by overlay and modeling; ligand structures and SMILES strings from PDB search; structures of 20 fragments; various binding sites for acetate identified in CK2α from PDB entries; X-ray crystallographic data collection; electron densities for <b>1</b> and <b>2</b> before modeling; ligand electron densities from the PDB validation reports; binding sites on CK2α; binding conformation of ADP; overlay of the compounds; six compounds used as probes in HDX and NMR competition studies; coverage map of overlapping peptides recovered in all HDX experiments; summary of HDX experimental conditions; heatmaps showing changes in deuterium uptake; kinetics of CX4945 binding to CK2α; relaxation-edited (CPMG) <sup>1</sup>H NMR analysis; ITC traces for <b>1</b> and <b>2</b> binding to KKK/AAA; binding site of IP6 for CK2α; HPLC trace and mass spectrometry data (Figures S1–S20) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_001.xlsx">jm0c01173_si_001.xlsx (1.17 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_002.pdb">jm0c01173_si_002.pdb (3.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_003.pdb">jm0c01173_si_003.pdb (4.26 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_004.csv">jm0c01173_si_004.csv (0.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01173/suppl_file/jm0c01173_si_005.pdf">jm0c01173_si_005.pdf (2.86 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01173&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01173%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-21" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01173" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bdf6d8fd196f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
